# EDGAR Filing Document

**Accession Number:** 0001437424
**File Stem:** 0001493152-26-014253
**Filing Date:** 2026-3
**Character Count:** 560231
**Document Hash:** a8492142e1f8c3f05d22475620fdb214
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-014253.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001493152-26-014253

**CONFORMED SUBMISSION TYPE**: 20-F

**PUBLIC DOCUMENT COUNT**: 300

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** POET TECHNOLOGIES INC.
- **CENTRAL INDEX KEY:** 0001437424
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6

**FILING VALUES:**
- **FORM TYPE:** 20-F
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41319
- **FILM NUMBER:** 26822863

**BUSINESS ADDRESS:**
- **STREET 1:** 120 EGLINTON AVENUE EAST
- **STREET 2:** SUITE 1107
- **CITY:** TORONTO, ONTARIO
- **STATE:** A6
- **ZIP:** M4P 1E2
- **BUSINESS PHONE:** 401-338-1212

**MAIL ADDRESS:**
- **STREET 1:** 120 EGLINTON AVENUE EAST
- **STREET 2:** SUITE 1107
- **CITY:** TORONTO, ONTARIO
- **STATE:** A6
- **ZIP:** M4P 1E2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** OPEL INTERNATIONAL INC
- **DATE OF NAME CHANGE:** 20080611

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 20-F**

(Mark One)

☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

&nbsp;&nbsp;&nbsp;&nbsp;☒ ANNUAL
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For
 the fiscal year ended December 31 , 2025

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report

For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to

Commission file number: 001-41319

**POET TECHNOLOGIES INC.**

(Exact name of Registrant as specified in its charter)

Ontario, Canada

(Jurisdiction of incorporation or organization)

1107 – 120 Eglinton Avenue East

Toronto, Ontario, M4P 1E2, Canada

(Address of principal executive offices)

Suresh Venkatesan, CEO

1107 – 120 Eglinton Avenue East

Toronto, Ontario, M4P 1E2, Canada

Telephone No.: 416 368 9411

Email: svv@poet-technologies.com

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Shares, no par value | POET | Nasdaq Capital Market |

---

Securities registered or to be registered pursuant to Section 12(g) of the Act: None.

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None.

Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.

132,290,739 Common Shares, no par value

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Emerging growth company ☐

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S GAAP ☐ International Financial Reporting Standards as issued by the International Accounting Standards Board ☒ Other ☐

If "Other" has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

☐ Item 17 ☐ Item 18

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes No ☒

POET TECHNOLOGIES INC.

FORM 20-F ANNUAL REPORT

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | Page |
| [Introduction](#sa_001) | [Introduction](#sa_001) | 1 |
| [PART I](#sa_002) | [PART I](#sa_002) | [PART I](#sa_002) |
| Item 1. | [Identity of Directors, Senior Management and Advisers](#sa_009) | 4 |
| Item 2. | [Offer Statistics and Expected Timetable](#sa_003) | 4 |
| Item 3. | [Key Information](#sa_004) | 4 |
| Item 4. | [Information on the Company](#sa_005) | 18 |
| Item 4A. | [Unresolved Staff Comments](#sa_006) | 26 |
| Item 5. | [Operating and Financial Review and Prospects](#sa_007) | 26 |
| Item 6. | [Directors, Senior Management and Employees](#sa_008) | 34 |
| Item 7. | [Major Shareholders and Related Party Transactions](#rma_025) | 52 |
| Item 8. | [Financial Information](#rma_026) | 53 |
| Item 9. | [The Offer and Listing](#rma_001) | 53 |
| Item 10. | [Additional Information](#rma_002) | 54 |
| Item 11. | [Quantitative and Qualitative Disclosures About Market Risk](#rma_003) | 63 |
| Item 12. | [Description of Securities Other than Equity Securities](#rma_004) | 64 |
| [PART II](#rma_005) | [PART II](#rma_005) | [PART II](#rma_005) |
| Item 13. | [Defaults, Dividend Arrearages and Delinquencies](#rma_006) | 65 |
| Item 14. | [Material Modifications to the Rights of Security Holders and Use of Proceeds](#rma_007) | 65 |
| Item 15. | [Controls and Procedures](#rma_008) | 65 |
| Item 16. | [Reserved](#rma_009) | 66 |
| Item 16A. | [Audit committee financial expert](#rma_010) | 66 |
| Item 16B. | [Code of Ethics](#rma_011) | 66 |
| Item 16C. | [Principal Accounting Fees and Services](#rma_012) | 67 |
| Item 16D. | [Exemptions from the Listing Standards for Audit Committees](#rma_013) | 67 |
| Item 16E. | [Purchases of Equity Securities by the Issuer and Affiliated Purchasers](#rma_014) | 67 |
| Item 16F. | [Change in Registrant's Certifying Accountant](#rma_015) | 67 |
| Item 16G. | [Corporate Governance](#rma_016) | 68 |
| Item 16H. | [Mine Safety Disclosure](#rma_017) | 68 |
| Item 16I. | [Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#rma_018) | 68 |
| Item 16J. | [Insider Trading Policies](#rma_019) | 68 |
| Item 16K. | [Cybersecurity](#rma_020) | 69 |
| [PART III](#rma_021) | [PART III](#rma_021) | [PART III](#rma_021) |
| Item 17. | [Financial Statements](#rma_022) | 70 |
| Item 18. | [Financial Statements](#rma_023) | 70 |
| Item 19. | [Exhibits](#rma_024) | 70 |

---

INTRODUCTION

POET Technologies Inc. is organized under the Business Corporations Act (Ontario). In this Annual Report on Form 20-F (the "Annual Report"), the "Company", "we", "our", "POET" and "us" refer to POET Technologies Inc. and its subsidiaries (unless the context otherwise requires). We refer you to the documents attached as exhibits hereto for more complete information than may be contained in this Annual Report. Our principal Canadian corporate offices are located at Suite 1107, 120 Eglinton Avenue East, Toronto, Ontario M4P 1E2, Canada. Our telephone number in Toronto is (416) 368-9411.

We file reports and other information with the United States Securities and Exchange Commission ("SEC") located at 100 F Street NE, Washington, D.C. 20549. You may obtain copies of our filings with the SEC by accessing their website located at www.sec.gov. We also file reports under Canadian regulatory requirements on SEDAR+. you may access our reports filed on SEDAR+ by accessing the website www.sedarplus.ca.

This Annual Report (including the consolidated audited financial statements for the years ended December 31, 2025, 2024 and 2023 attached thereto, together with the auditors' report thereon), and the exhibits thereto shall be deemed to be incorporated by reference as exhibits to (1) the registration statement on Form F-3 (File N. 333-292868), filed by the Company with the SEC on January 22, 2026 (the "Shelf Registration Statement"), (2) the registration statement on Form F-3 (File No. 333-291848), filed by the Company with the SEC on November 28, 2025, (3) the registration statement on Form S-8 (File No. 333-290470), filed by the Company with the SEC on September 23, 2025, (4) the registration statement on Form F-10 (File No. 333-280553), filed by the Company with the SEC on June 28, 2024, as amended by Amendment No. 1 thereto filed with the SEC on September 9, 2024 and (5) the registration statement on Form F-3 (File No. 333-273853) filed by the Company with the SEC on August 9, 2023, and to be a part thereof from the date on which this report was filed, in each case, to the extent not superseded by documents or reports subsequently filed or furnished.

Business of POET Technologies Inc.

The Company is incorporated under the laws of the Province of Ontario. The Company's shares trade under the symbol "POET" on the Nasdaq Capital Market ("Nasdaq") in the U.S.

POET Technologies is a design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photonic devices onto a single chip using advanced wafer-level semiconductor manufacturing techniques. The semiconductor industry has adopted the term "Wafer-Level Chip-Scale Packaging" (or "WLCSP") to describe similar approaches within the semiconductor industry. POET's Optical Interposer eliminates costly components and labor-intensive assembly, alignment, and testing methods employed in conventional photonics. We believe the cost-efficient integration scheme and scalability of the POET Optical Interposer brings value to devices or systems that integrate electronics and photonics, including high-growth areas of communications and computing. The emergence of Artificial Intelligence (AI) systems over the past few years has placed extraordinary demands on cloud-based AI service providers and hyperscale data centers for increases in network speeds and bandwidth and decreases in latency. We believe that chip-scale integration is essential to developing hardware that can meet such demands and that POET is on the forefront of providing scalable solutions for current and future AI systems.

POET targeted as the first application of the Optical Interposer the development of optical engines for optical transceivers used in internet data centers. Optical Engines include all the passive and active components related to the production, manipulation, and detection of light within an Optical Transceiver. Optical Transceivers plug into switches and servers within the data center and allow these network devices to send and receive data over fiber-optic cables. We chose this market because it is large in size, has established standards for device performance, and the unit volumes of devices shipped annually are exceptionally high. It is a market in which our advantages of chip-scale integration, power consumption and ability to scale rapidly allow us to be competitive with other suppliers.

The rapid growth of AI software systems represents a profound opportunity for POET. We believe that the rapid growth of software services, including large language models and agents, can only be sustained with hardware that meets the challenges of increasing speed and bandwidth, lower latency, lower power consumption, lower cost, and the ability to scale to the volumes that will be required by data centers globally. POET meets these challenges in two ways: first, by providing to the makers of pluggable optical transceiver modules fully-integrated, chip-scale Optical Engines that perform at the levels that are now being deployed in the most advanced AI clusters at speeds of 800Gbs (gigabits per second) and 1.6 Tbs (terabits per second); and second, by offering unique, proprietary Light Source products based on our Optical Interposer technology that address newly emerging architectures in data centers that are based on chip-to-chip data transfer using light, rather than electrons. The combination of POET's focus on leading-edge Optical Transceivers and Light Source products for next generation data center architectures essentially places POET among a small number of suppliers globally that are truly "pure play" AI hardware companies.

Net loss for the year ended December 31, 2025 was $62,963,213. The net loss included $18,084,303 incurred for research and development activities directly related to the development and commercialization of the POET Optical Interposer and POET Optical Engine products. Research and development included non-cash costs of $2,216,914 related to stock-based compensation. $25,081,957 was incurred for selling, marketing and administration expenses which included non-cash costs of $3,890,138 related to stock-based compensation and $3,315,899 related to depreciation and amortization.

The Company incurred $144,046 in interest costs, all of which was non-cash. Additionally, non-cash costs of $25,280,833 were incurred as fair value adjustment to the derivative warrant liability.

Total non-cash operating costs were approximately $35,000,000.

The Company's statement of financial position as of December 31, 2025 reflects assets with a book value of $328,572,438 compared to $69,652,449 as of December 31, 2024. Ninety six percent (96%) of the book value at December 31, 2025 was in current assets consisting primarily of cash, cash equivalents and short-term investments of $313,398,303 compared to eighty (80%) of the book value as of December 31, 2024, which consisted primarily of cash and cash equivalents of $53,816,570.

Financial and Other Information

In this Annual Report, unless otherwise specified, all dollar amounts are expressed in United States Dollars ("US$", "USD" or "$").

Market and Industry Information

This Annual Report includes market and industry data and forecasts that the Company has derived from publicly available information, industry publications and other industry sources, the Company's internal data and estimates and assumptions made by the Company based on such sources. Industry publications and other published industry sources generally indicate that the information contained therein was obtained from sources believed to be reliable. Although the Company believes that these third-party sources are reliable, neither the Company nor any of its affiliates or representatives guarantees the accuracy or completeness of this information, and neither the Company nor any of its affiliates or representatives has independently verified this information.

Cautionary Statements Regarding Forward-Looking Statements

This Annual Report on Form 20-F and other publicly available documents, including the documents incorporated herein and therein by reference contain forward-looking statements and forward-looking information within the meaning of U.S. and Canadian securities laws, respectively (collectively, "forward-looking statements"). Forward-looking statements can generally be identified by the use of forward- looking terminology or words, such as, "continues", "with a view to", "is designed to", "pending", "predict", "potential", "plans", "expects", "anticipates", "believes", "intends", "estimates", "projects", and similar expressions or variations thereon, or statements that events, conditions or results "can", "might", "will", "shall", "may", "must", "would", "could", or "should" occur or be achieved and similar expressions in connection with any discussion, expectation, or projection of future operating or financial performance, events or trends. Forward-looking statements are based on management's current expectations and assumptions, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict.

Our actual results, performance and achievements may differ materially from those expressed in, or implied by, the forward-looking statements in this Annual Report as a result of various risks, uncertainties and other factors, many of which are difficult to predict and generally beyond the control of the Company, including without limitation:

○ we have a limited operating history;

○ our need for additional financing, which may not be available on acceptable terms or at all;

○ the possibility that we will not be able to compete in the highly competitive semiconductor market;

○ the risk that our objectives will not be met within the timelines we expect or at all;

○ research and development risks;

○ the risks associated with successfully protecting patents and trademarks and other intellectual property;

○ the need to control costs and the possibility of unanticipated expenses;

○ manufacturing and development risks;

○ the risk that the price of our common shares will be volatile;

○ the risk that geopolitical uncertainties may negatively impact our business ventures in Asia;

○ the risk that shareholders' interests will be diluted through future stock offerings, option and warrant exercises; and

○ other risks and uncertainties described in Item 3.D. "Risk Factors".

For all of the reasons set forth above, investors should not place undue reliance on forward-looking statements. Other than any obligation to disclose material information under applicable securities laws or otherwise as maybe required by law, we undertake no obligation to revise or update any forward-looking statements after the date hereof.

Data relevant to estimated market sizes for our technologies under development are presented in this Annual Report. These data have been obtained from a variety of published resources including published scientific literature, websites and information generally available through publicized means. The Company attempts to source reference data from multiple sources whenever possible for confirmatory purposes. However, the Company has not independently verified the accuracy and completeness of this data.

**PART I**

**Item 1. Identity of Directors, Senior Management and Advisers**

Not required.

**Item 2. Offer Statistics and Expected Timetable**

Not required.

**Item 3. Key Information**

**A.** **[Reserved]** 

**B.**  ***Capitalization and Indebtedness.*** 

Not required.

**C.**  ***Reasons for the Offer and Use of Proceeds.*** 

Not required.

**D.**  ***Risk Factors*** .

We are subject to various risks, including those described below, which could materially adversely affect our business, financial condition and results of operations and, in turn, the value of our securities. In addition, other risks not presently known to us or that we currently believe to be immaterial may also adversely affect our business, financial condition and results of operations, perhaps materially. The risks discussed below also include forward-looking statements that involve risks and uncertainties. The Company's actual results may differ materially from the results discussed in the forward-looking statements and information Factors that might cause such differences include those discussed. Before making an investment decision with respect to any of our securities, you should carefully consider the following risks and uncertainties described below and elsewhere in this Annual Report. See also "Cautionary Statement Regarding Forward-Looking Statements."

Risks Related to Our Business

***We have a history of large operating losses. We may not be able to achieve or sustain profitability in the future and as a result we may not be able to maintain sufficient levels of liquidity.***

We have historically incurred losses and negative cash flows from operations since our inception. As of December 31, 2025, we had an accumulated deficit of approximately $297,000,000.

As of December 31, 2025, we held $313,398,303 in cash, cash equivalents and short-term investments. We had working capital of $170,708,559. The working capital includes non-cash current liabilities of $135,631,585 related to derivative warrant liability and $5,800,000 in convertible debt which will be paid over a period of four years, however, the holder has the right to convert any unpaid amount into shares of the Company at its discretion and it is therefore classified as current.

***We have engaged in, and in the future may engage in, strategic transactions, investments and other arrangements that could disrupt our business, cause dilution to our shareholders, reduce our financial resources and harm our operating results.***

We have previously engaged in strategic transactions, and, in the future, we may pursue opportunities to engage in additional strategic transactions, including transactions with companies in financial distress. Our ability to grow through future transactions will depend on the availability of, and our ability to identify, suitable acquisition and investment opportunities at an acceptable cost, our ability to compete effectively to attract those opportunities and the availability of cash or financing to complete such acquisitions. Future acquisitions may require us to (i) issue common shares that would dilute our current shareholders' percentage ownership, (ii) assume or otherwise be subject to liabilities of an acquired company, (iii) record goodwill and non-amortizable intangible assets that will be subject to impairment testing on a regular basis and potential periodic impairment charges, (iv) incur amortization expenses related to certain intangible assets, and (v) incur acquisition and integration costs. Although we and our advisors conduct due diligence on the operations of the businesses we acquire, there can be no guarantee that we will be aware of all liabilities associated with an acquired company. These liabilities, and any additional risks and uncertainties related to an acquired company not known to us or that we may deem immaterial or unlikely to occur at the time of the acquisition, could negatively impact our future business, financial condition, and results of operations.

There is no guarantee that we will realize the intended benefits of any particular acquisition in a timely manner, to the extent anticipated or at all. We may experience difficulties integrating the operations, technologies and personnel of an acquired company, including difficulties associated with managing the resulting larger and more complex company, aligning administrative and corporate structures, standards, controls, procedures and policies, integrating business cultures, hiring and retaining key employees, conforming compensation and benefits structures, coordinating geographically dispersed operations, and delivering on our strategy going forward. Such integration may divert management's attention from operating our business and may necessitate reallocating resources, both financially and otherwise.

***The process of developing new, technologically advanced photonic products using semiconductor processing techniques is highly complex and uncertain, and we cannot guarantee a positive result.***

The development of new, technologically advanced products is a complex and uncertain process requiring frequent innovation, highly-skilled engineering and development personnel and significant capital, as well as the accurate anticipation of technological and market trends. We cannot assure you that we will be able to identify, develop, manufacture, market or support new or enhanced products successfully or on a timely basis. Further, we cannot assure you that our new products will gain market acceptance or that we will be able to respond effectively to product introductions by competitors, technological changes or emerging industry standards. We also may not be able to develop the underlying core technologies necessary to create new products and enhancements, license these technologies from third parties, or remain competitive in our markets.

***The optical data communications industry in which we have chosen to operate is subject to significant risks, including rapid growth and volatility, dependence on rapidly changing underling technologies, market and political risks and uncertainties and extreme competition. We cannot guarantee that we will be able to anticipate or overcome any or all of these risks and uncertainties, especially as a relatively small company operating in an environment dominated by large, well-capitalized competitors with substantially more resources.***

The optical data communications industry is subject to significant operational fluctuations. In order to remain competitive, we incur substantial costs associated with research and development, qualification, prototype production capacity and sales and marketing activities in connection with products that may be purchased, if at all, long after we have incurred such costs. In addition, the rapidly changing industry in which we operate, the length of time between developing and introducing a product to market, frequent changing customer specifications for products, customer cancellations of products and general down cycles in the industry, among other things, make our prospects difficult to evaluate. As a result of these factors, it is possible that we may not (i) generate sufficient positive cash flow from operations; (ii) raise funds through the issuance of equity, equity-linked or convertible debt securities; or (iii) otherwise have sufficient capital resources to meet our future capital or liquidity needs. There are no guarantees we will be able to generate additional financial resources beyond our existing balances.

***Investors may not be able to obtain enforcement of civil liabilities against the Company.***

The Company has subsidiaries incorporated in the U.S., Singapore, China and Malaysia. Certain directors and officers reside outside of Canada, and substantially all of the assets of these persons are located outside of Canada. It may not be possible for Investors to effect service of process against the Company's directors, officers and subsidiaries who are not resident or located in Canada. In the event a judgment is obtained in a Canadian court against one or more of the Company's directors or officers for violations of Canadian securities laws or otherwise, it may not be possible to enforce such judgment against those directors and officers not resident in Canada. Additionally, it may be difficult for an investor, or any other person or entity, to assert Canadian securities law claims or otherwise in original actions instituted in the jurisdictions where the Company's subsidiaries are located. Courts in these jurisdictions may refuse to hear a claim based on a violation of Canadian securities laws or otherwise on the grounds that such jurisdiction is not the most appropriate forum to bring such a claim. Even if a foreign court agrees to hear a claim, it may determine that the local law, and not Canadian law, is applicable to the claim. If Canadian law is found to be applicable, the content of applicable Canadian law must be proven as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by foreign law. In addition, the enforcement by investors of civil liabilities under the U.S. federal or state securities laws may be adversely affected by the fact that several of the Company's officers and directors reside outside of the U.S. and that all, or a substantial portion, of their assets and a portion of our assets, are located outside the U.S. It may not be possible for an investor to effect service of process within the U.S. on, or enforce judgments obtained in the U.S. courts against, us, certain of our subsidiaries or certain of our directors and officers based upon the civil liability provisions of U.S. federal securities laws or the securities laws of any state of the U.S. In light of the above, there is doubt as to whether a judgment of a U.S. court based solely upon the civil liability provisions of U.S. federal or state securities laws would be enforceable against the Company, certain of its subsidiaries or the Company's directors and officers.

There is doubt as to whether a judgment of a United States court based solely upon the civil liability provisions of United States federal or state securities laws would be enforceable in Canada against the Company or the Company's directors and officers. There is also doubt as to whether an original action could be brought in Canada against the Company or the Company's directors and officers to enforce liabilities based solely upon United States federal or state securities laws.

***If our customers do not qualify our products for use on a timely basis, our results of operations may suffer.***

Prior to the sale of new products, our customers typically require us to "qualify" our products for use in their applications. At the successful completion of this qualification process, we refer to the resulting sales opportunity as a "design win." Additionally, new customers often audit our manufacturing facilities and perform other evaluations during this qualification process. The qualification process involves product sampling and reliability testing and collaboration with our product management and engineering teams in the design and manufacturing stages. If we are unable to accurately predict the amount of time required to qualify our products with customers, or are unable to qualify our products with certain customers at all, then our ability to generate revenue could be delayed or our revenue would be lower than expected and we may not be able to recover the costs associated with the qualification process or with our product development efforts, which would have an adverse effect on our results of operations.

***We have limited operating history in the data center market, and our business could be harmed if this market does not develop as we expect.***

The current target market for our Optical Interposer-based optical engines and light source products is the data center market for data communications within the data center and beyond. We have limited experience in selling products in this market. We may not be successful in developing a product for this market and even if we do, it may never gain widespread acceptance by large data center operators. If our expectations for the growth of the data center / datacom market are not realized, our financial condition or results of operations may be adversely affected.

***Customer demand is difficult to forecast accurately and, as a result, we may be unable to match production with customer demand.***

We make planning and spending decisions, including determining the levels of business that we will seek and accept, production schedules, component procurement commitments, personnel needs and other resource requirements, based on our estimates of product demand and customer requirements. Our products are typically sold pursuant to individual purchase orders. While our customers may provide us with their demand forecasts, they are typically not contractually committed to buy any quantity of products beyond firm purchase orders. Furthermore, many of our customers may increase, decrease, cancel or delay purchase orders already in place without significant penalty. The short-term nature of commitments by our expected customers and the possibility of unexpected changes in demand for their products reduce our ability to accurately estimate future customer requirements. If any of our customers decrease, stop or delay purchasing our products for any reason, we will likely have excess manufacturing capacity or inventory, and our business and results of operations would be harmed.

***The markets in which we operate are highly competitive, which could result in lost sales and lower revenues.***

The market for optical components and modules is highly competitive, and this competition could result in our existing customers moving their orders to our competitors. We are aware of a number of companies that have developed or are developing integrated optical products, including silicon photonics engines, remote light sources, pluggable components, modules and subsystems, photonic integrated circuits, among others, that compete (or may in the future compete) directly with our current and proposed product offerings.

Some of our current competitors, as well as some of our potential competitors, have longer operating histories, greater name recognition, broader customer relationships and industry alliances and substantially greater financial, technical and marketing resources than we do. We may not be able to compete successfully with our competitors and aggressive competition in the market may result in lower prices for our products and/or decreased gross margins. Any such development could have a material adverse effect on our business, financial condition and results of operations.

***We depend on a limited number of suppliers and key contract manufacturers who could disrupt our business and technology development activities if they stopped, decreased, delayed or were unable to meet our demand for shipments of their products or manufacturing of our products.***

We depend on a limited number of suppliers of wafers and components for our integrated photonic solutions, and on contract manufacturers for our optical interposer production activities. Some of these suppliers are sole source suppliers. We typically have not entered into long-term agreements with our suppliers. As a result, these suppliers generally may stop supplying us materials and other components at any time. Our reliance on a sole supplier or limited number of suppliers could result in delivery problems, reduced control over technology development, product development, pricing and quality, and an inability to identify and qualify another supplier in a timely manner. Some of our suppliers that may be small or under-capitalized may experience financial difficulties that could prevent them from supplying us materials and other components. In addition, our suppliers, including our sole source suppliers, may experience manufacturing delays or shutdowns due to circumstances beyond their control such as pandemics, earthquakes, floods, fires, labor unrest, political unrest or other natural disasters. A change in supplier could require technology transfer that could require multiple iterations of test wafers. This could result in significant delays in resumption of production.

Any supply deficiencies relating to the quality or quantities of materials or equipment we use to manufacture our products could materially and adversely affect our ability to fulfill customer orders and our results of operations. Lead times for the purchase of certain materials, components and equipment from suppliers have increased and, in some cases, have limited our ability to rapidly respond to increased demand, and may continue to do so in the future. To the extent we introduce additional contract manufacturing partners, introduce new products with new partners and/or move existing internal or external production lines to new partners, we could experience supply disruptions during the transition process. In addition, due to our customers' requirements relating to the qualification of our suppliers and contract manufacturing facilities and operations, we cannot quickly enter into alternative supplier relationships, which prevent us from being able to respond immediately to adverse events affecting our suppliers.

***Our international business and operations expose us to additional risks.***

We have significant tangible assets located outside Canada and the United States. Conducting business outside Canada and the United States subjects us to a number of additional risks and challenges, including:

● periodic changes in a specific country's or region's economic conditions, such as recession;

● licenses, tariffs and other trade barriers;

● the provision of services may require export licenses;

● environmental regulations;

● certification requirements;

● fluctuations in foreign currency exchange rates;

● inadequate protection of intellectual property rights in some countries;

● preferences of certain customers for locally produced products;

● potential political, legal and economic instability, foreign conflicts, and the impact of regional and global infectious illnesses in the countries in which we and our customers, suppliers and contract manufacturers are located;

● Canadian and U. S. and foreign anticorruption laws;

● seasonal reductions in business activities in certain countries or regions; and

● fluctuations in freight rates and transportation disruptions.

These factors, individually or in combination, could impair our ability to effectively operate one or more of our foreign facilities or deliver our products, result in unexpected and material expenses, or cause an unexpected decline in the demand for our products in certain countries or regions. Our failure to manage the risks and challenges associated with our international business and operations could have a material adverse effect on our business.

***If we fail to attract and retain key personnel, our business could suffer.***

Our future success depends, in large part, on our ability to attract and retain key personnel, including executive management. Competition for highly skilled technical and management personnel is extremely intense and we may face difficulty identifying and hiring qualified engineers and managers in many areas of our business. We may not be able to hire and retain such personnel at compensation levels consistent with our existing compensation and salary structure. Our future success also depends on the continued contributions of our executive management team and other key management and technical personnel, each of whom would be difficult to replace. The loss of services of these or other executive officers or key personnel or the inability to continue to attract qualified personnel could have a material adverse effect on our business.

***If we fail to protect, or incur significant costs in defending, our intellectual property and other proprietary rights, our business and results of operations could be materially harmed.***

Our success depends on our ability to protect our intellectual property and other proprietary rights. We rely on a combination of patent, trademark, copyright, trade secret and unfair competition laws, as well as license agreements and other contractual provisions, to establish and protect our intellectual property and other proprietary rights. We have applied for patent registrations in the U.S. and in foreign countries, some of which have been issued. We cannot guarantee that our pending applications will be approved by the applicable governmental authorities. Moreover, our existing and future patents and trademarks may not be sufficiently broad to protect our proprietary rights or may be held invalid or unenforceable in court. A failure to obtain patents or trademark registrations or a successful challenge to our registrations in the U.S. or foreign countries may limit our ability to protect the intellectual property rights that these applications and registrations intended to cover.

Policing unauthorized use of our technology is difficult and we cannot be certain that the steps we have taken will prevent the misappropriation, unauthorized use or other infringement of our intellectual property rights. Further, we may not be able to effectively protect our intellectual property rights from misappropriation or other infringement in foreign countries where we have not applied for patent protections, and where effective patent, trademark, trade secret and other intellectual property laws may be unavailable or may not protect our proprietary rights as fully as Canadian or U.S. law. We may seek to secure comparable intellectual property protections in other countries. However, the level of protection afforded by patent and other laws in other countries may not be comparable to that afforded in Canada and the U.S.

We also attempt to protect our intellectual property, including our trade secrets and know-how, through the use of trade secret and other intellectual property laws, and contractual provisions. We enter into confidentiality and invention assignment agreements with our employees and independent consultants. We also use non-disclosure agreements with other third parties who may have access to our proprietary technologies and information. Such measures, however, provide only limited protection, and there can be no assurance that our confidentiality and non-disclosure agreements will not be breached, especially after our employees end their employment, and that our trade secrets will not otherwise become known by competitors or that we will have adequate remedies in the event of unauthorized use or disclosure of proprietary information. Unauthorized third parties may try to copy or reverse engineer our products or portions of our products, otherwise obtain and use our intellectual property, or may independently develop similar or equivalent trade secrets or know-how. If we fail to protect our intellectual property and other proprietary rights, or if such intellectual property and proprietary rights are infringed or misappropriated, our business, results of operations or financial condition could be materially harmed.

In the future, we may need to take legal actions to prevent third parties from infringing upon or misappropriating our intellectual property or from otherwise gaining access to our technology. Protecting and enforcing our intellectual property rights and determining their validity and scope could result in significant litigation costs and require significant time and attention from our technical and management personnel, which could significantly harm our business. We may not prevail in such proceedings, and an adverse outcome may adversely impact our competitive advantage or otherwise harm our financial condition and our business.

***We may be involved in intellectual property disputes in the future, which could divert management's attention, cause us to incur significant costs and prevent us from selling or using the challenged technology.***

Participants in the markets in which we sell our products have experienced frequent litigation regarding patent and other intellectual property rights. There can be no assurance that third parties will not assert infringement claims against us, and we cannot be certain that our products would not be found infringing on the intellectual property rights of others. Regardless of their merit, responding to such claims can be time consuming, divert management's attention and resources and may cause us to incur significant expenses. Intellectual property claims against us could result in a requirement to license technology from others, discontinue manufacturing or selling the infringing products, or pay substantial monetary damages, each of could result in a substantial reduction in our revenue and could result in losses over an extended period of time.

***If we fail to obtain the right to use the intellectual property rights of others that are necessary to operate our business, and to protect their intellectual property, our business and results of operations will be adversely affected.***

From time to time, we may choose to or be required to license technology or intellectual property from third parties in connection with the development of our products. We cannot assure you that third party licenses will be available to us on commercially reasonable terms, if at all. Generally, a license, if granted, would include payments of up-front fees, ongoing royalties or both. These payments or other terms could have a significant adverse impact on our results of operations. Our inability to obtain a necessary third-party license required for our product offerings or to develop new products and product enhancements could require us to substitute technology of lower quality or performance standards, or of greater cost, either of which could adversely affect our business. If we are not able to obtain licenses from third parties, if necessary, then we may also be subject to litigation to defend against infringement claims from these third parties. Our competitors may be able to obtain licenses or cross-license their technology on better terms than we can, which could put us at a competitive disadvantage.

***Failure to comply with requirements to design, implement and maintain effective internal control over financial reporting could have a materially adverse impact on our financial reporting and our business. We are required to have our internal controls over financial reporting audited under Section 404(b) of the Sarbanes-Oxley Act.***

Preparing our consolidated financial statements involves a number of complex manual and automated processes, which are dependent upon individual data input or review and require significant management judgment. One or more of these elements may result in errors that may not be detected and could result in a material misstatement of our consolidated financial statements. The Sarbanes-Oxley Act in the U.S. requires, among other things, that as a publicly traded company we disclose whether our internal control over financial reporting and disclosure controls and procedures are effective. Until December 31, 2021 we qualified as an "emerging growth company" under the JOBS Act, and, as a result, were exempted from certain SEC reporting requirements, including those requiring registrants to include an auditor's report regarding the Company's internal controls as part of such registrant's periodic reports. Our "emerging growth company" status expired on December 31, 2021. The report of our auditors regarding the effectiveness of our internal controls over disclosure and financial reporting as of December 31, 2025 is attached as an exhibit to this annual report.

Our internal control over financial reporting cannot guarantee that no accounting errors exist or that all accounting errors, no matter how immaterial, will be detected because a control system, no matter how well designed and operated, can provide only reasonable, but not absolute assurance that the control system's objectives will be met. If we are unable to implement and maintain effective internal control over financial reporting, our ability to accurately and timely report our financial results could be adversely impacted. This could result in late filings of our annual and quarterly reports under the *Securities Act* (Ontario) and the Securities Exchange Act of 1934 (the "Exchange Act"), restatements of our consolidated financial statements, a decline in our stock price, suspension or delisting of our common shares by Nasdaq, or other material adverse effects on our business, reputation, results of operations or financial condition.

The process of designing and implementing effective internal control over financial reporting is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to expend significant resources to maintain a system of internal control that is adequate to satisfy our reporting obligations as a public company. In addition, we are required, pursuant to Section 404(a) of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting. This assessment must include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing and possible remediation. Testing and maintaining our internal control over financial reporting may divert our management's attention from other matters that are important to our business. In connection with the implementation of the necessary procedures and practices related to our internal control over financial reporting, we and/or our independent registered accounting firm may identify material weaknesses and other deficiencies that may require significant effort and expense to remediate. We may encounter problems or delays in completing the remediation of any such weaknesses or other deficiencies.

If there is a change in conditions, or the degree of compliance with policies or procedure deteriorates, internal review of our internal control over financial reporting or the subsequent testing by our independent registered public accounting firm may reveal deficiencies in our internal control over financial reporting that are deemed material weaknesses. If this occurs, our consolidated financial statements or disclosures may contain material misstatements and we could be required to restate our financial results. Additionally, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting or our independent registered public accounting firm may not in future issue an unqualified opinion, each of which could lead to investors losing confidence in our reported financial information, which could have a material adverse effect on the trading price of our common shares, and we may be unable to maintain compliance with applicable stock exchange listing requirements.

 ****

***We may not be able to obtain additional capital if and when desired, on favorable terms or at all.***

We operate in a market that makes the likelihood of our success difficult to evaluate and, to remain competitive, we will be required to make continued investments in capital equipment, facilities and technology. Additional capital may be required to continue technology and product development, to expand our contract manufacturing capacity if we need to do so and to fund working capital for anticipated growth. If we do not generate sufficient cash flow from operations or otherwise have the capital resources to meet our future capital needs, we may need additional financing to implement our business strategy.

The Company may need to raise additional capital in the future to fund more rapid expansion, respond to competitive pressures, acquire complementary businesses or technologies or take advantage of unanticipated opportunities, and it may seek to do so through public or private financing, strategic relationships or other arrangements. The ability of the Company to secure any such financing will depend in part upon prevailing capital market conditions and business success. There can be no assurance that the Company will be successful in its efforts to secure any additional financing on terms satisfactory to management or at all. Even if such funding is available, the Company cannot predict the size of future issues of common shares or securities convertible into common shares or the effect, if any, that any future issues and sales of common shares may have on the price of the Company's common shares.

If the Company raises additional capital through the issuance of equity securities, the percentage ownership of the Company's existing shareholders may be reduced, and such existing shareholders may experience additional dilution in net book value per share. Any such newly issued equity securities may also have rights, preferences or privileges senior to those of the holders of the common shares. If additional funds are raised through the incurrence of indebtedness, such indebtedness may involve restrictive covenants that impair the ability of the Company to pursue its growth strategy and other aspects of its business plan, expose the Company to greater interest rate risk and volatility, require the Company to dedicate a substantial portion of its cash flow from operations to payments on its indebtedness, thereby reducing the availability of its cash flow to fund working capital and capital expenditures, increase the Company's vulnerability to general adverse economic and industry conditions, place the Company at a competitive disadvantage compared to its competitors that have less debt, limit the Company's ability to borrow additional funds, and heighten the possible effects of the other risks discussed *i*n these risk factors. In connection with any such future capital raising transaction, whether involving the issuance of equity securities or the incurrence of indebtedness, the Company may be required to accept terms that restrict its ability to raise additional capital for a period of time, which may limit or prevent the Company from raising capital at times when it would otherwise be opportunistic to do so.

***Our ability to use our net operating losses and certain other tax attributes may be limited.***

As of December 31, 2025, we had accumulated net operating losses ("NOLs"), of approximately $180 million. Varying jurisdictional tax codes have restrictions on the use of NOLs, if a corporation undergoes an "ownership change," the Company's ability to use its pre-change NOLs, R&D credits and other pre-change tax attributes to offset its post-change income may be limited. An ownership change is generally defined as a greater than 50% change in equity ownership. Based upon an analysis of our equity ownership, we do not believe that we have experienced such ownership changes and therefore our annual utilization of our NOLs is not limited. However, should we experience additional ownership changes, our NOL carry forwards may be limited.

***We are subject to governmental export and import controls that could subject us to liability or impair our ability to compete in international markets. Such controls have increased for companies in China under the US government's "control list", and may further limit or impair our ability to use certain sub-contractors or to sell directly to companies on the list***

We are subject to export and import control laws, trade regulations and other trade requirements that limit which raw materials and technology we can import or export and which products we sell and where and to whom we sell our products. Specifically, the Bureau of Industry and Security of the U.S. Department of Commerce is responsible for regulating the export of most commercial items that are so called dual-use goods that may have both commercial and military applications. A limited number of our products are exported by license under certain classifications. Export Control Classification requirements are dependent upon an item's technical characteristics, the destination, the end-use, and the end-user, and other activities of the end-user. Should the regulations applicable to our products change, or the restrictions applicable to countries to which we ship our products change, then the export of our products to such countries could be restricted. As a result, our ability to export or sell our products to certain countries could be restricted, which could adversely affect our business, financial condition and results of operations. Changes in our products or any change in export or import regulations or related legislation, shift in approach to the enforcement or scope of existing regulations, or change in the countries, persons or technologies targeted by such regulations, could result in delayed or decreased sales of our products to existing or potential customers. In such event, our business and results of operations could be adversely affected.

***Our manufacturing operations are subject to environmental regulation that could limit our growth or impose substantial costs, adversely affecting our financial condition and results of operations.***

Our properties, operations and products are subject to the environmental laws and regulations of the jurisdictions in which we operate and sell products. These laws and regulations govern, among other things, air emissions, wastewater discharges, the management and disposal of hazardous materials, the contamination of soil and groundwater, employee health and safety and the content, performance, packaging and disposal of products. Our failure to comply with current and future environmental laws and regulations, or the identification of contamination for which we are liable, could subject us to substantial costs, including fines, cleanup costs, third-party property damages or personal injury claims, and make significant investments to upgrade our facilities or curtail our operations. Identification of presently unidentified environmental conditions, more vigorous enforcement by a governmental authority, enactment of more stringent legal requirements or other unanticipated events could give rise to adverse publicity, restrict our operations, affect the design or marketability of our products or otherwise cause us to incur material environmental costs, adversely affecting our financial condition and results of operations.

***We are exposed to risks and increased expenses and business risk as a result of Restriction on Hazardous Substances, or RoHS directives, which have been amended but are still in effect.***

Following the lead of the European Union, or EU, various governmental agencies have either already put into place or are planning to introduce regulations that regulate the permissible levels of hazardous substances in products sold in various regions of the world. For example, the RoHS directive for EU took effect on July 1, 2006. The labeling provisions of similar legislation in China went into effect on March 1, 2007 and is still in effect, as amended. Consequently, many suppliers of products sold into the EU have required their suppliers to be compliant with the new directive. We anticipate that our customers may adopt this approach and will require our full compliance, which will require a significant amount of resources and effort in planning and executing our RoHS program, it is possible that some of our products might be incompatible with such regulations. In such events, we could experience the following consequences: loss of revenue, damages reputation, diversion of resources, monetary penalties, and legal action.

***Failure to comply with the U.S. Foreign Corrupt Practices Act could subject us to penalties and other adverse consequences.***

We are subject to the U.S. Foreign Corrupt Practices Act, which generally prohibits companies operating in the U.S. from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. In addition, we are required to maintain records that accurately and fairly represent our transactions and have an adequate system of internal accounting controls. Non-U.S. companies, including some that may compete with us, may not be subject to these prohibitions, and therefore may have a competitive advantage over us. If we are not successful in implementing and maintaining adequate preventative measures, we may be responsible for acts of our employees or other agents engaging in such conduct. We could suffer severe penalties and other consequences that may have a material adverse effect on our financial condition and results of operations.

***Natural disasters or other catastrophic events could harm our operations.***

Our operations in the U.S., Canada, Singapore, Malaysia and China could be subject to significant risk of natural disasters, including earthquakes, hurricanes, typhoons, flooding and tornadoes, as well as other catastrophic events, such as epidemics, terrorist attacks or wars. For example, our testing facility in Singapore is in an area that is susceptible to hurricanes. Any disruption in our facilities or those of our contractors and suppliers arising from these and other natural disasters or other catastrophic events could cause significant delays in the production or shipment of our products until we are able to arrange for third parties to manufacture our products. We may not be able to obtain alternate capacity on favorable terms or at all. Our property insurance coverage with respect to natural disaster is limited and is subject to deductible and coverage limits. Such coverage may not be adequate or continue to be available at commercially reasonable rates and terms. The occurrence of any of these circumstances may adversely affect our financial condition and results of operation.

***We may be subject to disruptions or failures in information technology systems and network infrastructures that could have a material adverse effect on our business and financial condition.***

We rely on the efficient and uninterrupted operation of complex information technology systems and network infrastructures to operate our business. A disruption, infiltration or failure of our information technology systems as a result of software or hardware malfunctions, system implementations or upgrades, computer viruses, third-party security breaches, employee error, theft or misuse, malfeasance, power disruptions, natural disasters or accidents could cause a breach of data security, loss of intellectual property and critical data and the release and misappropriation of sensitive competitive information and partner, customer, and employee personal data. Any of these events could harm our competitive position, result in a loss of customer confidence, cause us to incur significant costs to remedy any damages and ultimately materially adversely affect our business and financial condition.

***A significant disruption in, or breach in security of, our information technology systems or violations of data protection laws could materially adversely affect our business and reputation.***

In the ordinary course of business, we collect and store confidential information, including proprietary business information belonging to us, our customers, suppliers, business partners and other third parties and personally identifiable information of our employees. We rely on information technology systems to protect this information and to keep financial records, process orders, manage inventory, coordinate shipments to customers, and operate other critical functions. Our information technology systems may be susceptible to damage, disruptions or shutdowns due to power outages, hardware failures, telecommunication failures and user errors. If we experience a disruption in our information technology systems, it could result in the loss of sales and customers and significant incremental costs, which could materially adversely affect our business. We may also be subject to security breaches caused by computer viruses, illegal break-ins or hacking, sabotage, or acts of vandalism by disgruntled employees or third parties. The risk of a security breach or disruption, particularly through cyberattack or cyber intrusion, including by computer hackers, foreign governments and cyber terrorists, has increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Our information technology network and systems have been and, we believe, continue to be under constant attack. Accordingly, despite our security measures or those of our third-party service providers, a security breach may occur, including breaches that we may not be able to detect. Security breaches of our information technology systems could result in the misappropriation or unauthorized disclosure of confidential information. Such breaches could also result in legal action against us by third parties.

***Outbreaks of diseases and public health crises could delay our development activities and adversely affect our results of operations.***

The Company faces risks related to health epidemics and other outbreaks of communicable diseases, which could significantly disrupt its operations and may materially and adversely affect its business and financial conditions.

The Company continues to monitor the developments and impacts of any health crises and pandemic diseases as they may arise. The Company cannot estimate whether, or to what extent, any future outbreak of epidemics or pandemics or other health crises may have an impact on the business, operations and financial condition of the Company. The outbreak of epidemics, pandemics or other public health crises, such as COVID-19 pandemic, may result in volatility and disruptions global supply chains and financial markets, as well as declining trade and market sentiment and reduced mobility of people, all of which could affect prices, interest rates, credit ratings, credit risk, share prices and inflation. The risks to the Company of such public health crises also include risks to employee health and safety, a slowdown or temporary suspension of operations in geographic locations impacted by an outbreak, increased labor costs, regulatory changes, political or economic instabilities or civil unrest as well as the Company's ability to service its obligations as they arise. As such, the impacts of such crises may have a material adverse effect on the Company's business, results of operations and financial condition and the market price of the Common Shares. There can be no assurance that the Company's personnel or its contractors' personnel will not be impacted by these pandemic diseases and ultimately see its workforce productivity reduced or incur increased safety and medical costs / insurance premiums as a result of these health risks.

***Tariffs may adversely impact our supply chain and cost structure.***

 ****

The current U.S. presidential administration previously significantly increased tariffs on U.S. imports. In 2026, the current U.S. presidential administration has continued to threaten the enactment of additional tariffs on Canada that could be as high as 100%. These tariffs have been in many cases amended, postponed, or changed in other ways since their initial announcements, including a subsequent exemption for goods compliant with the United States-Mexico-Canada Agreement (USMCA), which the U.S. presidential administration is reportedly considering pulling out of. Although the United States Supreme Court recently struck down many of the administration's tariffs as unconstitutional, the administration has responded by initiating investigations under the Trade Act of 1974 against certain countries, including Canada, whose goal is to reimpose the tariffs through alternate means. This has resulted in uncertainty over the quantum and duration of tariffs, and this lack of clarity has made it difficult to manage and mitigate the impacts of tariffs. In response to these tariffs, other countries have limited their trade with the United States and have retaliated through their own restrictions and/or increased tariffs, among other actions. In particular, there is uncertainty regarding U.S. tariffs and support for existing treaty and trade relationships, including with Canada, which has been targeted by the current U.S. presidential administration and there is substantial uncertainty as to further actions that may be taken under the current U.S. presidential administration with respect to U.S. trade policy.

The implementation of new tariffs or changes to existing trade policies, particularly in the United States, may negatively affect POET's global supply chain and cost structure, or otherwise negatively impact us, which may have a material adverse effect on our business, financial condition and operations. Tariffs on imported components or finished goods could increase the cost of materials and manufacturing, leading to higher overall production expenses. This could impact the company's profitability, pricing strategies, and competitive positioning in key markets. In addition, this uncertainty may adversely impact: (i) the ability of companies to transact business with companies such as us; (ii) global stock markets (including Nasdaq); and (iii) general global economic conditions. While POET continues to evaluate strategies to mitigate these risks, including potential alternative sourcing options, the unpredictability of future trade policies presents a significant challenge that could adversely affect the company's financial performance.

**Risks Related to Our Common Shares**

***Our stock price has been and may continue to be volatile.***

The trading price for our common shares on Nasdaq has been and is likely to continue to be highly volatile. The U.S. market for our shares has been slow to develop, and if and as such a market develops, prices are likely to be continue to be highly volatile. The market prices for securities of early-stage technology companies have historically been highly volatile.

Factors that could adversely affect our stock price include:

● fluctuations in our operating results and our financial condition;

● announcements of new products, partnerships or technological collaborations and announcements of the results or further actions in respect of any products, partnerships or collaborations, including termination of same;

● innovations by us or our competitors;

● governmental regulation;

● developments in patent or other proprietary rights;

● the results of technology and product development testing by us, our partners or our competitors;

● litigation;

● general stock market and economic conditions;

● number of shares available for trading (float); and

● inclusion in or dropping from stock indexes.

As of March 20, 2026, our 52-week high and low closing market prices for our common shares on Nasdaq were $9.22 and $3.21. In the past, following periods of volatility in the market price of a company's securities, securities class-action litigation has often been brought against that company. We may become involved in this type of litigation in the future. Litigation of this type may be expensive to defend and may divert our management's attention and resources from the operation of our business

***Future sales of common shares, or the prospect of future sales, may depress our stock price. The exercise of share purchase options and warrants will create dilution which could adversely affect the Company's shareholders.***

Sales of a substantial number of common shares, or the perception that sales could occur, could adversely affect the market price of our common shares. Additionally, as of March 20, 2026, there were outstanding options to purchase up to 5,792,465 of our common shares and outstanding warrants to purchase 37,364,941 of our common shares. The holders of these options and warrants have an opportunity to profit from a rise in the market price of our common shares with a resulting dilution in the interests of the other shareholders. The existence of these options and warrants may adversely affect the terms on which we may be able to obtain additional financing. The weighted average exercise price of issued and outstanding options is $1.93, the weighted average exercise price of warrants is $5.71, which compares to the $5.93 market price at closing on March 20, 2026. If all of these securities were exercised, an additional 43,157,406 common shares would become issued and outstanding. This represents an increase of 28.35% in the number of shares issued and outstanding and would result in significant dilution to current shareholders.

***The rights of our shareholders may differ from the rights typically afforded to shareholders of a U.S. corporation.***

We are incorporated under the Business Corporations Act (Ontario) (the "OBCA"). The rights of holders of our common shares are governed by the laws of the Province of Ontario, including the OBCA, by the applicable laws of Canada, and by our Articles of Continuance and all amendments thereto (collectively, the "Articles"), and our by-laws (the "By-laws"). These rights differ in certain respects from the rights of shareholders in typical U.S. corporations. The principal differences include without limitation the following:

Under the OBCA, we have a lien on any common share registered in the name of a shareholder or the shareholder's legal representative for any debt owed by the shareholder to us. Under U.S. state law, corporations generally are not entitled to any such statutory liens in respect of debts owed by shareholders.

With regard to certain matters, we must obtain approval of our shareholders by way of at least 66 2/3% of the votes cast at a meeting of shareholders duly called for such purpose being cast in favor of the proposed matter. Such matters include without limitation: (a) the sale, lease or exchange of all or substantially all of our assets out of the ordinary course of our business; and (b) any amendments to our Articles including, but not limited to, amendments affecting our capital structure such as the creation of new classes of shares, changing any rights, privileges, restrictions or conditions in respect of our shares, or changing the number of issued or authorized shares, as well as amendments changing the minimum or maximum number of directors set forth in the Articles. Under U.S. state law, the sale, lease, exchange or other disposition of all or substantially all of the assets of a corporation generally requires approval by a majority of the outstanding shares, although in some cases approval by a higher percentage of the outstanding shares may be required. In addition, under U.S. state law the vote of a majority of the shares is generally sufficient to amend a company's certificate of incorporation, including amendments affecting capital structure or the number of directors.

Pursuant to our By-laws, two persons present in person or represented by proxy and each entitled to vote thereat shall constitute a quorum for the transaction of business at any meeting of shareholders. Under U.S. state law, a quorum generally requires the presence in person or by proxy of a specified percentage of the shares entitled to vote at a meeting, and such percentage is generally not less than one-third of the number of shares entitled to vote.

Under rules of the Ontario Securities Commission, a meeting of shareholders must be called for consideration and approval of certain transactions between a corporation and any "related party" (as defined in such rules). A "related party" is defined to include, among other parties, directors and senior officers of a corporation, holders of more than 10% of the voting securities of a corporation, persons owning a block of securities that is otherwise sufficient to affect materially the control of the corporation, and other persons that manage or direct, to a substantial degree, the affairs or operations of the corporation. At such shareholders' meeting, votes cast by any related party who holds common shares and has an interest in the transaction may not be counted for the purposes of determining whether the minimum number of required votes have been cast in favor of the transaction. Under U.S. state law, a transaction between a corporation and one or more of its officers or directors can generally be approved either by the shareholders or a by majority of the directors who do not have an interest in the transaction.

Neither Canadian law nor our Articles or By-laws limit the right of a non-resident to hold or vote common shares of the Company, other than as provided in the Investment Canada Act (the "Investment Act"), as amended by the World Trade Organization Agreement Implementation Act (the "WTOA Act"). The Investment Act generally prohibits implementation of a direct reviewable investment by an individual, government or agency thereof, corporation, partnership, trust or joint venture that is not a "Canadian," as defined in the Investment Act (a "non-Canadian"), unless, after review, the minister responsible for the Investment Act is satisfied that the investment is likely to be of net benefit to Canada. An investment in the common shares of the Company by a non-Canadian (other than a "WTO Investor," as defined below) would be reviewable under the Investment Act if it were an investment to acquire direct control of the Company, and the value of the assets of the Company were CAD$5.0 million or more (provided that immediately prior to the implementation of the investment the Company was not controlled by WTO Investors). An investment in common shares of the Company by a WTO Investor (or by a non- Canadian other than a WTO Investor if, immediately prior to the implementation of the investment the Company was controlled by WTO Investors) would be reviewable under the Investment Act if it were an investment to acquire direct control of the Company and the value of the assets of the Company equaled or exceeded certain threshold amounts determined on an annual basis. The threshold for a pre-closing net benefit review depends on whether the purchaser is: (a) controlled by a person or entity from a member of the WTO; (b) a state-owned enterprise (SOE); or (c) from a country considered a "Trade Agreement Investor" under the Investment Act. A different threshold also applies if the Canadian business carries on a cultural business.

A non-Canadian, whether a WTO Investor or otherwise, would be deemed to acquire control of the Company for purposes of the Investment Act if he or she acquired a majority of the common shares of the Company. The acquisition of less than a majority, but at least one-third of the shares, would be presumed to be an acquisition of control of the Company, unless it could be established that the Company is not controlled in fact by the acquirer through the ownership of the shares. In general, an individual is a WTO Investor if he or she is a "national" of a country (other than Canada) that is a member of the WTO ("WTO Member") or has a right of permanent residence in a WTO Member. A corporation or other entity will be a "WTO Investor" if it is a "WTO Investor-controlled entity," pursuant to detailed rules set out in the Investment Act. The U.S. is a WTO Member. Certain transactions involving our common shares would be exempt from the Investment Act, including:

● an acquisition of our common shares if the acquisition were made in connection with the person's business as a trader or dealer in securities;

● an acquisition of control of the Company in connection with the realization of a security interest granted for a loan or other financial assistance and not for any purpose related to the provisions of the Investment Act; and

● an acquisition of control of the Company by reason of an amalgamation, merger, consolidation or corporate reorganization, following which the ultimate direct or indirect control of the Company, through the ownership of voting interests, remains unchanged. Under U.S. law, except in limited circumstances, restrictions generally are not imposed on the ability of non- residents to hold a controlling interest in a U.S. corporation.

***As a "foreign private issuer", the Company is exempt from certain sections of the Exchange Act, which results in shareholders having less complete and timely information concerning the Company than if the Company were a domestic U.S. issuer.***

As a "foreign private issuer," as defined under the U.S. securities laws, we are exempt from certain sections of the Exchange Act. In particular, we are exempt from the proxy statement rules that are applicable to domestic U.S. issuers and the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. The Company submits its proxy materials and annual meeting of shareholder information (which are prepared in accordance with Canadian standards) by filing a Form 6-K with the SEC, although those documents typically have more limited information than the corresponding documents required to be filed by U.S. domestic issuers, which results in our shareholders having less complete and timely data, including, among others, with respect to disclosure of: (i) personal and corporate relationships and age of directors and officers; (ii) material legal proceedings involving the Company, affiliates of the Company, and directors, officers promoters and control persons; (iii) the identity of principal shareholders and certain significant employees; (iv) related party transactions; (v) audit fees and change of auditors; (vi) voting policies and procedures; (vii) executive compensation; and (viii) composition of the Compensation Committee. In addition, in light of the Company's status as a foreign private issuer, the officers, directors and principal shareholders of the Company are exempt from the short-swing insider disclosure and profit recovery provisions of Section 16 of the Exchange Act. Although Section 8103 of the National Defense Authorization Act for Fiscal Year 2026, named the "Holding Foreign Insiders Accountable Act", which was signed into law in the U.S. on December 18, 2025, requires the directors and officers of certain foreign private issuers to make insider reports under Section 16(a) of the Exchange Act, effective March 18, 2026, the Company's directors and officers remain exempt because the Company is organized in Canada and its directors and officers are subject to the insider reporting requirements of Canada's National Instrument 55-104. Therefore, the Company's securityholders may not know on as timely a basis when its officers, directors and principal shareholders purchase or sell securities of the Company as the reporting periods under the corresponding Canadian insider reporting requirements are longer. The foregoing exemption results in our shareholders having less data in that regard than is made available by U.S. domestic issuers.

***As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with Nasdaq's corporate governance listing standards.***

As a foreign private issuer listed on Nasdaq, we are subject to Nasdaq's corporate governance listing standards. However, pursuant to Nasdaq rules, foreign private issuers are permitted to follow the corporate governance practices of their home country in certain instances, provided that disclosure regarding which requirements have not been complied with and confirmation regarding applicable Canadian corporate governance practices which are being followed has been provided. The Company has availed itself of the ability to follow applicable corporate governance standards of its home country in certain instances, and provided such disclosures and confirmations in applicable periodic reports filed with the SEC. Certain corporate governance practices in Canada, which is our home country, may differ significantly from Nasdaq corporate governance listing standards. Therefore, our shareholders may be afforded less protection than they otherwise would have in certain instances as a result of following such Canadian corporate governance practices.

***The Company will likely lose its foreign private issuer status, which would then require us to comply with the Exchange Act's domestic reporting regime and cause us to incur significant additional legal, accounting and other costs and expenses.***

We are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. The determination of foreign private issuer status is made annually on the last business day of an issuer's most recently completed second fiscal quarter, and, accordingly, the next determination will be made with respect to us on June 30, 2026. In order to maintain our current status as a foreign private issuer, either (a) a majority of our common shares must be owned of record by persons who are not residents or citizens of the United States or (b)(i) a majority of our executive officers and a majority of our directors cannot be citizens or residents of the United States, (ii) more than 50 percent of our assets must be located outside the United States and (iii) our business must be administered principally outside the United States. As a result of the Company's delisting of its common shares from the TSX Venture Exchange in 2024, resulting in Nasdaq being the sole stock exchange on which the common shares can be publicly traded and subsequent capital raises involving primarily U.S. investors, the Company may lose its status as a foreign private issuer in the future. In addition, on June 4, 2025, the SEC published a concept release soliciting public comment on whether to amend the eligibility criteria for foreign private issuer status. The concept release outlines several potential approaches to narrow foreign private issuer eligibility, including updating the existing shareholder and business contacts tests, adding minimum non-U.S. trading volume requirements or requiring issuers to have their securities listed on a non-U.S. stock exchange. If the SEC were to adopt any of these approaches, we may no longer qualify as a foreign private issuer.

If we lose our status as a foreign private issuer, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, including the requirement to prepare our financial statements in accordance with U.S. generally accepted accounting principles, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time consuming and costly. If we lose foreign private issuer status and are unable to comply with the reporting requirements applicable to a U.S. domestic issuer by the applicable deadlines, we would not be in compliance with applicable SEC rules or the rules of Nasdaq, which could cause investors could lose confidence in our public reports and could have a material adverse effect on the trading price of our common shares.

Additionally, we are currently eligible to use the multijurisdictional disclosure system ("MJDS"), which, among other things, allows eligible Canadian issuers to make registered public offerings in the United States using a prospectus prepared and reviewed in Canada that is mainly, although not exclusively, in accordance with Canadian disclosure requirements. If the Company no longer qualifies as a foreign private issuer, it would not be eligible to use the MJDS, or other foreign issuer forms for certain securities offerings. The regulatory and compliance costs under U.S. federal securities laws as a U.S. domestic issuer may be significantly more than the costs we currently incur as a Canadian foreign private issuer eligible for MJDS. Such additional compliance requirements could divert the time and attention of senior management from business strategy, which could have a material adverse effect on the Company's business and financial results.

***The Company may be classified as a passive foreign investment company for U.S. federal income tax purposes for the year ended December 31, 2025 and for the current and future years, which could result in adverse U.S. federal income tax consequences to U.S. holders of our common shares.***

We would be classified as a passive foreign investment company ("PFIC") for any taxable year if, after the application of certain look-through rules with respect to the income and assets of our corporate subsidiaries in which we own at least 25% (by value) of the stock, either: (i) 75% or more of our gross income for such year is "passive income" (as defined in the relevant provisions of the Internal Revenue Code of 1986, as amended (the "Code")), or (ii) 50% or more of the value of our assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income. Based on our income and assets for the year ended December 31, 2025, we believe that we may be treated as a PFIC for the preceding taxable year. Whether we will be treated as a PFIC for U.S. federal income tax purposes for the current taxable year or any future taxable year is a factual determination that must be made annually after the close of each taxable year and is dependent on many factors, including the value of our passive assets, the amount and type of our gross income and market capitalization. Therefore, there can be no assurance that we will not be classified as a PFIC for the current or future taxable years. Certain adverse U.S. federal income tax consequences could apply to a U.S. Holder (as defined below in Item 10.E. "Taxation" – U.S. Federal Income Tax Considerations") if we are treated as a PFIC for any taxable year during which a U.S. Holder holds our common shares. *See* discussion in Item 10.E. "Taxation" – U.S. Federal Income Tax Considerations - Passive Foreign Investment Company Status."

***If a U.S. Holder is treated as owning at least 10% of the common shares, such holder may be subject to adverse U.S. federal income tax consequences.***

If a U.S. Holder is treated as owning, directly, indirectly or constructively, at least 10% of the value or voting power of the common shares, such U.S. Holder may be treated as a "United States shareholder" with respect to each "controlled foreign corporation" in the Company's group, if any. If United States shareholders collectively own more than 50% of the voting power or value of the Company or any of its non-U.S. subsidiaries, the Company and such non-U.S. subsidiaries each would be classified as a controlled foreign corporation. Additionally, because the Company's group includes one or more U.S. subsidiaries, the application of certain stock attribution rules under the U.S. tax laws in effect for taxable years of foreign corporations that begin before January 1, 2026 (the "Downward Attribution Rules") could cause certain of the Company's non-U.S. subsidiaries to be treated as controlled foreign corporations, regardless of whether the Company is treated as a controlled foreign corporation. The Downward Attribution Rules were amended as part of the One Big Beautiful Bill Act (the "OBBBA") that was enacted on July 4, 2025. Effective for taxable years of foreign corporations beginning after December 31, 2025, the OBBBA amendments generally prohibit downward attribution from a foreign person, such as the Company, to its non-U.S. subsidiaries for purposes of determining United States shareholder and controlled foreign corporation status. Consequently, the Company's non-U.S. subsidiaries generally are not expected to be treated as controlled foreign corporations for taxable years beginning after December 31, 2025 solely as a result of the Company's ownership of U.S. subsidiaries.

A United States shareholder of a controlled foreign corporation may be required to annually report and include in its U.S. taxable income its pro rata share of "Subpart F income," "net CFC tested income" and investments in U.S. property by controlled foreign corporations, regardless of whether the Company makes any distributions. An individual who is a United States shareholder with respect to a controlled foreign corporation generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder to significant monetary penalties and may prevent the running of the statute of limitations with respect to such shareholder's U.S. federal income tax return for the year for which reporting was due. The Company cannot provide any assurances that it will assist its investors in determining whether it or any of its non-U.S. subsidiaries are treated as a controlled foreign corporation or whether any investor is treated as a United States shareholder with respect to it or any of such controlled foreign corporations. Further, the Company cannot provide any assurances that it will furnish to any U.S. Holder information that may be necessary to comply with the reporting and tax paying obligations described in this risk factor. U.S. Holders should consult their tax advisors regarding the potential application of these rules to their investment in our common shares.

**Item 4. Information on the Company**

**A.**  ***History and Development of the Company*.** 

The legal and commercial name of the Company is POET Technologies Inc. The Company was originally incorporated under the British Columbia Company Act on February 9, 1972 as Tandem Resources Ltd. On November 14, 1985, Tandem Resources Ltd. amalgamated with Stanmar Resources Ltd. and Keezic Resources Ltd., to continue as one company under the name Tandem Resources Ltd. under the British Columbia Company Act. By Articles of Continuance dated January 3, 1997, Tandem Resources Ltd. was continued under the OBCA. By Articles of Amendment dated September 26, 2006, Tandem Resources Ltd. changed its name to OPEL International Inc. By Certificate of Continuance dated January 30, 2007, OPEL International Inc. was continued under the New Brunswick Business Corporations Act. By Articles of Continuance dated November 30, 2010, OPEL International Inc. was continued under the OBCA and changed its name to OPEL Solar International Inc. By Articles of Amendment dated August 25, 2011, OPEL Solar International Inc. changed its name to OPEL Technologies Inc. By Articles of Amendment dated July 23, 2013, OPEL Technologies Inc. changed its name to POET Technologies Inc.

On May 11, 2016, in an all-stock transaction, the Company acquired all the issued and outstanding shares of DenseLight Semiconductor Pte. Ltd., a privately held Singapore company that provides optical solutions. DenseLight designs, manufactures and sells optical light source products. DenseLight was acquired for $10,500,000 of the Company's stock. The Company issued 1,361,115 common shares to the former shareholders of DenseLight.

On November 8, 2019, the Company sold 100% of the issued and outstanding shares of DenseLight for $26,000,000. The Company recognized a gain on the sale of $8,707,280.

On June 22, 2016, in an all-stock transaction, the Company acquired all the issued and outstanding shares of BB Photonics Inc., a privately held US Company with a wholly owned subsidiary, BB Photonics UK Ltd. Both companies design integrated photonics solutions for the data communications market. BB Photonics and its subsidiary were acquired for consideration of $1,550,000. The acquisition was settled with the issuance of 199,609 common shares of the Company to the former shareholders of BB Photonics. The Company dissolved BB Photonics UK Ltd. on October 6, 2020.

On May 17, 2019, the Company established POET Technologies Pte. Ltd. ("PTS"), a wholly owned subsidiary in Singapore. On August 4, 2020, PTS established POET Optoelectronics Shenzhen Co., Ltd ("POET SZ"), a wholly owned subsidiary in Shenzhen, China. On April 23, 2025, PTS established POET Technologies SDN BHD. ("PTM"), a wholly owned subsidiary in Malaysia.

On October 22, 2020, the Company signed a Joint Venture Agreement establishing a joint venture company, Super Photonics Xiamen Co., Ltd with Xiamen Sanan Integrated Circuit Co. Ltd. Super Photonics Xiamen Co., Ltd was formed on March 12, 2021.

On December 31, 2025, the Company acquired the shares of Super Photonics Xiamen Co., Ltd from Sanan for $6,500,000. As of December 31, 2025, the Company owned 100% of Super Photonics Xiamen Co., Ltd.

See Item 4.C Information on the Company—Organizational Structure" for a graphic depiction of the Company's organizational structure and a description of the Company's subsidiaries.

Capital Expenditures

Our capital expenditures for the last three years, which principally consist of purchases of research and development equipment and instrumentation and patents are as follows:

---

| | | |
|:---|:---|:---|
| Period | Capital Expenditure | Purpose |
| Fiscal 2025 | $2310367 | Instruments, equipment and patents |
| Fiscal 2024 | $10378210 | Instruments, equipment and patents |
| Fiscal 2023 | $1247064 | Instruments, equipment and patents |

---

The Company's registered office is located at Suite 1107, 120 Eglinton Avenue East, Toronto, Ontario, Canada M4P 1E2 and its phone number is (416) 368-9411. The Company has operations in California. Other operations include 10 Science Park Road, #04-28 The Alpha, Singapore, Singapore Science Park II, Singapore 117684, Unit 02, 10<sup>th</sup> Floor, A4 Building, Kexing Science Park, No.15 Keyuan Road, Science Park Middle District, Nanshan District, Shenzhen, 518057, SPX, No. 799 MinAn Avenue, HongTang Town, TongAn District, Xiamen City, Fujian Province, P.R.C., 11900 Bayan Lepas, Penang, Malaysia.

The information appearing in Item 5.B under the heading "Capital Expenditures" of this Annual Report is incorporated by reference herein.

Where You Can Find More Information

The information appearing in Item 10.H. "Documents on Display" of this Annual Report is incorporated by reference herein.

**B.**  ***Business Overview*.** 

**<u>Overview</u>**

The Company is incorporated under the laws of the Province of Ontario. The Company's shares trade under the symbol "POET" on the Nasdaq in the U.S.

POET Technologies is a design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photonic devices onto a single chip using advanced wafer-level semiconductor manufacturing techniques. The semiconductor industry has adopted the term "Wafer-Level Chip-Scale Packaging" (or "WLCSP") to describe similar approaches within the semiconductor industry. POET's Optical Interposer eliminates costly components and labor-intensive assembly, alignment, and testing methods employed in conventional photonics. We believe the cost-efficient integration scheme and scalability of the POET Optical Interposer brings value to devices or systems that integrate electronics and photonics, including high-growth areas of communications and computing. The emergence of Artificial Intelligence (AI) systems over the past year has placed extraordinary demands on cloud-based AI service providers and hyperscale data centers for increases in network speeds and bandwidth and decreases in latency. We believe that chip-scale integration is essential to developing hardware that can meet such demands and that POET is on the forefront of providing scalable solutions for current and future AI systems.

POET targeted as the first application of the Optical Interposer the development of optical engines for optical transceivers used in internet data centers. Optical Engines include all the passive and active components related to the production, manipulation, and detection of light within an Optical Transceiver. Optical Transceivers plug into switches and servers within the data center and allow these network devices to send and receive data over fiber-optic cables. We chose this market because it is large in size, has established standards for device performance, and the unit volumes of devices shipped annually are exceptionally high. It is a market in which our advantages of chip-scale integration, power consumption and ability to scale rapidly allow us to be competitive with other suppliers.

The rapid growth of AI software systems, including large language models and agents, represents a profound opportunity for POET. We believe that the rapid growth of software services can only be sustained with hardware that meets the challenges of increasing speed and bandwidth, lower latency, lower power consumption, lower cost, and the ability to scale to the volumes that will be required by data centers globally. POET meets the challenge of AI connectivity in two ways: first, by providing to the makers of pluggable optical transceiver modules fully-integrated, chip-scale Optical Engines at speeds of 800Gbs (gigabits per second), 1.6Tbs (terabits per second) and higher in industry-standard pluggable form factors, including so-called "CPO", "NPO", "LPO" and other formatsCo-Packaged Optics (CPO), Near-Packaged Optics (NPO) and Linear-drive Pluggable Optics (LPO). Second, we have used our Optical Interposer technology to develop Light Source products that address newly emerging architectures in data centers in proprietary formats and emerging industry standard formats, including External Laser Small Form-Factor Pluggable (ELSFP) that manage chip-to-chip data transfer using light, rather than electrons, which resolves speed, bandwidth, latency, heat-generation and cost issues at a fundamental level. The combination of POET's focus on leading-edge Optical Transceivers and Light Source products for next generation data center architectures essentially places POET in a leading position focused exclusively on AI Connectivity.

**<u>Research & Development ("R&D")</u>**

Beginning in 2017, POET began designing lasers for data communications applications and directed DenseLight Semiconductors, Pte. Ltd., a former subsidiary of the Company, to build such lasers to be compatible with the Optical Interposer platform. In 2019, the Company decided to adopt a "fab light" strategy, common among semiconductor companies, and divested its fabrication operations through the sale of DenseLight in November of that year. From 2018 - 2020, virtually all the R&D spending in the Company was dedicated to design & development of the Optical Interposer as a versatile platform technology, replete with features that enhance its utility across a variety of application spaces.

During the second half of 2021, the Company transitioned to product development by investing more than $2 million in the design & development of 100G and 200G optical engines in several configurations, including customized designs for specific customers and applications. Samples of optical engines at various stages of development were made available and delivered to customers in 2022 for initial evaluation and in 2023 for design and customer qualification. POET's effort in lower speed Optical Engine design and production was intended primarily as a way for POET to demonstrate the viability and market acceptance of its unique approach to integration and fabrication and to establish an initial presence in the market. However, the Company's primary strategy is to offer Optical Engines at the highest speeds at which customers are deploying optical transceivers. In 2025, we focused primarily on developing Optical Engines operating at 800Gps, and heavily focused on those hyperscale data centers actively implementing AI services. Our focus for 2026 is to develop for sale Optical Engines for 1.6Tbs optical modules and to produce Light Source products incorporating our proprietary hybrid laser, which we have named "Blazar™". Consistent with this strategy, the Company has invested approximately $20 million in design, development and engineering programs related to its 800G and 1.6T transmit and receive chipsets, in external light source products, which are delivered in module form, and in fabrication and test techniques related to its Optical Interposer platform.

The Company designed, tested and sampled a first generation of its 400G transmit (Tx) engines in 2024, and its 800G receive (Rx) engine with various customers. The 800G Rx engine was well received, fully qualified and has been designed into the optical transceiver modules of several customers during 2024 and 2025. The Company sampled its second generation of 400G and 800G Tx engines in 2025 as well as both Tx and Rx versions of its 1.6T optical engine chipsets. So long as the Company provides Optical Engines to optical transceiver module customers, there will always be customer centric adjustments to these products to fit their specific needs. The cost to make these adjustments will vary depending on the customer requirements.

The Company invested approximately $15.9 million in 2025 in the development of its 800G and 1.6T optical engine chipsets and light sources for artificial intelligence and is expected to invest an additional $30 million over the next two years on these products. The Company de-prioritized the development and sale of POET optical transceiver modules in 2025 to avoid conflicts with its module customers. Instead, we are deploying an estimated $8.0 million over the next two years toward our development of light source products

**<u>Target Markets</u>**

*<u>Data Center AI Market</u>*

To support the substantial increase in bandwidth consumption, data center operators are increasing the scale of their data centers and deploying infrastructure capable of higher data transmission rates. At the present time, much of the industry is moving from 400G to 800G and higher. With the growth of AI networks, interest in acquiring 1.6Tbs capable optical transceivers has literally skyrocketed. According to LightCounting, high-speed datacom pluggables (400G and 800G, overwhelmingly in pluggable form factors) is expected to reach ~$7–12 billion in revenue. 800G is the primary growth driver and majority share by 2026. The AI cluster Ethernet optics market (heavily 800G pluggable-driven, including coherent and some LPO) is $26 billion in 2026, up ~60% year-over-year from $16.5 billion in 2025 (LightCounting January 2026 forecast). Growth in 2026 is expected to be extremely strong (50–100%+ YoY for 800G volume/revenue in many forecasts), driven by AI capex surge. This segment alone is adding several billion dollars in incremental revenue year-over-year. The forecast for 2027 through 2030, is projected to moderate to 11–18% CAGR for 800G transceivers through 2033. The overall optical transceiver market (where 800G pluggables are a core driver) is projected to grow at 13–17% CAGR, reaching ~$25–40 billion by 2029–2033, with 800G volumes peak mid-to-late 2020s before 1.6T (and later 3.2T) ramps. Long-term TAM for 800G pluggables could hit $5–10 billion annually at peak before gradual displacement by higher-speed generations and emerging CPO/NPO/LPO architectures.

*<u>Light Source Markets</u>*

The Light Source market consists of two main segments: External lasers for CPO and chip-to-chip optical I/O. Both markets are high-growth but start from modest bases in 2025–2026 before exploding mid-decade as AI clusters scale beyond copper limits. External lasers for CPO provide a more immediate, pluggable revenue stream, while chip-to-chip optical I/O offers steeper long-term CAGR as true in-package integration matures. Data draws from DataIntelo, IDTechEx, Intel Market Research, Grand View Research, DataM Intelligence, and aligned 2025–2026 reports; actuals will depend on hyperscaler adoption (NVIDIA, AMD, Amazon, etc.) and supply-chain maturation.

IDTechEx forecasts the overall CPO market (where external lasers are a core value-chain element) to exceed US$20 billion by 2036 at a 37% CAGR from 2026, with network switches dominating but AI optical I/O growing as a share. Other reports (Future Markets Inc., SemiAnalysis) project early CPO shipments in the 10–15k unit range for 2026, scaling significantly thereafter, with external lasers highlighted for reliability, hot-swappability, and high-power delivery (e.g., supporting 1.6T+ engines).

Chip-to-Chip Optical Data Communication (GPU to GPU and GPU to Memory Optical I/O). This covers in-package or near-package photonic interconnects/chiplets for ultra-short-reach, high-bandwidth, low-latency links inside AI accelerators or clusters. These often integrate or pair with external laser sources and target disaggregated memory, scale-up fabrics, and "one giant GPU" architectures. Key forecasts include (a) In-Package Optical I/O market: US$32.1 million in 2024, growing to US$544 million by 2032 at 41.5% CAGR; (b) UCIe optical chiplets: ~US$35 million in 2024 growing to US$520 million by 2030; (c) GPU-to-GPU ultra-short-reach optical interconnects: US$302.2 million in 2024 to US$1.223 billion by 2030 at 26.8% CAGR; and (d) Broader Optical Interconnect in AI Data Centers (encompassing GPU/memory scale-up): US$9.94 billion in 2025 growing to US$31.04 billion by 2033 at 15.3% CAGR.

*<u>Other Potential Photonics Markets</u>*

 

Other markets for POET's integrated photonics solutions include 5G interconnect markets, such as PON and GPON, edge computing for machine-to-machine communications, and selected sensing markets, including LIDAR, Optical Coherence Tomography for medical devices, and certain consumer products, such as virtual reality systems.

**<u>Manufacturing</u>**

To address the challenge of producing devices in the large quantities needed by customers in the high-volume data communications industry, and in keeping with our "fab-light" strategy, POET has entered into agreements with Globetronics Manufacturing, Sdn. Bhd. ("GMSB") and NationGate Solution (M) Sdn. Bhd. ("NationGate") to establish and maintain optical engine assembly and test operations in Malaysia. Both companies are prominent manufacturers of electronic devices and equipment located in Penang, Malaysia and are ideal manufacturing partners for POET. In our Globetronics clean room of approximately 10,000 square feet, we have installed all our wafer-level processing equipment in a production line that has the capacity to produce 1 million optical engines annually. We are now installing specialized equipment dedicated to light source production into a cleanroom of comparable size within the NationGate facilty.

Our detailed assessment of our production needs and our desire to mitigate the geopolitical risk in China supported our relocation to Malaysia. We determined that we could not achieve full operational control of Super Photonics Xiamen (SPC) in the context of any joint venture. The first phase of transition out of China involved the transfer of all our production equipment to Globetronics and NationGate, a phase that has been completed. The second phase was the dissolution of the joint venture with Sanan IC, which has also been completed with that operation now permanently closed. Following completion of the final audit and the filing of certain documents with the Chinese authorities, the final stage will be the winding-up of that company, which we expect to complete within the next few months.

**<u>Our Strategy</u>**

Our vision for the Company is to become a global leader in chip-scale photonic solutions by deploying products based on our Optical Interposer technology and optical engine designs over a broad range of vertical market applications. Our Mission for the Company is to establish an industry leadership position based on the full "semiconductorization" of the photonics industry, producing validated, disruptive, IP protected products globally.

We recently refined our strategy to reflect our current thinking about how best to achieve our vision and mission for the Company:

●  ***Ramp production capabilities at GMSB and NationGate*** *.* POET's agreement with GMSB in Malaysia supports its vision and mission by establishing wafer-level manufacturing, reducing reliance on China, and enhancing supply chain resilience. The partnership enables POET to scale production efficiently, leveraging GMSB's expertise in high-volume semiconductor manufacturing to meet growing demand in the optical interconnect market. This collaboration enhances POET's operational control, ensuring high-quality standards, faster production, and better supply chain management. It also opens doors to key global markets, strengthening POET's position as a leader in optical solutions for data communications and AI technologies

●  ***Engage with industry leaders and incumbents.*** We will continue to promote the potential of the Optical Interposer and POET-designed Optical Engines to solve critical challenges with current approaches to data transfer in data center and telecom applications, especially to those hyperscale data centers implementing large-scale AI applications *.* We believe that the size, performance and design flexibility of POET's chip-scale approach to integration and to the rapid introduction of successive product generations is an enabling technology that will allow POET to enter markets where relatively few competitors will have the requisite technology to succeed.

●  ***Transition to making Optical Transceiver Modules for direct sales to end-users*** *.* In addition to adding features to the Optical Interposer, we have added essential electronic components, such as Trans Impedance Amplifiers (TIAs) and laser drivers to the interposer platform, which improves performance and lowers the cost of module assembly. We intend to add the necessary capabilities for design and development optical transceiver modules, either through internal development or in collaboration with other companies. Being most familiar with the unique capabilities of our technology, we believe that we are in a position to rapidly extend our expertise to complete optical modules. In addition, we want to own key components. Starting with our internally designed and developed hybrid laser, we intend to develop or acquire components with differentiated performance to include in our modules. Doing so has the advantage of avoiding a lengthy sales and qualification cycle (i.e., selling to module makers who then sell to end users) and being able to sell directly to end users, showcasing our own branded products to network equipment suppliers and data center operators. However, so as not to compete with our optical module customers, our current plan is to sell our optical modules, once developed, into niche rather than mainstream applications.

●  ***Pursue complementary strategic alliance or acquisition opportunities for inorganic growth*** *.* We intend to evaluate and selectively pursue strategic alliances or acquisition opportunities for growth and vertical integration that we believe will accelerate our penetration of specific applications or vertical markets with our technology or products.

●  ***Explore technology licensing opportunities for growth in non-target sectors*** *.* It is not possible for the Company to pursue all potential applications for the POET Optical Interposer. We will carefully consider opportunities to license our technology to others when and if appropriate.

**<u>Our Products</u>**

POET Optical Engine Products currently include the following:

● 100G
 LR4 Tx and Rx

● 200G
 FR4 Tx and Rx

● 400G/800G
 FR4 Rx with integrated TIA

● 400G/800G
 FR4 Tx with integrated Driver

● 1.6T
 4xFR4 Rx with integrated TIA

● 200G/Lane
 Tx & Rx for 1.6T and 3.2T

● LightBar:
 C-Band External Light Source

● LightBar:
 O-Band External Light Source

**Seasonality**

The industry doesn't experience significant fluctuations due to seasonality, but it is heavily influenced by longer-term trends such as technological advancements, product innovation, and shifts in global demand—like the growing need for data centers, 5G infrastructure, and electric vehicles. These factors can have a substantial impact on the industry's overall cycle.

**Competition**

The photonics market is intensely competitive and we expect experience intense competition from a number of manufacturers with alternative technologies. Many of our competitors will be larger than we are and have significantly greater financial, marketing and other resources.

In addition, several of our competitors, especially in the datacom markets, have large market capitalizations or cash reserves and are much better positioned to acquire other companies to gain new technologies or products that may displace our products. Data center equipment providers, who we expect to become our customers, and data center service providers, who are supplied by our customers, may decide to manufacture the optical subsystems that we plan to provide. We may also encounter potential customers that, because of existing relationships, are committed to the products offered by these competitors.

We believe the principal competitive factors in our target markets include the following:

● use of internally manufactured components;

● product breadth and functionality;

● timing and pace of new product development;

● breadth of customer base;

● technological expertise;

● reliability of products;

● product pricing; and

● manufacturing efficiency.

We believe that we can compete favorably with respect to the above factors based on processes, the projected performance, anticipated inherent reliability of our products, our technical expertise in photonic engine design and manufacture and cost.

**Intellectual Property**

We have 79 issued patents and 34 patent applications pending, including three provisional patent applications. Of the 79 issued patents, 45 are directly related to the Optical Interposer and include fundamental design and process patents. All 34 applications pending are Optical Interposer-related. Multiple additional applications are in various stages of preparation. The patents cover device structures, underlying technology related to the Optical Interposer, applications of the technology, and fabrication processes. We intend to continue to apply for additional patents in the future. We believe these patents provide a significant barrier to entry against competition along with company trade secrets and know-how. Currently, we are working on the design of integrated devices, manufacturing processes, assembly and packaging processes, and products for data communication applications in the data center market

**Regulation**

While there are no discreet governmental bodies that regulate the semiconductor industry, broader national and local policies may impact the sector in significant ways. Trade policies, such as export controls and tariffs, can influence global supply chains and access to critical technologies, affecting companies' ability to operate internationally. Government subsidies and incentives, like the U.S. CHIPS Act (the "CHIPS Act"), can stimulate domestic manufacturing and reduce reliance on foreign suppliers, shaping industry competitiveness. Conversely, stringent environmental regulations or labor laws can increase production costs and force companies to adapt their operations. Additionally, intellectual property protections and antitrust enforcement ensure fair competition and foster innovation, but may also lead to legal battles that affect market dynamics. Overall, while regulations are not centrally unified, the combination of these policies can either create opportunities or present challenges that impact the growth, strategy, and global positioning of semiconductor companies.

**Geographic Distribution of Revenue**

Revenue and geographic markets in 2025, 2024 and 2023 were approximately as follows:

---

| | | | |
|:---|:---|:---|:---|
| Region | 2025 | 2024 | 2023 |
| Europe & Asia | $505361 | $41427 | $191225 |
| North & South America | $569504 | $- | $274552 |

---

***C.***  ***Organizational Structure*.** 

The following graphically displays the organizational structure of the Company:

![](form20-f_001.jpg)

**OPEL Solar, Inc. (OPEL)**

There are 28,374,000 Class A Common Shares of OPEL Solar, Inc. issued and outstanding, all of which are held by the Company. There are no other outstanding securities of OPEL Solar, Inc. other than the Class A Common Shares.

OPEL is the assignee for all patents and patent applications filed by the Company prior to 2019.

**ODIS Inc. ("ODIS")**

There are 5 Common Shares of ODIS Inc. issued and outstanding, held by OPEL Solar, Inc. ODIS is the designer of the POET Optical Interposer platform, and developer of optical engines based on the POET Optical Interposer platform.

**BB Photonics Inc.**

There are 1,000,000 preferred shares and 1,050,100 common shares of BB Photonics Inc. issued and outstanding, all of which are held by the Company. There are no other outstanding securities of BB Photonics Inc. BB Photonics developed photonic integrated components for the datacom and telecom markets utilizing embedded dielectric technology that enabled the partial integration of active and passive devices into photonic integrated circuits. BB Photonics' operation is currently dormant.

**POET Technologies Pte Ltd. ("PTS")**

There is 1 ordinary share of POET Technologies Pte Ltd. issued and outstanding, held by POET Technologies Inc.

Situated in Singapore, PTS designs and tests variations of the POET Optical Interposer for specific applications. PTS also develops the assembly and test methodologies for the production of optical engines designed by ODIS.

**POET Optoelectronics Shenzhen Co., Ltd ("POET SZ")**

POET Optoelectronics Shenzen Co, Ltd. is a wholly owned subsidiary of POET Technologies Pte. Ltd with a registered capital of RMB1,168,833. Situated in Shenzhen, China, POET SZ validates optical engine designs produced by ODIS and works with customers to incorporate optical engine designs into modules.

**Super Photonics Xiamen Co., Ltd, ("SPX")**

Super Photonics Xiamen Co., Ltd is a wholly owned subsidiary of POET Technologies Pte. Ltd with a registered capital of RMB190,729,429. SPX is situated in Shenzhen, China. SPX was established with a sole purpose to assemble, test, package and sell cost-effective, high-performance optical engines based on POET's proprietary Optical Interposer platform technology.

**POET Technologies SDN. BHD. ("PTM")**

POET Technologies Sdn. Bhd is a wholly owned subsidiary of POET Technologies Pte. Ltd with a registered capital of MYR1,000,000. Situated in Malaysia, PTM manages the production of our devices at our contract manufacturers.

The Company operates geographically in the United States, Canada, Singapore and China.

**D.**  ***Property, Plants and Equipment*.** 

The Company's head Canadian office is located in a 400 sq. ft. leased office space in Toronto, Ontario, Canada.. Our testing operations are located in a 5100 sq. ft leased facility in Singapore. Our product development operation is located in a 2,830 sq. ft leased facility in Shenzhen, China.

**Item 4A. Unresolved Staff Comments**

Not applicable.

**Item 5. Operating and Financial Review and Prospects**

The following discussion should be read in conjunction with the audited consolidated financial statements of the Company and the related notes for the years ended December 31, 2025, 2024 and 2023 and the accompanying notes thereto included elsewhere in this Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. See "Cautionary Statements Regarding Forward-Looking Statements" discussed above. Actual results could differ materially from those anticipated by forward-looking information due to factors discussed under "Item 3.D. Risk Factors" and "Item 4.B. Business Overview."

**A.**  ***Operating Results*.** 

The information in this section should be read in conjunction with our audited consolidated financial statements for the years ended December 31, 2025, 2024 and 2023 and related notes and the information contained elsewhere in this report.

The company operates in a sector which is highly influenced by federal policies, however in 2024, these policies did not have a material impact on our operations. Federal incentives, such as the CHIPS Act, provide funding opportunities that could support our expansion and R&D efforts within the U.S. Additionally, trade policies and export controls may impact our ability to access certain markets or technologies, particularly in the context of international competition and national security concerns.

Cash and cash equivalents

Cash and cash equivalents consist of cash in current accounts of $1,759,709 (2024 - $21,871,082, 2023 - $1,249,116) and funds invested in US and Canadian cashable Term Deposits of $38,199,492 (2024 - $15,272,677, 2023 - $1,769,953) earning interest between 2.25% and 3.24% and maturing in less than one year.

Short-term investments

The short-term investments of $273,439,102 (2024 - $16,672,811, 2023 - nil) consist of guaranteed investment certificates (GICs) held with multiple Canadian chartered banks and earn interest at rates ranging from 3.4% to 4.91%, that mature within one year.

Selected Annual Data

The selected financial data of the Company for the years ended December 31, 2025, 2024 and 2023 was derived from the audited annual consolidated financial statements of the Company. The December 31, 2025 and 2024 audited consolidation financial statements were audited by Davidson & Company LLP and the December 31, 2023 audited consolidated financial statements were audited by Marcum LLP. Both firms are independent registered public accounting firms, as described in their respective reports which are included in this Annual Report.

The information contained in the selected financial data for the 2025, 2024 and 2023 years is qualified in its entirety by reference to the Company's consolidated financial statements and related notes included under the heading ITEM 17. "Financial Statements" and should be read in conjunction with such financial statements and with the information appearing under the heading ITEM 5 "Operating and Financial Review and Prospects". Except where otherwise indicated, all amounts are presented in accordance with IFRS as issued by IASB.

The selected annual information for continuing operations for 2025, 2024 and 2023 can be further analyzed as follows:

Research and development can be analyzed as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
| Wages and benefits | $7000637 | $4388075 | $4298207 |
| Subcontract fees | 2797721 | 2134948 | 1864122 |
| Stock-based compensation | 2216914 | 2091583 | 1539235 |
| Supplies | 6069031 | 2720035 | 2376366 |
|  | $18084303 | $11334641 | $10077930 |

---

Selling, marketing and administration costs can be analyzed as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | **2024** | **2023** |
| Stock-based compensation | $3890138 | $3377786 | $2662209 |
| Wages and benefits | 4552496 | 2975488 | 2649770 |
| Professional fees | 1713629 | 1936592 | 1744771 |
| General expenses | 2881736 | 1798643 | 1681899 |
| Depreciation and amortization | 3315899 | 2020195 | 1922140 |
| Finance advisory fees | 8227774 | 6501799 |  |
| Rent and facility costs | 500285 | 160918 | 134366 |
|  | $25081957 | $18771421 | $10795155 |

---

Factors Affecting Our Results of Operations

**Analysis of Continuing Operations**

Year Ended December 31, 2025 compared to Year Ended December 31, 2024

Net loss for 2025 was $62,963,213 compared to a net loss of $56,695,823 in 2024, an increase of $36,428,458 (180%). The following discusses the significant variances between 2025 and 2024:

Total R&D increased by $6,749,662 (60%) to $18,084,303 for the year ended December 31, 2025 from $11,334,641 for the same period in 2024. For the purposes of the following analysis, non-cash stock-based compensation of $2,216,914 has been excluded and is included with the analysis of non-cash stock-based compensation below.

Due to taking control of SPX in December 2024, the Company included SPX's operations in its consolidated R&D during 2025. Significant R&D compensation cost was incurred in terminating the SPX work force as part of its winding up plan. Additionally, the Company established production capacity and capabilities with two new facilities in Malaysia. The Company incurred significant costs in "bringing up" these facilities to meet expectations. The Company's expansion has also resulted in higher R&D related compensation in 2025 compared to 2024. R&D related compensation was $7,000,637 in 2025 compared to $4,388,075 in 2024, an increase of $2,612,562. It is expected that R&D for a Company at this stage of development will vary from period to period based on the development cycle and the immediate product development needs of the Company. As the Company transitions to manufacturing significant bring-up costs were incurred for equipment move and process testing. Related supplies costs increased from $2,720,035 in 2024 to $6,069,031 in 2025, an increase of $3,348,996.

Non-cash stock-based compensation increased by $637,683 (120%) to $6,107,052 in 2025 from $5,469,369 in 2024. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company's stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Company's Board of Directors (the "Board" or "Board of Directors") at the time of the grant consistent with the provisions of the Plan. Additionally, the Company has started to issue registered stock units ("RSUs") to its directors and employees. Non-cash stock-based compensation includes the periodic fair value of granted RSUs.

Professional fees decreased by $222,963 (12%) to $1,713,629 in 2025 from $1,936,592 in 2024. During 2024, the Company incurred professional fees related to various finance and corporate restructuring projects including the acquisition of the remaining interest in SPX. In addition, the Company changed its auditor from Marcum LLP to Davidson & Company LLP. The Company incurred charges related to the change in auditors and duplicate fees for matters that required both auditors to opine on, such as inclusion of prior year audited figures in various documents.

Wages and benefits increased by $1,577,008 (53%) to $4,552,496 in the period from $2,975,488 in 2024. The increase was a result of performance bonuses paid in the period to certain employees. Bonus in 2025 totaled $1,355,000. Only a small bonus was paid in 2024. The success of development to date and in the future is contingent on performance of key staff. Many development and financials goals were achieved during the period and retention of these employees will be critical to POET's continued success. The Company also had salary increases in the period.

Finance advisory fees increased by $1,725,975 (61%) to $8,227,774 in 2025 from $6,501,799 in 2024. The finance advisory fees are paid to a firm assisting the Company on financial and strategic matters. The firm's guidance contributed to the Company's capital raise success in 2025, which exceeded $293 million.

Non-cash derivative warrant liability adjustment increased by $4,649,751 to $25,280,833 in 2025 from $20,631,082 in 2024. The Company issued warrants in a foreign currency in 2024 and 2025. The issuance of those warrants created a derivative liability which is periodically remeasured and adjusted to reflect the fair value of the warrants. The Company had a non-cash adjustment in 2025 related to the fair value adjustment of the derivative liability on the remaining and exercised warrants. 5,692,428 of these warrants were exercised in 2025.

During 2024, the Company acquired the remaining 24.8% interest of SPX from SAIC. The acquisition of this interest resulted in a non-cash loss to the Company of $6,852,687. The Company did not have a similar loss in 2025.

Other income, including interest, increased by $3,597,807 (377%) to $4,553,061 in 2025 from $955,254 in 2024. The amounts recognized in both periods were all interest income earned on the Company's cash reserves. The company raised significant funds in 2024 and 2025.

General expenses and rent increased by $1,193,243 (61%) to $3,152,804 in 2025 from $1,959,561 in 2024. During 2025, the Company increased its investor relations and marketing initiatives. The Company engaged a new firm to assist with these services during the period. Additionally, the Company moved its operations in Singapore to a new and larger facility. The Company paid rent for both facilities for a portion of 2025.

Unrealized foreign exchange gain was $229,217 in 2025 compared to nil in 2024. The unrealized foreign exchange gain is a result of the volatility of the U.S. dollar during 2025 in relation to other currencies that the Company has in reserve.

Year Ended December 31, 2024 compared to Year Ended December 31, 2023

Net loss for 2024 was $56,695,823 compared to a net loss of $20,267,365 in 2023, an increase of $36,428,458 (180%). The following discusses the significant variances between the period and 2023:

Total R&D increased by $1,256,711 (12%) to $11,334,641 for the year ended December 31, 2024 from $10,077,930 for the same period in 2023. For the purposes of the following analysis, non-cash stock-based compensation of $2,091,583 has been excluded and is included with the analysis of non-cash stock-based compensation below.

Non-cash stock-based compensation increased by $1,267,925 (30%) to $5,469,369 in 2024 from $4,201,444 in 2023. The valuation of stock options is driven by a number of factors including the number of options granted, the strike price and the volatility of the Company's stock. The stock option expense is dependent on the timing of the stock option grant and the amortization of the options as they vest. The stock options vest in accordance with the policies determined by the Board of Directors at the time of the grant consistent with the provisions of the Plan.

Professional fees increased by $191,821 (11%) to $1,936,592 in 2024 from $1,744,771 in 2023. During 2024, the Company incurred professional fees related various finance and corporate restructuring projects including the acquisition of the remaining interest in SPX. In addition, the Company changed its auditor from Marcum LLP to Davidson & Company LLP. The Company incurred charges related to the change in auditors and duplicate fees for matters that required both auditors to opine on such as inclusion of prior year audited figures in various documents.

Wages and benefits increased by $325,718 (12%) to $2,975,488 in 2024 from $2,649,770 in 2023. The increase was a result of performance and retention bonuses and salary increases paid to certain members of the team.

During the year, the Company incurred $6,501,779 in finance advisory fees paid to a firm assisting the Company financial and strategic matters. The firm's guidance contributed to the Company's capital raise success in 2024 which exceeded $80 million. The Company did not engage other firms for similar services in 2023.

Non-cash derivative warrant liability increased by $20,606,217 to $20,631,082 in 2024 from $24,865 in 2023. The Company issued warrants in a foreign currency in Q4 2023 and during 2024. The issuance of those warrants created a derivative liability which is periodically remeasured and adjusted to reflect the fair value of the warrants. The Company had a non-cash adjustment during the period related to the fair value adjustment of the derivative liability on the remaining and exercised warrants. 1,598,200 of these warrants were exercised in 2024.

During 2024, the Company acquired the remaining 24.8% interest of SPX from SAIC. The acquisition of this interest resulted in a non-cash loss to the Company of $6,852,687. The Company did not have a similar loss in 2023.

Interest expense increased by $32,491 (46%) to $102,673 in 2024 from $70,182 in 2023. $90,041 of the interest expense was non-cash.

Other income, including interest increased by $720,264 (307%) to $955,254 in 2024 from $234,990 in 2023. The amounts recognized in both periods were all interest income earned on the Company's cash reserves. The company raised significant funds during 2024.

Exchange Rate Risk

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled except for the Canadian entity which has determined that the U.S. Dollar is its functional currency. Functional currencies include the Chinese Yuan, US, Singapore and Malaysian Ringgit. Most transactions within the entities are conducted in functional currencies. None of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk when its subsidiaries hold current assets or current liabilities in currencies other than its functional currency. A 10% change in foreign currencies held would increase or decrease other comprehensive loss by $2,000,000.

Liquidity Risk

The Company currently does not maintain credit facilities. The Company's existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the date of these consolidated financial statements. The Company may, however, need to seek additional financing in the future.

**B.**  ***Liquidity and Capital Resources*.** 

The Company had working capital of $170,708,559 on December 31, 2025 compared to working capital of $7,145,097 on December 31, 2024. The Company's statement of financial position as of December 31, 2025 reflects assets with a book value of $328,572,438 compared to $69,652,449 as of December 31, 2024. Ninety six percent (96%) of the book value at December 31, 2025 was in current assets consisting primarily of cash, cash equivalents and short-term investments of $313,398,303 compared to eighty (80%) of the book value as of December 31, 2024, which consisted primarily of cash and cash equivalents of $53,816,570. The working capital of $170,708,559 (2024 - $7,145,097) includes non-cash current liabilities of $135,631,585 (2024 - $35,750,607) related to derivative warrant liability and $5,800,000 (2024 - $6,500,000) in convertible debt which will be paid over a period of four years, however, the holder has the right to convert any unpaid amount into shares of the Company at its discretion, and it is therefore classified as current.

During the twelve months ended December 31, 2025, the Company had negative cash flows from operations of $31,086,629. The Company purchased short-term investments of $256,766,291 using its excess cash resources. Additionally, the Company purchased property and equipment and patents and licenses of $2,310,367. To fund its operations and investing activities during the period. The Company raised equity capital, net of issue costs of $293,241,655 while repaying $719,365 of convertible debt. Of the capital raised, the Company has approximately $313,000,000 remaining to be spent.

The following is a summary of Company's cash flows and working capital:

---

| | | | |
|:---|:---|:---|:---|
|  | 2025 | 2024 | 2023 |
|  | $ | $ | $ |
| Net cash used in operating activities) |  |  |  |
| Net cash from investing activities) |  |  |  |
| Net cash from financing activities |  |  |  |
| Effect of exchange rate changes on cash) |  |  |  |
| Change in cash) |  |  |  |
| Opening cash |  |  |  |
| Ending cash |  |  |  |

---

Operating Activities

During 2025, the Company recorded consolidated losses of $62,963,213 (2024 - $56,695,823, 2023 - $20,267,365).

The operating activities included the following non-cash items: non-cash stock-based compensation of $6,107,052 (2024 - $5,469,369, 2023 - $4,201,444), depreciation and amortization of $3,315,899 (2024 - $2,020,195, 2023 - $1,922,161), non-cash interest of $144,047 (2024 - $90,041, 2023 - $53,614). Gain on contribution of intellectual property to joint venture was nil (2024 – nil, 2023 - $1,031,807) while the Company had a share of loss in joint venture of nil (2024 – nil, 2023 - $1,031,807). The Company had a non-cash adjustment of $25,280,833 (2024 - $20,631,082, 2023 - $24,865) related to the fair value adjustment of the derivative liability. Other non-cash operating costs (income) was $399,182 (2024 -$(18,766), 2023 – nil). The Company reported a loss of nil (2024 - $6,852,687 on the acquisition of 24.8% of SPX, 2023 - nil).

The Company will regularly have high non-cash stock-based compensation as it uses stock options as method of attracting, retaining and motivating directors, employees and consultants of the Company and any of its subsidiaries and to closely align the personal interests of such directors, employees and consultants with those of the shareholders by providing them with the opportunity, through options, to acquire common shares in the capital of the Company while managing compensation through cash.

Prior to 2025, the Company's investment was accounted for as a joint venture. The Company recognized a gain of nil for the year ended December 31, 2024 (2023 - $1,031,807) related to its contribution of intellectual property to SPX in accordance with IAS 28. The Company only recognizes a gain on the contribution of the intellectual property equivalent to SAIC's interest in SPX. Additionally, the Company recognizes its share of SPX's losses using the equity method. On a weighted average basis, the Company's share of the net operating loss was 75.2% or $(2,942,820), however the Company recognized nil of the net operating loss of SPX for the year ended December 31, 2024 (2023 - 78.9% or ($1,031,807)). No further loss is recorded in 2024 and 2023 because the carrying value is nil.

On December 31, 2024, the Company acquired Sanan IC's 24.8% interest in SPX in exchange for a convertible debt of $6,500,000 to be paid, interest-free, over a period of five (5) years as follows:

---

| | | |
|:---|:---|:---|
| October 31, 2025 | $700000 | (paid) |
| October 31, 2026 | $1000000 |  |
| October 31, 2027 | $1300000 |  |
| October 31, 2028 | $1600000 |  |
| October 31, 2029 | $1900000 |  |

---

At any time before the convertible debt is fully settled, SAIC has the right to convert any remaining balance owing into shares of common stock of the Company at a conversion price equal to the greater of:

(a) the
 volume weighted average closing price ("VWAP") of the common stock of the Company as reported by the NASDAQ Capital Market
 for thirty (30) days prior to the conversion date; or

(b) the
 closing price of the common stock of the Company as reported by the NASDAQ Capital Market the day prior to the conversion date.

The acquisition of SAIC's 24.8% interest in SPX, under which the Company obtains full control over SPX, was determined to be an asset acquisition because SPX did not meet the threshold of a business as defined by IFRS 3. This acquisition provides the Company with flexibility to do business with partners and customers inside and outside of China without the limitations and restrictions imposed by the joint venture agreement. With 100% control of SPX, the Company now as the ability to focus on other opportunities not tied to the development of SPX.

The Company determined that the convertible debt represents a hybrid financial instrument that contains 1) a host debt principal component, 2) a market price conversion feature that is a non-derivative with a value of nil that is not separable from the host debt and, 3) the VWAP conversion option that is a derivative with a nil value. As Sanan IC can exercise the conversion option at any time, the convertible debt is classified as current liability. As SAIC can exercise the conversion option at any time, the convertible debt is classified as current liability.

The Company issued warrants in a foreign currency in 2023, 2024 and 2025. The issuance of those warrants created a derivative liability which is periodically remeasured and adjusted to reflect the fair value of the warrants. The Non-cash derivative warrant liability adjustment was $25,280,833 (2024 - $20,631,082, 2023 - $24,865).

Other income, including interest was $4,553,061 (2024 - $947,956, 2023 - $234,990). The amounts recognized were all interest income earned on the Company's cash reserves. Significant capital was raised in 2024 and 2025 which contributed to the high interest earned in 2024 and 2025.

Consolidated negative cash flow from operations was $31,086,629 for 2025 (2024 - $23,291,311, 2023 - $15,407,462).

Investing Activities

The Company had consolidated negative cash flows from investing activities of $259,170,200 (2024 - $23,661,580, 2023 - $1,247,064). The Company purchased short-term investments of $256,766,291 (2024 - $16,672,811, 2023 – nil). Short-term investments are in interest-bearing facilities in accordance with the Company's investment policy. In 2025, $2,310,367 (2024 - $6,978,712, 2023 - $1,247,064) was used to purchase new equipment and patents. In 2024, the Company received cash of $97,833 when it acquired the remaining shares of SPX. The Company leased new operating facilities in Singapore for which it was required to place a refundable deposit of $93,542 (2024 - $107,890, 2023 – nil) that will be returned at the end of the five year lease.

Financing Activities

During the year ended December 31, 2025, the Company raised net proceeds of $293,241,655 (2024 - $82,176,180, 2023 – $10,447,603) from the issuance common shares through various equity offerings, the exercise of stock options and warrants, and the use of its Equity Distribution Agreement, ("EDA"). Pursuant to the EDA, the Company established an at-the-market ("ATM") equity offering program whereby the Company may, at its discretion, during the term of the ATM agreement issue and sell, through the agents such number of common shares of the Company as would result in aggregate gross proceeds to the Company of up to $30 million. The ATM was not used to raise capital in 2025.

The following presents details of the funds raised in 2025 using the facilities above are presented below:

May 22, 2025

On May 22, 2025, the Company raised gross proceeds of CAD$41,574,279 ($30,000,000) from the issuance of 6,000,000 units through a non-brokered private placement financing at a price CAD$6.92 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 6,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.32 ($6.00) per share.

July 17, 2025

On July 17, 2025, the Company raised gross proceeds of CAD$34,000,000 ($25,000,000) from the issuance of 5,000,000 units through a non-brokered private placement financing at a price CAD$6.80 ($5.00) per unit. Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.16 ($6.00) per share.

October 7, 2025

On October 7, 2025, the Company raised gross proceeds of CAD$104,625,002 ($75,000,000) from the issuance of 13,636,364 units through a non-brokered private placement financing at a price CAD$7.67 ($5.50) per unit. Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$9.78 ($7.03) per share.

October 28, 2025

On October 28, 2025, the Company raised gross proceeds of $150,000,000 from the issuance of 20,689,655 common shares through a brokered registered direct offering at a price of $7.25 per share. The Company paid approximately $7,585,000 in fees related to this offering.

The Company incurred other share issuance costs of $8,048,167 related to these financings.

Operating and Investing Activities

The Company's existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the date of these consolidated financial statements.

**C.**  ***Research and Development*.** 

Beginning in 2017, POET began designing lasers for data communications applications and directed DenseLight Semiconductors, Pte. Ltd., a former subsidiary of the Company, to build such lasers to be compatible with the Optical Interposer platform. In 2019, the Company decided to adopt a "fab light" strategy, common among semiconductor companies, and divested its fabrication operations through the sale of DenseLight in November of that year. From 2018 - 2020, virtually all the R&D spending in the Company was dedicated to design & development of the Optical Interposer as a versatile platform technology, replete with features that enhance its utility across a variety of application spaces.

During the second half of 2021, the Company transitioned to product development by investing more than $2 million in the design & development of 100G and 200G optical engines in several configurations, including customized designs for specific customers and applications. Samples of optical engines at various stages of development were made available and delivered to customers in 2022 for initial evaluation and in 2023 for design and customer qualification. POET's effort in lower speed Optical Engine design and production was intended primarily as a way for POET to demonstrate the viability and market acceptance of its unique approach to integration and fabrication and to establish an initial presence in the market. However, the Company's primary strategy is to offer Optical Engines at the highest speeds at which customers are deploying optical transceivers. Our focus for 2026 is to develop for sale Optical Engines for 1.6Tbs optical modules and to produce Light Source products incorporating our proptietary hybrid laser, which we have named the "Blazar™". Our sales of these products will be to module makers that are heavily focused on selling to hyperscale data centers actively implementing AI services. Consistent with this strategy, the Company has invested approximately $30 million in design, development and engineering programs related to its 400G, 800G and 1.6T transmit and receive chipsets, in external light source products, which are delivered in module form, and in fabrication and testing techniques related to its Optical Interposer platform.

The Company designed, tested and sampled a first generation of its 400G transmit (Tx) engines in 2024, and its 800G receive (Rx) engine with various customers. The 800G Rx engine was well received, fully qualified and has been designed into the optical transceiver modules of several customers during 2024 and 2025. The Company sampled its second generation of 400G and 800G Tx engines in 2025 as well as both Tx and Rx versions of its 1.6T optical engine chipsets. So long as the Company provides Optical Engines to optical transceiver module customers, there will always be customer centric adjustments to these products to fit their specific needs. The cost to make these adjustments will vary depending on the customer requirements.

The Company invested approximately $15.9 million in 2025 in the development of its 800G and 1.6T optical engine chipsets and light sources for artificial intelligence and is expected to invest an additional $30 million over the next two years on these products. The Company de-prioritized the development and sale of POET optical transceiver modules in 2025 to avoid conflicts with its module customers. Instead, we are deploying an estimated $8.0 million over the next two years toward our development of light source products.

Internally generated research costs, including the costs of developing intellectual property and maintaining patents are expensed as incurred. Internal development costs are expensed as incurred unless such costs meet the criteria for capitalization and amortization under IFRS, which to date has not occurred.

We incurred a cumulative $18,084,303, $11,334,641 and $10,077,930 of research and development expenses during the years ended December 31, 2025, 2024 and 2023 which includes non-cash stock-based compensation of $2,216,914, $2,091,583 and $1,539,235 respectively. Other expenses related to research and development expenditures in the semiconductor business include costs associated with salaries, material costs, license fees, consulting services and third-party contract manufacturing. The expenses in all years presented can be analyzed for continuing and discontinuing operations as follows:

**R&D for Continuing Operations**

---

| | | | |
|:---|:---|:---|:---|
|  | For the Years Ended December 31, | For the Years Ended December 31, | For the Years Ended December 31, |
|  | 2025 | 2024 | 2023 |
| Wages and benefits | $7000637 | $4388075 | $4298207 |
| Subcontract fees | 2797721 | 2134948 | 1864122 |
| Stock-based compensation | 2216914 | 2091583 | 1539235 |
| Supplies | 606931 | 2720035 | 2376366 |
|  | $18084303 | $11334641 | $10077930 |

---

**D.**  ***Trend Information*.** 

Other than as may be disclosed elsewhere in this annual report and specifically in Item 4.B. "Business Overview," we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on our net revenues, income from operations, profitability, liquidity or capital resources, or that would cause the disclosed financial information to be not necessarily indicative of future operating results or financial condition.

**E.**  ***Critical Accounting Estimates*.** 

***Business combinations***

Acquisitions of businesses are accounted for using the acquisition method. The acquisition cost is measured at the acquisition date at the fair value of the consideration transferred, including all contingent consideration.

The determination of whether a corporate entity or set of assets acquired, and liabilities assumed, constitute a business may require the Company to make certain judgements, considering all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits. SPX was determined to constitute an acquisition of assets.

***Determination of functional currency***

The Company determines the functional currency through an analysis of several indicators such as expenses and cash flow, financing activities, retention of operating cash flows, and frequency of transactions within the reporting entity.

 ****

***Valuation of share-based compensation***

The Company uses the Black-Scholes Option Pricing Model for valuation of share-based compensation and derivative warrant liability. Option pricing models require the input of subjective assumptions including expected price volatility, risk-free interest rate, and forfeiture rate. Changes in the input assumptions can materially affect the fair value estimate and the Company's earnings and equity reserves.

**Property and equipment**

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

Machinery and equipment Straight Line, 5 years <br> Leasehold improvements Straight Line, term of the lease <br> Office equipment Straight Line, 3 - 5 years

**Patents and licenses**

Patents and licenses are recorded at cost and amortized on a straight line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

**Income taxes**

In assessing the probability of realizing income tax assets, management makes estimates related to expectation of future taxable income, applicable tax opportunities, expected timing of reversals of existing temporary differences and the likelihood that tax positions taken will be sustained upon examination by applicable tax authorities. In making its assessments, management gives additional weight to positive and negative evidence that can be objectively verified.

 

*Selected Annual Data*

The selected financial data of the Company for the years ended December 31, 2025, 2024 and 2023 was derived from the audited annual consolidated financial statements of the Company. The December 31, 2025 and 2024 audited consolidation financial statements were audited by Davidson & Company LLP and the December 31, 2022 audited consolidated financial statements were audited by Marcum LLP, both firms are independent registered public accounting firm, as described in their report which is included in this Annual Report.

The information contained in the selected financial data for the 2025, 2024 and 2023 years is qualified in its entirety by reference to the Company's consolidated financial statements and related notes included under the heading Item 17. "Financial Statements" and should be read in conjunction with such financial statements and with the information appearing under the heading Item 5 "Operating and Financial Review and Prospects". Except where otherwise indicated, all amounts are presented in accordance with IFRS as issued by IASB.

**Item 6. Directors, Senior Management and Employees**

**A.**  ***Directors and Senior Management*.** 

The following table sets forth information regarding our Directors and Senior Management for the most recent fiscal year.

---

| | | | |
|:---|:---|:---|:---|
| Name | Positions | Age | Date First Elected or<br> Appointed a<br> Director or Officer |
| Jean-Louis Malinge (1)(3)(4) | Lead Independent Director, Corporate Governance and Nominating Committee Chair | 72 | September 5, 2017 |
| Sohail Khan (3)(4) | Director | 71 | July 7, 2025 |
| Dr. Suresh Venkatesan (4) | Chief Executive Officer and Chairman<br> Chair of Ad Hoc Strategy Committee | 59 | June 11, 2015 |
| Kevin Barnes | VP Finance & Administration, Corporate Controller and Treasurer | 54 | December 1, 2012 |
| Thomas R. Mika | EVP & Chief Financial Officer | 74 | November 2, 2016 |
| Chris Tsiofas (1)(2)(5) | Director<br> Audit Committee Chair | 58 | August 21, 2012 |
| Glen Riley (1)(2)(4) | Director<br> Compensation Committee Chair | 63 | December 7, 2020 |
| Theresa Ende (2)(3)(4) | Director | 69 | October 14, 2022 |
| Robert Tirva (1)(2)(4) | Director, Audit Committee Chair | 60 | December 5, 2024 |
| Raju Kankipati | Chief Revenue Officer | 47 | May 1, 2022 |
| Dr. Mo Jinyu | SVP, Global Product Development | 51 | January 1, 2022 |
| Dr. Robert Ditizio | VP – Intellectual Property | 63 | December 1, 2021 |
| Ghazi Chaoui | SVP – Global Manufacturing & Digital Transformation | 71 | May 12, 2025 |
| Yong Meng (James) Lee | VP – Interposer Engineering | 53 | September 2, 2019 |
| Vivek Rajgarhia (6) | President & General Manager | 58 | November 4, 2019 |
| Dan Meerovich (7) | VP – Product Engineering | 65 | March 2, 2020 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Member
 of Audit Committee

(2) Member
 of Compensation Committee

(3) Member
 of Corporate Governance and Nominating Committee

(4) Member
 of Ad Hoc Strategy Committee

(5) Resigned
 from the Board on June 27, 2025

(6) Resigned
 on June 27, 2025

(7) Resigned
 on March 31, 2025

Dr. Suresh Venkatesan as CEO. Prior to joining POET in 2015 as CEO, Dr. Venkatesan was the Senior Vice President, Technology Development at GlobalFoundries and was responsible for the Company's Technology Research and Development. He joined GlobalFoundries in 2009, where he led the development and ramp of the 28nm node and was instrumental in the technology transfer and qualification of 14nm. In addition, he was responsible for the qualification and ramp up of multiple mainstream value-added technology nodes. Dr. Venkatesan is an industry veteran with over 22 years of experience in semiconductor technology development. Prior to joining GlobalFoundries, he held various leadership positions with Freescale Semiconductor in Austin, Texas. He holds over 25 US patents, and has co-authored over 50 technical papers. He earned a Bachelor of Technology degree in Electrical Engineering from the Indian Institute of Technology and a Master of Science and PhD degrees in Electrical Engineering from Purdue University.

Mr. Vivek Rajgarhia serves as President and General Manager. Before joining POET, Mr. Rajgarhia served as Senior Vice President & General Manager of the Lightwave Business Unit of MACOM (NASDAQ: MTSI). Mr. Rajgarhia joined MACOM through the acquisition of Optomai Inc., where he was the Co-Founder and CEO, to start MACOM's first optical business. He was then instrumental in identifying and leading several strategic acquisitions to build an extensive portfolio of optical and photonic businesses, which formed MACOM's Lightwave Business Unit. Mr. Rajgarhia has held several senior management positions during his 30 years in the optical communications industry. He was Director of Sales & Marketing (Asia) for Lucent Technologies' (now Nokia) optical components, where he started Lucent's Asia business; Vice President of Product Marketing and Business Development for OpNext (formerly Hitachi's Fiber Optics Division), now Lumentum, where he was part of the team to spin-off the optical business from Hitachi; Director of Product Management & Marketing for JDS Uniphase (now Lumentum), and VP of Global Sales for GigOptix. Mr. Rajgarhia has been a successful entrepreneur, founding two optical companies, and has held international assignments in Hong Kong, Germany and India. He holds a Bachelor of Engineering (Electrical) degree from Stevens Institute of Technology in New Jersey.

Mr. Thomas Mika serves as EVP & CFO. Prior to joining POET, Mika served for one year as the Executive Chairman of Rennova Health, Inc., the successor company to CollabRx and its predecessor, Tegal Corporation, a semiconductor capital equipment company (NASDAQ: TGAL). On the Board of Directors of Tegal since its spin-out from Motorola in 1989, Mika assumed the roles of Chief Financial Officer in 2002, CEO in 2005 and Chairman & CEO in 2006, positions which he held until 2015. In 2015, Tegal merged with Rennova Health with Mika retaining the position of Chairman until joining POET in November 2016. In 1980, Mika co-founded IMTEC, a boutique M&A, investment and consulting firm, serving clients in the U.S., Europe and Japan over a period of 20 years, taking on the role of CEO in several ventures. Earlier in his career, Mika was a managing consultant with Cresap, McCormick & Paget and a policy analyst for the National Science Foundation. He holds a Bachelor of Science in Microbiology from the University of Illinois at Urbana-Champaign and a Master of Business Administration from the Harvard Graduate School of Business.

Mr. Kevin Barnes has been serving as Corporate Controller and Treasurer since 2008 and briefly as Chief Financial Officer (2012 – 2016). Mr. Barnes holds a Master of Business Administration and is a member of the Institute of the Certified Management Accountants of Australia and an Accredited Chartered Secretary. Mr. Barnes served as a Corporate Controller and Business Performance Manager for EC English, one of the world's largest language training institutes between 2006 and 2014. Mr. Barnes also serves as Chief Financial Officer of VVC Exploration Corporation, a minerals exploration company since 2006. From 2000 to 2006, he was a reporting manager with Duguay and Ringler Corporate Services, which specializes in financial reporting for publicly traded companies.

Dr. Mo Jinyu is a highly experienced technical and business veteran of the photonics and optoelectronics industries. Her expertise covers optical transmission system, advanced optical modulation format, tunable semiconductor lasers, DFB and FP lasers and PD/APD, optical transceiver modules and high-speed integrated packaging. Dr. Mo has more than 22 years of experience spanning several companies, including MACOM Technology Solutions, Bookham/Oclaro, Huawei, I2R in Singapore and Nexvave Photonics Technology Co., which she founded and served as Chief Technology Officer. Dr. Mo was most recently with MACOM as the Senior Director and Chief Scientist of the Lightwave business unit in Asia and site leader in Shenzhen. Dr. Mo received her PhD degree in Optical Communications from Nanyang Technological University (NTU) Singapore. She is a senior member of IEEE and has been a member of IEEE's Technical Committees for several international conferences. She has over 11 patents and more than 40 papers published in tier one journals and conferences.

Mr. Raju Kankipati brings over 20 years of experience in Optical transceivers, Optical components, Cloud data center and networks to POET. He was a Senior Director of Product Management at MACOM, focused on optical components and photonic solutions. Prior to that, Raju worked at Arista Networks as a Senior Product Manager and Engineering Manager. During this time he collaborated closely with data center customers to bring unique switching products as well as Optical transceivers to market, that helped customers deploy 40G and 100Gbps products for highly scalable and efficient networks. Raju worked as a Product Manager at Cisco prior to joining Arista. Raju started his career as an Optics Engineer at Opnext and later held various roles in sales and marketing at the company. Raju received his MBA degree from UC Berkeley (Haas School of Business) and completed his Bachelor of Engineering in Electronics from BITS, Pilani in India.

Mr. Chris Tsiofas, CA, CPA, earned a Bachelor's of Commerce Degree from the University of Toronto and is a member of the Chartered Professional Accountants of Canada and the Canadian Tax Foundation. He has been on the Board of Directors since August of 2012 and has served as the Chair of the Audit Committee during his entire tenure In February 2024 he was appointed to the Board of Directors of Andrew Peller Limited (TSE:ADW) and serves as the Chair of the Audit and Pension Committees. Andrew Peller Ltd. is a leading producer and marketer of quality wines and craft beverage alcohol products in Canada. With wineries in British Columbia, Ontario, and Nova Scotia, the Company markets wines produced from grapes grown in Ontario's Niagara Peninsula, British Columbia's Okanagan and Similkameen Valleys, and from vineyards around the world. He is the president of MTN Chartered Professional Accountant Professional Corporation, a public accountancy firm. He sits on various private company boards. He has also served in a principal capacity in various entrepreneurial ventures resulting in successful divestitures

Mr. Jean-Louis Malinge recently retired as partner with ARCH Venture Partners, an early-stage venture capital firm with nearly $2 billion under management. Additionally, he is a board member of CAILabs. CAILabs is a venture-backed French innovative start-up founded in 2013 which has developed a unique spatial multiplexing platform.. From 2004 to 2013 Jean-Louis was President and CEO of Kotura, a Silicon Photonics pioneer which was acquired in 2013 by Mellanox Technologies. Prior to Kotura, Mr. Malinge was an executive with Corning Inc for 15 years. Jean-Louis hold an Executive M.B.A. from MIT Sloan School in Boston, Massachusetts. He also holds an engineering degree from the Institut National des Sciences Appliquées in Rennes, France.

Mr. Yong Meng (James Lee) is General Manager of the Company's Singapore subsidiary. Prior to his appointment in 2019, Mr. Lee was Vice President of Logic Technology at IMEC where he was responsible for defining the logic roadmap and developing the technology elements necessary to extend scaling with ultra-scaled FinFET, GAA devices, advanced metallization as well novel materials for emerging devices and quantum computing. Mr. Lee joined IMEC in 2015 where he was instrumental in driving collaborations with the foundries in China and was responsible for bringing in >100M euros of research partnership. Prior to IMEC, Mr. Lee had a 19-year career with GLOBALFOUNDRIES where he held various technical and management positions spanning the US and Singapore focused on developing, qualifying and ramping leading edge CMOS technology in the foundry. He has over 60 patents and holds a Bachelor of Engineering degree from the University of Illinois at Champaign-Urbana.

Mr. Glen Riley has more than 30 years' experience in leadership roles spanning both the semiconductor and optoelectronics industries. He most recently served as General Manager of the Filter Solutions Business Unit at Qorvo, where he was responsible for developing highly integrated RF modules used in flagship smartphones. Prior to the merger of RFMD and TriQuint that formed Qorvo, he held multiple leadership roles at TriQuint, including Managing Director of international headquarters in Singapore, General Manager of the GaAs foundry business, and General Manager of Optoelectronics. Riley was previously the Chief Executive Officer of Opticalis, an early stage optoelectronics company focused on the development of high-density wavelength division multiplexing products. He also held prior roles as Vice President and General Manager of the Optoelectronic business at Agere Systems, and President of Asia-Pacific Sales and Marketing at Lucent Technologies Microelectronics Group. He graduated as valedictorian with a B.S. degree in Electrical Engineering from the School of Engineering at the University of Maine and completed the General Manager Program at Harvard Business School.

Ms. Theresa Lan Ende serves as Chief Procurement Director of Arista Networks. Prior to her appointment as Chief Procurement Director in 2019, Ms. Ende served for 10 years as its Senior Director of Global Supply Chain Management. Prior to Arista, she held senior positions at JDSU Optical Division and Force10 Networks. At Cisco Systems and ROLM Telecommunications, Ms. Ende held various program management and planning management positions over a 20-year period. In 2019, she was honored as one of the "Top 100 Women of Influence" by Silicon Valley Business Journal.

Mr. Bob Tirva brings over 30 years of executive experience in the technology industry and several years of advisory experience as a director of companies advancing semiconductor technology. Throughout his career, Mr. Tirva held various management positions at IBM, Broadcom Corporation, Dropbox and Intermedia Cloud Communications Inc. before assuming the role of President, Chief Operating Officer and Chief Financial Officer of Sonim Technologies, Inc. until it was acquired by AJP Holding Company in 2022.

Mr. Sohail Khan is a seasoned business executive in high technology firms with wide ranging experience. He raised $1 billion in funding in 2023 and established "SiC LLC," a subsidiary of Coherent Corp., through strategic partnerships with Denso and Mitsubishi, leaders in the automotive and industrial markets. While at Coherent, Mr. Khan formed those strategic partnerships to expedite the corporation's technology roadmap and secure the necessary investments to compete with established Integrated Device Manufacturers. Along with his time as President of SiC, LLC, at Coherent, he most recently served as Executive Vice President, Wideband Gap Electronics. He was a member of the Board of Directors of LightPath Technologies for 16 years, Managing Partner of K5 Innovations LLC, and President & CEO of ViXS Systems Inc., a global fabless semiconductor company, and member of the Board of Intersil Corporation. Experienced in Corporate Governance, Mr. Khan has served on the Audit, Compensation and Finance committees of several private and public company boards. A strong leader with a track record of anticipating and developing new technologies, Mr. Khan has extensive M&A experience, having negotiated sale or purchase of multiple companies as CEO and Head of Strategy at Agere Systems.

Dr. Robert Ditizio joined POET Technologies Inc. as a consultant in 2017, assisting with the development of the Company's Intellectual Property portfolio for the Optical Interposer platform. Dr. Ditizio was appointed Vice President in December 2021. He brings to POET over 20 years of IP portfolio management expertise and an expansive knowledge of materials and semiconductor processing technology.

Prior to his work with POET Technologies, Dr. Ditizio played an instrumental role in the development of manufacturing and processing equipment for companies in the semiconductor industry, including plasma reactors and cluster tool platforms for advanced etching and deposition processes in a range of engineering positions, culminating as Chief Technologist of Tegal Corporation. In addition to equipment development, he also led the development of numerous semiconductor patterning applications including non-volatile memory etch applications, through silicon via applications, and compound semiconductor etch applications, among many others, and the development of deposition applications including CVD of polymeric films and pulsed CVD and ALD of barrier layers and complex stoichiometric films. Dr. Ditizio holds 10 patents in these areas and has published numerous technical papers. He holds BS, MS, and PhD degrees in Engineering Science from Pennsylvania State University and an MBA from the Sonoma State University.

Mr. Dan Meerovich brings to POET more than 30 years of experience in developing and manufacturing innovative photonics products at MACOM, Apogee (now Broadcom), Oclaro, Multiplex (now Hisense) and JDS Uniphase. At MACOM's Lightwave Business Unit, he led the test, product and process engineering for lasers, photodetectors, AWG waveguides, optical engines and silicon photonic PICs. Dan developed the low-cost and scalable process of laser integration onto silicon photonic integrated circuits.

As Vice President of Operations, Dan has set up wafer fabrication facilities, run manufacturing operations at Multiplex and Xtellus (acquired by Oclaro) and built and managed a China-based manufacturing subsidiary acquired by Hisense. In addition, Dan set up and managed contract manufacturers to scale production of both high performance and low-cost optical modules. Earlier in his career, Dan led the development of photonic engines incorporating high speed lasers and EMLs, including the first uncooled EML module in a low cost TO platform. The company, Apogee, was later acquired by Cyoptics which was then acquired by Broadcom. Dan holds BSEE and MBA degrees from Rutgers University.

Mr. Vivek Rajgarhia serves as President and General Manager. Before joining POET, Mr. Rajgarhia served as Senior Vice President & General Manager of the Lightwave Business Unit of MACOM (NASDAQ: MTSI). Mr. Rajgarhia joined MACOM through the acquisition of Optomai Inc., where he was the Co-Founder and CEO, to start MACOM's first optical business. He was then instrumental in identifying and leading several strategic acquisitions to build an extensive portfolio of optical and photonic businesses, which formed MACOM's Lightwave Business Unit. Mr. Rajgarhia has held several senior management positions during his 30 years in the optical communications industry. He was Director of Sales & Marketing (Asia) for Lucent Technologies' (now Nokia) optical components, where he started Lucent's Asia business; Vice President of Product Marketing and Business Development for OpNext (formerly Hitachi's Fiber Optics Division), now Lumentum, where he was part of the team to spin-off the optical business from Hitachi; Director of Product Management & Marketing for JDS Uniphase (now Lumentum), and VP of Global Sales for GigOptix. Mr. Rajgarhia has been a successful entrepreneur, founding two optical companies, and has held international assignments in Hong Kong, Germany and India. He holds a Bachelor of Engineering (Electrical) degree from Stevens Institute of Technology in New Jersey.

The Directors, unless otherwise noted above, have served in their respective capacities since their election and/or appointment, and will serve until the next Company's annual general meeting or until a successor is duly elected, unless the office is vacated in accordance with the Articles of Continuance.

The Board has adopted a written Code of Business Conduct and Ethics to promote a culture of ethical business conduct and relies upon the selection of persons as directors, senior management and employees who they consider to meet the highest ethical standards. The Company's Code of Business Ethics can be found on the Company's web site at: <u>www.poet-technologies.com</u>.

There are no family relationships between any of our Directors or senior management. There are no arrangements or understandings with major shareholders, customers, suppliers or others, pursuant to which any person referred to above was selected as a Director or member of senior management.

**B.**  ***Compensation*.** 

Fixed Stock Option Plan

On September 21, 2007, the Directors approved a fixed 20% vesting Stock Option Plan (the "Plan") to replace the Rolling Stock Option Plan that had been in effect since May 4, 2005. The Plan was approved by the disinterested shareholders of the Company at the Shareholders' Meeting of June 19, 2008. Under the Plan, the maximum number of shares (the "Maximum Number") which may be issued pursuant to options granted under the Plan or otherwise granted cannot exceed 20% of the issued and outstanding shares. The shareholders fixed the Maximum Number at 1,193,000. Thereafter, the Plan has been amended by the Directors, and such amendments have been approved by the shareholders in 2009, 2011, 2013, 2014, 2015, 2016, 2018, 2020 and 2021.

Omnibus Plan

On June 27, 2025, shareholders of the Company approved a fixed 20% omnibus equity incentive plan (the "Omnibus Plan"). The Omnibus Plan replaces the Plan. The Omnibus Plan provides flexibility to the Company to grant different forms of equity-based incentive awards to directors, officers, employees and consultants. The Omnibus plan provides the Company with the choice of granting stock options, share units and deferred share units.

The purpose of the Omnibus Plan is to assist the Company in attracting, retaining and motivating directors, employees and consultants of the Company and any of its subsidiaries and to closely align the personal interests of such directors, employees and consultants with those of the shareholders by providing them with the opportunity, through options, to acquire common shares in the capital of the Company.

The Omnibus Plan provides that the maximum number of common shares issuable pursuant to awards granted under the Omnibus Plan and pursuant to other previously granted awards is limited to 17,007,771. Any subsequent increase in the number of reserved common shares must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. The Omnibus plan was amended by the Directors and such amendment was approved by the shareholders in 2025. Awards vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the Omnibus Plan which grants discretion to the Board of Directors.

The following paragraphs summarize some of the terms of the Omnibus Plan:

Options

An Option is an option granted by the Company to a Participant (as defined in the Omnibus Plan) entitling such Participant to acquire a designated number of Shares (as defined in the Omnibus Plan) from treasury at an exercise price set at the time of grant (the "Option Price"). Options are exercisable, subject to vesting criteria established by the Board at the time of grant as set out in the Participant's option agreement ("Option Agreement"). Each Option shall be exercisable at such time or times and/or pursuant to the achievement of such Performance Criteria (as defined in the Omnibus Plan) and/or other vesting conditions as the Board at the time of granting the particular Option, may determine in its sole discretion. The Board shall determine, at the time of granting the particular Option, the period during which the Option is exercisable, which shall not be more than ten (10) years from the date the Option is granted. Notwithstanding the expiration provisions hereof, if the date on which an Option Term expires falls within a Blackout Period (as defined in the Omnibus Plan), the expiration date of the Option will be the date that is ten (10) Business Days (as defined in the Omnibus Plan) after the Blackout Period Expiry Date (as defined in the Omnibus Plan). The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Company during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period. The Omnibus Plan also permits the Board to grant an option holder, at any time, the right to deal with such Option on a cashless exercise basis, in whole or in part by notice in writing to the Company, where the Company has an arrangement with a brokerage firm that certain procedures must take place. The Omnibus Plan also permits the Board to grant an Option holder, at any time the right to deal with such Option on a net exercise mechanism, in whole or in part by notice in writing to the Company. The grant of an Option by the Board shall be evidenced by an Option Agreement.

Share Units

A Share Unit is an Award (as defined in the Omnibus Plan) in the nature of a bonus for services rendered, or for future services to be rendered, and that, upon settlement, entitles the recipient Participant to acquire to receive a cash payment equal to the Market Value (as defined in the Omnibus Plan) of a Share or at the discretion of the Company (or applicable Subsidiary (as defined in the Omnibus Plan)) one Share or any combination of cash and Shares as the Company (or applicable Subsidiary) in its sole discretion may determine, pursuant and subject to such restrictions and conditions on vesting as the Board may determine at the time of grant, unless such Share Unit expires prior to being settled. Unless permitted under the rules of the Exchange (as defined in the Omnibus Plan), no Share Unit shall vest before the one-year anniversary from the date of grant. Restrictions and conditions on vesting conditions may, without limitation, be based on the passage of time during continued employment (or other service relationship), in which case the Award is what is commonly referred to as a "Restricted Share Unit" or "RSU", or the achievement of specified Performance Criteria, in which case the Award is what is commonly referred to as a "Performance Share Unit" or "PSU", or both. The grant of a Share Unit by the Board shall be evidenced by a Share Unit Agreement. The Board shall have sole discretion to determine if any Performance Criteria and/or other vesting conditions with respect to a Share Unit, and as contained in the Share Unit Agreement governing such Share Unit, have been met and shall communicate to a Participant as soon as reasonably practicable when any such applicable vesting conditions or Performance Criteria have been satisfied and the Share Units have vested. Notwithstanding the foregoing, if the date on which any Share Units have vested falls within a Blackout Period , the vesting of such Share Units will be deemed to occur on the date that is ten Business Days after the Blackout Period Expiry Date. The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Company during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period. Subject to the vesting and other conditions and provisions in the Omnibus Plan and in the Share Unit Agreement, each Share Unit awarded to a Participant shall entitle the Participant to receive on settlement, a cash payment equal to the Market Value of a Share or at the discretion of the Company (or applicable Subsidiary) one Share or any combination of cash and Shares as the Company (or applicable Subsidiary) in its sole discretion may determine, in each case less any applicable withholding taxes. Dividend Equivalents (as defined in the Omnibus Plan) may, as determined by the Board in its sole discretion, be awarded in respect of unvested Share Units in a Participant's Account (as defined in the Omnibus Plan) on the same basis as cash dividends declared and paid on Shares as if the Participant was a shareholder of record of Shares on the relevant record date. In the event that the Participant's applicable Share Units do not vest, all Dividend Equivalents, if any, associated with such Share Units will be forfeited by the Participant and returned to the Company's account.

Deferred Share Units

A deferred share unit ("DSU") is an Award in the nature of a deferral of payment for services rendered, or for future services to be rendered, and that, upon settlement, entitles the recipient Participant to receive cash or acquire Shares, as determined by the Company in its sole discretion, unless such DSU expires prior to being settled. Subject to adjustments and amendments in the Plan, DSUs shall only vest, and a Participant is only entitled to redemption of a DSU, when the Participant ceases to be a director, officer or employee of the Company for any reason, including termination, retirement or death. The grant of a DSU by the Board shall be evidenced by a DSU Agreement. DSUs will be fully vested on the Termination Date (as defined in the Omnibus Plan) of the applicable Participant. Notwithstanding the foregoing, if the date on which any DSUs have vested falls within a Blackout Period, the vesting of such DSUs will be deemed to occur on the date that is ten Business Days after the Blackout Period Expiry Date. The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Company during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period. Subject to the vesting and other conditions and provisions in the Plan and in any DSU Agreement, each DSU awarded to a Participant the Participant to receive on settlement a cash payment equal to the Market Value of a Share, or at the discretion of the Company, one Share or any combination of cash and Shares as the Company in its sole discretion may determine. DSUs shall be redeemed and settled by the Company as soon as reasonably practicable following the Participant ceasing to be a director, officer or employee of the Corporation but in any event not later than December 15 of the year following the calendar year in which the Participant ceases to be any of a director, officer or employee. On redemption and settlement, the Company shall deliver the applicable number of Shares, or, in the sole discretion of the Company, cash equal to the redemption amount of such DSU specified in the applicable DSU Agreement, subject to the satisfaction of any applicable withholding tax.

Eligibility.

Awards may be granted under the Omnibus Plan to Directors (as defined in the Omnibus Plan), Officers (as defined in the Omnibus Plan), Employees (as defined in the Omnibus Plan) and Consultants (as defined in the Omnibus Plan) of the Company and any of its subsidiaries.

Omnibus Plan Administration.

The Plan shall be administered and interpreted by the Board or, if the Board by resolution so decides, by a committee or plan administrator appointed by the Board. Subject to the terms of the Plan, applicable law and the rules of the Exchange, the Board (or its delegate) will have the power and authority to: (i) designate the Eligible Participants (as defined in the Omnibus Plan) who will receive Awards, (ii) fix the number of Awards, if any, to be granted to each Eligible Participant and the date or dates on which such Awards shall be granted, (iii) determine the terms and conditions of any Award, including any vesting conditions or conditions based on performance of the Corporation or of an individual ("Performance Criteria"); and (iv) and make such amendments to the Omnibus Plan and Awards made under the Omnibus Plan as are permitted by the Omnibus Plan and the rules of the Exchange.

Exercise Price.

The exercise price for Shares subject to an Award shall be determined by the Board and set forth in the Option Agreement, but shall be either (i) not less than the Market Value of such Shares at the time of the grant, less any discount permitted by the Exchange.

Amendment.

The Board may suspend or terminate the Omnibus Plan at any time, or from time to time amend or revise the terms of the Omnibus Plan or any granted Award without the consent of the Participants provided that such suspension, termination, amendment or revision shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) not adversely alter or impair the rights of any Participant, without the consent of such Participant except as permitted by the provisions of the Omnibus Plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) be in compliance with applicable law and with the prior approval, if required, of the shareholders of the Company, the Exchange, or any other regulatory body having authority over the Company.

Subject to the terms of the Omnibus Plan, the Board may, from time to time, in its absolute discretion and without approval of the shareholders of the Company make the following amendments to the Omnibus Plan, unless where required by law or the requirements of the Exchange:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any amendment to the vesting provision, if applicable, of Options or Share Units, or assignability provisions of the Awards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any amendment to the expiration date of an Award that does not extend the terms of the Award past the original date of expiration of such Award;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any amendment regarding the effect of termination of a Participant's employment or engagement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) any amendment which accelerates the date on which any Option may be exercised under the Omnibus Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any amendment necessary to comply with applicable law or the requirements of the Exchange or any other regulatory body;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) any amendment of a "housekeeping" nature, including to clarify the meaning of an existing provision of the Omnibus Plan, correct or supplement any provision of the Omnibus Plan that is inconsistent with any other provision of the Omnibus Plan, correct any grammatical or typographical errors or amend the definitions in the Omnibus Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) any amendment regarding the administration of the Omnibus Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) any amendment to add provisions permitting the grant of Awards settled otherwise than with Shares issued from treasury, or adopt a clawback provision applicable to equity compensation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any other amendment that does not require the approval of the shareholders of the Company as outlined in the paragraph below.

The Board shall be required to obtain disinterested shareholder approval, if required under the rules of the Exchanges, to make the following amendments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) an increase in the maximum number of Shares issuable under the Plan, except in the event of an adjustment pursuant to the Omnibus Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) except in accordance with the terms of the Omnibus Plan, any amendment which reduces the exercise price of an Option or any cancellation of an Option and replacement of such Option with an Option with a lower exercise price;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any amendment reduction in the price of an Option or extension of the term of an Option if the

Participant is an Insider (as defined in the Omnibus Plan) of the Company at the time of the proposed amendment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) any amendment which extends the expiry date of any Award, or the Restriction Period (as defined in the Omnibus Plan) of any Share Unit beyond the original expiry date or Restriction Period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any amendment which increases the maximum number of Shares that may be issuable under the Omnibus Plan and any other proposed or established Share Compensation Arrangement (as defined in the Omnibus Plan); and;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) any amendment to the definition of Eligible Participant under the Omnibus Plan.

Vesting Schedule. In general, each Award granted pursuant to the Omnibus Plan shall vest in accordance with the terms of the Omnibus Plan and the Grant Agreement (as defined in the Omnibus Plan) entered into in respect of such Award. Subject to policies and vesting limits of the Exchange, the Board has the right, in its sole discretion, to waive any vesting conditions or accelerate the vesting of any Award (other than the date upon which DSUs become exercisable), or to deem any Performance Criteria or other vesting conditions to be satisfied, notwithstanding the vesting schedule set forth for such Award.

Assignment

Except as specifically provided in a Grant Agreement approved by the Board, each Award granted under the Omnibus Plan is personal to the Participant and shall not be assignable or transferable by the Participant, whether voluntarily or by operation of law, except by will or by the laws of succession of the domicile of the deceased Participant. No Award granted under the Omnibus Plan shall be pledged, hypothecated, charged, transferred, assigned or otherwise encumbered or disposed of on pain of nullity.

Change of Control

In the event of a potential Change of Control (as described in the Omnibus Plan) the Board will have the power, in its sole discretion, to modify the terms of the Omnibus Plan and/or the Awards to assist the Participants to tender into a take-over bid or participating in any other transaction leading to a Change of Control. For greater certainty, in the event of a take-over bid or any other transaction leading to a Change of Control, the Board shall have the power, in its sole discretion, subject to any required approval of the Exchange to (i) provide that any or all Awards shall thereupon terminate, provided that any such outstanding Awards that have vested shall remain exercisable until consummation of such Change of Control, and (ii) permit Participants to conditionally exercise their vested Options, such conditional exercise to be conditional upon the take-up by such offeror of the Shares or other securities tendered to such take-over bid in accordance with the terms of such take-over bid (or the effectiveness of such other transaction leading to a Change of Control).

If the Corporation completes a transaction constituting a Change of Control and within twelve (12) months following the Change of Control a Participant who was also an Officer or Employee of, or Consultant to, the Company prior to the Change of Control has their position, employment or consulting agreement terminated, or the Participant is constructively dismissed, then all unvested Awards of the Participant shall immediately vest and become exercisable, and remain open for exercise until the earlier of their expiry date as set out in the Award Agreement (as defined in the Omnibus Plan) and the date that is twelve (12) months after such termination or dismissal.

Termination of Options.

Upon a Participant ceasing to be an Eligible Participant for Cause (as defined in the Omnibus Plan), any vested or unvested Option granted to such Participant shall terminate automatically and become void immediately. For the purposes of the Omnibus Plan, the determination by the Company that the Participant was discharged for Cause shall be binding on the Participant.

Upon a Participant ceasing to be an Eligible Participant as a result of his or her employment or service relationship with the Company or a Subsidiary being terminated without Cause, (i) any unvested Option granted to such Participant shall terminate and become void immediately and (ii) any vested Option granted to such Participant may be exercised by such Participant. Unless otherwise determined by the Board, in its sole discretion, such Option shall only be exercisable within the earlier of a date set forth in the Grant Agreement which shall be no longer than twelve (12) months from the Termination Date, or the expiry date of the Award set forth in the Grant Agreement, after which the Option will expire.

Officer Compensation

Total cash compensation accrued and/or paid (directly and/or indirectly) to all of our Officers during fiscal year 2025 was $3,666,430 (refer to Item 7. "Major Shareholders and Related Party Transactions" for information regarding indirect payments)

In order to assist the Board of Directors in fulfilling its oversight responsibilities with respect to human resources matters, the Board established a Compensation Committee. The Compensation Committee reviews and makes determinations with respect to senior officer compensation on a regular basis with any discretionary compensation used only for extraordinary projects or significant milestone results that advance the Company's growth potential. When determining executive officers' compensation, the Compensation Committee receives input and guidance from the Executive Chairman of the Board and the Chief Executive Officer of the Company. In the past, the Compensation Committee has engaged an outside consultant to conduct a peer group review to provide guidance to the Compensation Committee with respect to appropriate comparative terms for executive compensation and stock option grants. The Company also utilizes peer group comparisons from subsidiary locations to assist in its salary review of various positions in those locations. The Compensation Committee utilizes such comparative reviews to assist it in making appropriate recommendations to the Board.

In addition to his or her fixed base salary, each officer may be eligible to receive variable pay compensation or bonus meant to motivate him or her to achieve short- term goals. Currently, the Company does not have in place established procedures for determining variable pay compensation. Stock options are an important element of the variable pay compensation and do not require cash disbursement from the Company. Stock options are also generally awarded to officers, qualifying employees and consultants at the time of hire and are used as a recruitment tool to attract highly qualified and experienced executives, employees and consultants to the Company. Stock options are also granted at other times during the year. As the Company is continuing to develop its Optical Interposer technology, it must conserve its limited financial resources and control costs to ensure that funds are available when needed to complete its scheduled developments. As a result, the Compensation Committee generally considers not only the financial situation of the Company at the time of the determination of the compensation, but also the estimated financial situation in the mid- and long-term. The use of stock options encourages and rewards performance by aligning an increase in each officer's compensation with increases in the Company's performance and in shareholder value.

The following table sets forth all annual and long-term compensation for services in all capacities to the Company for fiscal year 2025 of the Company.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | | | Share-based Awards | Share-based Awards | Option-based Awards | Option-based Awards | Non-Equity Incentive Plan Compensation | Non-Equity Incentive Plan Compensation | | | |
| First Name | Last Name | Year | Salary | Number of Shares or Units of Shares | Value based on Grant Date Fair Value | Number of Securities Underlying Options | Value based on Grant Date Fair Value (1) | Annual Incentive Plans | Long Term Incentive Plans | Pension Value | All Other Compensation | Total Compensation |
| Suresh | Venkatesan | 2025 | $539498 | 1107011 | $6000000 |  |  | 400000 |  |  |  | $6939498 |
| Thomas | Mika | 2025 | $376248 | 369004 | $2000002 |  |  | 420000 |  |  |  | $2796250 |
| Mo | Jinyu | 2025 | $319200 | 230627 | $1249998 |  |  | 75000 |  |  |  | $1644198 |
| Raju | Kankipati | 2025 | $317498 | 184502 | $1000001 |  |  | 200000 |  |  |  | $1517499 |
| Ghazi | Chaoui | 2025 | $184615 |  |  | 350000 | $1329455 |  |  |  |  | $1514070 |
| Yong Meng | Lee | 2025 | $241695 | 138376 | $749998 |  |  | 70000 |  |  |  | $1061693 |
| Kevin | Barnes | 2025 | $244200 | 92251 | $500000 |  |  | 190000 |  |  |  | $934200 |
| Robert | Ditizio | 2025 | $234656 | 36900 | $199998 |  |  | 10000 |  |  |  | $444654 |
| Daniel | Meerovich | 2025 | $151017 | 0 | $0 |  |  | 0 |  |  |  | $151017 |
| Vivek | Rajgarhia | 2026 | $77092 | 0 | $0 |  |  | 0 |  |  |  | $77092 |
|  |  |  | $**2685719** | **2158671** | $**11699997** | **350000** | $**1329455** | **1365000** |  |  |  | $**17080171** |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
 Company used the Black-Scholes model as the methodology to calculate the grant date fair value. The fair value will be recorded as
 an operating expense as the options vest based on the stock options vesting schedule from the date of grant.

**Positions**

---

| | |
|:---|:---|
| Suresh Venkatesan | CEO |
| Raju Kankipati | Chief Revenue Officer |
| Thomas Mika | Executive Vice President and CFO |
| Mo Jinyu | SVP, Global Product Development |
| Kevin Barnes | VP Finance and Administration, Corporate Controller and Treasurer |
| Robert Ditizio | VP Intellectual Property |
| James Lee | VP & Interposer Engineering |
| Daniel Meerovich | VP Product Engineering (Resigned) |
| Vivek Rajgarhia | President (Resigned) |
| Ghazi Chaoui | SVP Global Manufacturing and Digital Transformation |

---

The following table sets forth information concerning all awards outstanding under a stock option plan to each of the current officers, as of December 31, 2025:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | Option-based Awards | Option-based Awards | Option-based Awards | Option-based Awards | Option-based Awards | Share-based Awards | Share-based Awards | Share-based Awards | Share-based Awards | Share-based Awards |
| First Name | Last Name | Number of Securities Underlying Unexercised Options | Option Exercise Price | Option Exercise Price | Option Expiration Date | Value of Unexercised in-the-money Options | Number of Shares or Units of Shares that have not Vested | Market or Payout Value of Shares or Units of Shares that have not Vested | Market or Payout Value of Shares or Units of Shares that have not Vested | Market or Payout Value of Vested Shares or Units of Shares that have not Paid Out or Distributed | Market or Payout Value of Vested Shares or Units of Shares that have not Paid Out or Distributed |
| Kevin | Barnes | 2000 | $1.26575 | USD | 28-Mar-2028 | $10128.50 |  |  |  |  |  |
| Kevin | Barnes | 24500 | $1.26575 | USD | 13-Dec-2028 | $124074.13 |  |  |  |  |  |
| Kevin | Barnes | 50000 | $1.26575 | USD | 29-May-2029 | $253212.50 |  |  |  |  |  |
| Kevin | Barnes | 50000 | $1.26575 | USD | 15-Jan-2030 | $253212.50 |  |  |  |  |  |
| Kevin | Barnes | 15000 | $1.26575 | USD | 11-Jun-2030 | $75963.75 |  |  |  |  |  |
| Kevin | Barnes | 20000 | $1.26575 | USD | 11-Nov-2032 | $101285.00 |  |  |  |  |  |
| Kevin | Barnes | 20000 | $1.26575 | USD | 08-Aug-2033 | $101285.00 |  |  |  |  |  |
| Kevin | Barnes | 67500 | $1.793748 | USD | 25-Jun-2034 | $306197.01 |  |  |  |  |  |
| Kevin | Barnes | 50000 | $4.0287 | USD | 13-Nov-2034 | $115065.00 |  |  |  |  |  |
| Kevin | Barnes |  |  |  | 07-Aug-2035 |  | 92251 | $583948.83 | USD | $0.00 | USD |
| Ghazi | Chaoui | 350000 | $4.426507 | USD | 14-May-2035 | $666222.55 |  |  |  |  |  |
| Robert | Ditizio | 100000 | $1.26575 | USD | 01-Dec-2031 | $506425.00 |  |  |  |  |  |
| Robert | Ditizio | 15000 | $1.26575 | USD | 08-Aug-2033 | $75963.75 |  |  |  |  |  |
| Robert | Ditizio | 25000 | $1.793748 | USD | 25-Jun-2034 | $113406.30 |  |  |  |  |  |
| Robert | Ditizio | 50000 | $4.0287 | USD | 13-Nov-2034 | $115065.00 |  |  |  |  |  |
| Robert | Ditizio |  |  |  | 07-Aug-2035 |  | 36900 | $233577.00 | USD | $0.00 | USD |
| Mo | Jinyu | 100000 | $1.26575 | USD | 08-Jan-2031 | $506425.00 |  |  |  |  |  |
| Mo | Jinyu | 31250 | $1.26575 | USD | 11-Nov-2032 | $158257.81 |  |  |  |  |  |
| Mo | Jinyu | 50000 | $1.26575 | USD | 08-Aug-2033 | $253212.50 |  |  |  |  |  |
| Mo | Jinyu | 75000 | $1.793748 | USD | 25-Jun-2034 | $340218.90 |  |  |  |  |  |
| Mo | Jinyu |  |  |  | 07-Aug-2035 |  | 230627 | $1459868.91 | USD | $0.00 | USD |
| Raju | Kankipati | 42500 | $1.26575 | USD | 06-Apr-2032 | $215230.63 |  |  |  |  |  |
| Raju | Kankipati | 100000 | $1.26575 | USD | 11-Nov-2032 | $506425.00 |  |  |  |  |  |
| Raju | Kankipati | 50000 | $1.26575 | USD | 08-Aug-2033 | $253212.50 |  |  |  |  |  |
| Raju | Kankipati | 80000 | $1.294681 | USD | 16-Feb-2034 | $402825.52 |  |  |  |  |  |
| Raju | Kankipati | 112500 | $1.793748 | USD | 25-Jun-2034 | $510328.35 |  |  |  |  |  |
| Raju | Kankipati | 250000 | $4.0287 | USD | 13-Nov-2034 | $575325.00 |  |  |  |  |  |
| Raju | Kankipati |  |  |  | 07-Aug-2035 |  | 184502 | $1167897.66 | USD | $0.00 | USD |
| Yong Meng | Lee | 20000 | $1.26575 | USD | 04-Nov-2029 | $101285.00 |  |  |  |  |  |
| Yong Meng | Lee | 15000 | $1.26575 | USD | 11-Jun-2030 | $75963.75 |  |  |  |  |  |
| Yong Meng | Lee | 25000 | $1.26575 | USD | 06-Apr-2031 | $126606.25 |  |  |  |  |  |
| Yong Meng | Lee | 55000 | $1.26575 | USD | 11-Nov-2032 | $278533.75 |  |  |  |  |  |
| Yong Meng | Lee | 50000 | $1.26575 | USD | 08-Aug-2033 | $253212.50 |  |  |  |  |  |
| Yong Meng | Lee | 50000 | $1.294681 | USD | 16-Feb-2034 | $251765.95 |  |  |  |  |  |
| Yong Meng | Lee | 75000 | $1.793748 | USD | 25-Jun-2034 | $340218.90 |  |  |  |  |  |
| Yong Meng | Lee | 50000 | $4.0287 | USD | 13-Nov-2034 | $115065.00 |  |  |  |  |  |
| Yong Meng | Lee |  |  |  | 07-Aug-2035 |  | 138376 | $875920.08 | USD | $0.00 | USD |
| Thomas | Mika | 50000 | $1.26575 | USD | 29-May-2029 | $253212.50 |  |  |  |  |  |
| Thomas | Mika | 60000 | $1.26575 | USD | 11-Jun-2030 | $303855.00 |  |  |  |  |  |
| Thomas | Mika | 45000 | $1.26575 | USD | 06-Apr-2031 | $227891.25 |  |  |  |  |  |
| Thomas | Mika | 100000 | $1.26575 | USD | 11-Nov-2032 | $506425.00 |  |  |  |  |  |
| Thomas | Mika | 75000 | $1.26575 | USD | 08-Aug-2033 | $379818.75 |  |  |  |  |  |
| Thomas | Mika | 80000 | $1.294681 | USD | 16-Feb-2034 | $402825.52 |  |  |  |  |  |
| Thomas | Mika | 127500 | $1.793748 | USD | 25-Jun-2034 | $578372.13 |  |  |  |  |  |
| Thomas | Mika |  |  |  | 07-Aug-2035 |  | 369004 | $2335795.32 | USD | $0.00 | USD |
| Vivek | Rajgarhia | 25000 | $1.26575 | USD | 11-Nov-2032 | $126606.25 |  |  |  |  |  |
| Vivek | Rajgarhia | 25125 | $1.26575 | USD | 08-Aug-2033 | $127239.28 |  |  |  |  |  |
| Suresh | Venkatesan | 220625 | $1.26575 | USD | 11-Jun-2030 | $1117300.16 |  |  |  |  |  |
| Suresh | Venkatesan | 65000 | $1.26575 | USD | 06-Apr-2031 | $329176.25 |  |  |  |  |  |
| Suresh | Venkatesan | 200000 | $1.26575 | USD | 11-Nov-2032 | $1012850.00 |  |  |  |  |  |
| Suresh | Venkatesan | 100000 | $1.26575 | USD | 08-Aug-2033 | $506425.00 |  |  |  |  |  |
| Suresh | Venkatesan | 80000 | $1.294681 | USD | 16-Feb-2034 | $402825.52 |  |  |  |  |  |
| Suresh | Venkatesan | 150000 | $1.793748 | USD | 25-Jun-2034 | $680437.80 |  |  |  |  |  |
| Suresh | Venkatesan |  |  |  | 07-Aug-2035 |  | 1107011 | $7007379.63 | USD | $0.00 | USD |

---

The value vested or earned during fiscal year 2025 of incentive plan awards granted to our officers are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| <br> First Name | <br> Last Name | Option-based Awards | Option-based Awards | Option-based Awards | Share-based Awards | Share-based Awards | Non-equity Incentive Plan Compensation - Value Earned During The Year |
| <br> First Name | <br> Last Name | Number of Securities Underlying Options Vested | Value Vested During the Year | Value Vested During the Year | Number of Shares or Units of Shares Vested | Value Vested During the Year | Non-equity Incentive Plan Compensation - Value Earned During The Year |
| Kevin | Barnes | 157294 | $468845 | USD | N/A | N/A | N/A |
| Robert | Ditizio | 75625 | $334453 | USD | N/A | N/A | N/A |
| Mo | Jinyu | 211250 | $525746 | USD | N/A | N/A | N/A |
| Raju | Kankipati | 290938 | $789048 | USD | N/A | N/A | N/A |
| Yong Meng | Lee | 199688 | $483217 | USD | N/A | N/A | N/A |
| Daniel | Meerovich | 31875 | $79519 | USD | N/A | N/A | N/A |
| Thomas | Mika | 455313 | $1280822 | USD | N/A | N/A | N/A |
| Vivek | Rajgarhia | 76250 | $255091 | USD | N/A | N/A | N/A |
| Suresh | Venkatesan | 981250 | $2829201 | USD | N/A | N/A | N/A |

---

Director Compensation

The following table details compensation paid/accrued for fiscal year 2025 for each director who is not also an officer.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | | | Share-based Awards | Share-based Awards | Option-based Awards | Option-based Awards | Non-Equity Incentive Plan Compensation | Non-Equity Incentive Plan Compensation | | | |
| First Name | Last Name | Year | Salary | Number of Shares or Units of Shares | Value based on Grant Date Fair Value | Number of Securities Underlying Options | Value based on Grant Date Fair Value | Annual Incentive Plans | Long Term Incentive Plans | Pension Value | All Other Compensation | Total Compensation |
| Theresa | Ende | 2025 | $30000 | 16567 | $119779 |  |  |  |  |  |  | $149779 |
| Jean-Louis | Malinge | 2025 | $55000 | 19941 | $144173 |  |  |  |  |  |  | $199173 |
| Glen | Riley | 2025 | $40000 | 17916 | $129533 |  |  |  |  |  |  | $169533 |
| Bob | Tirva | 2025 | $35000 | 17916 | $129533 |  |  |  |  |  |  | $164533 |
| Sohail | Khan | 2025 | $15000 | 21200 | $163240 |  |  |  |  |  |  | $178240 |
| Chris | Tsiofas | 2025 | $32500 |  |  |  |  |  |  |  |  | $32500 |
|  |  |  | $**207500** | **93540** | $**686258** |  |  |  |  |  |  | $**893758** |

---

The following table sets forth information concerning all awards outstanding under the stock option plans to each of the directors who are not also officers as of December 31, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | Option-based Awards | Option-based Awards | Option-based Awards | Option-based Awards | Share-based Awards | Share-based Awards | Share-based Awards |
| First Name | Last Name | Number of Securities Underlying Unexercised Options | Option Exercise Price | Option Expiration Date | Value of Unexercised in-the-money Options | Number of Shares or Units of Shares that have not Vested | Market or Payout Value of Shares or Units of Shares that have not Vested | Market or Payout Value of Vested Shares or Units of Shares that have not Paid Out or Distributed |
| Theresa | Ende | 4745 | $1.27 | 1-Jun-32 | $24029.87 |  |  |  |
| Theresa | Ende | 41368 | $1.27 | 11-Nov-32 | $209497.89 |  |  |  |
| Theresa | Ende | 24949 | $1.27 | 14-Jul-33 | $126347.97 |  |  |  |
| Theresa | Ende | 58114 | $1.79 | 25-Jun-34 | $263619.75 |  |  |  |
| Theresa | Ende |  |  | 27-Jun-35 |  | 16567 | $104869.11 | $0.00 |
| Jean-Louis | Malinge | 36053 | $1.27 | 29-May-29 | $182581.41 |  |  |  |
| Jean-Louis | Malinge | 24949 | $1.27 | 14-Jul-33 | $126347.97 |  |  |  |
| Jean-Louis | Malinge | 74258 | $1.79 | 25-Jun-34 | $336853.00 |  |  |  |
| Jean-Louis | Malinge |  |  | 27-Jun-35 |  | 19941 | $126226.53 | $0.00 |
| Glen | Riley | 64572 | $1.79 | 25-Jun-34 | $292914.86 |  |  |  |
| Glen | Riley |  |  | 27-Jun-35 |  | 17916 | $113408.28 | $0.00 |
| Bob | Tirva | 18823 | $5.20 | 5-Dec-34 | $21262.05 |  |  |  |
| Bob | Tirva |  |  | 27-Jun-35 |  | 17916 | $113408.28 | $0.00 |

---

The value vested or earned during fiscal year 2025 of incentive plan awards granted to directors who are not also officers are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  | Option-based Awards | Option-based Awards | Option-based Awards | Share-based Awards | Share-based Awards |  |
| First Name | Last Name | Number of Securities Underlying Options Vested | Value Vested During the Year | Value Vested During the Year | Number of Shares or Units of Shares Vested | Value Vested During the Year | Non-equity Incentive Plan Compensation - Value Earned During The Year |
| Sohail | Khan |  | $- | USD | N/A | N/A | N/A |
| Bob Tirva | Tirva | 18823 | $83541 | USD | N/A | N/A | N/A |
| Theresa | Ende | 50058 | $124590 | USD | N/A | N/A | N/A |
| Glen | Riley | 69841 | $207279 | USD | N/A | N/A | N/A |
| Jean-Louis | Malinge | 134764 | $359390 | USD | N/A | N/A | N/A |
| Chris | Tsiofas | 166219 | $460476 | USD | N/A | N/A | N/A |

---

Termination and Change of Control Benefits

Other than as described in their individual management agreements, the Company has no plans or arrangements in respect of remuneration received or that may be received by the Officers the Company to compensate such Officers, in the event of termination of employment (as a result of resignation, retirement, change of control) or a change of responsibilities following a change of control.

Pension Plan Benefits

The Company does not provide a defined benefit plan to the Officers or any of its employees.

The Company offers a defined contribution plan that is a 401k Plan but does not contribute toward such plan. The Company does not have any deferred compensation plans other than that described above.

The following individuals were senior management of the Company in 2025:

---

| | |
|:---|:---|
| Name | Title |
| Suresh Venkatesan | CEO |
| Raju Kankipati | Chief Revenue Officer |
| Thomas Mika | Executive Vice President and CFO |
| Mo Jinyu | SVP, Global Product Development |
| Kevin Barnes | VP Finance and Administration, Corporate Controller and Treasurer |

---

**C.**  ***Board Practices*.** 

Our Board of Directors currently consists of six (6) directors, all of whom are independent, except for Suresh Venkatesan, our CEO who also currently serves on the Board of Directors. Each director holds office until the next annual general meeting of the Company or until his or her successor is elected or appointed, unless his office is earlier vacated in accordance with the Articles of Amalgamation and all amendments thereto (the "Articles"), or with the provisions of the OBCA. The Company's Officers are appointed to serve at the discretion of the Board, subject to the terms of the employment agreements described above.

Lead independent director

Our independent directors have selected Jean-Louis Malinge to serve as the lead independent director. The lead independent director's primary role is to facilitate the functioning of the board, and to maintain and enhance the quality of our corporate governance practices. The lead independent director presides over the private sessions of our independent directors that take place following each meeting of the board and conveys the results of these meetings to the chair of the board.

The Board and committees of the Board schedule regular meetings over the course of the year.

During fiscal 2025, the Board held 21 regularly scheduled meetings, including committee meetings. If for various reasons, Board members may not be able to attend a Board meeting, all Board members are provided information related to each of the agenda items before each meeting, and, therefore, can provide counsel outside the confines of regularly scheduled meetings.

The Board has adopted standards for determining whether a director is independent from management. The Board reviews, consistent with the Company's corporate governance guidelines, whether a director has any material relationship with the Company that would impair the director's independent judgment. The Board has affirmatively determined, that as of the filing of this Form 20-F, based on its standards, that the following directors are independent: Sohail Khan, Jean-Louis Malinge, Bob Tirva, Glen Riley and Theresa Lan Ende.

Directors' Service Contracts

As CEO, Mr. Venkatesan has an employment contract with the Company which allows him to receive a severance of twelve months on termination of employment by the Company, other than for cause. Unvested stock options will be cancelled. He will have one year to exercise vested stock options.

No other director has a service contract with the Company.

Audit and Compensation Committees of the Board of Directors

We currently have four board committees; (1) an Audit Committee; (2) a Compensation Committee, (3) a Corporate Governance & Nominating Committee, and (4) an Ad Hoc Strategy Committee. Committee charters for the Audit, Compensation and Corporate Governance & Nominating Committees can be found on the Company's website (poet-technologies.com). The Strategy Committee is an ad-hoc committee and therefore does not have a charter. The names of the members and a summary of the terms of the charter for each of the Audit Committee and the Compensation Committee is provided below.

Audit Committee

The Audit Committee is currently comprised of three members: Bob Tirva (Chair), Glen Riley and Jean-Louis Malinge. All three members are independent directors of the Company. Mr. Tirva was appointed chair of the Audit Committee on May 13, 2025. Chris Tsiofas served as the chair of the audit committee until May 13, 2025 and resigned on June 27, 2025. The Board has determined that Mr. Tirva satisfies the criteria of "audit committee financial expert" within the meaning of Item 401(h) of Regulation S-K and is independent in accordance with Rule 4200 of the Nasdaq Marketplace Rules. All members of the audit committee are financially literate, meaning they have the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Company's financial statements.

The Audit Committee is responsible for reviewing the Company's financial reporting procedures, internal controls and the performance of the Company's external auditors. The Audit Committee is also responsible for reviewing the annual and quarterly financial statements and accompanying Management's Discussion and Analysis prior to their approval by the full Board. The Audit Committee also reviews the Company's financial controls with the auditors of the Company on an annual basis.

The Company's independent auditor is accountable to the Board and to the Audit Committee. The Board, through the Audit Committee, has the ultimate responsibility to evaluate the performance of the independent auditor, and through the shareholders, to appoint, replace and compensate the independent auditor. Any non-audit services must be pre- approved by the Audit Committee.

Compensation Committee

The Compensation Committee is currently comprised of three members: Glen Riley (Chair), Bob Tirva and Theresa Ende. Mr. Riley was appointed chair of the Compensation Committee on October 14, 2022. All three members are independent directors. The Board has determined that all members of the Compensation Committee are qualified as members based on the following:

The Compensation Committee has extensive direct relevant experience in determining executive compensation policies and practices on behalf of the Company. In addition to being supported by outside compensation consultants on a periodic basis for peer group review, the members of the Committee are professional executives familiar with best practices associated with executive compensation, are knowledgeable about the tax implications to the Company and its executive officers of changes in the tax laws pertaining to executive compensation and have direct relevant experience with the incentives used throughout the Company's industry to align the interests of executive management with company and shareholder interests. This gives these individuals strong insight as to the incentive structures and programs appropriate for companies of a comparable size. The seniority, experience and level of achievement of the three current members of the Compensation Committee speak to the independent judgement exercised in making decisions about the suitability of the Company's compensation policies and practices.

The Compensation Committee discusses and makes recommendations to the Board for approval of compensation issues that pertain to the senior executives of the Company, and on issues involving employment company-wide compensation policies and practices. In general, the compensation programs of the Company are designed to reward performance and to be competitive with the compensation agreements of other comparable semiconductor companies. The Compensation Committee is responsible for evaluating the compensation of the senior management of the Company and assuring that they are compensated effectively in a manner consistent with the Company's business, stage of development, financial condition and prospects, and the competitive environment. Specifically, the Compensation Committee is responsible for: (i) reviewing the compensation practices and policies of the Company to ensure that they are competitive and that they provide appropriate motivation for corporate performance and increased shareholder value; (ii) overseeing the administration of the Company's compensation programs, and reviewing and approving the employees who receive compensation and the nature of the compensation provided under such programs, and ensuring that all management compensation programs are linked to meaningful and measurable performance targets; (iii) making recommendations to the Board regarding the adoption, amendment or termination of compensation programs and the approval of the adoption, amendment and termination of compensation programs of the Company, including for greater certainty, ensuring that if any equity- based compensation plan is subject to shareholder approval, and that such approval is sought; (iv) periodically surveying the executive compensation practices of other comparable companies; (v) establishing and ensuring the satisfaction of performance goals for performance-based compensation; (vi) annually reviewing and approving the annual base salary and bonus targets for the senior executives of the Company, other than the Chief Executive Officer (the "CEO"); (vii) reviewing and approving annual corporate goals and objectives for the CEO and evaluating the CEO's performance against such goals and objectives; (viii) annually reviewing and approving, based on the Compensation Committee's evaluation of the CEO, the CEO's annual base salary, the CEO's bonus, and any stock option grants and other awards to the CEO under the Company's compensation programs (in determining the CEO's compensation, the Compensation Committee will consider the Company's performance and relative shareholder return, the compensation of CEOs at other companies, and the CEO's compensation in past years); and (ix) reviewing the annual report on executive compensation required to be prepared under applicable corporate and securities legislation and regulation including the disclosure concerning members of the Compensation Committee and settling the reports required to be made by the Compensation Committee in any document required to be filed with a regulatory authority and/or distributed to shareholders.

Code of Ethics

The Board has adopted a written code of business conduct and ethics.

Corporate Governance

As a foreign private issuer, we are exempt from certain requirements of the Nasdaq listing rules that are applicable to U.S. listed companies. Please see "Item 16G. Corporate Governance" for additional information. The information appearing in Item 16B. "Code of Ethics" below is incorporated herein by reference.

**D.**  ***Employees*.** 

As of December 31, 2025, the Company had eighty (80) full-time employees and nine (10) consultants or full-time contractors. Nine (9) employees work in the United States; ten (10) employees work in China; nine (9) employees work in Malaysia; and fifty-two (52) employees work at our Singapore facility. We also engaged three (3) contractors in the United States, one (1) contractor in China, two (2) contractors in Malaysia, three (3) contractors in Singapore, and one (1) contractor in Italy. None of the Company's employees are covered by collective bargaining agreements.

**E.**  ***Share Ownership*.** 

The following table sets forth certain information regarding the beneficial ownership of our outstanding common shares as of March 20, 2026 for: (i) each of our Directors and Officers individually, who were directors and officers at December 31, 2025; (ii) all of our Directors and Officers as a group; and (iii) each other person known to us to own beneficially more than 5% of our common shares as of March 20, 2026. Beneficial ownership of shares is determined under rules of the SEC and generally includes any shares over which a person exercises sole or shared voting or investment power. The table also includes the number of shares underlying options that are exercisable within sixty (60) days of March 20, 2026. Common shares subject to these options are deemed to be outstanding for the purpose of computing the ownership percentage of the person holding these options, but are not deemed to be outstanding for the purpose of computing the ownership percentage of any other person.

Except as otherwise noted, the business address for each person listed in the table below is 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario M4P 1E2, Canada. The shareholders listed below do not have any different voting rights from our other shareholders.

---

| | | |
|:---|:---|:---|
|  | Number of Shares Beneficially Owned (1) | Percent of Class |
| Directors and Officers: |  |  |
| Thomas Mika | &nbsp;&nbsp;&nbsp;&nbsp; 12500 | \* |
| Kevin Barnes | 31746 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\* |
| Suresh Venkatesan | 7500 | \* |
| Raju Kankipati | 11111 | \* |
| Jean-Louis Malinge | 33892 | \* |
| Glen Riley | 31966 | \* |
| Directors and Officers Subtotal | 128715 | \* |
| Major Shareholders: |  |  |
| MM Asset Management Inc. SPC (2) | 1526205 | \* |

---

\* Less than one percent (1%).

&nbsp;&nbsp;&nbsp;&nbsp;(1) The
 number of shares set forth for each Director, Officer and Major Shareholder, if any, was determined in accordance with Rule 13d-3
 of the General Rules and Regulations under the Exchange Act.

(2) Based
 solely upon information contained in the Schedule 13G/A filed on February 17, 2026 provided to the Company by MMCAP International
 Inc. SPC (the "Fund"). MM Asset Management Inc., the investment adviser of the Fund (the "Adviser"), may
 be deemed to beneficially own the common shares directly beneficially owned by the Fund. The address of the Fund is c/o Mourant Governance
 Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, P.O. Box 1348, Grand Cayman, KY1-1108, Cayman Island, and the address of
 the Adviser is 161 Bay Street, TD Canada Trust Tower Suite 2240, Toronto, ON M5J 2S1 Canada.

See "Item 6.B. Compensation" for the exercise prices of options.

The following table presents the options exercisable for Directors and Officers within 60 days of March 20, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Last Name | First Name | Grant Date | Grant Price | Exercisable |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 2000 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 2500 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 3125 |
| Barnes | Kevin | 25-Jun-2024 | $1.793748 | 11250 |
| Barnes | Kevin | 13-Nov-2024 | $4.0287 | 15625 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 24500 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 25000 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 25000 |
| Barnes | Kevin | 21-Jun-2024 | $1.26575 | 50000 |
| Ditizio | Robert | 21-Mar-2024 | $1.26575 | 9375 |
| Ditizio | Robert | 25-Jun-2024 | $1.793748 | 9375 |
| Ditizio | Robert | 13-Nov-2024 | $4.0287 | 15625 |
| Ditizio | Robert | 21-Mar-2024 | $1.26575 | 100000 |
| Ende | Theresa | 21-Jun-2024 | $1.26575 | 4745 |
| Ende | Theresa | 21-Jun-2024 | $1.26575 | 24949 |
| Ende | Theresa | 21-Jun-2024 | $1.26575 | 41368 |
| Ende | Theresa | 25-Jun-2024 | $1.793748 | 58114 |
| Jinyu | Mo | 21-Jun-2024 | $1.26575 | 12500 |
| Jinyu | Mo | 25-Jun-2024 | $1.793748 | 28125 |
| Jinyu | Mo | 21-Jun-2024 | $1.26575 | 31250 |
| Jinyu | Mo | 21-Jun-2024 | $1.26575 | 100000 |
| Kankipati | Raju | 21-Jun-2024 | $1.26575 | 31250 |
| Kankipati | Raju | 21-Jun-2024 | $1.26575 | 36250 |
| Kankipati | Raju | 25-Jun-2024 | $1.793748 | 42188 |
| Kankipati | Raju | 13-Nov-2024 | $4.0287 | 78125 |
| Kankipati | Raju | 16-Feb-2024 | $1.294681 | 80000 |
| Kankipati | Raju | 21-Jun-2024 | $1.26575 | 81250 |
| Lee | Yong Meng | 21-Jun-2024 | $1.26575 | 15000 |
| Lee | Yong Meng | 13-Nov-2024 | $4.0287 | 15625 |
| Lee | Yong Meng | 21-Jun-2024 | $1.26575 | 25000 |
| Lee | Yong Meng | 25-Jun-2024 | $1.793748 | 28125 |
| Lee | Yong Meng | 21-Jun-2024 | $1.26575 | 31250 |
| Lee | Yong Meng | 21-Jun-2024 | $1.26575 | 44688 |
| Lee | Yong Meng | 16-Feb-2024 | $1.294681 | 50000 |
| Malinge | Jean-Louis | 21-Jun-2024 | $1.26575 | 24949 |
| Malinge | Jean-Louis | 21-Jun-2024 | $1.26575 | 36053 |
| Malinge | Jean-Louis | 25-Jun-2024 | $1.793748 | 74258 |
| Mika | Thomas | 21-Jun-2024 | $1.26575 | 45000 |
| Mika | Thomas | 21-Jun-2024 | $1.26575 | 46875 |
| Mika | Thomas | 25-Jun-2024 | $1.793748 | 47813 |
| Mika | Thomas | 21-Jun-2024 | $1.26575 | 50000 |
| Mika | Thomas | 21-Jun-2024 | $1.26575 | 60000 |
| Mika | Thomas | 16-Feb-2024 | $1.294681 | 80000 |
| Mika | Thomas | 21-Jun-2024 | $1.26575 | 81250 |
| Riley | Glen | 25-Jun-2024 | $1.793748 | 64572 |
| Tirva | Bob | 05-Dec-2024 | $5.200422 | 18823 |
| Venkatesan | Suresh | 25-Jun-2024 | $1.793748 | 56250 |
| Venkatesan | Suresh | 21-Jun-2024 | $1.26575 | 62500 |
| Venkatesan | Suresh | 21-Jun-2024 | $1.26575 | 65000 |
| Venkatesan | Suresh | 16-Feb-2024 | $1.294681 | 80000 |
| Venkatesan | Suresh | 21-Jun-2024 | $1.26575 | 162500 |
| Venkatesan | Suresh | 21-Jun-2024 | $1.26575 | 220625 |

---

---

| | | |
|:---|:---|:---|
|  | Number of Warrants exercisable<br> within 60 days of March 20, 2026 | Exercise price CAD$ |
| Glen Riley | 21966 | 1.52 |
| Raju Kankipati | 11111 | 1.52 |
| Jean-Louis Malinge | 16392 | 1.52 |
| Major Shareholder |  |  |
| MM Asset Management Inc. SPC | 12957165 | Ranging from $4.26 - $8.39 |

---

**F. *Disclosure of a Registrant's Action to Recover Erroneously Awarded Compensation*.**

In 2024, the Company adopted a compensation recovery policy (the "Compensation Recovery Policy") in compliance with Nasdaq listing standards and Rule 10D-1 of the Exchange Act, a copy of which is filed as Exhibit 97.1 to this Annual Report on Form 20-F.

We were not required to prepare an accounting restatement during the year ended December 31, 2025. As of December 31, 2025, there was no outstanding balance of erroneously awarded compensation to be recovered pursuant to the Compensation Recovery Policy.

**Item 7. Major Shareholders and Related Party Transactions**

&nbsp;&nbsp;&nbsp;&nbsp;**A.**  ***Major Shareholders*.** 

Holdings by Major Shareholders

Please refer to Item 6.E. "Share Ownership" for details regarding securities held by directors, officers and major shareholders. The Company's major shareholders do not have any different or special voting rights as compared to other holders of the Company's common shares.

U.S. Share Ownership

As of March 20, 2026, there were a total of 66,512 holders of record of our common shares with addresses in the U.S. We believe that the number of U.S beneficial owners is substantially greater than the number of U.S record holders, because a large portion of our common shares are held in broker "street names." As of March 20, 2026, U.S. holders of record held approximately 51.8% of our outstanding common shares.

Control of Company

The Company is a publicly owned Ontario corporation, the common shares of which are owned by Canadian residents, U.S. residents and other foreign residents. The Company is not controlled by any foreign government or other person(s) except as described in "Item 4.A. History and Progress of the Company" and "Item 6.E. Share Ownership."

Change of Control of Company Arrangements

None

&nbsp;&nbsp;&nbsp;&nbsp;**B.**  ***Related Party Transactions*.** 

Compensation to key management personnel was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| **Salaries** | $**3666430** | $2435726 | $2245853 |
| **Share-based payments (1)** | **3640115** | 3021067 | 2411669 |
| Total | $**7306545** | $5456793 | $4657522 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(1)** Share-based
 payments are the fair value of options granted to key management personnel and expensed during the various years as calculated using
 the Black-Scholes model.

&nbsp;&nbsp;&nbsp;&nbsp;**C.**  ***Interests of Experts and Counsel*.** 

Not applicable.

**Item 8. Financial Information**

&nbsp;&nbsp;&nbsp;&nbsp;**A.**  ***Consolidated Statements and Other Financial Information*.** 

The Company's financial statements are stated in U.S. dollars and are prepared in accordance with IFRS as issued by the IASB.

The financial statements as required under "Item 17. Financial Statements" are attached hereto and found immediately following the text of this Annual Report. The audit report of Marcum LLP, independent registered public accounting firm, is included herein immediately preceding the consolidated financial statements.

Legal Proceedings

The directors and the senior management of the Company do not know of any material, either active or pending, legal proceedings against them, nor is the Company involved in any material proceeding or pending litigation.

The directors and the senior management of the Company know of no active or pending proceedings against anyone that might materially adversely affect an interest in the Company.

Dividend Policy

The Company has not paid, and has no current plans to pay, dividends on its common shares. We currently intend to retain future earnings, if any, to finance the development of our business. Any future dividend policy will be determined by the Board, and will depend upon, among other factors, our earnings, if any, financial condition, capital requirements, any contractual restrictions with respect to the payment of dividends, the impact of the distribution of dividends on our financial condition, tax liabilities, and such economic and other conditions as the Board may deem relevant.

&nbsp;&nbsp;&nbsp;&nbsp;**B.**  ***Significant Changes*.** 

None

**Item 9. The Offer and Listing**

&nbsp;&nbsp;&nbsp;&nbsp;**A.**  ***Offer and Listing Details*.** 

The Company's common shares currently trade on the Nasdaq under the symbol "POET" since March 14, 2022. The CUSIP/ISN numbers are 73044W302/73044W3021.

&nbsp;&nbsp;&nbsp;&nbsp;**B.**  ***Plan of Distribution*.** 

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;**C.**  ***Markets*.** 

The information in Item 9.A "Offer and Listing Details" above is incorporated herein by reference.

&nbsp;&nbsp;&nbsp;&nbsp;**D.**  ***Selling Shareholders*.** 

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;E. Dilution

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;F. Expenses
 of the Issue

Not required.

**Item 10. Additional Information**

&nbsp;&nbsp;&nbsp;&nbsp;A. Share
 Capital

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;B.  ***Memorandum and Articles of Association*.** 

The Company was originally formed under the British Columbia Company Act on February 9, 1972 as Tandem Resources Ltd. ("Tandem"). The Company took its current form after Tandem amalgamated with Stanmar Resources Ltd. and Keezic Resources Ltd. pursuant to Articles of Amalgamation on November 14, 1985. Tandem moved to Ontario by Articles of Continuance on January 3, 1997. Tandem changed its name to OPEL International Inc. by Articles of Amendment on September 26, 2006. OPEL International Inc. was continued under the New Brunswick Business Corporations Act on January 30, 2007, then back to Ontario by Articles of Continuance on November 30, 2010, changing its name to OPEL Solar International Inc. By Articles of Amendment on August 25, 2011, OPEL Solar International Inc. changed its name to OPEL Technologies, Inc. By Articles of Amendment on July 23, 2013, OPEL Technologies Inc. changed its name to POET Technologies Inc. Today, the Company is an Ontario corporation governed by the OBCA. The following are summaries of material provisions of our Articles of Continuance, as amended from time to time (the "Articles"), in effect as of the date of this Annual Report insofar as they relate to the material terms of our common shares.

Register, Entry Number and Purposes

Our Articles of Continuance became effective on November 30, 2010. Our corporation number in Ontario is 641402. The Articles of Continuance do not contain a statement of the Company's objects and purposes. However, the Articles of Continuance provide that there are no restrictions on business that the Company may carry on or the powers the Company may exercise as permitted under the OBCA.

Board of Directors

Pursuant to our By-laws and the OBCA, a director or officer who is a party to, or who is a director or officer of, or has a material interest in, any person who is a party to, a material contract or proposed material contract with the Company, shall disclose the nature and extent of his interest at the time and in the manner provided by the OBCA. Any such contract or proposed contract shall be referred to the Board or shareholders for approval even if such contract is one that in the ordinary course of the Company's business would not require approval by the Board or shareholders, and a director interested in a contract so referred to the Board shall not vote on any resolution to approve the same unless the contract or transaction: (i) relates primarily to his or her remuneration as a director of the Company or an affiliate; (ii) is for indemnity or insurance of or for the director or officer as permitted by the OBCA; or (iii) is with an affiliate.

Directors shall be paid such remuneration for their services as the Board may determine by resolution from time to time, and will be entitled to reimbursement for traveling and other expenses properly incurred by them in attending meetings of the Board or any committee thereof. Neither the Company's Articles nor By-laws require an independent quorum for voting on director compensation. Directors are not precluded from serving the Company in any other capacity and receiving remuneration therefor. A director is not required to hold shares of the Company. There is no age limit requirement respecting the retirement or non-retirement of directors.

The directors may sign the name and on behalf of the Company, or appoint any officer or officers or any other person or persons on behalf of the Corporation either to sign on behalf of the Company, all instruments in writing and any instruments in writing so signed shall be binding upon the Company without further authorization or formality. The term "instruments in writing" includes contracts, documents, powers of attorney, deeds, mortgages, hypothecs, charges, conveyances, transfers and assignments of property (real or personal, immovable or movable), agreements, tenders, releases, receipts and discharges for the payment of money or other obligations, conveyances, transfers and assignments of shares, stocks, bonds, debentures or other securities, instruments of proxy and all paper writing.

Nothing in the Company's By-laws limits or restricts the borrowing of money by the Company on bills of exchange or promissory notes made, drawn, accepted or endorsed by or on behalf of the Company.

Each director serves until the next Company's annual general meeting or until a successor is duly elected, unless the office is vacated in accordance with the Articles of Continuance.

Rights, Preferences and Restrictions Attaching to Common Shares

The holders of common shares are entitled to vote at all meetings of the shareholders, except meetings at which only holders of a specified class of shares are entitled to vote. Each common share carries with it the right to one vote. Subject to the rights, privileges, restrictions and conditions attaching to any other class or series of shares of the Company, the holders of the common shares are entitled to receive any dividends declared and payable by the Company on the common shares. Dividends may be paid in money or property or by issuing fully paid shares of the Company. Subject to the rights, privileges, restrictions and conditions attaching to any other class or series of shares of the Company, the holders of the common shares are entitled to receive the remaining property of the Company upon dissolution.

No shares have been issued subject to call or assessment. There are no pre-emptive or conversion rights and no provisions for redemption or purchase for cancellation, surrender, or sinking or purchase funds. The common shares must be issued as fully-paid and non-assessable, and are not subject to further capital calls by the Company. The common shares are without par value. All of the common shares rank equally as to voting rights, participation in a distribution of the assets of the Company on a liquidation, dissolution or winding-up of the Company and the entitlement to dividends.

The Company does not currently have any preferred shares outstanding.

Ordinary and Special Shareholders' Meetings

The OBCA provides that the directors of a corporation shall call an annual meeting of shareholders not later than 15 months after holding the last preceding annual meeting. The OBCA also provides that, in the case of an offering corporation, the directors shall place before each annual meeting of shareholders, the financial statements required to be filed under the Ontario Securities Act and the regulation thereunder relating to the period that began immediately after the end of the last completed financial year and ended not more than six months before the annual meeting and the immediately preceding financial year, if any.

The Board has the power to call a special meeting of shareholders at any time.

Notice of the date, time and location of each meeting of shareholders must be given not less than 21 days or more than 50 days before the date of each meeting to each director, to the auditor of the Company and to each shareholder who at the close of business on the record date for notice is entered in the securities register as the holder of one or more shares carrying the right to vote at the meeting.

Notice of a meeting of shareholders called for any other purpose other than consideration of the minutes of an earlier meeting, financial statements, reports of the directors or auditor, setting or changing the number of directors, the election of directors and reappointment of the incumbent auditor, must state the general nature of the special business in sufficient detail to permit the shareholder to form a reasoned judgment on such business, must state the text of any special resolution to be submitted to the meeting, and must, if the special business includes considering, approving, ratifying, adopting or authorizing any document or the signing of or giving of effect to any document, have attached to it, a copy of the document or state that a copy of the document will be available for inspection by shareholders at the Company's records office or another accessible location.

The only persons entitled to be present at a meeting of shareholders are those entitled to vote, the directors of the Company and the auditor of the Company. Any other person may be admitted only on the invitation of the chairman of the meeting or with the consent of the meeting. In circumstances where a court orders a meeting of shareholders, the court may direct how the meeting may be held, including who may attend the meeting.

Limitations on Rights to Own Securities

No share may be issued until it is fully paid.

Neither Canadian law nor our Articles or By-laws limit the right of a non-resident to hold or vote common shares of the Company, other than as provided in the Investment Canada Act (the "Investment Act"), as amended by the World Trade Organization Agreement Implementation Act (the "WTOA Act"). The Investment Act generally prohibits implementation of a direct reviewable investment by an individual, government or agency thereof, corporation, partnership, trust or joint venture that is not a "Canadian," as defined in the Investment Act (a "non-Canadian"), unless, after review, the minister responsible for the Investment Act is satisfied that the investment is likely to be of net benefit to Canada. An investment in the common shares of the Company by a non-Canadian (other than a "WTO Investor," as defined below) would be reviewable under the Investment Act if it were an investment to acquire direct control of the Company, and the value of the assets of the Company were CAD$5.0 million or more (provided that immediately prior to the implementation of the investment the Company was not controlled by WTO Investors). An investment in common shares of the Company by a WTO Investor (or by a non- Canadian other than a WTO Investor if, immediately prior to the implementation of the investment the Company was controlled by WTO Investors) would be reviewable under the Investment Act if it were an investment to acquire direct control of the Company and the value of the assets of the Company equaled or exceeded certain threshold amounts determined on an annual basis.

The threshold for a pre-closing net benefit review depends on whether the purchaser is: (a) controlled by a person or entity from a member of the WTO; (b) a state- owned enterprise (SOE); or (c) from a country considered a "Trade Agreement Investor" under the Investment Act. A different threshold also applies if the Canadian business carries on a cultural business. The 2026 threshold for WTO investors that are SOEs will be CAD$578 million based on the book value of the Canadian business' assets, up from CAD$551 million in 2025. The 2026 thresholds for review for direct acquisitions of control of Canadian businesses by private sector investor WTO investors is $1.452 billion and private sector trade- agreement investors is $2.179 billion and are both based on the "enterprise value" of the Canadian business being acquired.

A non-Canadian, whether a WTO Investor or otherwise, would be deemed to acquire control of the Company for purposes of the Investment Act if he or she acquired a majority of the common shares of the Company. The acquisition of less than a majority, but at least one-third of the shares, would be presumed to be an acquisition of control of the Company, unless it could be established that the Company is not controlled in fact by the acquirer through the ownership of the shares. In general, an individual is a WTO Investor if he or she is a "national" of a country (other than Canada) that is a member of the WTO ("WTO Member") or has a right of permanent residence in a WTO Member. A corporation or other entity will be a "WTO Investor" if it is a "WTO Investor-controlled entity," pursuant to detailed rules set out in the Investment Act. The U.S. is a WTO Member. Certain transactions involving our common shares would be exempt from the Investment Act, including:

● an acquisition of the shares if the acquisition were made in the ordinary course of that person's business as a trader or dealer in securities;

● an acquisition of control of the Company in connection with the realization of a security interest granted for a loan or other financial assistance and not for any purpose related to the provisions of the Investment Act; and

● an acquisition of control of the Company by reason of an amalgamation, merger, consolidation or corporate reorganization, following which the ultimate direct or indirect control in fact of the Company, through the ownership of voting interests, remains unchanged.

Procedures to Change the Rights of Shareholders

In order to change the rights of our shareholders with respect to certain fundamental changes as described in Section 168 of the OBCA, the Company would need to amend our Articles to effect the change. Such an amendment would require the approval of holders of two-thirds of the votes of the Company's common shares, and any other shares carrying the right to vote at any general meeting of the shareholders of the Company, cast at a duly called special meeting. The OBCA also provides that a sale, lease or exchange of all or substantially all of the property of a corporation other than in the ordinary course of business of the corporation likewise requires the approval of the shareholders at a duly called special meeting. For such fundamental changes and sale, lease and exchange, a shareholder is entitled under the OBCA to dissent in respect of such a resolution amending the Articles and, if the resolution is adopted and the Company implements such changes, demand payment of the fair value of the shareholder's common shares.

Impediments to Change of Control

**Impediments to a Change of Control**

The take-over bid regime in Canada is governed by, among other things, National Instrument 62-104 – Take-Over Bids and Issuer Bids ("NI 62-104"). Under NI 62-104, a "take-over bid" is defined as an offer to acquire the outstanding voting securities or equity securities of a class made to one or more persons or companies in a jurisdiction of Canada (also referred to as a local jurisdiction) or whose last address on the books of the target company is in the local jurisdiction, where the securities subject to the offer, together with the offeror's securities, constitute 20% or more of the outstanding securities of the class.

Pursuant to NI 62-104, all non-exempt take-over bids are required to abide by certain technical requirements, including:

● **Initial Deposit Period** – The offer must remain open for an initial deposit period of at least 105 days from the date of the bid. A shorter initial deposit period (not less than 35 days from the date of the bid) is available in circumstances where a target company issues a deposit period news release in respect of a proposed or commenced take-over bid. In this circumstance, an outstanding or subsequent competing take-over bid may avail itself of the shorter deposit period specified in the bid referred to in the deposit period news release. A shorter initial deposit period (of at least 35 days from the date of the bid) is also available in the case of an outstanding or subsequent competing bid in circumstances where a target company issues a news release announcing its intention to effect a negotiated alternative transaction.

● **Minimum Tender Requirement** – An offeror may not take up securities under the terms of its take-over bid unless the bid has met a minimum tender requirement consisting of more than 50% of the outstanding securities of the class that are subject to the bid (excluding securities beneficially owned, or over which control or direction is exercised by the offeror or by any person acting jointly or in concert with the offeror) having been deposited under the bid and not withdrawn.

● **Mandatory 10-day extension period** – If, at the end of the initial deposit period, an offeror is obligated to take up securities deposited under the terms of a take- over bid, the offeror must extend the period during which securities may be deposited under the period of the bid for a mandatory 10-day extension period and promptly issue a news release announcing that, among other things, the minimum tender requirement has been satisfied, the number of securities deposited and not withdrawn as at the expiry of the initial deposit period and the period during which securities may be deposited under the bid has been extended for the mandatory ten-day extension period.

● **Equal Treatment** – The take-over bid rules require that all holders of the same class of securities be offered identical consideration (or an identical choice of consideration). If a bidder increases the consideration to be paid for the securities during a take-over bid, this consideration must be increased for all shareholders, even if the bidder has already taken up and paid for some shares. The bidder (and anyone acting jointly or in concert with the bidder) is prohibited from entering into any collateral agreements or understanding that will (directly or indirectly) provide a shareholder of the target company with consideration of greater value than that paid or payable to other shareholders of the same class, subject to certain exemptions.

In addition to NI 62-104, there are also further regulations and guidance (including certain disclosure requirements) provided pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues ("NI 62-103"), National Policy 62-202 – Take-Over Bids – Defensive Tactics, National Policy 62-203 – Take-Over Bids and Issuer Bids, and applicable exchange rules.

We believe that the take-over bid rules provide adequate protection against hostile bids. Having said that, it has been suggested that the new rules do not protect against creeping take-over bids for control which are exempt from the rules (such as the accumulation of 20% or more of the issuer's shares through market transactions or the acquisition of a control block through private agreements with a few large shareholders). These activities would however be identifiable through the early warning filing requirements. If, prior to making a determination that the Company ought to adopt a "strategic" SRP at an annual or special meeting of shareholders, the Company were faced with a hostile bid that we believed was not in the best interests of the Company and its shareholders, the directors could adopt a "tactical" plan which we could take to the shareholders for approval. Nevertheless, at this point in time, we are of the opinion that such action is not necessary, and the shareholders should be the best arbiters of when "the pill must go".

Stockholder Ownership Disclosure Threshold in Bylaws

Neither our Articles nor By-laws contain a provision governing the ownership threshold above which shareholder ownership must be disclosed. Pursuant to securities legislation, an Early Warning Report and an Insider Report must be filed if a shareholder obtains ownership on a partially diluted basis of 10% or greater of the Company.

Special Conditions for Changes in Capital

The conditions imposed by the Company's Articles are not more stringent than required under the OBCA.

&nbsp;&nbsp;&nbsp;&nbsp;**C.**  ***Material Contracts*.** 

In addition to any contracts described in "Item 7.B. Related Party Transactions" or "Item 4. Business Overview", below is a summary of material contracts, other than those entered into by the Company in the ordinary course of business, to which we are or have been a party during the two years immediately preceding the date of this document. Other than contracts entered into in the ordinary course of business, we have not been a party to any other material contract within such two-year period.

&nbsp;&nbsp;&nbsp;&nbsp;**D.**  ***Exchange Controls*.** 

Canada has no system of exchange controls. There are no Canadian restrictions on the repatriation of capital or earnings of a Canadian public company to non-resident investors. There are no laws in Canada or exchange restrictions affecting the remittance of dividends, profits, interest, royalties and other payments to non-resident holders of the Company's securities, except as discussed in "Item 10.E. Taxation" below.

&nbsp;&nbsp;&nbsp;&nbsp;**E.**  ***Taxation.*** 

The following summary discusses certain material U.S. and Canadian tax considerations related to the holding and disposition of common shares as of the hereof. Prospective purchasers of our common shares are advised to consult their own tax advisers concerning the consequences under the tax laws of the country of which they are resident or in which they are otherwise subject to tax of making an investment in our common shares.

Canadian Federal Income Tax Considerations

The Company believes the following is a brief summary of the material principal Canadian federal income tax consequences to a U.S. Holder (as defined below) of common shares of the Company who deals at arm's length with the Company, holds the shares as capital property and who, for the purposes of the Income Tax Act (Canada) (the "Tax Act") and the Canada — U.S. Income Tax Convention (1980) (the "Treaty"), is at all relevant times resident in the U.S., is not and is not deemed to be resident in Canada and does not use or hold and is not deemed to use or hold the shares in carrying on a business in Canada. Special rules, which are not discussed below, may apply to a U.S. Holder that is an insurer that carries on business in Canada and elsewhere. U.S. Holders are urged to consult their own tax advisors with respect to their particular circumstances.

This summary is based upon the current provisions of the Tax Act, the regulations thereunder in force at the date hereof, all specific proposals to amend such regulations and the Tax Act publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof and the current provisions of the Convention and the current administrative practices of the Canada Revenue Agency published in writing prior to the date hereof. This summary does not otherwise take into account or anticipate any changes in law or administrative practices whether by legislative, governmental or judicial decision or action, nor does it take into account tax laws of any province or territory of Canada or of the U.S. or of any other jurisdiction outside Canada.

For the purposes of the Tax Act, all amounts relating to the acquisition, holding or disposition of the common shares must be converted into Canadian dollars based on the relevant exchange rate applicable thereto.

This summary does not address all aspects of Canadian federal income taxation that may be relevant to any particular U.S. Holder in light of such holder's individual circumstances. Accordingly, U.S. Holders should consult with their own tax advisors for advice with respect to their own particular circumstances.

Under the Tax Act and the Treaty, a U.S. Holder of common shares will generally be subject to a 15% withholding tax on dividends paid or credited or deemed by the Tax Act to have been paid or credited on such shares. The withholding tax rate is 5% where the U.S. Holder is a corporation that beneficially owns at least 10% of the voting shares of the Company and the dividends may be exempt from such withholding in the case of some U.S. Holders such as qualifying pension funds and charities.

A U.S. Holder will generally not be subject to tax under the Tax Act on any capital gain realized on a disposition of common shares, provided that the shares do not constitute "taxable Canadian property" to the U.S. Holder at the time of disposition. Generally, common shares will not constitute taxable Canadian property to a U.S. Holder provided that such shares are listed on a designated stock exchange at the time of the disposition and, during the 60- month period immediately preceding the disposition, the U.S. Holder, persons with whom the U.S. Holder does not deal at arm's length, or the U.S. Holder together with all such persons has not owned 25% or more of the issued shares of any series or class of the Company's capital stock. If the common shares constitute taxable Canadian property to a particular U.S. Holder, any capital gain arising on their disposition may be exempt from Canadian tax under the Convention if at the time of disposition the common shares do not derive their value principally from real property situated in Canada.

U.S. Federal Income Tax Considerations

Subject to the limitations described herein, the following discussion summarizes certain U.S. federal income tax consequences to a U.S. Holder of our common shares. A "U.S. Holder" means a holder of our common shares who is:

● an individual who is a citizen or resident of the U.S. for U.S. federal income tax purposes;

● a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in the U.S. or under the laws of the U.S. or any political subdivision thereof, or the District of Columbia;

● an estate, the income of which is subject to U.S. federal income tax regardless of its source; or

● a trust (i) if, in general, a court within the U.S. is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions, or (ii) that has in effect a valid election under applicable U.S. Treasury Regulations to be treated as a U.S. person.

Unless otherwise specifically indicated, this discussion does not consider the U.S. tax consequences to a person that is not a U.S. Holder (a "Non-U.S. Holder"). This discussion considers only U.S. Holders that will own our common shares as capital assets (generally, for investment) and does not purport to be a comprehensive description of all of the tax considerations that may be relevant to each U.S. Holder's decision to purchase our common shares.

This discussion is based on current provisions of the Internal Revenue Code of 1986, as amended (the "Code"), current and proposed Treasury Regulations promulgated thereunder, and administrative and judicial decisions as of the date hereof, all of which are subject to change, possibly on a retroactive basis. This discussion does not address all aspects of U.S. federal income taxation that may be relevant to any particular U.S. Holder in light of such holder's individual circumstances. In particular, this discussion does not address the potential application of the alternative minimum tax or the U.S. federal income tax consequences to U.S. Holders that are subject to special treatment, including U.S. Holders that:

● are broker-dealers or insurance companies;

● have elected market-to-market accounting;

● are tax-exempt organizations or retirement plans;

● are financial institutions or "financial services entities";

● hold our common shares as part of a straddle, "hedge" or "conversion transaction" with other investments;

● acquired our common shares upon the exercise of employee stock options or otherwise as compensation;

● own directly, indirectly or by attribution at least 10% of our voting power;

● have a functional currency that is not the U.S. Dollar;

● are grantor trusts;

● are certain former citizens or long-term residents of the U.S.; or

● are real estate trusts or regulated investment companies.

If a partnership (or any other entity treated as a partnership for U.S. federal income tax purposes) holds our common shares, the tax treatment of the partnership and a partner in such partnership will generally depend on the status of the partner and the activities of the partnership. Such a partner or partnership should consult its own tax advisor as to its tax consequences.

In addition, this discussion does not address any aspect of state, local or non-U.S. laws or the possible application of U.S. federal gift or estate taxes.

Each potential U.S Holder of our common shares is advised to consult its own tax advisor with respect to the specific tax consequences to it of purchasing, holding or disposing of our common shares, including the applicability and effect of federal, state, local and foreign income tax and other laws to its particular circumstances.

Distributions

Subject to the discussion below under "Passive Foreign Investment Company Status," a U.S. Holder will be required to include in gross income as ordinary dividend income the amount of any distribution paid on our common shares, including any non-U.S. taxes withheld from the amount paid, to the extent the distribution is paid out of our current or accumulated earnings and profits as determined for U.S. federal income tax purposes. Distributions in excess of such earnings and profits will be applied against and will reduce the U.S. Holder's basis in our common shares and, to the extent in excess of such basis, will be treated as gain from the sale or exchange of our common shares. The dividend portion of such distributions generally will not qualify for the dividends received deduction available to corporations. U.S. Holders which are individuals, estates and trusts and whose income exceeds certain thresholds will be required to pay a 3.8% surtax on "net investment income" including, among other things, dividends (if any) and net gain realized from our common shares. U.S. Holders should consult with their own tax advisors regarding the application of this tax.

Subject to the discussion below under "Passive Foreign Investment Company Status," dividends that are received by U.S. Holders that are individuals, estates or trusts may qualify for taxation at the rate applicable to long-term capital gains (a maximum marginal federal income tax rate of 20%), provided that such U.S. Holders satisfy certain holding period requirements and such dividends meet the requirements of "qualified dividend income." For this purpose, dividends paid by a non-U.S. corporation may qualify if the non-U.S. corporation is eligible for benefits of a comprehensive income tax treaty with the U.S., which benefits include an information exchange program and is determined to be satisfactory by the U.S. Secretary of the Treasury. The IRS has determined that the U.S.- Canada Tax Treaty is satisfactory for this purpose. Dividends that fail to meet such requirements, and dividends received by corporate U.S. Holders, are taxed at ordinary income rates.

Distributions of current or accumulated earnings and profits paid in foreign currency to a U.S. Holder (including any non-U.S. taxes withheld therefrom) will be includible in the income of a U.S. Holder in a U.S. Dollar amount calculated by reference to the exchange rate on the day the distribution is received. A U.S. Holder that receives a foreign currency distribution and converts the foreign currency into U.S. dollars subsequent to receipt may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the U.S. dollar, €h will generally be U.S. source ordinary income or loss. A loss might not be deductible due to certain limitations.

U.S. Holders will have the option of claiming the amount of any non-U.S. income taxes withheld at source either as a deduction from gross income or as a dollar-for- dollar credit against their U.S. federal income tax liability. Individuals who do not claim itemized deductions, but instead utilize the standard deduction, may not claim a deduction for the amount of the non-U.S. income taxes withheld, but such amount may be claimed as a credit against the individual's U.S. federal income tax liability. The amount of non-U.S. income taxes which may be claimed as a credit in any taxable year is subject to complex limitations and restrictions, which must be determined on an individual basis by each shareholder. These limitations include, among others, rules that limit foreign tax credits allowable with respect to specific classes of income to the U.S. federal income taxes otherwise payable with respect to each such class of income. A U.S. Holder will be denied a foreign tax credit with respect to non-U.S. income tax withheld from a dividend received on the common shares if such U.S. Holder does not satisfy certain holding period requirements.

Distributions of current or accumulated earnings and profits generally will be foreign source income for U.S. foreign tax credit purposes.

Disposition of Common Shares

Subject to the discussion below under "Passive Foreign Investment Company Status," upon the sale, exchange or other taxable disposition of our common shares, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such U.S. Holder's basis in such common shares, which is usually the cost of such shares, and the amount realized on the disposition. Capital gain from the sale, exchange or other disposition of common shares held more than one year is long-term capital gain, and is eligible for a reduced rate of taxation for individuals (currently a maximum marginal federal income tax rate of 20%, plus the 3.8% net investment income tax discussed above, if applicable). Gains recognized by a U.S. Holder on a sale, exchange or other disposition of common shares generally will be treated as U.S. source income for U.S. foreign tax credit purposes. A loss recognized by a U.S. Holder on the sale, exchange or other taxable disposition of common shares generally is allocated to U.S. source income. The deductibility of capital losses recognized on the sale, exchange or other taxable disposition of common shares is subject to limitations. A U.S. Holder that receives foreign currency upon disposition of common shares and converts the foreign currency into U.S. dollars subsequent to the settlement date or trade date (whichever date the taxpayer was required to use to calculate the value of the proceeds of sale) may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the U.S. Dollar, which will generally be U.S. source ordinary income or loss. Such loss may not be deductible due to certain limitations.

Passive Foreign Investment Company Status

We would be a passive foreign investment company (a "PFIC") if (taking into account certain "look-through" rules with respect to the income and assets of our corporate subsidiaries in which we own 25 percent (by value) of the stock) either (i) 75 percent or more of our gross income for the taxable year was passive income or (ii) the average percentage (by value) of our total assets that are passive assets during the taxable year was at least 50 percent.

If we were a PFIC, each U.S. Holder would (unless it made one of the elections discussed below on a timely basis) be taxable on gains recognized from the disposition of our common shares (including gain deemed recognized if the common shares are used as security for a loan) and upon receipt of certain "excess distributions" (generally, distributions that exceed 125% of the average amount of distributions in respect to such common shares received during the preceding three taxable years or, if shorter, during the U.S. Holder's holding period prior to the distribution year) with respect to our common shares as if such income had been recognized ratably over the U.S. Holder's holding period for the common shares. The U.S. Holder's income for the current taxable year would include (as ordinary income) amounts allocated to the current taxable year and to any taxable year period prior to the first day of the first taxable year for which we were a PFIC. Tax would also be computed at the highest ordinary income tax rate in effect for each other taxable year period to which income is allocated, and an interest charge on the tax as so computed would also apply. Additionally, if we were a PFIC, U.S. Holders who acquire our common shares from decedents (other than non resident aliens) would be denied the normally available step-up in basis for such shares to fair market value at the date of death and, instead, would have a tax basis in such shares equal to the decedent's basis, if lower.

As an alternative to the tax treatment described above, a U.S. Holder could elect to treat us as a "qualified electing fund" (a "QEF"), in which case the U.S. Holder would be taxed currently, for each taxable year that we are a PFIC, on its pro rata share of our ordinary earnings and net capital gain (subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge). Special rules apply if a U.S. Holder makes a QEF election after the first taxable year in its holding period in which we are a PFIC. In the event that we conclude that we will be classified as a PFIC, we will make a determination at such time as to whether we will be able to provide U.S. Holders with the information that is necessary to make a QEF election. Amounts includable in income as a result of a QEF election will be determined without regard to our prior year losses or the amount of cash distributions, if any, received from us. A U.S. Holder's basis in its common shares will increase by any amount included in income and decrease by any amounts not included in income when distributed because such amounts were previously taxed under the QEF rules. So long as a U.S. Holder's QEF election is in effect with respect to the entire holding period for its common shares, any gain or loss realized by such holder on the disposition of its common shares held as a capital asset ordinarily will be capital gain or loss.

As an alternative to making the QEF election, a U.S. Holder of PFIC stock which is regularly traded on a qualified exchange may avoid the negative effects of the PFIC rules by electing to mark the stock to market and recognizing as ordinary income or loss, each taxable year that we are a PFIC, an amount equal to the difference as of the close of the taxable year between the fair market value of the PFIC stock and the U.S. Holder's adjusted tax basis in the PFIC stock. Losses would be allowed only to the extent of net mark-to-market gain previously included by the U.S. Holder under the election for prior taxable years. This election is available for so long as the Company's common shares constitute "marketable stock," which includes stock of a PFIC that is "regularly traded" on a "qualified exchange or other market." Generally, a "qualified exchange or other market" includes a national market system established pursuant to Section 11A of the Exchange Act, or a foreign securities exchange that is regulated or supervised by a governmental authority of the country in which the market is located and that has certain characteristics. A class of stock that is traded on one or more qualified exchanges or other markets is "regularly traded" on an exchange or market for any calendar year during which that class of stock is traded, other than in de minimis quantities, on at least 15 days during each calendar quarter, subject to special rules relating to an initial public offering. It is not entirely clear whether either Nasdaq is a "qualified exchange or other market," or whether there will be sufficient trading volume with respect to the Company's common shares, and accordingly, whether the common shares will be "marketable stock" for these purposes. Furthermore, there can be no assurances that the Company's common shares will continue to trade on any of the exchange listed above.

We believe we were not a PFIC for the year ending December 31, 2025 and do not expect to be classified as a PFIC for the year ending December 31, 2026. However, PFIC status is determined as of the end of each taxable year and is dependent on a number of factors, including the value of our passive assets, the amount and type of our gross income, and our market capitalization. Therefore, there can be no assurance that we will not be classified as a PFIC for the current taxable year or in a future taxable year. We will notify U.S. Holders in the event we conclude that we will be treated as a PFIC for any taxable year.

Information Reporting and Backup Withholding

U.S. Holders (other than exempt recipients, such as corporations) generally are subject to information reporting requirements with respect to dividends paid on, or proceeds from the disposition of, our common shares. U.S. Holders are also generally subject to backup withholding (currently at a rate of 24%) on dividends paid on, or proceeds from the disposition of, our common shares unless the U.S. Holder provides IRS Form W-9 or otherwise establishes an exemption.

The amount of any backup withholding will be allowed as a credit against a U.S. or Non-U.S. Holder's U.S. federal income tax liability and may entitle such holder to a refund, provided that certain required information is furnished to the IRS.

&nbsp;&nbsp;&nbsp;&nbsp;**F.**  ***Dividends and Paying Agents*.** 

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;**G.**  ***Statements by Experts*.** 

Note required

&nbsp;&nbsp;&nbsp;&nbsp;**H.**  ***Documents on Display*.** 

The Company's documents can be viewed at its Canadian office, located at: Suite 1107, 120 Eglinton Avenue East, Toronto, Ontario M4P 1E2, Canada. Further, we file reports under Canadian regulatory requirements on SEDAR+; you may access our reports filed on SEDAR+ by accessing their website at www.sedarplus.ca. The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the Exchange Act), and files reports, Annual Reports and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. The Company's reports, Annual Reports and other information can be inspected on the SEC's website.

We maintain a corporate website at www.poet-technologies.com. Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F. We have included our website address in this Annual Report on Form 20-F solely as an inactive textual reference.

&nbsp;&nbsp;&nbsp;&nbsp;**I.**  ***Subsidiary Information*.** 

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;**J.**  ***Annual Report to Security Holders*.** 

If we are required to furnish an annual report to security holders on Form 6-K, we will submit such annual report in electronic format in accordance with the EDGAR Filer Manual.

**Item 11. Quantitative and Qualitative Disclosures About Market Risk**

Market Risk

Market risk arises from the possibility that changes in market prices will affect the value of the financial instruments of the Company. The Company is exposed to fair value fluctuations on its cash equivalents. The Company's other financial instruments (cash and accounts payable and accrued liabilities) are not subject to market risk, due to the short- term nature of these instruments. The Company manages market risk through its investment policy where surplus funds are only invested in a manner that will provide the optimal blend of investment returns and principal protection while meeting its daily cash flow and liquidity demands.

Interest Rate Risk

Short-term investments bear interest at fixed rates, and as such, are subject to interest rate risk resulting from changes in fair value from market fluctuations in interest rates. The Company does not depend on interest from its investments to fund its operations.

Exchange Rate Risk

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled except for the Canadian entity which has determined that the U.S. Dollar is its functional currency. Functional currencies include the Chinese Yuan, US, Singapore and Malaysian Ringgit. Most transactions within the entities are conducted in functional currencies. As such, none of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk when its subsidiaries hold current assets or current liabilities in currencies other than its functional currency. A 10% change in foreign currencies held would increase or decrease other comprehensive loss by $2,000,000.

The following table shows exchange rates, from SGD to USD, for the past six months:

---

| | | | |
|:---|:---|:---|:---|
| Period | High (1) | Low (1) | Average (2) |
| February 2026 | 0.7933 | 0.7839 | 0.7875 |
| January 2026 | 0.7875 | 0.7720 | 0.7808 |
| December 2025 | 0.7924 | 0.7702 | 0.7747 |
| November 2025 | 0.7900 | 0.7650 | 0.7683 |
| October 2025 | 0.7764 | 0.7696 | 0.7719 |
| September 2025 | 0.7830 | 0.7722 | 0.7781 |
| September 2025 — February 2026 | 0.7933 | 0.7650 | 0.7791 |

---

(1) Bank
 of Singapore monthly average rates

(2) Bank
 of Singapore daily closing average rates

The following table shows exchange rates, from CNY to USD, for the past six months:

---

| | | | |
|:---|:---|:---|:---|
| Period | High (1) | Low (1) | Average (2) |
| February 2026 | 0.1449 | 0.1429 | 0.1440 |
| January 2026 | 0.1435 | 0.1410 | 0.1428 |
| December 2025 | 0.1429 | 0.1408 | 0.1419 |
| November 2025 | 0.1412 | 0.1395 | 0.1408 |
| October 2025 | 0.1410 | 0.1396 | 0.1404 |
| September 2025 | 0.1409 | 0.1396 | 0.1403 |
| September 2025 — February 2026 | 0.1449 | 0.1395 | 0.1422 |

---

(1) Bank
 of China monthly average rates

(2) Bank
 of China daily closing average rates

The following table shows exchange rates, from MYR to USD, for the past six months:

---

| | | | |
|:---|:---|:---|:---|
| Period | High (1) | Low (1) | Average (2) |
| February 2026 | 0.2253 | 0.2218 | 0.2238 |
| January 2026 | 0.2242 | 0.2200 | 0.2229 |
| December 2025 | 0.2231 | 0.2187 | 0.2214 |
| November 2025 | 0.2220 | 0.2180 | 0.2202 |
| October 2025 | 0.2210 | 0.2170 | 0.2191 |
| September 2025 | 0.2195 | 0.2168 | 0.2181 |
| September 2025 — February 2026 | 0.2253 | 0.2168 | 0.2210 |

---

(1) Bank
 Negara Malaysia monthly average rates

(2) Bank
 Negara Malaysia daily closing average rates

**Item 12. Description Of Securities Other Than Equity Securities**

&nbsp;&nbsp;&nbsp;&nbsp;**A.**  ***Debt Securities*.** 

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;B. Warrants
 and Rights

Not required.

&nbsp;&nbsp;&nbsp;&nbsp;C. Other
 Securities

Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;**D.**  ***American Depositary Shares*.** 

Not applicable.

**PART II**

**Item 13. Defaults, Dividend Arrearages and Delinquencies**

Not applicable.

**Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds**

Not applicable.

**Item 15. Controls and Procedures**

**(a)** **Disclosure Controls and Procedures.** 

Disclosure controls and procedures are defined by Rules 13a-15(e) and 15d-15(e) under the Exchange Act as controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2025, the Company's disclosure controls and procedures were effective.

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Management's Annual Report on Internal Control over Financial Reporting** 

Our management, under the oversight of our Board of Directors (in particular its audit committee), is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act and as set forth in Section 404 of SOX). The Company's internal control over financial reporting is designed to provide reasonable assurance to management and the Board of Directors regarding the reliability of financial reporting and the preparation and fair presentation of its published consolidated financial statements. Under the SOX framework, our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board. Our internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with IFRS, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

All internal controls over financial reporting, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective may not prevent or detect misstatements and can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2025. In making this assessment, it used the criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on that assessment and those criteria, management concluded our internal controls over financial reporting was effective as of December 31, 2025

&nbsp;&nbsp;&nbsp;&nbsp;**(c)** **Attestation Report of Registered Public Accounting Firm** 

Davidson & Company LLP, the independent registered public accounting firm that audited the consolidated financial statements of the Company included in this Annual Report on Form 20-F, and has issued an attestation report on the effectiveness of the Company's internal control over financial reporting as of December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Management Remediation Initiatives** 

As previously reported in the Company's Form 20-F for the year ended December 31, 2024, a material weakness was identified in internal controls performed by management due to insufficient resources to properly execute the designed controls or perform an effective review over certain manual controls related to the financial statement close process. The material weakness did not result in any identified misstatements to the consolidated financial statements and there were no changes to previously released financial results.

To remediate the material weakness in the Company's internal control over financial reporting, the Company hired additional resources for accounting management and oversight. Their contribution is ongoing as of the filing of this Form 20-F. As of December 31, 2025, management believes that this material weakness in internal controls has been remediated.

&nbsp;&nbsp;&nbsp;&nbsp;**(e)** **Changes in Internal Controls over Financial Reporting** 

We have undertaken the remediation efforts described. Except for those efforts, there were no other changes in our internal control over financial reporting during year ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting

**Item 16. [Reserved]**

**Item 16A. Audit Committee Financial Expert**

The Board has determined that Bob Tirva satisfies the criteria of "audit committee financial expert" set forth in Item 16A of Form 20-F and is independent in accordance with Rule 4200 of the Nasdaq Marketplace Rules.

**Item 16B. Code of Ethics**

Our Board of Directors adopted a Code of Business Conduct and Ethics, as amended in March 2025 (the "Code"), that applies to all our employees, including without limitation our chief executive officer, chief financial officer and principal accounting officer. Our Code may be viewed on our website at www.poet-technologies.com and is filed as an Exhibit to this Annual Report. A copy of our Code may be obtained, without charge, upon a written request addressed to our office at, 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario M4P 1E2, Canada. We will disclose on our website any amendment to, or waiver from, a provision of the Code as required by applicable securities rules and regulations. During the year ended December 31, 2025, the Company did not waive or implicitly waive any provision of the Code with respect to any of the Company's principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.

**Item 16C. Principal Accountant Fees and Services**

Marcum LLP ("Marcum") served as our independent registered public accounting firm for the year ended December 31, 2023, and up to the date of its resignation, and Davidson & Company LLP ("Davidson") was appointed as our independent registered public accounting firm, including to audit the Company's consolidated financial statements for the years ended December 31, 2024 and 2025 that appear in this Annual Report. See Item 16.F. "Change in Registrant's Certifying Accountant" for further details regarding the change in our independent registered public accounting firm. Set forth below are the total fees billed (or expected to be billed) on a consolidated basis by Davidson for providing audit and other professional services in each of the last two years.

---

| | | |
|:---|:---|:---|
|  | Year Ended December 31, | Year Ended December 31, |
| Services Rendered | 2025 | 2024 |
| Audit Fees (1) | $282500 | $302771 |
| Audit-Related Fees (2) |  |  |
| Tax Fees (3) | 36466 | 14111 |
| All Other Fees (4) | - | - |
| Total | $318966 | 316882 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Audit
 Fees included fees for the audit of the Company's annual consolidated financial statements, SOX 404(b) audit and professional
 services rendered in connection with filing of registration statements.

(2) Audit-Related
 Fees include fees for assurance and related services that are reasonably related to the performance of the audit and are not reported
 under audit fees. These fees primarily include accounting consultations regarding the accounting treatment of matters that occur
 in the regular course of business, implications of new accounting pronouncements, acquisitions and other accounting issues that occur
 from time to time.

(3) Tax
 Fees include fees for professional services rendered by our independent registered public accounting firm for tax compliance and
 tax advice on actual or contemplated transactions.

(4) All
 Other Fees include fees for services rendered by our independent registered public accounting firm with respect to government incentives
 and other matters.

Our Audit Committee, in accordance with its charter, reviews and pre-approves all audit services and permitted non-audit services (including the fees and other terms) to be provided by our independent auditors. All of the services provided by Davidson & Company LLP over the past two years were pre-approved by the Audit Committee.

**Item 16D. Exemptions from the Listing Standards for Audit Committees**

Not applicable.

**Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers**

Not applicable.

**Item 16F. Change in Registrant's Certifying Accountant.**

April 22, 2024, Marcum resigned as the Company's independent registered public accounting firm at the Company's request effective as of such date.

Following the foregoing, on April 23, 2024, the Company engaged Davidson as its independent registered public accounting firm to audit the Company's financial statements for the fiscal years ended December 31, 2024 and 2025. The appointment of Davidson was recommended to the Company's Board by the Audit Committee of the Board and subsequently approved by the Board.

The audit reports of Marcum on the Company's consolidated financial statements for the fiscal year ended December 31, 2023 that are filed herewith did not contain an adverse opinion or disclaimer of opinion, or qualification or modification as to uncertainty, audit scope, or accounting principles, except (i) solely with respect to the audit report for the fiscal year ended December 31, 2023, to express an adverse opinion on the effectiveness of the Company's internal control over financial reporting because of the existence of a material weakness and (ii) to indicate that there was substantial doubt about the Company's ability to continue as a going concern.

In connection with the audit of the Company's financial statements for the fiscal year ended December 31, 2023, and in the subsequent interim period through April 22, 2024, there were (i) no disagreements within the meaning of Item 16F(a)(1)(iv) of Form 20-F between the Company and Marcum on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedure that, if not resolved to the satisfaction of Marcum, would have caused it to make reference to the subject matter thereof in connection with its reports for such years, and (ii) no "reportable events" within the meaning of Item 16F(a)(1)(v) of Form 20-F, except for the material weakness described in the Form 20-F, Item 15.b "Management's Annual Report on Internal Control over Financial Reporting" filed on March 28, 2024.

Prior to engaging Davidson as the Company's independent auditor for the fiscal year ended December 31, 2024, the Company had not consulted Davidson regarding the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements or a reportable event, nor did the Company consult with Davidson regarding any matter that was either (i) the subject of any disagreements (as that term is described in Item 16F(a)(1)(iv) of Form 20-F and the related instructions) with its prior auditor or (ii) a reportable event (as that term is defined in Item 16F(a)(1)(v) of Form 20-F).

The Company provided Marcum with a copy of the disclosure above prior to its filing of this Annual Report and requested that Marcum furnish the Company with a letter addressed to the SEC stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. Their letter to the SEC dated March 31, 2025 is filed as Exhibit 16.1 to this Annual Report.

**Item 16G. Corporate Governance**

A foreign private issuer that follows home country practices in lieu of certain provisions of the Nasdaq rules must disclose the ways in which its corporate governance practices differ from those followed by U.S. domestic companies. As required by Nasdaq Rule 5615(a)(3), the Company discloses on its website, www.poet-technologies.com, each requirement of the Nasdaq rules that it does not follow and describes the home country practice it follows in lieu of such requirements.

**Item 16H. Mine Safety Disclosure**

Not applicable.

**Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections**

Not applicable.

**Item 16J. Insider Trading Policies**

The Company has adopted an Insider Trading Policy governing the purchase, sale and other dispositions of the Company's securities by directors, senior management and employees that is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and all applicable listing standards. A copy of the policy is filed as Exhibit 11.2 hereto.

**Item 16K. Cybersecurity**

We believe cybersecurity, which is a part of our broader risk management framework is key to the Company achieving its strategic goals and objectives. Based on the nature of our business and the industry in which we operate, we are faced with a variety of cybersecurity threats including phishing emails, ransomware attacks, malicious attachments, social engineering attacks and denial of service attacks, among others. Our customers, suppliers, subcontractors and partners face similar cybersecurity threats, and a cybersecurity incident impacting us or any of these entities could materially adversely affect our operations, performance and results of operations.

Our information security organization has implemented a governance structure and processes to assess, identify, manage and report cybersecurity risks. We also engage third-party service providers to conduct evaluations of our security controls, including testing both the design and operational effectiveness of security controls. We conduct internal due diligence of all third-party providers before engagement and maintain ongoing monitoring to ensure compliance with our cybersecurity standards, including strict controls of privileged access granted to service providers. This approach is designed to mitigate risks related to data breaches or other security incidents originating from third parties.

In the event of an incident, we intend to follow our incident management procedures, which outline the steps to be followed from incident detection to mitigation, recovery and notification, including notifying functional areas (e.g., legal, compliance and internal audit), as well as senior leadership and the Board, as appropriate.

On a regular basis, the Company analyzes its internet-based services to identify vulnerabilities and assesses the protection and the detection capabilities. The cybersecurity compliance status of assets is centrally evaluated across the Company's global sites and business and operational functions. Results are shared within the Company's relevant business units and across global functions. The Company implements corrective measures and improvement actions in response to these processes, as appropriate. Data classification and protection tools are in place, such as the implementation of a specific process and technology aimed at detecting and responding to abnormal data flows.

Cybersecurity risks and threats, including as a result of any previous cybersecurity incidents, have not materially impacted and are not reasonably expected to materially impact us or our operations to date. However, we recognize the ever-evolving cyber risk landscape and cannot provide any assurances that we will not be subject to a material cybersecurity incident in the future.

***Governance***

The Board of Directors and our Audit Committee oversee management's processes for identifying and mitigating risks, including cybersecurity risks, to help align our risk exposure with our strategic objectives. Senior leadership have developed a process to regularly brief the Audit Committee and Board of Directors on our cybersecurity and information security policies and procedures, and the Board of Directors will be apprised of cybersecurity incidents deemed to have a potential material impact on the Company.

The CFO and VP Finance are responsible for managing cybersecurity risks. Both have experience through years of service as leaders in corporate administration including managing IT systems in their former roles. They oversee the activities of the Company's outsourced IT firm, which assists with managing our overall information security strategy, policy, cyber threat detection and response, cyber architecture and processes for the security of our network and intellectual property. Various technologies and techniques are used to monitor and manage cybersecurity risks. Policies and processes are regularly updated.

**PART III**

**Item 17. Financial Statements**

The Company's consolidated financial statements are stated in U.S. dollars and are prepared in accordance with IFRS as issued by the International Accounting Standards Board.

The consolidated financial statements required under Item 17 are attached hereto and found immediately following the text of this Annual Report and are incorporated by reference herein. The audit reports of Marcum LLP and Davidson & Company LLP, independent registered public accounting firms, are included herein immediately preceding the audited consolidated financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. <u>Audited Financial Statements</u> — for the years ended December 31, 2025, 2024 and 2023 and as of December 31, 2025, 2024 and 2023

**Item 18. Financial Statements**

The Company has elected to provide financial statements pursuant to Item 17.

**Item 19. Exhibits**

1.1 [Certificate and Articles of Continuance (1)](https://www.sec.gov/Archives/edgar/data/1437424/000110465914039326/a14-12231_1ex1d1.htm)

1.2 [Amended and Restated Bylaws (2)](https://www.sec.gov/Archives/edgar/data/1437424/000110465915027261/a15-8939_1ex1d2.htm)

1.3 [Articles of Amendment, dated February 24, 2022 (8)](https://www.sec.gov/Archives/edgar/data/1437424/000149315222011268/ex1-3.htm)

2.0 [Description of Securities (6)](https://www.sec.gov/Archives/edgar/data/1437424/000117184320003048/exh_2.htm)

4.1 [License Agreement with the University of Connecticut, dated April 28, 2003, as amended April 15, 2014 (1)](https://www.sec.gov/Archives/edgar/data/1437424/000110465914039326/a14-12231_1ex4d3.htm)

4.3 [Shareholder Rights Plan Agreement between the Company and TMX Equity Transfer Services, Inc.(2)](https://www.sec.gov/Archives/edgar/data/1437424/000110465915027261/a15-8939_1ex4d10.htm)

4.4 [Employment Agreement with Suresh Venkatesan, dated June 10, 2015 (3)](https://www.sec.gov/Archives/edgar/data/1437424/000117184316008667/exh_413.htm)

4.5 [Employment Agreement with Vivek Rajgarhia, dated November 4, 2019 (6)](https://www.sec.gov/Archives/edgar/data/1437424/000117184320003048/exh_416.htm)

4.6 [Employment Agreement with Thomas Mika, dated November 2, 2016 (4)](https://www.sec.gov/Archives/edgar/data/1437424/000117184317002153/exh_416.htm)

4.7 [Definitive agreement with San'an Integrated Circuit Co., Ltd dated October 21, 2020 (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex4-7.htm)

4.8 [Sale and Purchase Agreement for DenseLight Semiconductors PTE, LTD, dated April 27, 2016 (4)](https://www.sec.gov/Archives/edgar/data/1437424/000117184317002153/exh_420.htm)

4.9 [Sale and Purchase Agreement for BB Photonics Inc. dated May 16, 2016 (4)](https://www.sec.gov/Archives/edgar/data/1437424/000117184317002153/exh_421.htm)

4.10 [2021 Stock Option Plan (8)](https://www.sec.gov/Archives/edgar/data/1437424/000149315222011268/ex4-10.htm)

4.11 [Form of Option Agreement(1)](https://www.sec.gov/Archives/edgar/data/1437424/000110465914039326/a14-12231_1ex4d14.htm)

4.12 [Form of Warrant for Purchase of Common Shares (1)](https://www.sec.gov/Archives/edgar/data/1437424/000110465914039326/a14-12231_1ex4d15.htm)

4.13 [Stock Specimen Certificate (1)](https://www.sec.gov/Archives/edgar/data/1437424/000110465914039326/a14-12231_1ex4d16.htm)

4.15 [Share Sale Agreement for DenseLight Semiconductors PTE, Ltd dated August 20, 2019 (6)](https://www.sec.gov/Archives/edgar/data/1437424/000117184320003048/exh_415.htm)

4.16 [Omnibus Incentive Plan (12)](ex4-16.htm)

4.18 [Underwriting Agreement with Maxim Group LLC (10)](https://www.sec.gov/Archives/edgar/data/1437424/000149315224011806/ex4-18.htm)

4.20 [Form of Warrant Certificate, December 4, 2023 (10)](https://www.sec.gov/Archives/edgar/data/1437424/000149315224011806/ex4-20.htm)

4.23 [Equity Distribution Agreement Dated June 29, 2023 (10)](https://www.sec.gov/Archives/edgar/data/1437424/000149315224011806/ex4-23.htm)

4.24 [Equity Distribution Agreement Dated September 1, 2023 (10)](https://www.sec.gov/Archives/edgar/data/1437424/000149315224011806/ex4-24.htm)

4.27 [Warrant indenture with TSX Trust Company, dated February 11, 2021 (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex4-27.htm)

4.28 [Engagement letter with Cormark Securities Inc, dated January 25, 2021 (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex4-28.htm)

4.29 [Upsize letter with Cormark Securities Inc, dated January 26, 2021 (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex4-29.htm)

4.30 [Form of Subscription for Units of Private Placement, dated February 11, 2021 (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex4-30.htm)

4.31 [Form of Subscription for Units of Private Placement, dated December 2, 2022 (9)](https://www.sec.gov/Archives/edgar/data/1437424/000149315223010387/ex4-31.htm)

4.32 [Form of Warrant Certificate, dated December 2, 2022 (9)](https://www.sec.gov/Archives/edgar/data/1437424/000149315223010387/ex4-32.htm)

4.33 [Securities purchase agreement, December 3, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-33.htm)

4.34 [Securities purchase agreement, July 19, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-34.htm)

4.35 [Securities purchase agreement, September 25, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-35.htm)

4.36 [Equity Transfer agreement, purchase of SPX (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-36.htm)

4.37 [Warrant for purchase of common shares, December 3, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-37.htm)

4.38 [Warrant for purchase of common shares, July 19, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-38.htm)

4.39 [Form of warrant for purchase of common shares, September 25, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-39.htm)

4.40 [Securities purchase agreement, May 3, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-40.htm)

4.41 [Termination agreement of JV (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-41.htm)

---

| | |
|:---|:---|
| 4.42 | [Warrant for purchase of common shares, May 3, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-42.htm) |
| 4.43 | [Form of securities purchase agreement, January 12, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-43.htm) |
| 4.44 | [Form of warrant certificate, January 12, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-44.htm) |
| 4.45 | [Form of warrant certificate, May 10, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-45.htm) |
| 4.46 | [Form of share purchase agreement, May 10, 2024 (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-46.htm) |
| 4.47 | [Amended L5 Consulting Agreement (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex4-47.htm) |
| 4.48 | [Securities purchase agreement, May 22, 2025 (12)](ex4-48.htm) |
| 4.49 | [Securities purchase agreement, July 17, 2025 (12)](ex4-49.htm) |
| 4.50 | [Securities purchase agreement, October 7, 2025 (12)](ex4-50.htm) |
| 4.51 | [Securities purchase agreement, October 26, 2025 (12)](ex4-51.htm) |
| 4.52 | [Warrant for purchase of common shares, May 22, 2025 (12)](ex4-52.htm) |
| 4.53 | [Warrant for purchase of common shares, July 17, 2025 (12)](ex4-53.htm) |
| 4.54 | [Warrant for purchase of common shares, October 7, 2025 (12)](ex4-54.htm) |
| 8.1 | [List of Subsidiaries (12)](ex8-1.htm) |
| 11.1 | [Code of Business Conduct and Ethics (7)](https://www.sec.gov/Archives/edgar/data/1437424/000149315221008410/ex11-1.htm) |
| 11.2 | [Insider Trading Policy (12)](ex11-2.htm) |
| 12.1 | [Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (12)](ex12-1.htm) |
| 12.2 | [Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (12)](ex12-2.htm) |
| 13.1 | [Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (12)](ex13-1.htm) |
| 13.2 | [Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (12)](ex13-2.htm) |
| 16.1 | [Letter to SEC (11)](https://www.sec.gov/Archives/edgar/data/1437424/000164117225002143/ex16-1.htm) |
| 23.1 | [Consent of Marcum LLP, independent registered accounting firm (12)](ex23-1.htm) |
| 23.2 | [Consent of Davidson & Company LLP, independent registered accounting firm (12)](ex23-2.htm) |
| 97.1 | [POET Technologies Inc. Clawback Policy (10)](https://www.sec.gov/Archives/edgar/data/1437424/000149315224011806/ex97-1.htm) |
| 101. INS(\*) | Inline XBRL Instance Document (12) |
| 101.SCH(\*) | Inline XBRL Taxonomy Extension Schema Linkbase Document (12) |
| 101. AL(\*) | Inline XBRL Taxonomy Extension Calculation Linkbase Document (12) |
| 101.DEF(\*) | Inline XBRL Taxonomy Extension Definition Linkbase Document (12) |
| 101.LAB(\*) | Inline XBRL Taxonomy Extension Label Linkbase Document (12) |
| 101.PRE(\*) | Inline XBRL Taxonomy Extension Presentation Linkbase Document (12) |
| 104(\*) | Cover Page Interactive Data File (embedded within Inline XBRL document) (12) |

---

(1) Filed as an exhibit to the Company's registration statement under the Securities and Exchange Act on Form 20-F on May 15, 2014 and incorporated herein by reference.

(2) Filed as an exhibit to the Company's annual report on Form 20-F on April 13, 2015 and incorporated herein by reference.

(3) Filed as an exhibit to the Company's annual report on Form 20-F on March 18, 2016 and incorporated herein by reference.

(4) Filed as an exhibit to the Company's annual report on Form 20-F on April 18, 2017 and incorporated herein by reference.

(5) Filed as an exhibit to the Company's annual report on Form 20-F on April 30, 2019 and incorporated herein by reference

(6) Filed as an exhibit to the Company's annual report on Form 20-F on April 30, 2020 and incorporated herein by reference.

(7) Filed as an exhibit to the Company's annual report on Form 20-F on April 9, 2021 and incorporated herein by reference

(8) Filed as an exhibit to the Company's annual report on Form 20-F on April 27, 2022 and incorporated herein by reference

(9) Filed as an exhibit to the Company's annual report on Form 20-F on March 31, 2023 and incorporated herein by reference

(10) Filed as an exhibit to the Company's annual report on Form 20-F on March 28, 2024 and incorporated herein by reference

(11) Filed as an exhibit to the Company's annual report on Form 20-F on April 1, 2025 and incorporated herein by reference

(12) Filed as an exhibit to this Form 20-F.

(\*) In accordance with Rule 402 of Regulation S-T, the information in these exhibits shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

The Registration hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.

---

| |
|:---|
| POET TECHNOLOGIES INC. |
| */s/ Suresh Venkatesan* |
| Suresh Venkatesan |
| Chief Executive Officer |

---

Date: March 31, 2026

![](reporticfr_001.jpg)

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Shareholders and Directors of

POET Technologies Inc.

**Opinion on Internal Control Over Financial Reporting**

We have audited POET Technologies Inc.'s (the "Company") internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the "COSO criteria"). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the Company's consolidated statements of financial position as of December 31, 2025 and 2024, and the related consolidated statements of operations and deficit, changes in shareholders' equity, and cash flows for the years then ended, and the related notes and schedules and our report dated March 31, 2026 expressed an unqualified opinion thereon.

**Basis for Opinion**

The Company's management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Form 20-F. Our responsibility is to express an opinion on the entity's internal control over financial reporting based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

**Definition and Limitations of Internal Control Over Financial Reporting**

An entity's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (IFRS Accounting Standards). An entity's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the entity; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS Accounting Standards, and that receipts and expenditures of the entity are being made only in accordance with authorizations of management and directors of the entity; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the entity's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

We have served as the Company's auditor since 2024.

**/s/ DAVIDSON & COMPANY LLP**

731

Chartered Professional Accountants Vancouver, Canada

Licensed Public Accountants

March 31, 2026

![](reporticfr_002.jpg)

![](reportdavid_001.jpg)

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the Shareholders and Directors of

POET Technologies Inc.

**Opinion on the Consolidated Financial Statements**

We have audited the accompanying consolidated statements of financial position of POET Technologies Inc. (the "Company") as of December 31, 2025 and 2024, and the related consolidated statements of operations and deficit, changes in shareholders' equity*,* and cash flows for the years ended December 31, 2025 and 2024, and the related notes and schedules (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for the years ended December 31, 2025 and 2024, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board ("IFRS Accounting Standards").

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB"), the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) ("COSO") and our report dated March 31, 2026 expressed an unqualified opinion on the effectiveness of the Company's internal control over financial reporting.

**Basis for Opinion**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Critical Audit Matters**

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

We have not identified any critical audit matters for the year ended December 31, 2025.

We have served as the Company's auditor since 2024.

**/s/ DAVIDSON & COMPANY LLP**

Chartered Professional Accountants Vancouver, Canada

Licensed Public Accountants

March 31, 2026

![](reportdavid_002.jpg)

![](reportmarcum_001.jpg)

**<u>Report of Independent Registered Public Accounting Firm</u>**

To the Shareholders and Board of Directors of

**POET Technologies Inc.**

**Opinion on the Financial Statements**

We have audited, before the effects of the adjustments to retrospectively apply the change in accounting described in Note 2, the accompanying consolidated balance sheet of POET Technologies Inc. (the "Company") as of December 31, 2023, the related consolidated statements of operations and deficit, comprehensive loss, changes in shareholders' equity and cash flows for the year ended December 31, 2023, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and the results of its operations and its cash flows for year ended December 31, 2023, in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board.

We were not engaged to audit, review, or apply any procedures to the adjustment to retrospectively apply the change in accounting described in Note 2 and, accordingly, we do not express an opinion or any other form of assurance about whether such adjustment is appropriate and have been properly applied. That adjustment was audited by Davidson & Company LLP.

**Explanatory Paragraph – Going Concern**

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. ,The Company has incurred significant losses over the past few years and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

**Basis for Opinion**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission, Onterio Securities Commission, and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

**Critical Audit Matters**

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

![](reportmarcum_002.jpg)

Marcum LLP

We have served as the Company's auditor 2009 through 2023

Hartford, Connecticut

March 15, 2024

PCAOB ID 668

**Marcum LLP */*** CityPlace I ***/*** 185 Asylum Street ***/*** 25th Floor ***/*** Hartford, CT 06103 ***/* Phone** 860.760.0600 ***/* marcumllp.com**

**POET TECHNOLOGIES INC.**

**CONSOLIDATED STATEMENTS OF FINANCIAL POSITION**

**(Expressed in US Dollars)**

---

| | | | |
|:---|:---|:---|:---|
| December 31, | **2025** | 2024 | 2023 |
| **Assets** |  |  |  |
| &nbsp;&nbsp;&nbsp;Current |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**39959201** | $37143759 | $3019069 |
| &nbsp;&nbsp;&nbsp;Short-term investments (Note 2) | **273439102** | 16672811 |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable (Notes 3) | **-** | 7257 |  |
| &nbsp;&nbsp;&nbsp;Prepaids and other current assets (Note 4) | **1063528** | 1658207 | 150676 |
| Total current assets | **314461831** | 55482034 | 3169745 |
| &nbsp;&nbsp;&nbsp;Long term deposit (Note 15) | **208125** | 107890 |  |
| &nbsp;&nbsp;&nbsp;Property and equipment (Note 6) | **12233828** | 12757682 | 4623228 |
| &nbsp;&nbsp;&nbsp;Patents and licenses (Note 7) | **556375** | 606708 | 502055 |
| &nbsp;&nbsp;&nbsp;Right of use asset (Note 8) | **1112279** | 698135 | 482389 |
| Total assets | $**328572438** | $69652449 | $8777417 |
| **Liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Current |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities (Note 9) | $**1639543** | $5970537 | $2301457 |
| &nbsp;&nbsp;&nbsp;Convertible debt (Note 5) | **5800000** | 6500000 |  |
| &nbsp;&nbsp;&nbsp;Lease liability (Note 8) | **236304** | 115793 | 204939 |
| &nbsp;&nbsp;&nbsp;Derivative warrant liability (Note 10 and 11(b)) | **135631585** | 35750607 | 1002264 |
| &nbsp;&nbsp;&nbsp;Contract liabilities (Note 3) | **445840** |  |  |
| &nbsp;&nbsp;&nbsp;Covid-19 government support loans (Note 23) | **-** | - | 30200 |
| Total current liabilities | **143753272** | 48336937 | 3538860 |
| &nbsp;&nbsp;&nbsp;Non-current lease liability (Note 8) | **1029894** | 626625 | 307141 |
| Total liabilities | **144783166** | 48963562 | 3846001 |
| **Shareholders' Equity**<br>|  |  |  |
| &nbsp;&nbsp;&nbsp;Share capital (Note 11(b)) | **443076163** | 223742335 | 165705423 |
| &nbsp;&nbsp;&nbsp;Warrants and compensation options (Note 12) | **30599602** | 11157738 | 670115 |
| &nbsp;&nbsp;&nbsp;Contributed surplus (Note 13) | **9329724** | 58724750 | 55447961 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(2121883)** | (1949088) | (2601058) |
| &nbsp;&nbsp;&nbsp;Deficit | **(297094334)** | (270986848) | (214291025) |
| Total shareholders' equity | **183789272** | 20688887 | 4931416 |
| Total shareholders' equity and liabilities | $**328572438** | $69652449 | $8777417 |

---

Nature of operations (Note 1)

Commitments and contingencies (Note 15)

On behalf of the Board of Directors

---

| | |
|:---|:---|
| */s/ Suresh Venkatesan* | */s/ Robert Tirva* |
| Director | Director |

---

The accompanying notes are an integral part of these consolidated financial statements.

**POET TECHNOLOGIES INC.**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND DEFICIT**

**(Expressed in US Dollars)**

---

| | | | |
|:---|:---|:---|:---|
| **For the Years Ended December 31,** | **2025** | **2024** | 202**3** |
| Revenue (Note 21) | $**1074865** | $41427 | $465777 |
| Operating expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;Selling, marketing and administration (Note 20) | **25081957** | 18771421 | 10795155 |
| &nbsp;&nbsp;&nbsp;Research and development (Note 20) | **18084303** | 11334641 | 10077930 |
| Operating expenses | **43166260** | 30106062 | 20873085 |
| Operating loss before the following | **(42091395)** | (30064635) | (20407308) |
| Loss on acquisition of 24.8% of SPX (Note 5) | **-** | (6852687) |  |
| Interest expense (Note 8) | **(144046)** | (102673) | (70182) |
| Other income, including interest | **4553061** | 947956 | 234990 |
| Forgiveness of Covid-19 government support loans (Note 23) | **-** | 7298 |  |
| Gain on contribution of intellectual property to joint venture (Note 5) | **-** |  | 1031807 |
| Share of loss in joint venture (Note 5) | **-** |  | (1031807) |
| Fair value adjustment to derivative warrant liability (Note 10 and 11(b)) | **(25280833)** | (20631082) | (24865) |
| Net loss | **(62963213)** | (56695823) | (20267365) |
| Deficit, beginning of year | **(270986848)** | (214291025) | (194023660) |
| Adjustment due to change in functional currency | **36855727** |  |  |
| Net loss | **(62963213)** | (56695823) | (20267365) |
| Deficit, end of year | $**(297094334)** | $**(270986848)** | $**(214291025)** |
| Basic and diluted net loss per share (Note 14) | $**(0.68)** | $(0.94) | $(0.51) |

---

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

**(Expressed in US Dollars)**

---

| | | | |
|:---|:---|:---|:---|
| <br>**For the Years Ended December 31,** | **2025** | **2024** | **2023** |
| Net loss | $**(62963213)** | $(56695823) | $(20267365) |
| Other comprehensive (loss) - net of income taxes Items that may in the future be reclassified to profit (loss): |  |  |  |
| &nbsp;&nbsp;&nbsp; Exchange differences on translating foreign operations | **(172795)** | 651970 | 59223 |
| Comprehensive loss | $**(63136008)** | $(56043853) | $(20208142) |

---

The accompanying notes are an integral part of these consolidated financial statements.

**POET TECHNOLOGIES INC.**

**CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY**

**(Expressed in US Dollars)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **For the Years Ended December 31,** | **2025** | 2024 | 2023 | 2023 |
| **Share Capital** |  |  |  |  |
| Beginning balance | $**223742335** | $165705423 | $— | 151206539 |
| Funds from the exercise of stock options | **5441922** | 754711 |  | 668259 |
| Fair value of stock options exercised | **11513569** | 2209196 |  | 587035 |
| Funds from the exercise of warrants | **15847899** | 3725565 |  | 7767067 |
| Fair value of warrants exercised | **30813000** | 4816224 |  | 4418783 |
| Funds from common shares issued through ATM Financing | **-** | 9362235 |  | 983194 |
| Funds from common shares issued on public or private offerings | **280000001** | 69211854 |  | 1607400 |
| Share issue costs | **(8048167)** | (878185) |  | (578317) |
| Fair value of warrants issued on public or private offering | **(88176282)** | (31164688) |  | (954537) |
| Adjustment due to change in functional currency | **(28058114)** | - |  | - |
| December 31, | **443076163** | 223742335 |  | 165705423 |
| **Warrants** |  |  |  |  |
| Beginning balance | **11157738** | 670115 |  | 5905642 |
| Fair value of warrants exercised | **(2098780)** | (1260120) |  | (4418783) |
| Fair value of expired warrants | **-** | (16616) |  | (816744) |
| Fair value of warrants issued on private placement | **36706752** | 11764359 |  |  |
| Adjustment due to change in functional currency | **(15166108)** | - |  | - |
| December 31, | **30599602** | 11157738 |  | 670115 |
| **Contributed Surplus** |  |  |  |  |
| Beginning balance | **58724750** | 55447961 |  | 51016808 |
| Stock-based compensation | **6107052** | 5469369 |  | 4201444 |
| Fair value of stock options exercised | **(11513569)** | (2209196) |  | (587035) |
| Fair value of expired warrants | **-** | 16616 |  | 816744 |
| Adjustment due to change in functional currency | **(43988509)** | - |  | - |
| December 31, | **9329724** | 58724750 |  | 55447961 |
| **Accumulated Other Comprehensive Loss** |  |  |  |  |
| Beginning balance | **(1949088)** | (2601058) |  | (2660281) |
| Other comprehensive income (loss) attributable to common shareholders - translation adjustment | **(172795)** | 651970 |  | 59223 |
| December 31, | **(2121883)** | (1949088 |  | (2601058) |
| **Deficit** |  |  |  |  |
| Beginning balance | **(270986848)** | (214291025) |  | (194023660) |
| Adjustment due to change in functional currency | **36855727** |  |  |  |
| Net loss | **(62963213)** | (56695823 |  | (20267365) |
| December 31, | **(297094334)** | (270986848 |  | (214291025) |
| **Total Shareholders' Equity** | $**183789272** | $20688887 | $— | 4931416 |

---

The accompanying notes are an integral part of these consolidated financial statements.

**POET TECHNOLOGIES INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Expressed in US Dollars)**

---

| | | | |
|:---|:---|:---|:---|
| **For the Years Ended December 31,** | **2025** | 2024 | 2023 |
| CASH AND CASH EQUIVALENTS (USED IN) PROVIDED BY: |  |  |  |
| OPERATING ACTIVITIES |  |  |  |
| Net loss | $**(62963213)** | $(56695823) | $(20267365) |
| Adjustments for: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation of property and equipment (Note 6) | **2985140** | 1713686 | 1653798 |
| &nbsp;&nbsp;&nbsp;Amortization of patents and licenses (Note 7) | **96870** | 92344 | 87761 |
| &nbsp;&nbsp;&nbsp;Amortization of right of use asset (Note 8) | **233889** | 214165 | 180602 |
| &nbsp;&nbsp;&nbsp;Fair value adjustment to derivative warrant liability (Note 10) | **25280833** | 20631082 | 24865 |
| &nbsp;&nbsp;&nbsp;Non-cash interest (Notes 8) | **144046** | 90041 | 53614 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation (Note 13) | **6107052** | 5469369 | 4201444 |
| &nbsp;&nbsp;&nbsp;Non-cash operating costs | **399182** | (18766) |  |
| &nbsp;&nbsp;&nbsp;Loss on acquisition of 24.8% of SPX | **-** | 6852687 |  |
| &nbsp;&nbsp;&nbsp;Gain on contribution of intellectual property to joint venture (Note 5) | **-** |  | (1031807) |
| &nbsp;&nbsp;&nbsp;Share of loss in joint venture (Note 5) | **-** |  | 1031807 |
| &nbsp;&nbsp;&nbsp;Forgiveness of covid-19 government support loans (Note 23) | **-** | (7298) | - |
|  | **(27716201)** | (21658513) | (14065281) |
| Net change in non-cash working capital accounts: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts receivable | **7257** | (7257) | 62000 |
| &nbsp;&nbsp;&nbsp;Prepaid and other current assets | **630208** | (1659615) | 126936 |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | **(4446794)** | 34074 | (1256925) |
| &nbsp;&nbsp;&nbsp;Contract liabilities | **438900** | - | (274192) |
| Cash flows from operating activities | **(31086630)** | (23291311) | (15407462) |
| INVESTING ACTIVITIES |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of short-term investments (Note 2) | **(271626182)** | (26357782) |  |
| &nbsp;&nbsp;&nbsp;Proceeds from the sale of short-term investments (Note 2) | **14859891**  | 9684971 | - |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment (Note 6) | **(2255107)** | (6781715) | (1167953) |
| &nbsp;&nbsp;&nbsp;Purchase of patents and licenses (Note 7) | **(46537)** | (196997) | (79111) |
| &nbsp;&nbsp;&nbsp;Long term deposit (Note 15) | **(93542)** | (107890) |  |
| &nbsp;&nbsp;&nbsp;Cash received on acquisition of remaining portion of SPX (Note 5) | **-** | 97833 | - |
| Cash flows from investing activities | **(259161477)** | (23661580) | (1247064) |
| FINANCING ACTIVITIES |  |  |  |
| &nbsp;&nbsp;&nbsp;Issue of common shares for cash, net of issue costs (Note 11) | **293241655** | 82176180 | 10447603 |
| &nbsp;&nbsp;&nbsp;Payment of lease liability (Note 8) | **(223403)** | (255953) | (252103) |
| &nbsp;&nbsp;&nbsp;Repayment of covid-19 government support loans (Note 23) | **-** | (21894) |  |
| &nbsp;&nbsp;&nbsp;Repayment of convertible debt (Note 5) | **(700000)** | - | - |
| Cash flows from financing activities | **292318252** | 81898333 | 10195500 |
| Effect of exchange rate on cash | **745297** | (820752) | 248250 |
| Net change in cash and cash equivalents | **2815442** | 34124690 | (6210776) |
| Cash and cash equivalents, beginning of year | **37143759** | 3019069 | 9229845 |
| Cash and cash equivalents, end of year | $**39959201** | $37143759 | $3019069 |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES |  |  |  |
| Purchase of property and equipment financed through accounts payable | $**-** | $3399498 | $- |

---

Cash and cash equivalents consist of cash in current accounts of $1,759,709 (2024 - $21,871,082, 2023 - $1,249,116) and funds invested in US and Canadian cashable Term Deposits of $38,199,492 (2024 - $15,272,677, 2023 - $1,769,953) earning interest between 2.25% and 3.24% and maturing in less than one year.

The accompanying notes are an integral part of these consolidated financial statements.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**1.** **NATURE OF OPERATIONS** 

POET Technologies Inc. is incorporated in the Province of Ontario. POET Technologies Inc. and its subsidiaries (the "Company") design and develop the POET Optical Interposer and Photonic Integrated Circuits for the data center and tele-communications markets. The Company's common shares are listed on the Nasdaq under the symbol "POET". The Company's head office is located at 120 Eglinton Avenue East, Suite 1107, Toronto, Ontario, Canada M4P 1E2. These audited consolidated financial statements of the Company were approved by the Board of Directors of the Company on March 31, 2026.

These consolidated financial statements have been prepared using IFRS Accounting Standards ("IFRS") applicable to a going concern, which assumes that the Company will be able to realize its assets, discharge its liabilities and continue in operation for the following twelve months.

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION** 

**Statement of compliance and basis of presentation**

These consolidated financial statements of the Company and its subsidiaries were prepared in accordance with IFRS Accounting Standards, as issued by the International Accounting Standards Board ("IASB"). These consolidated financial statements have been prepared on a historical cost basis, except for financial instruments classified as fair value through profit or loss, which are stated at their fair value. In addition, these consolidated financial statements have been prepared using the accrual basis of accounting except for cash flow information.

**Basis of consolidation**

These consolidated financial statements include the accounts of POET Technologies Inc. and its subsidiaries; ODIS Inc. ("ODIS"), Opel Solar Inc. ("OPEL"), BB Photonics Inc. ("BB Photonics"), POET Technologies Pte Ltd. ("PTS"), POET Optoelectronics Shenzhen Co., Ltd ("POET Shenzhen"), POET Technologies Sdn Bhd ("PTM"), and Super Photonics Xiamen Co., Ltd ("SPX"). Subsidiaries are all entities over which the Company has exposure to variable returns from its involvement and has the ability to use power over the investee to affect its returns. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company until the date on which control ceases. The accounts of subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies. All intercompany balances and transactions have been eliminated on consolidation.

The preparation of financial statements in accordance with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed below:

**Critical accounting judgments and significant estimates and uncertainties**

**Business combinations**

Acquisitions of businesses are accounted for using the acquisition method. The acquisition cost is measured at the acquisition date at the fair value of the consideration transferred, including all contingent consideration.

The determination of whether a corporate entity or set of assets acquired, and liabilities assumed, constitute a business may require the Company to make certain judgements, considering all facts and circumstances. A business is presumed to be an integrated set of activities and assets capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or economic benefits. SPX was determined to constitute an acquisition of assets (Note 5).

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)** 

**Determination of functional currency**

The Company determines the functional currency through an analysis of several indicators such as expenses and cash flow, financing activities, retention of operating cash flows, and frequency of transactions within the reporting entity.

**Valuation of share-based compensation**

The Company uses the Black-Scholes Option Pricing Model for valuation of share-based compensation and derivative warrant liability. Option pricing models require the input of subjective assumptions including expected price volatility, risk-free interest rate, and forfeiture rate. Changes in the input assumptions can materially affect the fair value estimate and the Company's earnings and equity reserves.

**Income taxes**

In assessing the probability of realizing income tax assets, management makes estimates related to expectation of future taxable income, applicable tax opportunities, expected timing of reversals of existing temporary differences and the likelihood that tax positions taken will be sustained upon examination by applicable tax authorities. In making its assessments, management gives additional weight to positive and negative evidence that can be objectively verified.

**Foreign currency translation**

These consolidated financial statements are presented in U.S. dollars ("USD"), which is the Company's presentation currency.

Items included in the financial statements of each of the Company's subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the "functional currency"). Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transaction. Foreign exchange gains and losses resulting from the settlement of such transactions and from the translation of monetary assets and liabilities not denominated in the functional currency of an entity are recognized in the statement of operations and deficit.

The following table presents the jurisdiction under which each entity in the group is incorporated and the functional currency of each entity:

---

| | | |
|:---|:---|:---|
| **Entity** | **Incorporating Jurisdiction** | **Functional Currency** |
| POET Technologies Inc | Canada | US dollars (1) |
| ODIS | United States of America | US dollars |
| OPEL | United States of America | US dollars |
| BB Photonics | United States of America | US dollars |
| PTS | Singapore | Singapore dollar |
| PTM | Malaysia | Malaysian Ringgit |
| POET Shenzhen | China | Renminbi |
| SPX | China | Renminbi |

---

Assets and liabilities of entities with functional currencies other than U.S. dollars are translated into the presentation currency at the year end rates of exchange, and the results of their operations are translated at average rates of exchange for the year. The resulting translation adjustments are included in accumulated other comprehensive loss in shareholders' equity. Additionally, foreign exchange gains and losses related to certain intercompany loans that are permanent in nature are included in accumulated other comprehensive loss. Elements of equity are translated at historical rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Effective October 1, 2025, management determined that the Canadian entity's functional currency changed from the Canadian dollar to the U.S. dollar due to a shift in the primary economic environment, being the change in primary sources of funding of the Canadian entity. In accordance with IAS 21, the change was applied prospectively. All assets, liabilities, and equity were translated into U.S. dollars using the exchange rate on the date of change, and these amounts became the new historical carrying values.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)** 

This resulted in adjustments of ($28,058,114) to share capital, ($204,117) to warrants, ($8,255,576) to contributed surplus and $36,855,727 to deficit. Further, changes to the derivative warrant liability (note 10), resulted in adjustments of ($14,961,966) to warrants and ($35,732,933) to contributed surplus. These amounts are presented as "adjustment due to change in functional currency" on the consolidated statements of changes in shareholders' equity.

**Financial instruments**

Financial assets held with an objective to hold assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest are measured at amortised cost using the effective interest method. Debt investments held with an objective to hold both assets in order to collect contractual cash flows which arise on specified dates that are solely principal and interest as well as selling the asset on the basis of fair value are measured at FVTOCI. All other financial assets are classified and measured at fair value through profit or loss ("FVTPL"). Financial liabilities are classified as either FVTPL or other financial liabilities, and the portion of the change in fair value that relates to the Company's credit risk is presented in other comprehensive income (loss). Instruments classified as FVTPL are measured at fair value with unrealized gains and losses recognized in net income (loss). Other financial liabilities are subsequently measured at amortised cost using the effective interest method.

Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities, other than financial assets and financial liabilities classified as FVTPL, are added to or deducted from the fair value on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities classified as FVTPL are recognized immediately in consolidated net income (loss).

**Financial assets**

The Company derecognizes a financial asset when the contractual rights to the cash flows from the financial asset expire, or it transfers the rights to receive the contractual cash flows in a transaction in which substantially all of the risks and rewards of ownership of the financial asset are transferred or in which the Company neither transfers nor retains substantially all of the risks and rewards of ownership and it does not retain control of the financial asset. Any interest in transferred financial assets that is created or retained by the Company is recognized as a separate asset or liability.

**Financial liabilities**

A financial liability is derecognized from the statement of financial position when it is extinguished, that is, when the obligation specified in the contract is either discharged, cancelled or expires. Where there has been an exchange between an existing borrower and lender of debt instruments with substantially different terms, or there has been a substantial modification of the terms of an existing financial liability, this transaction is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. A gain or loss from extinguishment of the original financial liability is recognized in profit or loss.

The Company's financial instruments include cash and cash equivalents, short-term investments, accounts receivable, deposit, accounts payable and accrued liabilities, convertible debt, derivative warrant liability, contract liabilities and Covid-19 government support loans.

**Derivative financial instruments**

The Company issued warrants exercisable in a currency other than the Company's functional currency and as a result, the warrants are derivative financial instruments. Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)** 

The following table outlines the classification of financial instruments under IFRS 9:

---

| | |
|:---|:---|
| **Financial Assets** |  |
| Cash and cash equivalents | Amortized cost |
| Short-term investments | Amortized cost |
| Accounts receivable | Amortized cost |
| Deposit | Amortized cost |
| **Financial Liabilities** |  |
| Accounts payable and accrued liabilities | Amortized cost |
| Contract liabilities | Amortized cost |
| Covid-19 government support loans | Amortized cost |
| Convertible debt | Amortized cost |
| Derivative warrant liability | Fair value through profit and loss (FVTPL) |

---

**Cash and cash equivalents**

Cash and cash equivalents include cash on hand, bank deposits, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash.

**Short-term investments**

The short-term investments of $273,439,102 (2024 - $16,672,811, 2023 - nil) consist of guaranteed investment certificates (GICs) held with multiple Canadian chartered banks and earn interest at rates ranging from 3.4% to 4.91%, that mature within one year.

**Property and equipment**

Property and equipment are recorded at cost. Depreciation is calculated based on the estimated useful life of the asset using the following method and useful lives:

Machinery and equipment Straight Line, 5 years <br> Leasehold improvements Straight Line, term of the lease <br> Office equipment Straight Line, 3 - 5 years

**Patents and licenses**

Patents and licenses are recorded at cost and amortized on a straight line basis over 12 years. Ongoing maintenance costs are expensed as incurred.

**Impairment of long-lived assets**

The Company's tangible and intangible assets are reviewed for indications of impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be recoverable. An assessment is made at each reporting date whether there is any indication that an asset may be impaired.

An impairment loss is recognized when the carrying amount of an asset exceeds its recoverable amount. Impairment losses are recognized in profit and loss for the year. The recoverable amount is the greater of the asset's fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit ("CGU") to which the asset belongs.

An impairment loss is reversed if there is an indication that there has been a change in the estimates used to determine the recoverable amount. An impairment loss is reversed only to the extent that the asset's carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization, if no impairment loss had been recognized. No impairment loss has been reported for the years ended December 31, 2025, 2024 and 2023.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)** 

**Income taxes**

The Company follows the liability method of accounting for income taxes. Under this method, deferred income taxes are provided on differences between the financial reporting and income tax bases of assets and liabilities and on income tax losses available to be carried forward to future years for tax purposes. Deferred income taxes are measured using the substantively enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. Deferred tax assets are only recognized if the amount is expected to be realized in the future.

**Revenue recognition**

Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties. The Company recognizes revenue when it transfers control over a product or service to a customer.

**Sale of goods**

Revenue from the sale of goods is recognized, net of discounts and customer rebates, at the point in time the transfer of control of the related products has taken place as specified in the sales contract and collectability is reasonably assured.

**Service revenue**

The Company provides contract services, primarily in the form of non-recurring revenue ("NRE") where control is passed to the customer over time. The contracts generally provide agreed upon milestones for customer payment which include but are not limited to the delivery of sample products, design reports and test reports. The customer makes payment when it has approved the delivery of the milestone. The Company must determine if the contract is made up of a series of independent performance obligations or a single performance obligation. Where NRE contracts contain multiple performance obligations for which a standalone transaction price can be assessed, revenue is recognized as each performance obligation is satisfied. Where NRE contracts contain a single performance obligation to be settled over time, revenue is recognized progressively based on the output method.

**Other income**

**Interest income**

Interest income on cash and cash equivalents and short term investments is recognized as earned using the effective interest method.

**Government Grants**

Loans received exclusively from governmental agencies to support the Company throughout the COVID-19 pandemic qualify to be forgiven if certain conditions are met. Forgiveness of COVID-19 related loans will be recognized as other income on the consolidated statements of operations and deficit.

**Intangible assets**

**Research and development costs**

Research costs are expensed in the year incurred. Development costs are also expensed in the year incurred unless the Company believes a development project meets IFRS criteria as set out in IAS 38, *Intangible Assets*, for deferral and amortization. IAS 38 requires all research costs be charged to expense while development costs are capitalised only after technical and commercial feasibility of the asset for sale or use have been established. This means that the entity must intend and be able to complete the intangible asset and either use it or sell it and be able to demonstrate how the asset will generate future economic benefits. Development costs are tested for impairment whenever events or changes indicate that its carrying amount may not be recoverable.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**2.** **SUMMARY OF MATERIAL ACCOUNTING POLICY INFORMATION (Continued)** 

**In-Process Research and Development**

Under IFRS, in-process research and development ("IPR&D") acquired in a business combination that meets the definition of an intangible asset is capitalized with amortization commencing when the asset is ready for use (i.e., when development is complete). The Company does not capitalize its IPR&D.

**Stock-based compensation**

Stock options awarded to non employees are measured using the fair value of the goods or services received unless that fair value cannot be estimated reliably, in which case measurement is based on the fair value of the stock options. Stock options awarded to employees are accounted for using the fair value method. The fair value of such stock options granted is recognized as an expense on a proportionate basis consistent with the vesting features of each tranche of the grant. The fair value is calculated using the Black-Scholes option pricing model with assumptions applicable at the date of grant. When stock options are exercised, the proceeds received, together with any related amount in the reserves, are credited to share capital. In the event share options are forfeited prior to vesting, the associated fair value recorded to date is reversed.

**Valuation of equity units issued in private placements**

When the Company issues warrants that are exercisable in the Company's functional currency, the proceeds from the issue of units is allocated between common shares and common share purchase warrants on a residual values basis as follows: the fair value of the common shares is based on the subscription price of the units issued and the fair value of the common share purchase warrants is determined using the Black-Scholes Option Pricing Model. The fair value of warrants that expire, is reversed to contributed surplus.

**Loss per share**

Basic loss per share, net of taxes is calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Diluted loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period after giving effect to potentially dilutive financial instruments. The dilutive effect of stock options and warrants is determined using the treasury stock method.

**Joint Venture**

A joint arrangement is an arrangement among two or more parties where the parties are bound by a contractual arrangement and the contractual arrangement gives the parties joint control of the arrangement. A joint venture is a form of joint arrangement where an entity is independently formed and the parties jointly have rights to the net assets of the arrangement and therefore account for their interests under the equity method. Prior to December 31, 2024, the Company had a joint venture in China and used the equity method to account for its share of the joint venture's operations. On December 31, 2024, the Company acquired the other joint venturer's interest in the joint venture (Note 5).

**Leases**

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset over a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether it has the right to obtain substantially all of the economic benefits from the use of the asset during the term of the contract and it has the right to direct the use of the asset.

The right-of-use asset is subsequently depreciated from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. The right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date discounted by the interest rate implicit in the lease or, if that rate cannot be readily determined the incremental borrowing rate. The lease liability is subsequently measured at amortized cost using the effective interest method. Lease payments included in the measurement of the lease liability comprise of fixed payments, variable lease payments, and amounts expected to be payable at the end of the lease term.

The Company has elected not to recognize the right-of-use assets and lease liabilities for short-term leases that have a lease term of twelve months or less. The lease payments associated with these leases are charged directly to income on a straight-line basis over the lease term.

**Future standards not yet adopted**

IFRS 18 Presentation and Disclosure in Financial Statements

In April 2024, the IASB issued IFRS 18 Presentation and Disclosure in Financial Statements ("IFRS 18") which replaces IAS 1 Presentation of Financial Statements. This standard aims to improve how companies communicate in their financial statements, with a focus on information about financial performance in the statement of profit or loss, in particular additional defined subtotals, disclosures about management-defined performance measures and new principles for aggregation and disaggregation of information. IFRS 18 is accompanied by limited amendments to the requirements in IAS 7 Statement of Cash Flows. IFRS 18 is effective from January 1, 2027. Companies are permitted to apply IFRS 18 before that date. The Company is currently assessing the impact the new standard will have on its consolidated financial statements.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**3.** **ACCOUNTS RECEIVABLE AND CONTRACT LIABILITIES** 

**** 

Revenue Contract Balances

---

| | | |
|:---|:---|:---|
|  | **Contract** | **Contract** |
|  | **Receivables** | **Liabilities** |
| Opening balance, January 1, 2023 | $62842 | $(274192) |
| Changes due to payment, fulfillment of performance obligations or revenues recognized | (62842) | 271069 |
| Effect of changes in foreign exchange rates | - | 3123 |
| Opening balance, December 31, 2023 |  |  |
| Changes due to payment, fulfillment of performance obligations or revenues recognized | 7257 | - |
| Balance, December 31, 2024 | 7257 |  |
| Customer deposits |  | 1175000 |
| Revenues recognized | 725000 |  |
| Changes due to payment, fulfillment of performance obligations or other | (732257) | (725000) |
| Effect of changes in foreign exchange rates | - | (4160) |
| Balance, December 31, 2025 | $- | $445840 |

---

**4.** **PREPAIDS AND OTHER CURRENT ASSETS** 

The following table reflects the details of prepaids and other current assets at December 31:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Sales tax recoverable and other current assets | $**208888** | $1399955 | $57200 |
| Prepaid expenses | **854640** | 258252 | 93476 |
|  | $**1063528** | $1658207 | $150676 |

---

**5.** **JOINT VENTURE** 

On October 20, 2020, the Company signed a Joint Venture Agreement ("JVA") establishing a joint venture, Super Photonics Xiamen Co., Ltd ("SPX") in Xiamen China, with Xiamen Sanan Integrated Circuit Co. Ltd. ("Sanan IC") whose purpose is to design, develop, manufacture and sell 100G, 200G and 400G optical engines based on POET's proprietary Optical Interposer platform technology. SPX was registered on March 12, 2021. SPX was subsequently capitalized through a combination of committed cash, capital equipment and intellectual property from Sanan IC and intellectual property and know-how from the Company. SPX was determined to be a joint venture as both Sanan IC and POET exercise joint control over SPX. All relevant activity of SPX required unanimous consent.

The Company's contribution of intellectual property to SPX was independently valued at $22,500,000 at the time of its contribution. During the year ended December 31, 2024, the Company recognized a gain of nil (2023 - $1,031,807) related to its contribution of intellectual property to SPX in accordance with IAS 28. The Company only recognized a gain on the contribution of the intellectual property equivalent to Sanan IC's interest in SPX, the unrecognized gain at December 31, 2024 of $17,133,706 (2023 - $17,133,706) was applied against the investment and periodically realized as the Company's ownership interest in SPX was reduced. At December 31, 2024, Sanan IC's and the Company's ownership interests were approximately 0% and 100% respectively (2023 - 23.9% and 76.1%).

The Company recognized its share of SPX's profits or losses using the equity method. On a weighted average basis, the Company's share of the net operating loss during the year ended December 31, 2024 was 75.2% or $(2,942,820), however the Company recognized nil of the net operating loss of SPX (2023 - 78.9% or ($1,031,807)).

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**5.** **JOINT VENTURE (Continued)** 

The Company's investment in joint venture during the year can be summarized as follows:

---

| | |
|:---|:---|
| Investment balance, January 1, 2023 |  |
| Recognized gain on contribution of intellectual property | 1031807 |
| Share of loss in joint venture for the year ended December 31, 2023 | (1031807) |
| Investment balance, December 31, 2023 and 2024 | $- |

---

On December 31, 2024, the Company acquired Sanan IC's 24.8% interest in SPX in exchange for a convertible debt of $6,500,000. The acquisition cost will be paid over a period of five (5) years. The unpaid balances are interest free and will be settled based on the following schedule:

---

| | | |
|:---|:---|:---|
| October 31, 2025 | $700000 | (Paid) |
| October 31, 2026 | $1000000 |  |
| October 31, 2027 | $1300000 |  |
| October 31, 2028 | $1600000 |  |
| October 31, 2029 | $1900000 |  |

---

At any time before the convertible debt is fully settled, Sanan IC has the right to convert any remaining unpaid amounts due into shares of common stock of the Company. The conversion shall be executed at a conversion price equal to the greater of: (a) the volume weighted average closing price ("VWAP") of the common stock of the Company as reported by the NASDAQ Capital Market for thirty (30) days prior to the conversion date, or (b) the closing price of the common stock of the Company as reported by the NASDAQ Capital Market the day prior to the conversion date.

The acquisition of Sanan IC's 24.8% interest in SPX, under which the Company obtains full control over SPX, was determined to be an asset acquisition because SPX did not meet the threshold of a business as defined by IFRS 3.

The Company determined that the convertible debt represents a hybrid financial instrument that contains 1) a host debt principal component , 2) a market price conversion feature that is a non-derivative with a value of nil that is not separable from the host debt and, 3) the VWAP conversion option that is a derivative with a nil value. As Sanan IC can exercise the conversion option at any time, the convertible debt is classified as current liability.

The assessment of the purchase price allocation on the date of purchase has been determined as follows:

---

| | |
|:---|:---|
| **Fair value consideration paid** |  |
| Convertible debt to be paid over five years | $6500000 |
| **Recognized amounts of identifiable net assets:** |  |
| Cash | $97833 |
| Other non-current assets | 237216 |
| Accounts payable | (388470) |
| Payables to the Company | (299266) |
| Net assets (liabilities) acquired | $(352687) |
| Loss on acquisition | $6852687 |
|  | $6500000 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**5.** **JOINT VENTURE (Continued)** 

Summarized financial information of the joint venture is as follows:

---

| | | | |
|:---|:---|:---|:---|
| December 31, | **2025** | 2024 | 2023 |
| Current assets | $&nbsp;&nbsp;&nbsp;&nbsp; **-** | $- | $1758587 |
| Intangible assets | **-** |  | 16155786 |
| Liabilities | **-** |  | (149306) |
| Owners Equity | **-** | - | (17765067) |
| Net loss | $**-** | $3913325 | $3830962 |

---

The following table discloses the amount of transactions the Company conducted with SPX prior to being acquired:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Sales** | **Purchases** | **Loans** | **Recoverables** |
| PTZ | $- | $- | $- | $300685 |
| PTS | - | 178320 | - | - |

---

During 2025, the Company suspended operations at SPX and initiated a plan to wind-up its operations.

**6.** **PROPERTY AND EQUIPMENT** 

**** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | Equipment not ready for use | Leasehold improvements | Machinery and equipment | Office equipment | Total |
| **Cost** |  |  |  |  |  |
| Balance, January 1, 2023 | $1815909 | $123659 | $6091621 | $177902 | $8209091 |
| Additions, net of returns | 206018 |  | 949551 | 12384 | 1167953 |
| Reclassification | (2013090) |  | 2013090 |  |  |
| Effect of changes in foreign exchange rates | (8837) | 597 | 41246 | 5560 | 38566 |
| Balance, December 31, 2023 |  | 124256 | 9095508 | 195846 | 9415610 |
| Additions, net of returns | 8893033 | 613192 | 668857 | 6131 | 10181213 |
| Disposals |  |  | (17221) |  | (17221) |
| Effect of changes in foreign exchange rates | (182884) | (7925) | (109759) | (2904) | (303472) |
| Balance, December 31, 2024 | 8710149 | 729523 | 9637385 | 199073 | 19276130 |
| Additions | 930036 | 229060 | 1025757 | 70254 | 2255107 |
| Reclassification | (8363829) |  | 8363829 |  |  |
| Disposals |  |  | (30433) |  | (30433) |
| Effect of changes in foreign exchange rates | (9893) | 32932 | 187792 | 4985 | 215816 |
| Balance, December 31, 2025 | 1266463 | 991515 | 19184330 | 274312 | 21716620 |
| **Accumulated Depreciation** |  |  |  |  |  |
| Balance, January 1, 2023 |  | 56134 | 2958538 | 123912 | 3138584 |
| Depreciation for the year | - | 24684 | 1600981 | 28133 | 1653798 |
| Balance, December 31, 2023 |  | 80818 | 4559519 | 152045 | 4792382 |
| Depreciation for the year |  | 24802 | 1664712 | 24172 | 1713686 |
| Effect of changes in foreign exchange rates | - | - | 12380 | - | 12380 |
| Balance, December 31, 2024 |  | 105620 | 6236611 | 176217 | 6518448 |
| Depreciation for the year |  | 175662 | 2786708 | 22770 | 2985140 |
| Disposals | - | - | (20796) | - | (20796) |
| Balance, December 31, 2025 | - | 281282 | 9002523 | 198987 | 9482792 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**6.** **PROPERTY AND EQUIPMENT (Continued)** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Carrying Amounts** |  |  |  |  |  |
| At December 31, 2023 | $- | $43438 | $4535989 | $43801 | $4623228 |
| At December 31, 2024 | $8710149 | $623903 | $3400774 | $22856 | $12757682 |
| At December 31, 2025 | $1266463 | $710233 | $10181807 | $75325 | $12233828 |

---

**7.** **PATENTS AND LICENSES** 

---

| | |
|:---|:---|
| **Cost** |  |
| Balance, January 1, 2023 | $1058936 |
| Additions | 79111 |
| Balance, December 31, 2023 | 1138047 |
| Additions | 196997 |
| Balance, December 31, 2024 | 1335044 |
| Additions | 46537 |
| Balance, December 31, 2025 | 1381581 |
| **Accumulated Amortization** |  |
| Balance, January 1, 2023 | 548231 |
| Amortization | 87761 |
| Balance, December 31, 2023 | 635992 |
| Amortization | 92344 |
| Balance, December 31, 2024 | 728336 |
| Amortization | 96870 |
| Balance, December 31, 2025 | 825206 |
| **Carrying Amounts** |  |
| At December 31, 2023 | $502055 |
| At December 31, 2024 | $606708 |
| At December 31, 2025 | $556375 |

---

**8.** **RIGHT OF USE ASSET AND LEASE LIABILITY** 

The Company recognizes a lease liability and right of use asset relating to its commercial leases. The lease liability is measured at the present value of the remaining lease payments, discounted using the Company's incremental borrowing rate, ranging from 12% - 16%.

---

| | |
|:---|:---|
| **Right of use asset** | **Building** |
| **Cost** |  |
| Balance, January 1, 2023 | $730652 |
| Additions | 420806 |
| Balance, December 31, 2023 | 1151458 |
| Additions | 603725 |
| Lease modification | (439568) |
| Effect of changes in foreign exchange rates | (7749) |
| Balance, December 31, 2024 | 1307866 |
| Addition | 707618 |
| Lease modification | (160454) |
| Effect of changes in foreign exchange rates | 36565 |
| Balance, December 31, 2025 | 1891595 |
| **Accumulated Amortization** |  |
| Balance, January 1, 2023 | 489605 |
| Amortization | 180602 |
| Effect of changes in foreign exchange rates | (1138) |
| Balance, December 31, 2023 | 669069 |
| Amortization | 214165 |
| Lease modification | (273503) |
| Balance, December 31, 2024 | 609731 |
| Amortization | 233889 |
| Lease modification | (64304) |
| Balance, December 31, 2025 | 779316 |
| **Carrying Amounts** |  |
| At December 31, 2023 | $482389 |
| At December 31, 2024 | $698135 |
| At December 31, 2025 | $1112279 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**8.** **RIGHT OF USE ASSET AND LEASE LIABILITY (Continued)** 

---

| | |
|:---|:---|
| **Lease liability** |  |
| Balance, January 1, 2023 | $279263 |
| Interest expense | 53614 |
| Lease modification | 424021 |
| Lease payments | (252103) |
| Effect of changes in foreign exchange rates | 7285 |
| Balance, December 31, 2023 | 512080 |
| Interest expense <sup>(1)</sup> | 90041 |
| Lease modification | (183251) |
| Additions | 589063 |
| Lease payments | (255953) |
| Effect of changes in foreign exchange rates | (9562) |
| Balance, December 31, 2024 | 742418 |
| Interest expense <sup>(1)</sup> | 144046 |
| Lease modification | (109538) |
| Additions | 690151 |
| Lease payments | (223403) |
| Effect of changes in foreign exchange rates | 22524 |
| Balance, December 31, 2025 | $1266198 |
| Less current portion | $236304 |
| Long term portion | $1029894 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) In addition to
the non-cash interest of $90,041 , the Company also incurred interest of $12,632 related to its financed insurance costs.

**9.** **ACCOUNTS PAYABLE AND ACCRUED LIABILITIES** 

Accounts payable and accrued liabilities at December 31 was as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Trade payables | $**1236210** | $5269426 | $1370658 |
| Payroll related liabilities | **247968** | 368289 | 563588 |
| Accrued liabilities | **155365** | 332822 | 367211 |
|  | $**1639543** | $5970537 | $2301457 |

---

**10.** **DERIVATIVE WARRANT LIABILITY** 

**2022**

On December 2, 2022, the Company completed a non-brokered private placement offering of 1,126,635 units at a price of $2.78 (CAD$3.81) per unit for gross proceeds of $3,184,332 (CAD$4,292,479). Each unit consists of one common share and one half common share purchase warrant. Each whole warrant entitles the holder to purchase one common share of the Company at a price of $3.61 (CAD$4.95) per share until December 2, 2025. The Company paid finders' fees aggregating to $42,090 (CAD$57,897) to four firms. The Company paid other share issue costs of $205,802 related to this private placement offering.

The fair value of the share purchase warrants and broker warrants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk-free interest rate of 3.48%, volatility of 69.93%, and estimated life of 3 years. The estimated fair value assigned to the warrants was $656,734.The remaining warrants were remeasured using the Black-Scholes option pricing model on October 1, 2025, being the date the Company changed its functional currency from Canadian Dollars to United States Dollars. The estimated fair value on the remeasurement date was $48,640.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**10.** **DERIVATIVE WARRANT LIABILITY (continued)** 

**2024**

January 24, 2024

On January 24, 2024, the Company raised gross proceeds of CA$6,219,667 ($4,613,312) from the issuance of 5,098,088 units through a private placement financing facility at an offering price CA$1.22 ($0.90). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,098,088 common shares for a period of five (5) years from the date of closing at a price of CA$1.52 ($1.12) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.5%, volatility of 78.35%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $2,815,861. The remaining warrants were remeasured using the Black-Scholes option pricing model on October 1, 2025, being the date the Company changed its functional currency from Canadian Dollars to United States Dollars. The estimated fair value on the remeasurement date was $16,447,723.

May 2024

On May 3 and 10, 2024, the Company raised gross proceeds of CA$10,000,000 ($7,299,270) and CA$10,000,000 ($7,299,270) respectively from the issuance of 3,258,390 and 3,448,275 units through non brokered private placement financing offerings at CA$3.069 ($2.24) and CA$2.90 ($2.12). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 3,258,390 and 3,448,275 common shares for a period of five (5) years from the date of closing at a price of CA$4.26 per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.67%, volatility of 83%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $8,948,498. The remaining warrants were remeasured using the Black-Scholes option pricing model on October 1, 2025, being the date the Company changed its functional currency from Canadian Dollars to United States Dollars. The estimated fair value on the remeasurement date was $22,470,999.

**2025**

May 22, 2025

On May 22, 2025, the Company raised gross proceeds of CA$41,574,279 ($30,000,000) from the issuance of 6,000,000 units through a non brokered private placement financing at a price CA$6.92 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 6,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.32 ($6.00) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 2.96%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $22,916,634.

July 17, 2025

On July 17, 2025, the Company raised gross proceeds of CA$34,000,000 ($25,000,000) from the issuance of 5,000,000 units through a non brokered private placement financing at a price CA$6.80 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.16 ($6.00) per share.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**10.** **DERIVATIVE WARRANT LIABILITY (continued)** 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.1%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $16,629,514. The remaining warrants were remeasured using the Black-Scholes option pricing model on October 1, 2025, being the date the Company changed its functional currency from Canadian Dollars to United States Dollars. The estimated fair value on the remeasurement date was $19,360,076.

October 7, 2025

On October 7, 2025, the Company raised gross proceeds of CA$104,625,002 ($75,000,000) from the issuance of 13,636,364 units through a non brokered private placement financing at a price CA$7.67 ($5.50). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 13,636,364 common shares for a period of five (5) years from the date of closing at a price of CAD$9.78 ($7.03) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.71%, volatility of 91.875%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $51,469,530.

Because the functional currency of the entity issuing the warrant is United States dollars but the warrants are exercisable in Canadian dollars, the Company may receive a variable amount in United States dollars when the warrants are exercised as the foreign exchange may vary over the warrant exercise period. The variability in potential future cashflows resulted in a derivative warrant liability which will be periodically remeasured with any gains or losses charged to the consolidated statements of operations and deficit.

During 2025, 24,000 warrants were exercised. The remaining warrants and corresponding derivative liability was remeasured on December 31, 2025. The cumulative impact of the remeasurement resulted in a loss of $25,280,833 (2024 - $20,631,082, 2023 - $24,865).

The following table presents the details of the derivative warrant liability:

---

| | | | |
|:---|:---|:---|:---|
| December 31, | **2025** | 2024 | 2023 |
| Stock price | $**6.33** | $8.39 | $1.25 |
| Exercise price range | $**1.09 - $6.00** | $1.52 -$8.39 | $1.52 |
| Expected life in years | **3.07 - 4.77** | 3.93 - 4.93 | 5.00 |
| Volatility | **93.70% - 105.78%** | 88.05% | 75.66% |
| Dividend yield | **0%** | 0% | 0% |
| Risk free interest rate | **3.55%** | 2.93% | 3.54% |
| Fair value of derivative warrant liability | $**135631585** | $35750607 | $1002264 |
| Number of warrants | **29253826** | 8298912 | 1786000 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**11.** **SHARE CAPITAL** 

---

| | |
|:---|:---|
| (a) | AUTHORIZED |
|  | Unlimited number of common shares |
|  | One special voting share |
| (b) | COMMON SHARES ISSUED |

---

---

| | | |
|:---|:---|:---|
|  | Number<br> of Shares | Amount |
| Balance, January 1, 2023 | 37841950 | 151206539 |
| Funds from common shares issued through ATM financing | 227673 | 983194 |
| Funds from common shares issued on private placement | 1786000 | 1607400 |
| Fair value of warrants issued on private placement |  | (954537) |
| Share issue costs |  | (578317) |
| Funds from the exercise of stock options | 268356 | 668259 |
| Fair value of stock options exercised |  | 587035 |
| Funds from the exercise of warrants and compensation warrants | 2364066 | 7767067 |
| Fair value of warrants and compensation warrants exercised | - | 4418783 |
| Balance, December 31, 2023 | 42488045 | 165705423 |
| Funds from common shares issued through ATM financing | 5449723 | 9362235 |
| Funds from Common shares issued on private placement | 24693643 | 69211854 |
| Fair value of warrants issued on private placement |  | (31164688) |
| Share issue costs |  | (878185) |
| Funds from the exercise of stock options | 597151 | 754711 |
| Fair value of stock options exercised |  | 2209196 |
| Funds from the exercise of warrants | 3278595 | 3725565 |
| Fair value of warrants exercised | - | 4816224 |
| Balance, December 31, 2024 | 76507157 | 223742335 |
| Funds from common shares issued on private placement | 45326019 | 280000001 |
| Fair value of warrants issued on private placement |  | (88176282) |
| Share issue costs |  | (8048167) |
| Funds from the exercise of stock options | 3944589 | 5441922 |
| Fair value of stock options exercised |  | 11513569 |
| Funds from the exercise of warrants and compensation warrants | 6243761 | 15847899 |
| Fair value of warrants and compensation warrants exercised |  | 30813000 |
| Adjustment due to change in functional currency | - | (28058114) |
| Balance, December 31, 2025 | 132021526 | $443076163 |

---

**2023**

During the year ended December 31, 2023, the Company raised gross proceeds of $983,194 from the issuance of 227,673 common shares through an Equity Distribution Agreement, ("EDA") with multiple agents. Pursuant to the EDA, the Company established an at-the-market ("ATM") equity offering program whereby the Company may, at its discretion, during the term of the ATM agreement issue and sell, through the agents such number of common shares of the Company as would result in aggregate gross proceeds to the Company of up to $30,000,000. The agents were paid a commission of 3% or $29,486 of the gross proceeds raised through the ATM. The Company incurred additional financing costs including legal and filing fees of $291,226.

On December 4, 2023, the Company raised gross proceeds of $1,607,400 from the issuance of 1,786,000 units through an underwritten public offering in the United States. The Offering consisted of 1,600,000 common shares of the Company and warrants to purchase up to 1,600,000 common shares of the Company at a combined public offering price of $0.90 per common share and accompanying warrant. Each warrant has an exercise price of $1.12 per common share and is exercisable for five years from the date of issuance. In addition, the Company granted the underwriter a 45 day option to purchase up to an additional 240,000 common shares and/or warrants to purchase up to an additional 240,000 common shares at the public offering price in any combination, less underwriting discounts and commissions, which the underwriter has partially exercised to purchase 186,000 additional common shares and additional warrants to purchase up to 186,000 common shares. The agents were paid a commission of 7% or $112,518 of the gross proceeds raised. The Company incurred additional financing costs including legal and filing fees of $145,089.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**11.** **SHARE CAPITAL (Continued)** 

The fair value of the share purchase warrants was estimated using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk-free interest rate of 3.54%, volatility of 75.66%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $954,537 (Note 10).

**2024**

January 24, 2024

On January 24, 2024, the Company raised gross proceeds of CA$6,219,667 ($4,613,312) from the issuance of 5,098,088 units through a private placement financing facility at an offering price CA$1.22 ($0.90). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,098,088 common shares for a period of five (5) years from the date of closing at a price of CA$1.52 ($1.12) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.5%, volatility of 78.35%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $2,815,861.

May 3, 2024

On May 3, 2024, the Company raised gross proceeds of CA$10,000,000 ($7,299,270) from the issuance of 3,258,390 units through a non brokered private placement financing offering at a price CA$3.069 ($2.24). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 3,258,390 common shares for a period of five (5) years from the date of closing at a price of CA$4.26 per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.67%, volatility of 83%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $4,513,393.

May 10, 2024

On May 10, 2024, the Company raised gross proceeds of CA$10,000,000 ($7,299,270) from the issuance of 3,448,275 units through a non brokered private placement financing at a price CA$2.90 ($2.12). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 3,448,275 common shares for a period of five (5) years from the date of closing at a price of CA$4.26 per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.67%, volatility of 83%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $4,435,105.

July 19, 2024

On July 19, 2024, the Company raised gross proceeds of CA$13,700,003 ($10,000,000) from the issuance of 3,333,334 units through a non brokered private placement financing at a price CA$4.09 ($3.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 3,333,334 common shares for a period of five (5) years from the date of closing at a price of CA$5.45 ($4.00) per share.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

11. SHARE CAPITAL (Continued)

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.35%, volatility of 85.93%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $6,430,362.

September 25, 2024

On September 25, 2024, the Company raised gross proceeds of CA$20,400,000 ($15,000,000) from the issuance of 4,000,000 units through a non brokered private placement financing at a price CA$5.10 ($3.75). Each unit consisted of one common share of the Company and one-half common share purchase warrant to purchase up to 2,000,000 common shares for a period of five (5) years from the date of closing at a price of CA$6.78 ($5.00) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 2.79%, volatility of 87.63%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $4,842,347.

December 3, 2024

On December 3, 2024, the Company raised gross proceeds of CA$35,000,003 ($25,000,002) from the issuance of 5,555,556 units through a non brokered private placement financing at a price CA$6.29 ($4.50). Each unit consisted of one common share of the Company and one-half common share purchase warrant to purchase up to 2,777,778 common shares for a period of five (5) years from the date of closing at a price of $6.00 per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 2.91%, volatility of 88.05%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $8,127,620.

The Company incurred other share issuance costs of $7,767,300 related to these financings. <u>ATM Financing</u>

During the year ended December 31, 2025, the Company raised gross proceeds of $9,362,235 from the issuance of 5,449,723 common shares at an average price of $1.72 per common share through the EDA. The Agent was paid a commission of 3% or $280,867 on the gross proceeds raised from the ATM.

**2025**

May 22, 2025

On May 22, 2025, the Company raised gross proceeds of CA$41,574,279 ($30,000,000) from the issuance of 6,000,000 units through a non brokered private placement financing at a price CA$6.92 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 6,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.32 ($6.00) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 2.96%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $20,077,238.

July 17, 2025

On July 17, 2025, the Company raised gross proceeds of CA$34,000,000 ($25,000,000) from the issuance of 5,000,000 units through a non brokered private placement financing at a price CA$6.80 ($5.00). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 5,000,000 common shares for a period of five (5) years from the date of closing at a price of CAD$8.16 ($6.00) per share.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**11.** **SHARE CAPITAL (Continued)** 

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.1%, volatility of 88.65%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $16,629,514.

October 7, 2025

On October 7, 2025, the Company raised gross proceeds of CA$104,625,002 ($75,000,000) from the issuance of 13,636,364 units through a non brokered private placement financing at a price CA$7.67 ($5.50). Each unit consisted of one common share of the Company and one common share purchase warrant to purchase up to 13,636,364 common shares for a period of five (5) years from the date of closing at a price of CAD$9.78 ($7.03) per share.

The fair value of the share purchase warrants was estimated using the Black Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%, risk free interest rate of 3.71%, volatility of 91.875%, and estimated life of 5 years. The estimated fair value assigned to the warrants was $51,469,530.

October 28, 2025

On October 28, 2025, the Company raised gross proceeds of $150,000,000 from the issuance of 20,689,655 common shares through a brokered registered direct offering at a price $7.25. The Company paid approximately $7,585,000 in fees related to this offering.

**12.** **WARRANTS AND COMPENSATION OPTIONS** 

The following table reflects the continuity of warrants and compensation options:

---

| | | | |
|:---|:---|:---|:---|
|  | Historical<br> Average Exercise Price | Number of<br> Warrants/ Compensation options | Historical Fair value |
| Balance, January 1, 2023 | $6.15 | 3512171 | $5905642 |
| Historical fair value assigned to warrants exercised | 3.27 | (2364066) | (4418783) |
| Fair value of expired warrants | 4.50 | (584787) | (816744) |
| Fair value of warrant issued on public offering | - | 1786000 | - |
| Balance, December 31, 2023 | 1.77 | 2349318 | 670115 |
| Historical fair value assigned to warrants exercised | 0.74 | (1680395) | (1260120) |
| Fair value of expired warrants | 1.17 | (14250) | (16616) |
| Fair value of warrants issued on private placements | 1.00 | 11804753 | 11764359 |
| Other warrants issued on private placements <sup>(1)</sup> |  | 8111112 |  |
| Other warrants exercised <sup>(1)</sup> | - | (1598200) | - |
| Balance, December 31, 2024 | 1.05 | 18972338 | 11157738 |
| Fair value of warrants issued on private placements | 3.34 | 11000000 | 36706752 |
| Historical fair value assigned to warrants exercised | 1.07 | (1961733) | (2098780) |
| Other warrants exercised <sup>(1)</sup> |  | (4282028) |  |
| Other warrants issued on private placements <sup>(1)</sup> |  | 13636364 |  |
| Adjustment due to change in functional currency | - | - | (15166108) |
| Balance, December 31, 2025 | $3.77 | 37364941 | $30599602 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) The fair value
of these warrants is included in derivative warrant liability. (Note 10)

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**12.** **WARRANTS AND COMPENSATION OPTIONS (Continued)** 

The following table reflects the details of warrants:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Expiry Date | Exercise Price | Balance January 1, 2025 | Warrants Issued | Warrants Exercised | Balance December 31, 2025 |
| &nbsp;&nbsp;&nbsp;Dec 2, 2025 | 3.56 | 24000 |  | (24000) |  |
| &nbsp;&nbsp;&nbsp;Dec 4, 2028 | 1.09 | 187800 |  | (187800) |  |
| &nbsp;&nbsp;&nbsp;Jan 24, 2029 | 1.09 | 3942761 |  | (1373571) | 2569190 |
| &nbsp;&nbsp;&nbsp;May 3, 2029 | 3.06 | 3258390 |  | (3258390) |  |
| &nbsp;&nbsp;&nbsp;May 10, 2029 | 3.06 | 3448275 |  | (1400000) | 2048275 |
| &nbsp;&nbsp;&nbsp;July 19, 2029 | 4.00 | 3333334 |  |  | 3333334 |
| &nbsp;&nbsp;&nbsp;Sep 25, 2029 | 5.00 | 2000000 |  |  | 2000000 |
| &nbsp;&nbsp;&nbsp;Dec 4, 2029 | 6.00 | 2777778 |  |  | 2777778 |
| &nbsp;&nbsp;&nbsp;May 22, 2030 | 6.00 |  | 6000000 |  | 6000000 |
| &nbsp;&nbsp;&nbsp;Jul 17, 2030 | 5.86 |  | 5000000 |  | 5000000 |
| &nbsp;&nbsp;&nbsp;Oct 7, 2030 | 7.03 | - | 13636364 | - | 13636364 |
|  | $1.09 - $7.03 | 18972338 | 24636364 | (6243761) | 37364941 |

---

**13.** **STOCK OPTIONS AND CONTRIBUTED SURPLUS** 

**Stock Options**

On June 27, 2025, shareholders of the Company approved the amendment to the Company's fixed 20% omnibus equity incentive plan (the "Omnibus Plan"). The Omnibus Plan provides flexibility to the Company to grant different forms of equity based incentive awards to directors, officers, employees and consultants. The Omnibus plan provides the Company with the choice of granting stock options ("Options"), share units ("Share Units") and deferred share units ("DSUs"). The Omnibus Plan provides that the maximum number of common shares issuable pursuant to awards granted under the Omnibus Plan and pursuant to other previously granted awards is limited to 16,696,252 (the "Number Reserved"). Any subsequent increase in the Number Reserved must be approved by shareholders of the Company and cannot, at the time of the increase, exceed 20% of the number of issued and outstanding shares. Awards vest in accordance with the policies determined by the Board of Directors from time to time consistent with the provisions of the Omnibus Plan which grants discretion to the Board of Directors.

Stock option transactions and the number of stock options outstanding were as follows:

SCHEDULE OF STOCK OPTION OUTSTANDING

---

| | | |
|:---|:---|:---|
|  | Number of<br> Options | Historical<br> Weighted Average<br> Exercise Price |
| Balance, January 1, 2023 | 6741825 | $4.10 |
| Expired/cancelled | (182750) | 4.66 |
| Exercised | (268356) | 2.49 |
| Granted | 1002170 | 4.11 |
| Balance, December 31, 2023 | 7292889 | 3.92 |
| Expired/cancelled | (184996) | 5.33 |
| Exercised | (597151) | 1.28 |
| Granted | 3051482 | 2.12 |
| Modified options <sup>(1)</sup> | (7153358) | 3.92 |
| Repriced options <sup>(1)</sup> | 7153358 | 1.29 |
| Balance, December 31, 2024 | 9562224 | 1.47 |
| Expired/cancelled | (345091) | 2.38 |
| Exercised | (3944589) | 1.43 |
| Granted | 555000 | 5.13 |
| Balance, December 31, 2025 | 5827544 | $1.93 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**13.** **STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)** 

&nbsp;&nbsp;&nbsp;&nbsp;(1) During the year
ended December 31, 2025, the Company amended 7,153,358 stock options granted to directors, officers, employees and consultants. The amended
stock options were initially granted at prices ranging from CA$2.60 to CA$11.90 . The amended stock options were repriced to CA$1.75 .

During the year ended December 31, 2025, the Company recorded stock-based compensation of $6,107,052 (2024 - $5,469,369, 2023 - $4,201,444).

The stock options granted and re-priced were valued using the Black-Scholes option pricing model using the following assumptions:

SCHEDULE OF STOCK OPTIONS ASSUMPTIONS

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2025** | Re-priced<br> stock options <br>2024 | 2024 | 2023 |
| Weighted average exercise price | $**5.13** | $1.29 | $2.12 | $4.11 |
| Weighted average risk-free interest rate | **3.02%** | 3.47% | 2.99% - 3.55 | 2.88% - 3.48 |
| Weighted average dividend yield | **0%** | 0% | 0% | 0% |
| Weighted average volatility | **87.12%** | 83.70% | 85.75% - 86.97 | 82.17% - 82.45 |
| Weighted average estimated life | **10 years** | 6.4 years | 10 years | 10 years |
| Weighted average share price | $**5.13** | $1.29 | $2.12 | $4.11 |
| Share price on the various grant dates | $**3.83 - $6.60** | $1.29 | $1.79 - $5.20 | $4.05 - $4.63 |
| Weighted average fair value | $**3.83** | $0.96 | $2.01 | $3.42 |

---

The underlying expected volatility was determined by reference to the Company's historical share price movements, its dividend policy and dividend yield and past experience relating to the expected life of granted stock options.

The weighted average remaining contractual life and weighted average exercise price of options outstanding and of options exercisable as at December 31, 2025 are as follows:

SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE AND WEIGHTED AVERAGE EXERCISE PRICE OF OPTIONS

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Options Outstanding** | **Options Outstanding** | **Options Outstanding** | **Options Exercisable** | **Options Exercisable** | **Options Exercisable** |
| **Exercise Range** | **Number Outstanding** | **Historical Weighted Average <br>Exercise Price** | **Weighted Average Remaining <br>Contractual Life (years)** | **Number Exercisable** | **Historical Weighted Average <br>Exercise Price** |
| $1.27 - $3.00 | 4753721 | $&nbsp;&nbsp;&nbsp;&nbsp;1.42 | 7.06 | 3012788 | $&nbsp;&nbsp;&nbsp;&nbsp;1.38 |
| $3.01 - $5.00 | 1005000 | $3.99 | 8.99 | 175000 | $3.72 |
| $5.01 - $6.60 | 68823 | $6.22 | 9.59 | 31323 | $5.76 |
|  | 5827544 | $1.93 | 7.42 | 3219111 | $1.55 |

---

**Restricted Share Units (RSUs)**

During the year ended December 31, 2025, the Company granted 3,183,038 RSUs to directors, officers and employees under the the Company's Omnibus Plan. The RSUs were granted at a weighted average fair value of $5.45 per unit. 93,540 RSUs will vest fully one year from the grant date and 3,089,498 will vest 33% yearly over three years.

Details of the RSU grants are as follows:

SCHEDULE OF RSU GRANTS

---

| | | |
|:---|:---|:---|
|  | Grant Price ($) | Number |
| June 27, 2025 | 5.19 | 72340 |
| July 4, 2025 | 5.53 | 21200 |
| August 7, 2025 | 5.42 | 3005009 |
| November 3, 2025 | 6.60 | 84489 |
|  |  | 3183038 |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**13.** **STOCK OPTIONS AND CONTRIBUTED SURPLUS (Continued)** 

The RSUs are equity-settled and are accounted for in accordance with IFRS 2 – Share-based Payment. The fair value of the RSUs is recognized as compensation expense over the respective vesting periods on a straight-line basis.

For the year ended December 31, 2025, the Company recognized $2,451,486 in stock-based compensation related to these RSUs, with a corresponding increase in contributed surplus. The remaining unrecognized compensation expense of $14,886,292 will be recognized over the remaining vesting periods.

**14.** **LOSS PER SHARE** 

**SCHEDULE OF INCOME (LOSS) PER SHARE**

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Numerator |  |  |  |
| &nbsp;&nbsp;&nbsp; Net loss | $**(62963213)** | $(56695823) | $(20267365) |
| Denominator |  |  |  |
| &nbsp;&nbsp;&nbsp;Weighted average number of common shares outstanding | **93156184** | 60246653 | 40099752 |
| &nbsp;&nbsp;&nbsp;Weighted average number of common shares outstanding - diluted | **93156184** | 60246653 | 40099752 |
| Basic and diluted loss per share | $**(0.68)** | $(0.94) | $(0.51) |

---

The effect of common share purchase options and warrants on the net loss in 2025, 2024 and 2023 is not reflected as they are anti-dilutive.

**15.** **COMMITMENTS AND CONTINGENCIES** 

The Company has operating leases on three facilities; head office located in Toronto, Canada, and operating facilities located in Singapore and China. The lease on the Company's operating facilities in Singapore terminated on March 31, 2025. The Company has expanded its operating facilities in Singapore, as a result it entered into a lease arrangement on October 1, 2024, expiring March 1, 2030. A security deposit in the amount of $200,351 was placed with the landlord. The lease on the Company's operating facilities in China terminated in January 2025. The company entered into a new lease on December 20, 2024, which expires on December 19, 2027. As of September 30, 2025, the Company's head office was on a month-to-month lease term. Deposits were made on other long-term commitments of $7,774.

Remaining annual lease payments to the lease expiration dates are as follows:

SCHEDULE OF REMAINING ANNUAL RENTAL PAYMENTS LEASE

---

| | |
|:---|:---|
| 2026 | $388895 |
| 2027 and beyond | 1190087 |
|  | $1578982 |

---

**16.** **RELATED PARTY TRANSACTIONS** 

Compensation to key management personnel were as follows:

SCHEDULE OF COMPENSATION TO KEY MANAGEMENT PERSONNEL

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Salaries | $**3666430** | $2435726 | $2245853 |
| Share-based payments <sup>(1)</sup> | **3640115** | 3021067 | 2411669 |
| Total | $**7306545** | $5456793 | $4657522 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Share-based payments
are the fair value of options granted to key management personnel and expensed during the various years as calculated using the Black-Scholes
model.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**16.** **RELATED PARTY TRANSACTIONS (Continued)** 

All transactions with related parties have occurred in the normal course of operations and are measured at the exchange amounts, which are the amounts of consideration established and agreed to by the related parties.

**17.** **SEGMENT INFORMATION** 

The Company and its subsidiaries operate in a single segment; the design, manufacture and sale of semiconductor products and services for commercial applications. The Company's operating and reporting segment reflects the management reporting structure of the organization and the manner in which the chief operating decision maker regularly assesses information for decision making purposes, including the allocation of resources. A summary of the Company's operations is below:

**OPEL, ODIS, POET Shenzhen, PTM, SPX and PTS**

OPEL, ODIS, POET Shenzhen, PTM, SPX and PTS are the designers and developers of the POET Optical Interposer platform and optical engines based on the POET Optical Interposer platform.

**BB Photonics**

BB Photonics developed photonic integrated components for the datacom and telecom markets utilizing embedded dielectric technology that enabled the partial integration of active and passive devices into photonic integrated circuits. BB Photonics' operation is currently dormant.

On a consolidated basis, the Company operates geographically in Malaysia, Singapore, China (collectively "Asia"), the United States and Canada. Geographical information is as follows:

**** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** |
| <br>**As of December 31,** | **Asia** | **US** | **Canada** | **Consolidated** |
| **Current assets** | $**1325632** | $**358665** | $**312777534** | $**314461831** |
| **Long-term deposit** | **208125** | **-** | **-** | **208125** |
| **Property and equipment** | **11914787** | **319041** | **-** | **12233828** |
| **Patents and licenses** | **-** | **556375** | **-** | **556375** |
| **Right of use asset** | **1112279** | **-** | **-** | **1112279** |
| **Total Assets** | $**14560823** | $**1234081** | $**312777534** | $**328572438** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year Ended December 31,** | **Asia** | **US** | **Canada** | **Consolidated** |
| **Revenue** | $**1074865** | $**-** | $**-** | $**1074865** |
| **Selling, marketing and administration** | **(5246942)** | **(8000257)** | **(11834758)** | **(25081957)** |
| **Research and development** | **(15474358)** | **(2405183)** | **(204762)** | **(18084303)** |
| **Interest expense** | **(144046)** | **-** | **-** | **(144046)** |
| **Loss on fair value of derivative** |  |  |  |  |
| **warrant liability** | **-** | **-** | **(25280833)** | **(25280833)** |
| **Other income, including interest** | **30352** | **-** | **4522709** | **4553061** |
| **Net loss** | $**(19760129)** | $**(10405440)** | $**(32797644)** | $**(62963213)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2024** | **2024** | **2024** | **2024** |
| <br>**As of December 31,** | **Asia** | **US** | **Canada** | **Consolidated** |
| **Current assets** | $**1325632** | $**341240** | $**53815162** | $**55482034** |
| **Long-term deposit** | **107890** | **-** | **-** | **107890** |
| **Property and equipment** | **12256402** | **501280** | **-** | **12757682** |
| **Patents and licenses** | **-** | **606708** | **-** | **606708** |
| **Right of use asset** | **677553** | **20582** | **-** | **698135** |
| **Total Assets** | $**14367477** | $**1469810** | $**53815162** | $**69652449** |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**17.** **SEGMENT INFORMATION (Continued)** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Year Ended December 31,** | **Asia** | **US** | **Canada** | **Consolidated** |
| **Revenue** | $**41427** | $**-** | $**-** | $**41427** |
| **Selling, marketing and administration** | **(3329834)** | **(6615379)** | **(8826208)** | **(18771421)** |
| **Research and development** | **(7536414)** | **(3618983)** | **(179244)** | **(11334641)** |
| **Loss on the acquisition of the remaining interest of SPX** | **-** | **-** | **(6852687)** | **(6852687)** |
| **Interest expense** | **(74644)** | **(28029)** | **-** | **(102673)** |
| **Loss on fair value of derivative warrant liability** | **-** | **-** | **(20631082)** | **(20631082)** |
| **Other income, including interest** | **5873** | **-** | **942083** | **947956** |
| **Forgiveness of Covid-19 government support loans** | **-** | **-** | **7298** | **7298** |
| **Net loss** | $**(10893592)** | $**(10262391)** | $**(35539840)** | $**(56695823)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | 2023 | 2023 | 2023 | 2023 |
| As of December 31, | Asia | US | Canada | Consolidated |
| Current assets | $326926 | $149227 | $2693592 | $3169745 |
| Property and equipment | 4089653 | 533575 |  | 4623228 |
| Patents and licenses |  | 502055 |  | 502055 |
| Right of use asset | 379462 | 102927 | - | 482389 |
| Total Assets | $4796041 | $1287784 | $2693592 | $8777417 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| The Year Ended December 31, | Asia | US | Canada | Consolidated |
| Revenue | $465777 | $- | $- | $465777 |
| Selling, marketing and administration | $(2753484) | $(6226291) | $(1815380) | $(10795155) |
| Research and development | (6249120) | (3662418) | (166392) | (10077930) |
| Loss on fair value of derivative |  |  |  |  |
| warrant liability |  |  | (24865) | (24865) |
| Interest expense | (27906) | (42276) |  | (70182) |
| Gain on contribution of intellectual to joint venture | 1031807 |  |  | 1031807 |
| Other income, including interest |  |  | 234990 | 234990 |
| Share of loss in joint venture | (1031807) | - | - | (1031807) |
| Net loss | $(8564733) | $(9930985) | $(1771647) | $(20267365) |

---

**18.** **FINANCIAL INSTRUMENTS AND RISK MANAGEMENT** 

The Company's financial instruments consist of cash and cash equivalents, short-term investments, deposit, covid-19 government support loans, convertible debt, contract liabilities, derivative warrant liability and accounts payable and accrued liabilities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest risk arising from these financial instruments. The Company estimates that carrying value of these instruments approximates fair value due to their short term nature.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**18.** **FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Continued)** 

The Company has classified financial assets and (liabilities) as follows at December 31:

SCHEDULE OF CLASSIFIED FINANCIAL ASSETS AND LIABILITIES

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Financial assets, measured at amortized cost: |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**39959201** | $37143759 | $3019069 |
| &nbsp;&nbsp;&nbsp;Short-term investments | $**273439102** | $16672811 | $- |
| &nbsp;&nbsp;&nbsp;Accounts receivable | $**-** | $7257 | $- |
| Other liabilities, measured at amortized cost: |  |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $**(1639543)** | $(5970537) | $(2301457) |
| &nbsp;&nbsp;&nbsp;Covid-19 government support loans | $**-** | $- | $(30200) |
| &nbsp;&nbsp;&nbsp;Convertible debt | $**(5800000)** | $(6500000) | $- |
| &nbsp;&nbsp;&nbsp;Fair value through profit or loss (FVTPL): |  |  |  |
| &nbsp;&nbsp;&nbsp;Derivative warrant liability | $**(135631585)** | $(35750607) | $(1002264) |

---

**Exchange Rate Risk**

The functional currency of each of the entities included in the accompanying consolidated financial statements is the local currency where the entity is domiciled except for the Canadian entity which has determined that the U.S. dollar is its functional currency. Functional currencies include the Chinese Yuan, US, Singapore and Malaysian Ringgit. Most transactions within the entities are conducted in functional currencies. None of the entities included in the consolidated financial statements engage in hedging activities. The Company is exposed to a foreign currency risk when its subsidiaries hold current assets or current liabilities in currencies other than its functional currency. A 10% change in foreign currencies held would increase or decrease other comprehensive loss by $2,000,000.

**Liquidity Risk**

The Company currently does not maintain credit facilities. The Company's existing cash and cash resources are considered sufficient to fund operating and investing activities beyond one year from the date of these consolidated financial statements.

**19.** **CAPITAL MANAGEMENT** 

In the management of capital, the Company includes shareholders' equity (excluding accumulated other comprehensive loss and deficit) and cash, cash equivalents and short-term investments. The components of capital on December 31, 2025 were:

SCHEDULE OF COMPONENTS OF CAPITAL

---

| | |
|:---|:---|
| Cash, cash equivalents and short-term investments | $313398303 |
| Shareholders' equity, excluding deficit and accumulated other comprehensive loss | $483005489 |

---

The Company's objective in managing capital is to ensure that financial flexibility is present to increase shareholder value through growth and responding to changes in economic and/or market conditions; to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business and to safeguard the Company's ability to obtain financing should the need arise.

In maintaining its capital, the Company has a strict investment policy which includes investing its surplus capital only in highly liquid, highly rated financial instruments.

The Company reviews its capital management approach on an ongoing basis.

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**20.** **EXPENSES** 

Research and development costs can be analysed as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Wages and benefits | $**7000637** | $4388075 | $4298207 |
| Subcontract fees | **2797721** | 2134948 | 1864122 |
| Stock-based compensation | **2216914** | 2091583 | 1539235 |
| Supplies | **6069031** | 2720035 | 2376366 |
|  | $**18084303** | $11334641 | $10077930 |

---

Selling, marketing and administration costs can be analysed as follows:

---

| | | | |
|:---|:---|:---|:---|
| Stock-based compensation | $**3890138** | $3377786 | $2662209 |
| Wages and benefits | **4552496** | 2975488 | 2649770 |
| Professional fees | **1713629** | 1936592 | 1744771 |
| General expenses | **2881736** | 1798643 | 1681899 |
| Depreciation and amortization | **3315899** | 2020195 | 1922140 |
| Finance advisory fees | **8227774** | 6501799 |  |
| Rent and facility costs | **500285** | 160918 | 134366 |
|  | $**25081957** | $18771421 | $10795155 |

---

**21.** **REVENUE** 

**Disaggregated Revenues**

The Company disaggregates revenue by timing of revenue recognition, that is, at a point in time and revenue over time. During the year ended December 31, 2025, the Company recognized $1,074,865 (2024 - $41,427, 2023 - $465,777) from non-recurring engineering services and product sales. Non-recurring revenue may be recognized over time or at a point in time while product sales are recorded at a point in time.

22. INCOME TAXES

The following table reconciles the expected income tax recovery at the Canadian statutory income tax rate of 26.5% for 2025 (2024 - 26.5%, 2023 - 26.5%) to the amounts recognized in operations.

---

| | | | |
|:---|:---|:---|:---|
| For the Year Ended December 31, | **2025** | 2024 | 2023 |
| Net loss before taxes | $**(62963213)** | $(56695823) | $(20267365) |
| Expected current income tax recovery | $**16685000** | $15024000 | $5370852 |
| Change in statutory, foreign tax, foreign exchange rates and other | **(1136000)** | (1717000) | (783538) |
| Amounts not deductible for tax purposes | **(4334000)** | (8988000) | (1113000) |
| Other deductible items | **2133000** | 232000 |  |
| Adjustment to prior years provision versus statutory tax returns and expiry of non-capital losses | **304000** | 6623000 |  |
| Change in unrecognized deductible temporary differences | **(13652000)** | (11174000) | (3474314) |
| Income tax recovery recognized | $**-** | $- | $- |

---

**POET TECHNOLOGIES INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Expressed in US Dollars)**

**22.** **INCOME TAXES (Continued)** 

The following table reflects future income tax assets at December 31:

---

| | | | |
|:---|:---|:---|:---|
|  | **2025** | 2024 | 2023 |
| Resource assets | $**868000** | $827000 | $1024271 |
| Gross unamortized share issue costs | **11137000** | 1280000 | 810000 |
| Capitalized S.174 expenses | **4223000** | 10088000 | 5900000 |
| Canadian non-capital losses | **34271000** | 27466000 | 22585000 |
| Canadian capital losses | **5515000** | 5252000 | 5300000 |
| US non-capital losses | **114235601** | 98396000 | 95300000 |
| Singapore non-capital losses | **30462000** | 18254000 | 19300000 |
| Property and equipment | **7552000** | 4783000 | - |
|  | **208263601** | 166346000 | 150219271 |
| Unrecognized deferred tax assets | **(208263601)** | (166346000) | (150219271) |
| Deferred income tax assets recognized | $**-** | $- | $- |

---

**23.** **COVID-19 GOVERNMENT SUPPORT LOANS** 

On April 9, 2020, the Canadian government launched the Canada Emergency Business Account ("CEBA") which is intended to support businesses during COVID19 by providing interest free financing of up to $30,200 (CA$40,000) until December 31, 2023. If 75% of the loan is repaid by December 31, 2023 (extended to January 18, 2024), the loan recipient will be eligible for a loan forgiveness of the remaining 25% of the amount loaned. On April 15, 2020, the Company received a loan in the amount of $30,200 through the CEBA. If the loan has not been repaid by January 18, 2024, the outstanding amount will be automatically extended for an additional two years at 5% interest per annum payable monthly and maturing on December 31, 2025. The Company repaid 75% of the amount borrowed on January 15, 2024. The balance was forgiven, resulting in a gain of $7,298.

**24.** **SUBSEQUENT EVENTS** 

On January 23, 2026, the Company raised gross proceeds of $150,000,000 from the issuance of 20,689,656 common shares through a brokered registered direct offering at a price $7.25 per common share. The Company paid approximately $7,585,000 in fees related to this offering.

## Exhibit 4.16

**Exhibit 4.16**

**POET TEchnologies inc.**

**(THE "CORPORATION")**

**OMNIBUS INCENTIVE PLAN**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| **Article 1 INTERPRETATION** | **Article 1 INTERPRETATION** | **1** |
| 1.1 | Definitions | 1 |
| 1.2 | Interpretation | 1 |
| **Article 2 PURPOSE AND ADMINISTRATION OF THE PLAN; GRANTING OF AWARDS** | **Article 2 PURPOSE AND ADMINISTRATION OF THE PLAN; GRANTING OF AWARDS** | **6** |
| 2.1 | Purpose of the Plan | 6 |
| 2.2 | Implementation and Administration of the Plan | 6 |
| 2.3 | Participation in this Plan | 7 |
| 2.4 | Shares Subject to the Plan | 7 |
| 2.5 | Intentionally Omitted | 8 |
| 2.6 | Granting of Awards | 9 |
| **Article 3 OPTIONS** | **Article 3 OPTIONS** | **9** |
| 3.1 | Nature of Options | 9 |
| 3.2 | Option Awards | 9 |
| 3.3 | Option Price | 9 |
| 3.4 | Option Term | 10 |
| 3.5 | Exercise of Options | 10 |
| 3.6 | Method of Exercise and Payment of Purchase Price | 10 |
| 3.7 | Option Agreements | 11 |
| **Article 4 RESTRICTED AND PERFORMANCE SHARE UNITS** | **Article 4 RESTRICTED AND PERFORMANCE SHARE UNITS** | **11** |
| 4.1 | Nature of Share Units | 11 |
| 4.2 | Share Unit Awards | 12 |
| 4.3 | Share Unit Agreements | 12 |
| 4.4 | Vesting of Share Units | 13 |
| 4.5 | Redemption / Settlement of Share Units | 13 |
| 4.6 | Determination of Amounts | 14 |
| 4.7 | Award of Dividend Equivalents | 15 |
| **Article 5 DEFERRED SHARE UNITS** | **Article 5 DEFERRED SHARE UNITS** | **15** |
| 5.1 | Nature of Deferred Share Units | 15 |
| 5.2 | Market Fluctuation | 15 |
| 5.3 | DSU Awards | 15 |
| 5.4 | DSU Agreements | 16 |
| 5.5 | Vesting of DSUs | 16 |
| 5.6 | Redemption / Settlement of DSUs | 16 |
| **Article 6 GENERAL CONDITIONS** | **Article 6 GENERAL CONDITIONS** | **18** |
| 6.1 | General Conditions Applicable to Awards | 18 |
| 6.2 | General Conditions Applicable to Options | 19 |
| 6.3 | General Conditions Applicable to Share Units | 20 |
| **Article 7 ADJUSTMENTS AND AMENDMENTS** | **Article 7 ADJUSTMENTS AND AMENDMENTS** | **21** |
| 7.1 | Adjustment to Shares Subject to Outstanding Awards | 21 |
| 7.2 | Change of Control | 21 |
| 7.3 | Amendment or Discontinuance of the Plan | 22 |
| **Article 8 MISCELLANEOUS** | **Article 8 MISCELLANEOUS** | **23** |
| 8.1 | Use of an Administrative Agent and Trustee | 23 |
| 8.2 | Tax Withholding | 23 |
| 8.3 | Clawback | 24 |
| 8.4 | Securities Law Compliance | 24 |
| 8.5 | Reorganization of the Corporation | 25 |
| 8.6 | Quotation of Shares | 25 |
| 8.7 | No Fractional Shares | 25 |
| 8.8 | Governing Laws | 25 |
| 8.9 | Severability | 25 |
| 8.10 | Section 409A of the Tax Code | 25 |

---

**POET TECHNOLOGIES INC.**

**OMNIBUS INCENTIVE PLAN**

POET Technologies Inc. (the "**Corporation**") hereby establishes an omnibus incentive plan for certain qualified directors, executive officers, employees, or consultants of the Corporation or any of its Subsidiaries (as defined herein).

**Article 1**

**INTERPRETATION**

1.1 Definitions

Where used herein or in any amendments hereto or in any communication required or permitted to be given hereunder, the following terms shall have the following meanings, respectively, unless the context otherwise requires:

"**Account**" means an account maintained for each Participant on the books of the Corporation which will be credited with Awards in accordance with the terms of this Plan.

"**Award**" means any of an Option, Share Unit or DSU granted to a Participant pursuant to the terms of the Plan.

"**Award Agreement**" means any of an Option Agreement, Share Unit Agreement or DSU Agreement governing an Option, Share Unit or DSU, respectively, granted to a Participant.

"**Blackout Period**" means the period during which Participants cannot trade securities of the Corporation pursuant to the Corporation's policy respecting restrictions on trading which is in effect at that time (which, for greater certainty, does not include the period during which a cease trade order is in effect to which the Corporation or in respect of an insider, that insider, is subject).

"**Blackout Period Expiry Date**" means the date on which a Blackout Period expires.

"**Board**" has the meaning ascribed thereto in Section 2.2(1) hereof.

"**Business Day**" means a day other than a Saturday, Sunday or statutory holiday, when banks are generally open for business in Toronto, Ontario for the transaction of banking business.

"**Cashless Exercise Right**" has the meaning ascribed thereto in Section 3.6(3) hereof.

"**Cause**" has the meaning ascribed thereto in Section 6.2(1) hereof.

"**Change of Control**" means, unless the Board determines otherwise, the happening, in a single transaction or in a series of related transactions, of any of the following events:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any
 transaction (other than a transaction described in clause (c) below) pursuant to which any
 Person or group of Persons acting jointly or in concert acquires the direct or indirect beneficial
 ownership of securities of the Corporation representing 50% or more of the aggregate voting
 power of all of the Corporation's then issued and outstanding securities entitled to
 vote in the election of directors of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) there
 is consummated an arrangement, amalgamation, merger, consolidation or similar transaction
 involving (directly or indirectly) the Corporation and, immediately after the consummation
 of such arrangement, amalgamation, merger, consolidation or similar transaction, the shareholders
 of the Corporation immediately prior thereto do not beneficially own, directly or indirectly,
 either (A) outstanding voting securities representing more than 50% of the combined outstanding
 voting power of the surviving or resulting entity in such amalgamation, merger, consolidation
 or similar transaction or (B) more than 50% of the combined outstanding voting power of the
 parent of the surviving or resulting entity in such arrangement, amalgamation, merger, consolidation
 or similar transaction, in each case in substantially the same proportions as their beneficial
 ownership of the outstanding voting securities of the Corporation immediately prior to such
 transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the
 sale, lease, exchange, license or other disposition, in a single transaction or a series
 of related transactions, of assets, rights or properties of the Corporation or any of its
 subsidiaries which have an aggregate book value greater than 50% of the book value of the
 assets, rights and properties of the Corporation and its Subsidiaries on a consolidated basis
 to any other person or entity, other than a disposition to a wholly-owned Subsidiary of the
 Corporation in the course of a reorganization of the assets of the Corporation and its wholly-owned
 Subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the
 passing of a resolution by the Board or shareholders of the Corporation to substantially
 liquidate the assets of the Corporation or wind up the Corporation's business or significantly
 rearrange its affairs in one or more transactions or series of transactions or the commencement
 of proceedings for such a liquidation, winding-up or re-arrangement (except where such re-arrangement
 is part of a bona fide reorganization of the Corporation in circumstances where the business
 of the Corporation is continued and the shareholdings remain substantially the same following
 the re-arrangement); or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) individuals
 who, on the Effective Date, are members of the Board (the "**Incumbent Board** ")
 cease for any reason to constitute at least a majority of the members of the Board; provided,
 however, that if the appointment or election (or nomination for election) of any new Board
 member was approved or recommended by a majority vote of the members of the Incumbent Board
 then still in office, such new member will, for purposes of this Plan, be considered as a
 member of the Incumbent Board.

"**Consultant**" means any individual who is a natural person and who provides services to the Corporation or any of its Subsidiaries, so long as such natural person (i) renders bona fide services that are not in connection with the offer and sale of the Corporation's securities in a capital-raising transaction and (ii) does not directly or indirectly promote or maintain a market for the Corporation's securities.

"**Consulting Agreement**" means, with respect to any Participant, any written consulting agreement between the Corporation or a Subsidiary and such Participant.

"**Corporation**" means POET Technologies Inc., a corporation existing under the *Business Corporations Act* (Ontario) as amended from time to time.

"**Designated Broker**" means a broker who is independent of, and deals at arm's length with, the Corporation and its Subsidiaries, and is designated by the Corporation or its Subsidiaries.

"**Dividend Equivalent**" means additional Share Units credited to a Participant's Account as a dividend equivalent pursuant to Section 4.6(1).

"**Director**" means a director (as defined under Securities Laws) of the Corporation or of any of its Subsidiaries.

"**DSU**" has the meaning ascribed thereto in Section 5.1 hereof.

"**DSU Agreement**" means a written agreement between the Corporation and a Participant evidencing the grant of DSUs and the terms and conditions thereof, a form of which is attached hereto as Exhibit "D."

"**DSU Redemption Date**" means, with respect to a particular DSU, the date on which such DSU is redeemed in accordance with the provisions of this Plan.

"**Effective Date**" means the effective date of this Plan.

"**Eligibility Date**" means the effective date on which a Participant becomes eligible to receive long-term disability benefits (provided that, for greater certainty, such effective date shall be confirmed in writing to the Corporation by the insurance company providing such long-term disability benefits).

"**Eligible Participants**" means any Director, Officer, Employee, or Consultant of the Corporation or any of its Subsidiaries.

"**Employee**" means an individual who is considered an employee of the Corporation or any of its Subsidiaries under the Tax Act.

"**Employment Agreement**" means, with respect to any Participant, any written employment agreement between the Corporation or a Subsidiary and such Participant.

"**Exchange**" means the Nasdaq Stock Market or such other stock exchange or quotation system upon which the Shares may be listed or posted for trading from time to time.

"**Exercise Notice**" means a notice in writing signed by a Participant and stating the Participant's intention to exercise a particular Option, if applicable.

"**Existing Option Plan**" means the fixed stock option plan of the Corporation, which was last approved by shareholders of the Corporation on August 27, 2021.

"**Existing Option**" means an option grant made under the Existing Option Plan.

"**Grant Agreement**" means an agreement evidencing the grant to a Participant of an Award, including an Option Agreement, a Share Unit Agreement, a DSU Agreement, an Employment Agreement or a Consulting Agreement.

"**Market Value**" means at any date when the market value of Shares is to be determined, (i) if the Shares are listed on the Nasdaq Stock Market, the closing price of the Shares on the Nasdaq Stock Market for the Trading Session on the day prior to the relevant time as it relates to an Award, (ii) if the Shares are not listed on the Nasdaq Stock Market, then as calculated in paragraph (i) by reference to the price on any other stock exchange on which the Shares are listed (if more than one, then using the exchange on which a majority of trading in the Shares occurs), or (iii) if the Shares are not listed on any stock exchange, the value as is determined solely by the Board, acting reasonably and in good faith and such determination shall be conclusive and binding on all Persons.

"**Net Exercise Right**" has the meaning ascribed thereto in Section 3.6(4) hereof.

"**Officer**" means an officer (as defined under Securities Laws) of the Corporation or of any of its Subsidiaries.

"**Option**" means an option granted by the Corporation to a Participant entitling such Participant to acquire a designated number of Shares from treasury at the Option Price, but subject to the provisions hereof.

"**Option Agreement**" means a written agreement between the Corporation and a Participant evidencing the grant of Options and the terms and conditions thereof, a form of which is attached hereto as Exhibit "A."

"**Option Price**" has the meaning ascribed thereto in Section 3.2 hereof.

"**Option Term**" has the meaning ascribed thereto in Section 3.4 hereof.

"**Outstanding Issue**" means the number of Shares that are outstanding as at a specified time, on a non- diluted basis.

"**Participants**" means Eligible Participants that are granted Awards under the Plan.

"**Performance Criteria**" means specified criteria, other than the mere continuation of employment or the mere passage of time, the satisfaction of which is a condition for the grant, exercisability, vesting or full enjoyment of an Option or Share Unit.

"**Performance Period**" means the period determined by the Board at the time any Option or Share Unit is granted or at any time thereafter during which any Performance Criteria and any other vesting conditions specified by the Board with respect to such Option or Share Unit are to be measured.

"**Person**" means an individual, corporation, company, cooperative, partnership, trust, unincorporated association, entity with juridical personality or governmental authority or body, and pronouns which refer to a Person shall have a similarly extended meaning.

"**Plan**" means this POET Technologies Inc. Omnibus Incentive Plan, including the exhibits hereto and any amendments or supplements hereto made after the effective date hereof.

"**Restriction Period**" means the period determined by the Board pursuant to Section 4.4 hereof.

"**Securities Laws**" means securities legislation, securities regulation and securities rules, as amended, and the policies, notices, instruments and blanket orders in force from time to time that are applicable to the Corporation.

"**Shares**" means the common shares in the share capital of the Corporation.

"**Share Compensation Arrangement**" means a stock option, stock option plan, employee stock purchase plan, long-term incentive plan or any other compensation or incentive mechanism involving the issuance or potential issuance of Shares from treasury, including a share purchase from treasury by a full-time Employee, Director, Officer, or Consultant which is financially assisted by the Corporation or a Subsidiary by way of a loan, guarantee or otherwise.

"**Share Unit**" means a right awarded to a Participant to receive a payment in the form of Shares as provided in Article 4 hereof and subject to the terms and conditions of this Plan.

"**Share Unit Agreement**" means a written agreement between the Corporation and a Participant evidencing the grant of Share Units and the terms and conditions thereof, a form of which is attached hereto as Exhibit "C."

"**Subsidiary**" means a corporation, company or partnership that is controlled, directly or indirectly, by the Corporation.

"**Tax Act**" means the *Income Tax Act* (Canada) and the regulations thereunder, as amended from time to time.

"**Tax Obligations**" means the aggregate amount of all withholdings, source deductions and similar amounts required under any governing tax law with respect to either (i) the redemption of a Share Unit, or (ii) the exercise or cancellation of an Option (including pursuant to a Cashless Exercise Right or Net Exercise Right), as the context requires, including amounts funded by the Corporation on behalf of previous withholding tax, source deduction or similar payments and owed by the Participant to the Corporation, as applicable (which Tax Obligations are to be determined by the Corporation in its sole discretion).

"**Termination Date**" means (i) in the event of a Participant's resignation, the date on which such Participant ceases to be a Director, Officer, Employee, or Consultant of the Corporation or one of its Subsidiaries, (ii) in the event of the termination of the Participant's employment, or position as Director, or Officer of the Corporation or a Subsidiary, or Consultant, the effective date of the termination as specified in the notice of termination provided to the Participant by the Corporation or the Subsidiary, as the case may be, and (iii) in the event of a Participant's death, on the date of death.

"**Termination of Service**" means that a Participant has ceased to be an Eligible Participant.

"**Trading Session**" means a trading session on a day which the applicable Exchange is open for trading.

"**US Tax Code**" means the United States Internal Revenue Code of 1986, as amended.

"**US Taxpayer**" means a Participant who (i) is a US citizen, US permanent resident or other person who is subject to taxation on their income under the US Tax Code, and (ii) is subject to income taxation solely in the United States.

"**Vested Awards**" has the meaning described thereto in Section 6.2(5) hereof.

"**VWAP**" means the volume weighted average trading price of the Shares on the Exchange calculated by dividing the total value by the total volume of such securities traded for the five trading days immediately preceding the reference date or if the Shares are not listed on any stock exchange, "VWAP" of Shares means the VWAP on the over-the-counter market determined by dividing the aggregate sale price of the Shares sold by the total number of such Shares so sold on the applicable market for the five days immediately preceding the reference date.

1.2 Interpretation

(1) Whenever
 the Board is to exercise discretion or authority in the administration of the terms and conditions
 of this Plan, the term "discretion" or "authority" means the sole
 and absolute discretion of the Board.

(2) The
 provision of a table of contents, the division of this Plan into Articles, Sections and other
 subdivisions and the insertion of headings are for convenient reference only and do not affect
 the interpretation of this Plan.

(3) In
 this Plan, words importing the singular shall include the plural, and vice versa and words
 importing any gender include any other gender.

(4) The
 words "including", "includes" and "include" and any derivatives
 of such words mean "including (or includes or include) without limitation". As
 used herein, the expressions "Article", "Section" and other subdivision
 followed by a number, mean and refer to the specified Article, Section or other subdivision
 of this Plan, respectively.

(5) Unless
 otherwise specified in the Participant's Grant Agreement, all references to money amounts
 are to Canadian currency, and where any amount is required to be converted to or from a currency
 other than Canadian currency, such conversion shall be based on the exchange rate as quoted
 by the Bank of Canada on the particular date.

(6) For
 purposes of this Plan, the legal representatives of a Participant shall only include the
 administrator, the executor or the liquidator of the Participant's estate or will.

(7) If
 any action may be taken within, or any right or obligation is to expire at the end of, a
 period of days under this Plan, then the first day of the period is not counted, but the
 day of its expiry is counted.

**Article 2**

**PURPOSE AND ADMINISTRATION OF THE PLAN; GRANTING OF AWARDS**

2.1 Purpose of the Plan

The purpose of the Plan is to permit the Corporation to grant Awards to Eligible Participants, subject to certain conditions as hereinafter set forth, for the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) to
 increase the interest in the Corporation's welfare of those Eligible Participants,
 who share responsibility for the management, growth and protection of the business of the
 Corporation or a Subsidiary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) to
 provide an incentive to such Eligible Participants to continue their services for the Corporation
 or a Subsidiary and to encourage such Eligible Participants whose skills, performance and
 loyalty to the objectives and interests of the Corporation or a Subsidiary are necessary
 or essential to its success, image, reputation or activities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) to
 reward Participants for their performance of services while working for the Corporation or
 a Subsidiary; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) to
 provide a means through which the Corporation or a Subsidiary may attract and retain able
 Persons to enter its employment or service.

2.2 Implementation and Administration of the Plan

(1) The
 Plan shall be administered and interpreted by the board of directors of the Corporation (the
 "**Board**") or, if the Board by resolution so decides, by a committee or
 plan administrator appointed by the Board. If such committee or plan administrator is appointed
 for this purpose, all references to the "Board" herein will be deemed references
 to such committee or plan administrator. Nothing contained herein shall prevent the Board
 from adopting other or additional Share Compensation Arrangements or other compensation arrangements,
 subject to any required approval.

(2) Subject
 to Article 7 and any applicable rules of an Exchange, the Board may, from time to time, as
 it may deem expedient, adopt, amend and rescind rules and regulations or vary the terms of
 this Plan and/or any Award hereunder for carrying out the provisions and purposes of the
 Plan and/or to address tax or other requirements of any applicable jurisdiction.

(3) Subject
 to the provisions of this Plan, the Board is authorized, in its sole discretion, to make
 such determinations under, and such interpretations of, and take such steps and actions in
 connection with, the proper administration and operations of the Plan as it may deem necessary
 or advisable. The Board may delegate to officers or managers of the Corporation, or committees
 thereof, the authority, subject to such terms as the Board shall determine, to perform such
 functions, in whole or in part. Any such delegation by the Board may be revoked at any time
 at the Board's sole discretion. The interpretation, administration, construction and
 application of the Plan and any provisions hereof made by the Board, or by any officer, manager,
 committee or any other Person to which the Board delegated authority to perform such functions,
 shall be final and binding on the Corporation, its Subsidiaries and all Eligible Participants.

(4) No
 member of the Board or any Person acting pursuant to authority delegated by the Board hereunder
 shall be liable for any action or determination taken or made in good faith in the administration,
 interpretation, construction or application of the Plan or any Award granted hereunder. Members
 of the Board or and any person acting at the direction or on behalf of the Board, shall,
 to the extent permitted by law, be fully indemnified and protected by the Corporation with
 respect to any such action or determination.

(5) The
 Plan shall not in any way fetter, limit, obligate, restrict or constrain the Board with regard
 to the allotment or issuance of any Shares or any other securities in the capital of the
 Corporation. For greater clarity, the Corporation shall not by virtue of this Plan be in
 any way restricted from declaring and paying stock dividends, repurchasing Shares or varying
 or amending its share capital or corporate structure.

2.3 Participation in this Plan

(1) The
 Corporation makes no representation or warranty as to the future market value of the Shares
 or with respect to any income tax matters affecting any Participant resulting from the grant
 of an Award, the exercise or cancellation of an Option, the redemption of a Share Unit or
 transactions in the Shares or otherwise in respect of participation under the Plan. Neither
 the Corporation, nor any of its directors, officers, employees, shareholders or agents shall
 be liable for anything done or omitted to be done by such Person or any other Person with
 respect to the price, time, quantity or other conditions and circumstances of the issuance
 of Shares hereunder, or in any other manner related to the Plan. For greater certainty, no
 amount will be paid to, or in respect of, a Participant (or a Person with whom the Participant
 does not deal at arm's length) under the Plan or pursuant to any other arrangement,
 and no additional Awards will be granted to such Participant (or Person with whom the Participant
 does not deal at arm's length) to compensate for a downward fluctuation in the price
 of the Shares, nor will any other form of benefit be conferred upon, or in respect of, a
 Participant (or a Person with whom the Participant does not deal at arm's length) for
 such purpose. The Corporation and its Subsidiaries do not assume and shall not have responsibility
 for the income or other tax consequences resulting to any Participant and each Participant
 is advised to consult with his or her own tax advisors.

(2) Participants
 (and their legal representatives) shall have no legal or equitable right, claim, or interest
 in any specific property or asset of the Corporation or any of its Subsidiaries. No asset
 of the Corporation or any of its Subsidiaries shall be held in any way as collateral security
 for the fulfillment of the obligations of the Corporation or any of its Subsidiaries under
 this Plan. Unless otherwise determined by the Board, this Plan shall be unfunded. To the
 extent any Participant or his or her estate holds any rights by virtue of a grant of Awards
 under this Plan, such rights (unless otherwise determined by the Board) shall be no greater
 than the rights of an unsecured creditor of the Corporation.

(3) Unless
 otherwise determined by the Board and subject to the rules of the Exchange, the Corporation
 shall not offer financial assistance to any Participant in regards to the exercise of any
 Award granted under this Plan.

2.4 Shares Subject to the Plan

(1) Subject
 to adjustment pursuant to Article 7 hereof, the securities that may be acquired by Participants
 pursuant to Awards under this Plan shall consist of authorized but unissued Shares.

(2) The
 maximum number of Shares reserved for issuance, in the aggregate, under this Plan shall be
 16,696,252 Shares and, for greater certainty, shall not exceed 20% of the Outstanding Issue
 as at the date of implementation of the Plan by the Corporation, less any Shares underlying
 Options granted under the Existing Option Plan or other Share Compensation Arrangement of
 the Corporation, if any. For the purposes of calculating the number of Shares reserved for
 issuance under this Plan, each Share subject to a Share Unit shall be counted as reserving
 one Share under the Plan, each Share subject to a DSU shall be counted as reserving one Share
 under the Plan and each Share subject to an Option shall be counted as reserving one Share
 under the Plan.

(3) No
 Award that can be settled in Shares issued from treasury may be granted if such grant would
 have the effect of causing the total number of Shares available for issuance under this Plan
 to exceed the above noted total numbers of Shares reserved for issuance pursuant to the settlement
 of Awards.

(4) No
 new grants of Options will be made under the Existing Option Plan.

(5) If
 an outstanding Award or Existing Option (or portion thereof) expires or is forfeited, surrendered,
 cancelled or otherwise terminated for any reason without having been exercised or settled
 in full, or if Shares acquired pursuant to an Award or Existing Option, as applicable, subject
 to forfeiture are forfeited, the Shares covered by such Award or Existing Option, if any,
 will again be available for issuance under the Plan. Shares will not be deemed to have been
 issued pursuant to the Plan with respect to any portion of an Award that is settled in cash.
 For greater certainty, any Shares acquired by a Participant under an Award or an Existing
 Option shall not continue to be issuable under the Plan.

(6) All
 Awards are subject to applicable limitations on sale or resale under Securities Laws and
 the policies of the Exchange.

2.5 Intentionally Omitted

2.6 Granting of Awards

Any Award granted under the Plan shall be subject to the requirement that, if at any time counsel to the Corporation shall determine that the listing, registration or qualification of the Shares subject to such Award, if applicable, upon any stock exchange or under any law or regulation of any jurisdiction, or the consent or approval of any stock exchange or any governmental or regulatory body, is necessary as a condition of, or in connection with, the grant of such Awards or exercise of any Option or the issuance or purchase of Shares thereunder, if applicable, such Award may not be accepted or exercised in whole or in part unless such listing, registration, qualification, consent or approval shall have been effected or obtained on conditions acceptable to the Board. Nothing herein shall be deemed to require the Corporation to apply for or to obtain such listing, registration, qualification, consent or approval. For the avoidance of doubt, if the Board determines in its sole discretion that an Eligible Participant or a Participant would be subject to the laws and regulations of both Canada and the United States with respect to an Award, and that compliance with the laws and regulations of one country would, absent action by the Board, cause noncompliance with the laws and regulations of the other country, the Board shall use commercially reasonable efforts to modify the terms of the Award so that the Award complies with the laws and regulations of both Canada and the United States and is consistent from an economic perspective of the originally contemplated Award. If, however, the Board determines in its sole discretion that compliance with the laws and regulations of both Canada and the United States with respect to such an Award is not possible, or is not possible without modification of the material terms or economic terms of the Award, the Board shall have complete authority in its sole discretion to withdraw the Award or cause the Award not to be granted, or to cause the Award to be forfeited or cancelled, immediately on such terms as the Board in its sole discretion shall determine.

**Article 3**

**OPTIONS**

3.1 Nature of Options

An Option is an option granted by the Corporation to a Participant entitling such Participant to acquire a designated number of Shares from treasury at the Option Price, but subject to the provisions hereof. For the avoidance of doubt, no Dividend Equivalents shall be granted in connection with an Option.

3.2 Option Awards

Subject to the provisions set forth in this Plan and any shareholder or regulatory approval which may be required, the Board shall, from time to time by resolution, in its sole discretion, (i) designate the Eligible Participants who may receive Options under the Plan, (ii) fix the number of Options, if any, to be granted to each Eligible Participant and the date or dates on which such Options shall be granted, (iii) determine the price per Share to be payable upon the exercise of each such Option (the "**Option Price**") and the relevant vesting provisions (including Performance Criteria, if applicable) and the Option Term, the whole subject to the terms and conditions prescribed in this Plan or in any Option Agreement, and any applicable rules of an Exchange.

3.3 Option Price

The Option Price for Shares that are the subject of any Option shall be determined and approved by the Board when such Option is granted, but shall not be less than the Market Value of such Shares at the time of the grant, less any discount permitted by the Exchange.

3.4 Option Term

The Board shall determine, at the time of granting the particular Option, the period during which the Option is exercisable, which shall not be more than ten (10) years from the date the Option is granted ("**Option Term**"). Unless otherwise determined by the Board, all unexercised Options shall be cancelled at the expiry of such Options. Notwithstanding the expiration provisions hereof, if the date on which an Option Term expires falls within a Blackout Period, the expiration date of the Option will be the date that is ten Business Days after the Blackout Period Expiry Date. The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Corporation during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period.

3.5 Exercise of Options

Prior to its expiration or earlier termination in accordance with the Plan, each Option shall be exercisable at such time or times and/or pursuant to the achievement of such Performance Criteria and/or other vesting conditions as the Board at the time of granting the particular Option, may determine in its sole discretion. For greater certainty, any exercise of Options by a Participant shall be made in accordance with the Corporation's insider trading policy. The Corporation shall not issue any Shares to a Participant prior to the Corporation being satisfied in its sole discretion that all applicable taxes under Section 8.2 will be timely withheld or received and remitted to the appropriate taxation authorities in respect of any particular Participant and any particular Option.

3.6 Method of Exercise and Payment of Purchase Price

(1) Subject
 to the provisions of the Plan, an Option granted under the Plan shall be exercisable (from
 time to time as provided in Section 3.5 hereof) by the Participant (or by the liquidator,
 executor or administrator, as the case may be, of the estate of the Participant) by delivering
 a fully completed Exercise Notice, a form of which is attached hereto as Exhibit "B",
 to the Corporation at its registered office to the attention of the Chief Financial Officer
 of the Corporation (or the individual that the Chief Financial Officer of the Corporation
 may from time to time designate) or give notice in such other manner as the Corporation may
 from time to time designate, which notice shall specify the number of Shares in respect of
 which the Option is being exercised and shall be accompanied by full payment, by cash, certified
 cheque, bank draft or any other form of payment deemed acceptable by the Board of the purchase
 price for the number of Shares specified therein and, if required by Section 8.2, the amount
 necessary to satisfy any taxes.

(2) Upon
 the exercise, the Corporation shall, as soon as practicable after such exercise but no later
 than ten (10) Business Days following such exercise, forthwith cause the transfer agent and
 registrar of the Shares either to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) deliver
 to the Participant (or to the liquidator, executor or administrator, as the case may be,
 of the estate of the Participant) a certificate in the name of the Participant representing
 in the aggregate such number of Shares as the Participant (or to the liquidator, executor
 or administrator, as the case may be, of the estate of the Participant) shall have then paid
 for and as are specified in such Exercise Notice; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) in
 the case of Shares issued in uncertificated form, cause the issuance of the aggregate number
 of Shares as the Participant (or the liquidator, executor or administrator, as the case may
 be, of the estate of the Participant) shall have then paid for and as are specified in such
 Exercise Notice to be evidenced by a book position on the register of the shareholders of
 the Corporation to be maintained by the transfer agent and registrar of the Shares.

(3) Subject
 to the provisions of this Plan, the Board may, in its discretion and at any time, determine
 to grant a Participant the alternative right (the "**Cashless Exercise Right** "),
 when entitled to exercise an Option, to elect to deal with such Option on a "cashless
 exercise" basis, in whole or in part by notice in writing to the Corporation, where
 the Corporation has an arrangement with a brokerage firm pursuant to which the following
 events shall occur in the order specified below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 brokerage firm agrees to loan money to the Participant equal to the amount of the Option
 Price of the Options to be exercised;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the
 Participant exercises the Option using the proceeds of the loan referred to in (a) above;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the
 brokerage firm receives such number of Shares underlying the Options to sell, at the direction
 of and on behalf of the Participant, the aggregate proceeds of which are sufficient to cover
 the Option Price in order to permit the Participant to repay the loan made to the Participant;
 and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the
 Participant receives the balance of the Shares underlying the Options pursuant to such exercise,
 or cash proceeds from the sale of the balance of the Shares underlying the Options.

(4) Subject
 to the provisions of this Plan, the Board may, in its discretion and at any time, determine
 to permit a Participant to, when entitled to exercise an Option, elect to exercise such Option
 through a net exercise mechanism (the "**Net Exercise Right** "), in whole
 or in part by notice in writing to the Corporation, such that the Corporation does not receive
 any cash from the exercise of such Option and the Participant receives, disregarding fractions,
 only the number of Shares from the exercise of the Option that is equal to the quotient obtained
 by dividing: (A) the product of the number of Options being exercised and the difference
 between the VWAP of the underlying Shares and the Option Price of the subject Options; by
 (B) the VWAP of the underlying Shares.

3.7 Option Agreements

Options shall be evidenced by an Option Agreement, in such form not inconsistent with the Plan as the Board may from time to time determine with reference to the form attached as Exhibit "A". The Option Agreement shall contain such terms that may be considered necessary in order that the Option will comply with any provisions respecting options in the income tax or other laws in force in any country or jurisdiction of which the Participant may from time to time be a resident or citizen or the rules of any regulatory body having jurisdiction over the Corporation.

**Article 4**

**RESTRICTED AND PERFORMANCE SHARE UNITS**

4.1 Nature of Share Units

A Share Unit is an Award in the nature of a bonus for services rendered, or for future services to be rendered, and that, upon settlement, entitles the recipient Participant to receive a cash payment equal to the Market Value of a Share or at the discretion of the Corporation (or applicable Subsidiary) one Share or any combination of cash and Shares as the Corporation (or applicable Subsidiary) in its sole discretion may determine, pursuant and subject to such restrictions and conditions on vesting as the Board may determine at the time of grant, unless such Share Unit expires prior to being settled. Restrictions and conditions on vesting conditions may, without limitation, be based on the passage of time during continued employment (or other service relationship), in which case the Award is what is commonly referred to as a "<u>Restricted Share Unit</u>" or "RSU", or the achievement of specified Performance Criteria, in which case the Award is what is commonly referred to as a "<u>Performance Share Unit</u>" or "PSU", or both.

4.2 Share Unit Awards

(1) The
 Board shall, from time to time by resolution, in its sole discretion, (i) designate the Eligible
 Participants who may receive Share Units under the Plan, (ii) fix the number of Share Units,
 if any, to be granted to each Eligible Participant and the date or dates on which such Share
 Units shall be granted, (iii) determine the relevant conditions, vesting provisions (including
 the applicable Performance Period and Performance Criteria, if any) and Restriction Period
 of such Share Units, and (iv) any other terms and conditions applicable to the granted Share
 Units, which need not be identical and which, without limitation, may include non-competition
 provisions, subject to the terms and conditions prescribed in this Plan and in any Share
 Unit Agreement.

(2) Subject
 to the vesting and other conditions and provisions in this Plan and in the Share Unit Agreement,
 each Share Unit awarded to a Participant shall entitle the Participant to receive on settlement,
 a cash payment equal to the Market Value of a Share or at the discretion of the Corporation
 (or applicable Subsidiary) one Share or any combination of cash and Shares as the Corporation
 (or applicable Subsidiary) in its sole discretion may determine, in each case less any applicable
 withholding taxes. For greater certainty, no Participant shall have the right to demand to
 be paid in, or receive, Shares in respect of any Share Unit, and, notwithstanding any discretion
 exercised by the Corporation (or applicable Subsidiary) to settle any Share Unit, or portion
 thereof, in the form of Shares, the Corporation (and each Subsidiary) reserves the right
 to change such form of payment at any time until the payment is actually made.

4.3 Share Unit Agreements

(1) The
 grant of a Share Unit by the Board shall be evidenced by a Share Unit Agreement in such form
 not inconsistent with the Plan as the Board may from time to time determine with reference
 to the form attached as Exhibit "C". Such Share Unit Agreement shall be subject
 to all applicable terms and conditions of this Plan and may be subject to any other terms
 and conditions (including without limitation any recoupment, reimbursement or claw-back compensation
 policy as may be adopted by the Board from time to time) which are not inconsistent with
 this Plan and which the Board deems appropriate for inclusion in a Share Unit Agreement.
 The provisions of the various Share Unit Agreements issued under this Plan need not be identical.

(2) The
 Share Unit Agreement shall contain such terms that the Corporation considers necessary in
 order that the Share Unit will comply with any provisions respecting restricted share units
 in the income tax or other laws in force in any country or jurisdiction of which the Participant
 may from time to time be a resident or citizen or the rules of any regulatory body having
 jurisdiction over the Corporation.

4.4 Vesting of Share Units

The Board shall have sole discretion to determine if any Performance Criteria and/or other vesting conditions with respect to a Share Unit, and as contained in the Share Unit Agreement governing such Share Unit, have been met and shall communicate to a Participant as soon as reasonably practicable when any such applicable vesting conditions or Performance Criteria have been satisfied and the Share Units have vested (the "**Vesting Date**"), provided that, unless permitted under the rules of the Exchange, no Share Unit shall vest before the one-year anniversary from the date of grant. Notwithstanding the foregoing, if the date on which any Share Units have vested falls within a Blackout Period, the vesting of such Share Units will be deemed to occur on the date that is ten Business Days after the Blackout Period Expiry Date. The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Corporation during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period. The period between the date of the grant of Share Units and the last Vesting Date in respect of the last portion of such Share Units is referred to as the "**Restriction Period**."

4.5 Redemption / Settlement of Share Units

(1) Subject
 to the terms of the applicable Share Unit Agreement (including confirmation of satisfaction
 of any vesting conditions or Performance Criteria, which shall be at the sole discretion
 of the Corporation), vested Share Units shall be redeemed by the Corporation on the 15<sup>th</sup>
 day following the Vesting Date (the "**Redemption Date** ").

(2) Subject
 to the provisions of this Section 4.5 and Section 4.6, during the period between the Vesting
 Date and the Redemption Date in respect of a Participant's vested Share Units, the
 Corporation (or any Subsidiary that is a party to an Employment Agreement or Consulting Agreement
 with the Participant whose vested Share Units are to be redeemed) shall, at its sole discretion,
 be entitled to elect to settle all or any portion of the cash payment obligation otherwise
 arising in respect of the Participant's vested Share Units either (i) by the issuance
 of Shares to the Participant (or the legal representative of the Participant, if applicable)
 on the Redemption Date, or (ii) by paying all or a portion of such cash payment obligation
 to the Designated Broker, who shall use the funds received to purchase Shares in the open
 market, which Shares shall be registered in the name of the Designated Broker in a separate
 account for the Participant's benefit.

(3) Settlement
 of a Participant's vested Share Units shall take place on the Redemption Date as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) where
 the Corporation (or applicable Subsidiary) has elected to settle all or a portion of the
 Participant's vested Share Units in Shares issued from treasury:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in
 the case of Shares issued in certificated form, by delivery to the Participant (or to the
 legal representative of the Participant, if applicable) of a certificate in the name of the
 Participant (or the legal representative of the Participant, if applicable) representing
 the aggregate number of Shares that the Participant is entitled to receive, subject to satisfaction
 of any applicable withholding in accordance with Section 8.2; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) in
 the case of Shares issued in uncertificated form, by the issuance to the Participant (or
 to the legal representative of the Participant, if applicable) of the aggregate number of
 Shares that the Participant is entitled to receive, subject to satisfaction of any applicable
 withholding tax under Section 8.2, which Shares shall be evidenced by a book position on
 the register of the shareholders of the Corporation to be maintained by the transfer agent
 and registrar of the Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) where
 the Corporation or a Subsidiary has elected to settle all or a portion of the Participant's
 vested Share Units in Shares purchased in the open market, by delivery to the Designated
 Broker of readily available funds in an amount equal to the Market Value of a Share as of
 the Redemption Date multiplied by the number of vested Share Units to be settled in Shares
 purchased in the open market, less the amount of any applicable withholding tax under Section
 8.2, along with directions instructing the Designated Broker to use such funds to purchase
 Shares in the open market for the benefit of the Participant and to be evidenced by a confirmation
 from the Designated Broker of such purchase;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any
 cash payment to which the Participant is entitled (excluding, for the avoidance of doubt,
 any amount payable in respect of the Participant's Share Units that the Corporation
 or a Subsidiary has elected to settle in Shares) shall, subject to satisfaction of any applicable
 withholding tax under Section 8.2, be paid to the Participant (or to the legal representative
 of the Participant, if applicable) by the Corporation or Subsidiary of which the Participant
 is a Director, Employee, Officer, or Consultant, in cash, by cheque or by such other payment
 method as the Corporation and Participant may agree; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) where
 the Corporation or a Subsidiary has elected to settle a portion, but not all, of the Participant's
 vested Share Units in Shares, the Participant shall be deemed to have instructed the Corporation
 or Subsidiary, as applicable, to withhold from the cash portion of the payment to which the
 Participant is otherwise entitled such amount as may be required in accordance with Section
 8.2 and to remit such withheld amount to the applicable taxation authorities on account of
 any withholding tax obligations, and the Corporation or Subsidiary, as applicable, shall
 deliver any remaining cash payable, after making any such remittance, to the Participant
 (or to the legal representative of the Participant, if applicable) as soon as reasonable
 practicable. In the event that the cash portion payable to settle a Participant's Share
 Units in the foregoing circumstances is not sufficient to satisfy the withholding obligations
 of the Corporation or a Subsidiary pursuant to Section 8.2, the Corporation or Subsidiary,
 as applicable, shall be entitled to satisfy any remaining withholding obligation by any other
 mechanism as may be required or determined by the Corporation or Subsidiary as appropriate.

(4) Notwithstanding
 any other provision in this Article 4, no payment, whether in cash or in Shares, shall be
 made in respect of the settlement of any Share Units later than December 15 of the third
 (3<sup>rd</sup>) calendar year following the end of the calendar year in respect of which
 such Share Unit is granted.

4.6 Determination of Amounts

(1) If
 the Corporation (or applicable Subsidiary), in its sole discretion, elects to settle all
 or a portion of the Participant's vested Share Units in cash, the cash payment obligation
 arising in respect of the redemption and settlement of a vested Share Unit pursuant to Section
 4.5 shall be equal to the Market Value of a Share as of the applicable Redemption Date. For
 the avoidance of doubt, the aggregate cash amount to be paid to a Participant (or the legal
 representative of the Participant, if applicable) in respect of a particular redemption of
 the Participant's vested Share Units shall, subject to any adjustments in accordance
 with Section 7.1 and any withholding required pursuant to Section 8.2, be equal to the Market
 Value of a Share as of the Redemption Date for such vested Share Units multiplied by the
 number of vested Share Units in the Participant's Account at the commencement of the
 Redemption Date.

(2) If
 the Corporation (or applicable Subsidiary), in its sole discretion, elects to settle all
 or a portion of the Participant's vested Share Units by the issuance of Shares, the
 Corporation shall, subject to any adjustments in accordance with Section 7.1 and any withholding
 required pursuant to Section 8.2, issue to the Participant (or the legal representative of
 the Participant, if applicable), for each vested Share Unit which the Corporation (or applicable
 Subsidiary) elects to settle in Shares, one Share. Where, as a result of any adjustment in
 accordance with Section 7.1 and/or any withholding required pursuant to Section 8.2, the
 aggregate number of Shares to be received by a Participant upon an election by the Corporation
 (or applicable Subsidiary) to settle all or a portion of the Participant's vested Share
 Units in Shares includes a fractional Share, the aggregate number of Shares to be received
 by the Participant shall be rounded down to the nearest whole number of Shares.

4.7 Award of Dividend Equivalents

Dividend Equivalents may, as determined by the Board in its sole discretion, be awarded in respect of unvested Share Units in a Participant's Account on the same basis as cash dividends declared and paid on Shares as if the Participant was a shareholder of record of Shares on the relevant record date, subject to the permitted limits on participation as outlined in Section 2.4. Dividend Equivalents, if any, will be credited to the Participant's Account in additional Share Units, the number of which shall be equal to a fraction where the numerator is the product of (i) the number of Share Units in such Participant's Account on the date that dividends are paid multiplied by (ii) the dividend paid per Share and the denominator of which is the Market Value of one Share calculated as of the date that dividends are paid. Any additional Share Units credited to a Participant's Account as a Dividend Equivalent shall be subject to the same terms and conditions (including vesting and Restriction Periods) as the Share Units in respect of which such additional Share Units are credited and shall be deemed to have been awarded on the same date and subject to the same expiry date as the Share Units of which such additional Share Units are credited.

In the event that the Participant's applicable Share Units do not vest, all Dividend Equivalents, if any, associated with such Share Units will be forfeited by the Participant and returned to the Corporation's account.

**Article 5**

**DEFERRED SHARE UNITS**

5.1 Nature of Deferred Share Units

A deferred share unit ("**DSU**") is an Award in the nature of a deferral of payment for services rendered, or for future services to be rendered, and that, upon settlement, entitles the recipient Participant to receive cash or acquire Shares, as determined by the Corporation in its sole discretion, unless such DSU expires prior to being settled. Subject to Article 7, DSUs shall only vest, and a Participant is only entitled to redemption of a DSU, when the Participant ceases to be any of a Director, Officer or Employee of the Corporation for any reason, including termination, retirement or death.

5.2 Market Fluctuation

For greater certainty, no amount will be paid or benefit provided to, or in respect of, a Participant, or to any person who does not deal at arm's length with a Participant for the purposes of the Tax Act, under the Plan or pursuant to any other arrangement, and no additional Awards will be granted to such Participant for the purpose of reducing the impact, in whole or in part, of any reduction in the fair market value of the shares of the Corporation or any corporation related thereto.

5.3 DSU Awards

(1) The
 Board shall, from time to time by resolution, in its sole discretion, (i) designate the Eligible
 Participants who may receive DSUs under the Plan, (ii) fix the number of DSUs, if any, to
 be granted to each Eligible Participant and the date or dates on which such DSUs shall be
 granted, and (iii) any other terms and conditions applicable to the granted DSUs.

(2) Subject
 to the vesting and other conditions and provisions in this Plan and in any DSU Agreement,
 each DSU awarded to a Participant shall entitle the Participant to receive on settlement
 a cash payment equal to the Market Value of a Share, or at the discretion of the Corporation,
 one Share or any combination of cash and Shares as the Corporation in its sole discretion
 may determine. For greater certainty, no Participant shall have any right to demand to be
 paid in, or receive, Shares in respect of any DSU, and, notwithstanding any discretion exercised
 by the Corporation to settle any DSU, or portion thereof, in the form of Shares, the Corporation
 reserves the right to change such form of payment at any time until payment is actually made.

5.4 DSU Agreements

(1) The
 grant of a DSU by the Board shall be evidenced by a DSU Agreement in such form not inconsistent
 with the Plan as the Board may from time to time determine with reference to the form attached
 as Exhibit "D". Such DSU Agreement shall be subject to all applicable terms and
 conditions of this Plan and may be subject to any other terms and conditions (including without
 limitation any recoupment, reimbursement or claw-back compensation policy as may be adopted
 by the Board from time to time) which are not inconsistent with this Plan and which the Board
 deems appropriate for inclusion in a DSU Agreement. The provisions of the various DSU Agreements
 issued under this Plan need not be identical.

(2) The
 DSU Agreement shall contain such terms that the Corporation considers necessary in order
 that the DSU will comply with any provisions respecting restricted share units in the income
 tax or other laws in force in any country or jurisdiction of which the Participant may from
 time to time be a resident or citizen or the rules of any regulatory body having jurisdiction
 over the Corporation.

5.5 Vesting of DSUs

DSUs will be fully vested on the Termination Date of the applicable Participant, provided that, unless permitted under the Exchange rules, no DSU shall vest before the one-year anniversary from the date of grant. Notwithstanding the foregoing, if the date on which any DSUs have vested falls within a Blackout Period, the vesting of such DSUs will be deemed to occur on the date that is ten Business Days after the Blackout Period Expiry Date. The Blackout Period must expire following the general disclosure of the undisclosed material information; provided that if an additional Blackout Period is subsequently imposed by the Corporation during the ten Business Days after the initial Blackout Period, then Blackout Period Expiry Date shall be such the tenth trading day following the end of the last imposed Blackout Period.

5.6 Redemption / Settlement of DSUs

(1) DSUs
 shall be redeemed and settled by the Corporation as soon as reasonably practicable following
 the Participant ceasing to be any of a Director, Officer or Employee of the Corporation but
 in any event not later than December 15 of the year following the calendar year in which
 the Participant ceases to be any of a Director, Officer or Employee. On redemption and settlement,
 the Corporation shall deliver the applicable number of Shares, or, in the sole discretion
 of the Corporation, cash equal to the redemption amount of such DSU specified in the applicable
 DSU Agreement, subject to the satisfaction of any applicable withholding tax under Section
 8.2.

(2) The
 Corporation, will have, at its sole discretion, the ability to elect to settle all or any
 portion of the cash payment obligation arising in respect of the redemption and settlement
 of the Participant's DSUs by issuance of Shares.

(3) The
 redemption and settlement of a Participant's DSUs shall occur on the applicable DSU
 Redemption Date as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) where
 the Corporation has elected to settle all or a portion of the Participant's DSUs in
 Shares,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) in
 the case of Shares issued in certificated form, delivery to the Participant (or to the liquidator,
 executor or administrator, as the case may be, of the estate of the Participant) of a certificate
 in the name of the Participant representing in the aggregate such number of Shares as the
 Participant (or to the liquidator, executor or administrator, as the case may be, of the
 estate of the Participant) shall be entitled to receive, subject to satisfaction of any applicable
 withholding tax under Section 8.2; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) in
 the case of Shares issued in uncertificated form, issuance of the aggregate number of Shares
 as the Participant (or the liquidator, executor or administrator, as the case may be, of
 the estate of the Participant) shall be entitled to receive, subject to satisfaction of any
 applicable withholding tax under Section 8.2, to be evidenced by a book position on the register
 of the shareholders of the Corporation to be maintained by the transfer agent and registrar
 of the Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any
 cash payment to which the Participant is entitled (excluding, for the avoidance of doubt,
 any amount payable in respect of the Participant's DSUs that the Corporation has elected
 to pay in Shares) shall, subject to satisfaction of any applicable withholding tax under
 Section 8.2, be paid to the Participant (or to the legal representative of the Participant,
 if applicable) by the Corporation in cash, by cheque or by such other payment method as the
 Corporation and Participant may agree; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) where
 the Corporation has elected to settle a portion, but not all, of the Participant's
 DSUs in Shares, the Participant shall be deemed to have instructed the Corporation to withhold
 from the cash portion of the payment to which the Participant is otherwise entitled such
 amount as may be required in accordance with Section 8.2 and to remit such withheld amount
 to the applicable taxation authorities on account of any withholding obligations of the Corporation,
 and the Corporation shall deliver any remaining cash payable, after making any such remittance,
 to the Participant (or to the legal representative of the Participant, if applicable) as
 soon as reasonable practicable. In the event that the cash portion elected by the Corporation
 to settle the Participant's Share Units is not sufficient to satisfy the withholding
 obligations of the Corporation pursuant to Section 8.2, any remaining amounts shall be satisfied
 by the Corporation by any other mechanism as may be required or determined by the Corporation
 as appropriate.

**Article 6**

**GENERAL CONDITIONS**

6.1 General Conditions Applicable to Awards

Each Award, as applicable, shall be subject to the following conditions:

(1) **Vesting Period**. Each Award granted hereunder shall vest in accordance with the terms of this
 Plan and the Grant Agreement entered into in respect of such Award. Subject to policies and
 vesting limits of the Exchange, the Board has the right, in its sole discretion, to waive
 any vesting conditions or accelerate the vesting of any Award (other than the date upon which
 DSUs become exercisable), or to deem any Performance Criteria or other vesting conditions
 to be satisfied, notwithstanding the vesting schedule set forth for such Award.

(2) **Employment**.
 Notwithstanding any express or implied term of this Plan to the contrary, the granting of
 an Award pursuant to the Plan shall in no way be construed as a guarantee by the Corporation
 or a Subsidiary to the Participant of employment or another service relationship with the
 Corporation or a Subsidiary. The granting of an Award to a Participant shall not impose upon
 the Corporation or a Subsidiary any obligation to retain the Participant in its employ or
 service in any capacity. Nothing contained in this Plan or in any Award granted under this
 Plan shall interfere in any way with the rights of the Corporation or any of its Subsidiaries
 in connection with the employment, retention or termination of any such Participant. The
 loss of existing or potential profit in Shares underlying Awards granted under this Plan
 shall not constitute an element of damages in the event of termination of a Participant's
 employment or service in any office or otherwise.

(3) **Grant of Awards**. Eligibility to participate in this Plan does not confer upon any Eligible
 Participant any right to be granted Awards pursuant to this Plan. Granting Awards to any
 Eligible Participant does not confer upon any Eligible Participant the right to receive nor
 preclude such Eligible Participant from receiving any additional Awards at any time. The
 extent to which any Eligible Participant is entitled to be granted Awards pursuant to this
 Plan will be determined in the sole discretion of the Board. Participation in the Plan shall
 be entirely voluntary and any decision not to participate shall not affect an Eligible Participant's
 relationship or employment with the Corporation or any Subsidiary.

(4) **Rights as a Shareholder**. Neither the Participant nor such Participant's personal representatives
 or legatees shall have any rights whatsoever as shareholder in respect of any Shares covered
 by such Participant's Awards by reason of the grant of such Award until such Award
 has been duly exercised, as applicable, and settled and Shares have been issued in respect
 thereof. Without in any way limiting the generality of the foregoing, no adjustment shall
 be made for dividends or other rights for which the record date is prior to the date such
 Shares have been issued.

(5) **Conformity to Plan**. In the event that an Award is granted or a Grant Agreement is executed which
 does not conform in all particulars with the provisions of the Plan, or purports to grant
 Awards on terms different from those set out in the Plan, the Award or the grant of such
 Award shall not be in any way void or invalidated, but the Award so granted will be adjusted
 to become, in all respects, in conformity with the Plan.

(6) **Non-Transferrable Awards**. Except as specifically provided in a Grant Agreement approved by the Board, each
 Award granted under the Plan is personal to the Participant and shall not be assignable or
 transferable by the Participant, whether voluntarily or by operation of law, except by will
 or by the laws of succession of the domicile of the deceased Participant. No Award granted
 hereunder shall be pledged, hypothecated, charged, transferred, assigned or otherwise encumbered
 or disposed of on pain of nullity.

(7) **Participant's Entitlement**. Except as otherwise provided in this Plan or unless the Board permits otherwise,
 upon any Subsidiary of the Corporation ceasing to be a Subsidiary of the Corporation, Awards
 previously granted under this Plan that, at the time of such change, are held by a Person
 who is a Director, Officer, Employee, or Consultant of such Subsidiary of the Corporation
 and not of the Corporation itself, whether or not then exercisable, shall automatically terminate
 on the date of such change.

6.2 General Conditions Applicable to Options

Each Option shall be subject to the following conditions:

(1) **Termination for Cause**. Upon a Participant ceasing to be an Eligible Participant for Cause, any vested
 or unvested Option granted to such Participant shall terminate automatically and become void
 immediately. For the purposes of the Plan, the determination by the Corporation that the
 Participant was discharged for Cause shall be binding on the Participant. "Cause"
 shall include, among other things, gross misconduct, theft, fraud, breach of confidentiality
 or breach of the Corporation's codes of conduct and any other reason determined by
 the Corporation to be cause for termination.

(2) **Termination not for Cause**. Upon a Participant ceasing to be an Eligible Participant as a result of
 his or her employment or service relationship with the Corporation or a Subsidiary being
 terminated without Cause, (i) any unvested Option granted to such Participant shall terminate
 and become void immediately and (ii) any vested Option granted to such Participant may be
 exercised by such Participant. Unless otherwise determined by the Board, in its sole discretion,
 such Option shall only be exercisable within the earlier of a date set forth in the Grant
 Agreement which shall be no longer than twelve (12) months from the Termination Date, or
 the expiry date of the Award set forth in the Grant Agreement, after which the Option will
 expire.

(3) **Resignation**.
 Upon a Participant ceasing to be an Eligible Participant as a result of his or her resignation
 from the Corporation or a Subsidiary, (i) each unvested Option granted to such Participant
 shall terminate and become void immediately upon resignation and (ii) each vested Option
 granted to such Participant will cease to be exercisable on the earlier of ninety (90) days
 following the Termination Date and the expiry date of the Option set forth in the Grant Agreement,
 after which the Option will expire.

(4) **Permanent Disability/Retirement**. Upon a Participant ceasing to be an Eligible Participant by reason
 of retirement or permanent disability, (i) any unvested Option shall terminate and become
 void immediately, and (ii) any vested Option will cease to be exercisable on the earlier
 of the ninety (90) days from the date of retirement or the date on which the Participant
 ceases his or her employment or service relationship with the Corporation or any Subsidiary
 by reason of permanent disability, and the expiry date of the Award set forth in the Grant
 Agreement, after which the Option will expire.

(5) **Death**.
 Upon a Participant ceasing to be an Eligible Participant by reason of death, any vested Option
 granted to such Participant may be exercised by the liquidator, executor or administrator,
 as the case may be, of the estate of the Participant for that number of Shares only which
 such Participant was entitled to acquire under the respective Options (the "**Vested Awards**") on the date of such Participant's death. Such Vested Awards shall
 only be exercisable within twelve (12) months after the Participant's death or prior
 to the expiration of the original term of the Options whichever occurs earlier.

(6) **Leave of Absence**. Upon a Participant electing a voluntary leave of absence of more than twelve
 (12) months, including maternity and paternity leaves, the Board may determine, at its sole
 discretion but subject to applicable laws, that such Participant's participation in
 the Plan shall be terminated, provided that all vested Options in the Participant's
 Account shall remain outstanding and in effect until the applicable exercise date, or an
 earlier date determined by the Board at its sole discretion.

6.3 General Conditions Applicable to Share Units

Each Share Unit shall be subject to the following conditions:

(1) **Termination for Cause and Resignation**. Upon a Participant ceasing to be an Eligible Participant for
 Cause or as a result of his or her resignation from the Corporation or a Subsidiary, the
 Participant's participation in the Plan shall be terminated immediately, all Share
 Units credited to such Participant's Account that have not vested shall be forfeited
 and cancelled, and the Participant's rights that relate to such Participant's
 unvested Share Units shall be forfeited and cancelled on the Termination Date.

(2) **Death, Leave of Absence or Termination of Service**. Except as otherwise determined by the Board
 from time to time, at its sole discretion, upon a Participant electing a voluntary leave
 of absence of more than twelve (12) months, including maternity and paternity leaves, or
 upon a Participant ceasing to be Eligible Participant as a result of (i) death, (ii) retirement,
 (iii) Termination of Service for reasons other than for Cause, (iv) his or her employment
 or service relationship with the Corporation or a Subsidiary being terminated by reason of
 injury or disability or (v) becoming eligible to receive long-term disability benefits, all
 unvested Share Units in the Participant's Account as of such date relating to a Restriction
 Period in progress shall remain outstanding and in effect pursuant to the terms of the applicable
 Share Unit Agreement, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If
 the Board determines that the vesting conditions are not met for such Share Units, then all
 unvested Share Units credited to such Participant's Account shall be forfeited and
 cancelled and the Participant's rights that relate to such unvested Share Units shall
 be forfeited and cancelled; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) If
 the Board determines that the vesting conditions are met for such Share Units, the Participant
 shall be entitled to receive pursuant to Section 4.5 that number of cash or Shares or combination
 thereof, as the case may be, equal to the number of Share Units outstanding in the Participant's
 Account in respect of such Restriction Period multiplied by a fraction, the numerator of
 which shall be the number of completed months of service of the Participant with the Corporation
 or a Subsidiary during the applicable Restriction Period as of the date of the Participant's
 death, retirement, termination or Eligibility Date and the denominator of which shall be
 equal to the total number of months included in the applicable Restriction Period (which
 calculation shall be made as of the date that the applicable Share Units are to be settled)
 and the Corporation shall (i) pay the amount of cash or issue such number of Shares or provide
 a combination thereof, as determined in its sole discretion, to the Participant or the liquidator,
 executor or administrator, as the case may be, of the estate of the Participant, as soon
 as practicable thereafter, but no later than the end of the Restriction Period, and (ii)
 debit the corresponding number of Share Units from the Account of such Participant's
 or such deceased Participants', as the case may be, and the Participant's rights
 to all other cash or Shares that relate to such Participant's Share Units shall be
 forfeited and cancelled.

(3) **General**.
 For greater certainty, where (i) a Participant's employment or service relationship
 with the Corporation or a Subsidiary is terminated pursuant to Section 6.3(1) or Section
 6.3(2) hereof or (ii) a Participant elects for a voluntary leave of absence pursuant to Section
 6.3(2) hereof following the satisfaction of all vesting conditions in respect of particular
 Share Units but before receipt of the corresponding distribution or payment in respect of
 such Share Units, the Participant shall remain entitled to such distribution or payment.
 Notwithstanding anything else contained in this Section 6.3, any Award granted or issued
 to any Participant who is a Director, Officer, Employee, or Consultant must expire on such
 date that is no later than twelve (12) months from such date that a Participant ceases to
 be an Eligible Participant.

**Article 7**

**ADJUSTMENTS AND AMENDMENTS**

7.1 Adjustment to Shares Subject to Outstanding Awards

At any time after the grant of an Award to a Participant and prior to the expiration of the term of such Award or the forfeiture or cancellation of such Award, in the event of (i) any subdivision of the Shares into a greater number of Shares, (ii) any consolidation of Shares into a lesser number of Shares, (iii) any reclassification, reorganization or other change affecting the Shares, (iv) any merger, amalgamation or consolidation of the Corporation with or into another corporation, or (v) any distribution to all holders of Shares or other securities in the capital of the Corporation, of cash, evidences of indebtedness or other assets of the Corporation (excluding an ordinary course dividend in cash or shares, but including for greater certainty shares or equity interests in a subsidiary or business unit of the Corporation or one of its subsidiaries or cash proceeds of the disposition of such a subsidiary or business unit) or any transaction or change having a similar effect, then the Board shall in its sole discretion, subject to the required approval of the Exchange, determine the appropriate adjustments or substitutions to be made in such circumstances in order to maintain the economic rights of the Participant in respect of such Award in connection with such occurrence or change, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) adjustments
 to the exercise price of such Award without any change in the total price applicable to the
 unexercised portion of the Award;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) adjustments
 to the number of Shares to which the Participant is entitled upon exercise of such Award;
 or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) adjustments
 to the number of kind of Shares reserved for issuance pursuant to the Plan.

7.2 Change of Control

(1) In
 the event of a potential Change of Control, the Board shall have the power, in its sole discretion,
 to modify the terms of this Plan and/or the Awards to assist the Participants to tender into
 a takeover bid or participating in any other transaction leading to a Change of Control.
 For greater certainty, in the event of a take-over bid or any other transaction leading to
 a Change of Control, the Board shall have the power, in its sole discretion, subject to any
 required approval of the Exchange, to (i) provide that any or all Awards shall thereupon
 terminate, provided that any such outstanding Awards that have vested shall remain exercisable
 until consummation of such Change of Control, and (ii) permit Participants to conditionally
 exercise their vested Options, such conditional exercise to be conditional upon the take-up
 by such offeror of the Shares or other securities tendered to such take-over bid in accordance
 with the terms of such take-over bid (or the effectiveness of such other transaction leading
 to a Change of Control).

(2) If
 the Corporation completes a transaction constituting a Change of Control and within twelve
 (12) months following the Change of Control a Participant who was also an Officer, Employee,
 or Consultant of the Corporation prior to the Change of Control has their position, employment
 or consulting agreement terminated, or the Participant is constructively dismissed, then
 all unvested Awards of the Participant shall immediately vest and become exercisable, and
 remain open for exercise until the earlier of their expiry date as set out in the Award Agreement
 and the date that is twelve (12) months after such termination or dismissal.

7.3 Amendment or Discontinuance of the Plan

(1) The
 Board may suspend or terminate the Plan at any time, or from time to time amend or revise
 the terms of the Plan or any granted Award without the consent of the Participants provided
 that such suspension, termination, amendment or revision shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) not
 adversely alter or impair the rights of any Participant, without the consent of such Participant
 except as permitted by the provisions of the Plan; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) be
 in compliance with applicable law and with the prior approval, if required, of the shareholders
 of the Corporation, the Exchange, or any other regulatory body having authority over the
 Corporation.

(2) Subject
 to Sections 7.3(1) and 7.3(3), the Board may, from time to time, in its absolute discretion
 and without approval of the shareholders of the Corporation make the following amendments
 to this Plan, unless where required by law or the requirements of the Exchange:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any
 amendment to the vesting provisions, if applicable, of Options and Share Units, or assignability
 provisions of the Awards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any
 amendment to the expiration date of an Award that does not extend the terms of the Award
 past the original date of expiration of such Award;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any
 amendment regarding the effect of termination of a Participant's employment or engagement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) any
 amendment which accelerates the date on which any Option may be exercised under the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any
 amendment necessary to comply with applicable law or the requirements of the Exchange or
 any other regulatory body;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) any
 amendment of a "housekeeping" nature, including to clarify the meaning of an
 existing provision of the Plan, correct or supplement any provision of the Plan that is inconsistent
 with any other provision of the Plan, correct any grammatical or typographical errors or
 amend the definitions in the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) any
 amendment regarding the administration of the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) any
 amendment to add provisions permitting the grant of Awards settled otherwise than with Shares
 issued from treasury, or adopt a clawback provision applicable to equity compensation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any
 other amendment that does not require the approval of the shareholders of the Corporation
 under Section 7.3(3).

(3) Notwithstanding
 Section 7.3(2), the Board shall be required to obtain disinterested shareholder approval,
 if required under the rules of the Exchange, to make the following amendments:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any
 increase to the maximum number of Shares issuable under the Plan, except in the event of
 an adjustment pursuant to Article 7;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) except
 in the case of an adjustment pursuant to Article 7, any amendment which reduces the exercise
 price of an Option or any cancellation of an Option and replacement of such Option with an
 Option with a lower exercise price;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any
 amendment which extends the expiry date of any Award, or the Restriction Period of any Share
 Unit beyond the original expiry date or Restriction Period;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) any
 amendment which increases the maximum number of Shares that may be issuable under the Plan
 and any other proposed or established Share Compensation Arrangement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any
 amendment to the definition of an Eligible Participant under the Plan.

**Article 8**

**MISCELLANEOUS**

8.1 Use of an Administrative Agent and Trustee

The Board may in its sole discretion appoint from time to time one or more entities to act as administrative agent or trustee to administer the Awards granted under the Plan and to act as trustee to hold and administer the assets that may be held in respect of Awards granted under the Plan, the whole in accordance with the terms and conditions determined by the Board in its sole discretion. The Corporation and the administrative agent will maintain records showing the number of Awards granted to each Participant under the Plan.

8.2 Tax Withholding

(1) Notwithstanding
 any other provision of this Plan, all distributions, delivery of Shares or payments to a
 Participant (or to the liquidator, executor or administrator, as the case may be, of the
 estate of the Participant) under this Plan shall be made net of any applicable withholdings,
 including in respect of applicable withholding taxes required to be withheld at source and
 other source deductions, as the Corporation determines. If the event giving rise to the withholding
 obligation involves an issuance or delivery of Shares, then, the withholding may be satisfied
 in such manner as the Corporation determines, including by (a) the sale of a portion of such
 Shares sold by the Corporation, the Corporation's transfer agent and registrar or any
 trustee appointed by the Corporation pursuant to Section 8.1 hereof, on behalf of and as
 agent for the Participant as soon as permissible and practicable, with the proceeds of such
 sale delivered to the Corporation, which in turn will remit such amounts to the appropriate
 governmental authorities, or (b) any other mechanism as may be required or determined by
 the Corporation as appropriate.

(2) Notwithstanding
 Section 8.2(1), the applicable tax withholdings may be waived where a Participant directs
 in writing that a payment be made directly to the Participant's registered retirement
 savings plan in circumstances to which subsection 100(3) of the regulations made under the
 Tax Act apply.

8.3 Clawback

Notwithstanding any other provisions in this Plan, any Award which is subject to recovery under any law, government regulation or stock exchange listing requirement, will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange listing requirement (or any policy adopted by the Corporation pursuant to any such law, government regulation or stock exchange listing requirement) or any policy adopted by the Corporation. Without limiting the generality of the foregoing, the Board may provide in any case that outstanding Awards (whether or not vested or exercisable) and the proceeds from the exercise or disposition of Awards or Shares acquired under Awards will be subject to forfeiture and disgorgement to the Corporation, with interest and other related earnings, if the Participant to whom the Award was granted violates (i) a non-competition, non- solicitation, confidentiality or other restrictive covenant by which he or she is bound, or (ii) any policy adopted by the Corporation applicable to the Participant that provides for forfeiture or disgorgement with respect to incentive compensation that includes Awards under the Plan. In addition, the Board may require forfeiture and disgorgement to the Corporation of outstanding Awards and the proceeds from the exercise or disposition of Awards or Shares acquired under Awards, with interest and other related earnings, to the extent required by law or applicable stock exchange listing standards, including any related policy adopted by the Corporation. Each Participant, by accepting or being deemed to have accepted an Award under the Plan, agrees to cooperate fully with the Board, and to cause any and all permitted transferees of the Participant to cooperate fully with the Board, to effectuate any forfeiture or disgorgement required hereunder. Neither the Board nor the Corporation nor any other person, other than the Participant and his or her permitted transferees, if any, will be responsible for any adverse tax or other consequences to a Participant or his or her permitted transferees, if any, that may arise in connection with this Section 8.3.

8.4 Securities Law Compliance

(1) The
 Plan (including any amendments to it), the terms of the grant of any Award under the Plan,
 the grant of any Award, the exercise of any Option, the delivery of Shares upon exercise
 of any Option, and the Corporation's obligation to sell and deliver Shares in respect
 of any Awards, shall be subject to all applicable federal, provincial, state and foreign
 laws, rules and regulations, the rules and regulations of applicable Exchange and to such
 approvals by any regulatory or governmental agency as may, as determined by the Corporation,
 be required. The Corporation shall not be obliged by any provision of the Plan or the grant
 of any Award or exercise of any Option hereunder to issue, sell or deliver Shares in violation
 of such laws, rules and regulations or any condition of such approvals.

(2) No
 Awards shall be granted, and no Shares shall be issued, sold or delivered hereunder, where
 such grant, issue, sale or delivery would require registration of the Plan or of the Shares
 under the securities laws of any jurisdiction or the filing of any prospectus for the qualification
 of same thereunder, and any purported grant of any Award or purported issue or sale of Shares
 hereunder in violation of this provision shall be void.

(3) The
 Corporation shall have no obligation to issue any Shares pursuant to this Plan unless upon
 official notice of issuance such Shares shall have been duly listed with an Exchange. Shares
 issued, sold or delivered to Participants under the Plan may be subject to limitations on
 sale or resale under applicable securities laws.

(4) If
 Shares cannot be issued to a Participant upon the exercise of an Option due to legal or regulatory
 restrictions, the obligation of the Corporation to issue such Shares shall terminate and
 any funds paid to the Corporation in connection with the exercise of such Option will be
 returned to the applicable Participant as soon as practicable.

8.5 Reorganization of the Corporation

The existence of any Awards shall not affect in any way the right or power of the Corporation or its shareholders to make or authorize any adjustment, reclassification, recapitalization, reorganization or other change in the Corporation's capital structure or its business, or any amalgamation, combination, merger or consolidation involving the Corporation or to create or issue any bonds, debentures, shares or other securities of the Corporation or the rights and conditions attaching thereto or to affect the dissolution or liquidation of the Corporation or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar nature or otherwise.

8.6 Quotation of Shares

So long as the Shares are listed on one or more Exchange, the Corporation must apply to such Exchange or Exchange for the listing or quotation, as applicable, of the Shares underlying the Awards granted under the Plan, however, the Corporation cannot guarantee that such Shares will be listed or quoted on the Exchange.

8.7 No Fractional Shares

No fractional Shares shall be issued upon the exercise of any Option granted under the Plan and, accordingly, if a Participant would become entitled to a fractional Share upon the exercise of such Option, or from an adjustment permitted by the terms of this Plan, such Participant shall only have the right to purchase the next lowest whole number of Shares, and no payment or other adjustment will be made with respect to the fractional interest so disregarded.

8.8 Governing Laws

The Plan and all matters to which reference is made herein shall be governed by and interpreted in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein.

8.9 Severability

The invalidity or unenforceability of any provision of the Plan shall not affect the validity or enforceability of any other provision and any invalid or unenforceable provision shall be severed from the Plan.

8.10 Section 409A of the Tax Code

It is intended that any payments under the Plan to US Taxpayers shall be exempt from or comply with US Tax Code Section 409A, and all provisions of the Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes and penalties under US Tax Code Section 409A. Awards granted to US Taxpayers shall also be subject to the terms set forth on Exhibit "E" hereto.

**Exhibit "A"**

**TO OMNIBUS INCENTIVE PLAN OF POET TECHNOLOGIES INC.**

**<u>FORM OF OPTION AGREEMENT</u>**

This Option Agreement is entered into between POET Technologies Inc. (the "**Corporation**") and the Participant named below, pursuant to the Corporation's Omnibus Incentive Plan (the "**Plan**"), a copy of which is attached hereto, and confirms that on:

1. ____________________
 (the "**Grant Date** "),

2. ____________________
 (the "**Participant** ")

3. was
 granted options ()"**Options**") to purchase ___________________ common shares
 of the Corporation (each, a "**Share** "), in accordance with the terms of
 the Plan, which Options will bear the following terms:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Exercise Price and Expiry</u>. Subject to the vesting conditions specified below, the Options will
 be exercisable by the Participant at a price of $____________ per Share (the "**Option Price**") at any time prior to expiry on ________________ (the "**Expiration Date** "). If the Participant ceased to be an Eligible Participant as a result of **[his or her] [employment or service]** relationship with the Corporation or a Subsidiary
 being terminated without Cause any vested Option shall be exercisable within the earlier
 of _____________ **[months / days]** from the Termination Date or the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Vesting; Time of Exercise</u>. Subject to the terms of the Plan, the Options shall vest and become
 exercisable as follows:

---

| | |
|:---|:---|
| **Number of Options** | **Vested On** |

---

If the aggregate number of Shares vesting in a tranche set forth above includes a fractional common share, the aggregate number of Shares will be rounded down to the nearest whole number of Shares. Notwithstanding anything to the contrary herein, the Options shall expire on the Expiration Date set forth above and must be exercised, if at all, on or before the Expiration Date. The Option Price is denominated in Canadian dollars (C$).

4. The
 Options shall be exercisable only by delivery to the Corporation of a duly completed and
 executed notice in the form attached to this Option Agreement (the "**Exercise Notice** "),
 together with payment of the Option Price for each Share covered by the Exercise Notice (plus
 an amount equal to any applicable Tax Obligations, as defined in the Plan) **[and/or, if applicable, a notice that the Participant intends to utilize the Participant's Cashless Exercise Right as set out in the Plan or terminate the Options in lieu of exercise, pursuant to the Participant's Net Exercise Right as set out in the Plan]**.

5. Subject
 to the terms of the Plan, unless otherwise specified in the Exercise Notice, the Options
 shall be deemed to be: (i) exercised upon receipt by the Corporation of such written Exercise
 Notice accompanied by (a) the aggregate Option Price (plus an amount equal to any applicable
 Tax Obligations), **[or (b) notice of exercise of the Participant's Cashless Exercise Right and receipt (from the broker on behalf of the Participant) of the aggregate Option Price, or (ii) terminated upon election by the Participant in lieu of exercise, pursuant to the Participant's Net Exercise Right]**.

6. The
 Participant hereby represents and warrants (on the date of this Option Agreement and upon
 each exercise or termination of Options) that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Participant has not received any offering memorandum, or any other documents (other than
 annual financial statements, interim financial statements or any other document the content
 of which is prescribed by statute or regulation, other than an offering memorandum) describing
 the business and affairs of the Corporation that has been prepared for delivery to, and review
 by, a prospective purchaser in order to assist it in making an investment decision in respect
 of the Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the
 Participant is acquiring the Shares without the requirement for the delivery of a prospectus
 or offering memorandum, pursuant to an exemption under applicable securities legislation
 and, as a consequence, is restricted from relying upon the civil remedies otherwise available
 under applicable securities legislation and may not receive information that would otherwise
 be required to be provided to it;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the
 Participant has such knowledge and experience in financial and business matters that it is
 capable of evaluating the merits and risks of an investment in the Corporation and does not
 desire to utilize a registrant in connection with evaluating such merits and risks;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the
 Participant acknowledges that an investment in the Shares involves a high degree of risk,
 and represents that it understands the economic risks of such investment and is able to bear
 the economic risks of this investment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) the
 Participant acknowledges that he or she is responsible for paying any applicable taxes and
 withholding taxes arising from the exercise or termination (including upon exercise of the
 Cashless Exercise Right or Net Exercise Right) of any Options, as provided in Section 8.2
 of the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) this
 Option Agreement constitutes a legal, valid and binding obligation of the Participant, enforceable
 against him in accordance with its terms; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) the
 execution and delivery of this Option Agreement and the performance of the obligations of
 the Participant hereunder will not result in the creation or imposition of any lien, charge
 or encumbrance upon the common shares.

The Participant acknowledges that the Corporation is relying upon such representations and warranties in granting the Options and issuing any common shares upon exercise thereof.

7. The
 Participant's delivery of the signed Exercise Notice to exercise the Options (in whole
 or in part) shall be accompanied by full payment of the aggregate Option Price for the Shares
 being purchased (plus an amount equal to the Tax Obligations) **[and/or a notice that the Participant intends to exercise the Participant's Cashless Exercise Right or Net Exercise Right as set out in the Plan]**. Payment for the Shares may be made by certified cheque
 or wire transfer in readily available funds.

8. The
 Participant acknowledges and represents that: (a) the Participant fully understands and agrees
 to be bound by the terms and provisions of this Option Agreement and the Plan; (b) agrees
 and acknowledges that the Participant has received a copy of the Plan and that the terms
 of the Plan form part of this Option Agreement, (c) hereby accepts these Options subject
 to all of the terms and provisions hereof and of the Plan, and (d) acknowledges and accepts
 that in the event that the Option Price is less than the Market Value of a Share at the Grant
 Date, the Participant will be unable to take an additional tax deduction under paragraph
 110(1)(d) of the Tax Act upon exercise of the Options granted hereunder. To the extent of
 any inconsistency between the terms of this Option Agreement and those of the Plan, the terms
 of the Plan shall govern. The Participant has reviewed this Option Agreement and the Plan,
 has had an opportunity to obtain the advice of counsel prior to executing this Option Agreement.

9. This
 Option Agreement and the terms of the Plan incorporated herein (with the Exercise Notice,
 if the Option is exercised) constitutes the entire agreement of the Corporation and the Participant
 (collectively the "**Parties**") with respect to the Options and supersedes
 in its entirety all prior undertakings and agreements of the Parties with respect to the
 subject matter hereof, and may not be modified adversely to the Participant's interest
 except by means of a writing signed by the Parties. This Option Agreement and the terms of
 the Plan incorporated herein are to be construed in accordance with and governed by the laws
 of the Province of Ontario. Should any provision of this Option Agreement or the Plan be
 determined by a court of law to be illegal or unenforceable, such provision shall be enforced
 to the fullest extent allowed by law and the other provisions shall nevertheless remain effective
 and shall remain enforceable.

All capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Plan.

**[Remainder of page left intentionally blank]**

**IN WITNESS WHEREOF** the Corporation and the Participant have executed this Option Agreement as of _______________________, 20___.

---

| | |
|:---|:---|
| **POET TECHNOLOGIES INC.** | **POET TECHNOLOGIES INC.** |
| Per: | |
|  | Authorized Signatory |

---

If the Participant is an individual:))))))))) 

If the Participant is <u>not</u> an individual:

---

| | |
|:---|:---|
| **[NAME OF PARTICIPANT]** | **[NAME OF PARTICIPANT]** |
| Per: | |
|  | Authorized Signatory |

---

**Note to Plan Participants**

This Agreement must be signed where indicated and returned to the Corporation within 30 days of receipt. Failure to acknowledge acceptance of this grant will result in the cancellation of your Options.

**Exhibit "B"**

**TO OMNIBUS INCENTIVE PLAN OF POET TECHNOLOGIES INC.**

**<u>FORM OF OPTION EXERCISE NOTICE</u>**

---

| | |
|:---|:---|
| **TO:** | **POET TECHNOLOGIES INC.** |

---

This Exercise Notice is made in reference to stock options ("**Options**") granted under the Omnibus Incentive Plan (the "**Plan**") of POET Technologies Inc. (the "**Corporation**").

The undersigned (the "**Participant**") holds options ("**Options**") under the Plan to purchase **[●]** common shares of the Corporation (each, a "**Share**") at a price per Share of $**[●]** (the "**Option Price**") pursuant to the terms and conditions set out in that certain option agreement between the Participant and the Corporation dated **[●]** (the "**Option Agreement**"). The Participant confirms the representations and warranties contained in the Option Agreement.

The Participant hereby:

☐ irrevocably gives notice of the exercise of ___ Options held by the Participant pursuant to the Option Agreement at the Option Price for an aggregate exercise price of $________ (the "**Aggregate Option Price**") on the terms specified in the Option Agreement and encloses herewith a certified cheque payable to the Corporation or evidence of wire transfer to the Corporation in full satisfaction of the Aggregate Option Price. The Participant acknowledges that, in addition to the Aggregate Option Price, the Corporation will require that the Participant also provide to the Corporation a certified cheque or evidence of wire transfer equal to the amount of any Tax Obligations (as defined in the Plan) associated with the exercise of such Options before the Corporation will issue any Shares to the Participant in settlement of the Options. The Corporation shall have the sole discretion to determine the amount of any such Tax Obligations and shall inform the Participant of this amount as soon as reasonably practicable upon receipt of this completed Exercise Notice.

- or -

☐ irrevocably gives notice of the Participant's exercise of the Cashless Exercise Right (as defined in the Plan) with respect to ___ Options held by the Participant pursuant to the Option Agreement, and agrees to receive that number of common shares of the Corporation equal to the following (with the remaining Shares subject to the Options to be sold by the broker on its behalf as provided in the Plan): <u>((A – B) x C) - D</u> A where A is the price per Share at which the underlying Shares are being sold by the brokerage firm, B is the Option Price, C is the number of Options being exercised in this Exercise Notice, and D is the amount of Tax Obligations (as defined in the Plan) applicable to the Options subject to exercise of the Cashless Exercise Right pursuant to this Exercise Notice. For greater certainty, where a Participant elects to exercise his/her Cashless Exercise Right, the amount of any Tax Obligation determined pursuant to the above formula will be deemed to have been directed by the Participant to be paid in cash by the broker on its behalf to the Corporation out of the proceeds of the Shares, which cash will be withheld by the Corporation and remitted to the applicable taxation authorities as may be required.

- or -

☐ irrevocably gives notice of the Participant's exercise of the Net Exercise Right (as defined in the Plan) with respect to ___ Options held by the Participant pursuant to the Option Agreement, and agrees to receive that number of Shares of the Corporation equal to the following: <u>((A – B) x C) - D</u> A where A is the VWAP (as defined in the Plan) per Share on the date prior to the date of this Exercise Notice, B is the Option Price, C is the number of Options being exercised in this Exercise Notice, and D is the amount of Tax Obligations (as defined in the Plan) applicable to the Options terminated at the election of the Participant pursuant to this Exercise Notice. For greater certainty, where a Participant elects to exercise his/her Net Exercise Right, the amount of any Tax Obligation determined pursuant to the above formula will be deemed to have been paid in cash by the Corporation to the Participant as partial consideration for the termination of the Options, which cash will be withheld by the Corporation and remitted to the applicable taxation authorities as may be required.

**Registration:**

The Shares issued pursuant to this Exercise Notice (other than any Shares to be sold by a broker pursuant to the Cashless Exercise Right) are to be registered in the name of the undersigned and are to be delivered, as directed below:

Name:   <br> Address:  

<br> Date Name of Participant

Date <br> Signature of Participant or Authorized Signatory

**Exhibit "C"**

**TO OMNIBUS INCENTIVE PLAN OF POET TECHNOLOGIES INC.**

**<u>FORM OF SHARE UNIT AGREEMENT</u>**

This Share Unit Agreement is entered into between POET Technologies Inc. (the "**Corporation**") and the Participant named below, pursuant to the Corporation's Omnibus Incentive Plan (the "**Plan**"), a copy of which is attached hereto, and confirms that on:

1. ___________________
 (the "**Grant Date** ")

2. ___________________
 (the "**Participant** ")

3. was
 granted ____________________________ Share Units ()"**Share Units** "), in accordance
 with the terms of the Plan, which Share Units will vest as follows:

---

| | | |
|:---|:---|:---|
| **Number of Share Units** | **Time Vesting**<br> **Conditions** | **Performance Vesting Conditions** |

---

all on the terms and subject to the conditions set out in the Plan.

4. Subject
 to the terms and conditions of the Plan, including provisions governing the vesting of Awards
 while the Corporation is in a Blackout Period, the performance period for this grant of Share
 Units commences on the Grant Date and ends at the close of business on [●] (the "**Performance Period** "). The restriction period for this grant of Share Units commences on the
 Grant Date and ends at the close of business on **[●]** (the "**Restriction Period** "). Subject to the terms and conditions of the Plan, Shares Units will be
 redeemed and settled fifteen days after the applicable Vesting Date, all in accordance with
 the terms of the Plan.

5. By
 signing this agreement, the Participant:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) acknowledges
 that he or she has read and understands the Plan, agrees with the terms and conditions thereof
 which shall be deemed to be incorporated into and form part of this Share Unit Agreement
 (subject to any specific variations contained in this Share Unit Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) acknowledges
 that, subject to the vesting and other conditions and provisions in this Share Unit Agreement,
 each Share Unit awarded to the Participant shall entitle the Participant to receive on settlement
 an aggregate cash payment equal to Market Value of a Share or, at the election of the Corporation
 and in its sole discretion, one Share of the Company. For greater certainty, no Participant
 shall have any right to demand to be paid in, or receive, Shares in respect of any Share
 Unit, and, notwithstanding any discretion exercised by the Company to settle any Share Unit,
 or portion thereof, in the form of Shares, the Company reserves the right to change such
 form of payment at any time until payment is actually made;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) acknowledges
 that he or she is responsible for paying any applicable taxes and withholding taxes arising
 from the vesting and redemption of any Share Unit, as determined by the Corporation in its
 sole discretion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) agrees
 that a Share Unit does not carry any voting rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) acknowledges
 that the value of the Share Units granted herein are denominated in Canadian dollars (C$),
 and such value is not guaranteed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) recognizes
 that, at the sole discretion of the Corporation, the Plan can be administered by a designee
 of the Corporation by virtue of Section 2.2 of the Plan and any communication from or to
 the designee shall be deemed to be from or to the Corporation.

6. The
 Participant acknowledges and represents that: (a) the Participant fully understands and agrees
 to be bound by the terms and provisions of this Share Unit Agreement and the Plan; (b) agrees
 and acknowledges that the Participant has received a copy of the Plan and that the terms
 of the Plan form part of this Share Unit Agreement, and (c) hereby accepts these Share Units
 subject to all of the terms and provisions hereof and of the Plan. To the extent of any inconsistency
 between the terms of this Share Unit Agreement and those of the Plan, the terms of the Plan
 shall govern. The Participant has reviewed this Share Unit Agreement and the Plan, has had
 an opportunity to obtain the advice of counsel prior to executing this Share Unit Agreement.

7. This
 Share Unit Agreement and the terms of the Plan incorporated herein constitutes the entire
 agreement of the Corporation and the Participant (collectively the "**Parties** ")
 with respect to the Share Units and supersedes in its entirety all prior undertakings and
 agreements of the Parties with respect to the subject matter hereof, and may not be modified
 adversely to the Participant's interest except by means of a writing signed by the
 Parties. This Share Unit Agreement and the terms of the Plan incorporated herein are to be
 construed in accordance with and governed by the laws of the Province of Ontario. Should
 any provision of this Share Unit Agreement or the Plan be determined by a court of law to
 be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed
 by law and the other provisions shall nevertheless remain effective and shall remain enforceable.

All capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Plan.

**[Remainder of page left intentionally blank]**

**IN WITNESS WHEREOF** the Corporation and the Participant have executed this Share Unit Agreement as of _______________________, 20__.

---

| | |
|:---|:---|
| **POET TECHNOLOGIES INC.** | **POET TECHNOLOGIES INC.** |
| Per: | |
|  | Authorized Signatory |

---

If the Participant is an individual:))))))))) 

If the Participant is <u>not</u> an individual:

---

| | |
|:---|:---|
| **[NAME OF PARTICIPANT]** | **[NAME OF PARTICIPANT]** |
| Per: | |
|  | Authorized Signatory |

---

**Note to Plan Participants**

This Agreement must be signed where indicated and returned to the Corporation within 30 days of receipt. Failure to acknowledge acceptance of this grant will result in the cancellation of your Share Units.

**Exhibit "D"**

**TO OMNIBUS INCENTIVE PLAN OF POET TECHNOLOGIES INC.**

**<u>FORM OF DSU AGREEMENT</u>**

This DSU Agreement is entered into between POET Technologies Inc. (the "**Corporation**") and the Participant named below, pursuant to the Corporation's Omnibus Incentive Plan (the "**Plan**"), a copy of which is attached hereto, and confirms that on:

1. ____________________
 (the "**Grant Date** "),

2. ____________________
 (the "**Participant** ")

3. was
 granted _________________ deferred share units ()"**DSUs** "), in accordance
 with the terms of the Plan.

4. The
 DSUs subject to this DSU Agreement will be fully vested on the Termination Date of the Participant.

5. The
 settlement of the DSUs, either in common shares of the Corporation, a lump sum cash payment
 or a combination of the foregoing, shall be payable to you net of any applicable withholding
 taxes in accordance with the Plan not later than December 15 of the year following the end
 of the calendar year in which the Termination Date occurs.

6. By
 signing this agreement, the Participant:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) acknowledges
 that he or she has read and understands the Plan, agrees with the terms and conditions thereof
 which shall be deemed to be incorporated into and form part of this DSU Agreement (subject
 to any specific variations contained in this DSU Agreement);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) acknowledges
 that he or she is responsible for paying any applicable taxes and withholding taxes arising
 from the vesting and redemption of any DSU, as determined by the Corporation in its sole
 discretion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) agrees
 that a DSU does not carry any voting rights;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) acknowledges
 that the value of the DSUs granted herein are denominated in Canadian dollars (C$), and such
 value is not guaranteed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) recognizes
 that, at the sole discretion of the Corporation, the Plan can be administered by a designee
 of the Corporation by virtue of Section 2.2 of the Plan and any communication from or to
 the designee shall be deemed to be from or to the Corporation.

7. The
 Participant acknowledges and represents that: (a) the Participant fully understands and agrees
 to be bound by the terms and provisions of this DSU Agreement and the Plan; (b) agrees and
 acknowledges that the Participant has received a copy of the Plan and that the terms of the
 Plan form part of this DSU Agreement, and (c) hereby accepts these DSUs subject to all of
 the terms and provisions hereof and of the Plan. To the extent of any inconsistency between
 the terms of this DSU Agreement and those of the Plan, the terms of the Plan shall govern.
 The Participant has reviewed this DSU Agreement and the Plan, has had an opportunity to obtain
 the advice of counsel prior to executing this DSU Agreement.

8. This
 DSU Agreement and the terms of the Plan incorporated herein constitutes the entire agreement
 of the Corporation and the Participant (collectively the "**Parties**") with
 respect to the DSUs and supersedes in its entirety all prior undertakings and agreements
 of the Parties with respect to the subject matter hereof, and may not be modified adversely
 to the Participant's interest except by means of a writing signed by the Parties. This
 DSU Agreement and the terms of the Plan incorporated herein are to be construed in accordance
 with and governed by the laws of the Province of Ontario. Should any provision of this DSU
 Agreement or the Plan be determined by a court of law to be illegal or unenforceable, such
 provision shall be enforced to the fullest extent allowed by law and the other provisions
 shall nevertheless remain effective and shall remain enforceable.

All capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Plan.

**[Remainder of page left intentionally blank]**

**IN WITNESS WHEREOF** the Corporation and the Participant have executed this DSU Agreement as of ________________________, 20__.

---

| | |
|:---|:---|
| **POET TECHNOLOGIES INC.** | **POET TECHNOLOGIES INC.** |
| Per: | |
|  | Authorized Signatory |

---

If the Participant is an individual:))))))))) 

If the Participant is <u>not</u> an individual:

---

| | |
|:---|:---|
| **[NAME OF PARTICIPANT]** | **[NAME OF PARTICIPANT]** |
| Per: | |
|  | Authorized Signatory |

---

**Note to Plan Participants**

This Agreement must be signed where indicated and returned to the Corporation within 30 days of receipt. Failure to acknowledge acceptance of this grant will result in the cancellation of your DSUs.

**Exhibit "E"**

**OMNIBUS INCENTIVE PLAN OF POET TECHNOLOGIES INC**

RULES APPLICABLE TO US TAXPAYERS

Notwithstanding any contrary provisions of the Plan or any Award Agreement, the following provisions shall apply to Awards granted to US Taxpayers:

&nbsp;&nbsp;&nbsp;&nbsp;1. To
 the extent that any Award constitutes "deferred compensation" as defined in US
 Tax Code Section 409A, if a "Change of Control" as defined in Section 1.1 would
 trigger a right of a US Taxpayer to receive payment with respect to an Award, such amount
 shall be payable only if such Change in Control, as so defined, constitutes a "change
 in control event" within the meaning of US Treasury Regulation Section 1.409A-3(i)(5)(i);
 provided, however, that a Participant shall become vested in such payment as provided in
 the Plan without regard to whether such Change of Control as defined in Section 1.1 constitutes
 such a "change in control event."

&nbsp;&nbsp;&nbsp;&nbsp;2. In
 determining the Option Price for Shares with respect to any Option granted to a US Taxpayer,
 the Option Price shall be no less than the "fair market value" (within the meaning
 of US Tax Code Section 409A) of the Shares on the date the relevant Option is granted, and
 such Option Price shall not be subject to any discount even if a discount is permitted by
 the Exchange.

&nbsp;&nbsp;&nbsp;&nbsp;3. For
 purposes of Section 3.6(4) of the Plan, any net exercise mechanism applicable to an exercise
 of an Option granted to a US Taxpayer shall be modified to the extent necessary to comply
 with the requirements of US Tax Code Section 409A, including with respect to the use of "fair
 market value" (within the meaning of US Tax Code Section 409A) of the underlying Shares
 instead of the VWAP of the underlying Shares if required so that the Option remains exempt
 from the provisions of US Tax Code Section 409A with respect to the US Taxpayer.

&nbsp;&nbsp;&nbsp;&nbsp;4. For
 purposes of Sections 5.3 and 6.3 of the Plan, the applicable Award Agreement for a Share
 Unit or DSU granted to a US Taxpayer shall include such provisions as are necessary so that,
 notwithstanding the provisions of Sections 5.3 and 6.3 of the Plan, the payment date with
 respect to the applicable Award shall be compliant with, or exempt from, US Tax Code Section
 409A.

&nbsp;&nbsp;&nbsp;&nbsp;5. Notwithstanding
 Section 7.1, for Awards granted to US Taxpayers, no adjustments, including any adjustment
 to the exercise price of an Award, shall result in an Option becoming subject to US Tax Code
 Section 409A, or result in changing the original treatment of a Share Unit or DSU as compliant
 with or exempt from US Tax Code Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;6. In
 addition to the provisions of Section 8.10 of the Plan, the following shall also apply to
 Awards granted to US Taxpayers: The term "termination" as it relates to a Participant's
 status as an Employee, and similar terms in relation to the Employee's employment relationship,
 shall mean, to the extent an Award constitutes "deferred compensation" within
 the meaning of US Tax Code Section 409A, a "separation from service" within the
 meaning of Section 409A. A series of separately identifiable payments shall be considered
 "separate payments" for purposes of Section 409A. Notwithstanding anything in
 the Plan or an Award Agreement to the contrary, the following special six (6) month delay
 rule shall apply if and to the extent required by US Tax Code Section 409A in the event that
 (i) a Participant is deemed to be a "specified employee" within the meaning of
 US Tax Code Section 409A(a)(2)(B)(i), (ii) amounts or benefits granted pursuant an Award
 are due or payable on account of the Participant's "separation from service"
 within the meaning of US Tax Code Section 409A, and (iii) the Participant is employed by
 a public company or a controlled group affiliate thereof: no payments hereunder that are
 "deferred compensation" subject to US Tax Code Section 409A shall be made to
 the Participant prior to the date that is six (6) months after the date of the Participant's
 separation from service or, if earlier, the Participant's date of death, and following
 any applicable six (6) month delay, all such delayed payments shall be paid in a single lump
 sum on the earliest permissible payment date.

## Exhibit 4.48

**Exhibit 4.48**

![](ex4-48_001.jpg)

![](ex4-48_002.jpg)

![](ex4-48_003.jpg)

![](ex4-48_004.jpg)

![](ex4-48_005.jpg)

![](ex4-48_006.jpg)

![](ex4-48_007.jpg)

![](ex4-48_008.jpg)

![](ex4-48_009.jpg)

![](ex4-48_010.jpg)

![](ex4-48_011.jpg)

![](ex4-48_012.jpg)

![](ex4-48_013.jpg)

![](ex4-48_014.jpg)

![](ex4-48_015.jpg)

![](ex4-48_016.jpg)

![](ex4-48_017.jpg)

![](ex4-48_018.jpg)

![](ex4-48_019.jpg)

## Exhibit 4.49

**Exhibit 4.49**

![](ex4-49_001.jpg)

![](ex4-49_002.jpg)

![](ex4-49_003.jpg)

![](ex4-49_004.jpg)

![](ex4-49_005.jpg)

![](ex4-49_006.jpg)

![](ex4-49_007.jpg)

![](ex4-49_008.jpg)

![](ex4-49_009.jpg)

![](ex4-49_010.jpg)

![](ex4-49_011.jpg)

![](ex4-49_012.jpg)

![](ex4-49_013.jpg)

![](ex4-49_014.jpg)

![](ex4-49_015.jpg)

![](ex4-49_016.jpg)

![](ex4-49_017.jpg)

![](ex4-49_018.jpg)

![](ex4-49_019.jpg)

![](ex4-49_020.jpg)

## Exhibit 4.50

**Exhibit 4.50**

![](ex4-50_001.jpg)

![](ex4-50_002.jpg)

![](ex4-50_003.jpg)

![](ex4-50_004.jpg)

![](ex4-50_005.jpg)

![](ex4-50_006.jpg)

![](ex4-50_007.jpg)

![](ex4-50_008.jpg)

![](ex4-50_009.jpg)

![](ex4-50_010.jpg)

![](ex4-50_011.jpg)

![](ex4-50_012.jpg)

![](ex4-50_013.jpg)

![](ex4-50_014.jpg)

![](ex4-50_015.jpg)

![](ex4-50_016.jpg)

![](ex4-50_017.jpg)

![](ex4-50_018.jpg)

![](ex4-50_019.jpg)

## Exhibit 4.51

**Exhibit 4.51**

![](ex4-51_001.jpg)

![](ex4-51_002.jpg)

![](ex4-51_003.jpg)

![](ex4-51_004.jpg)

![](ex4-51_005.jpg)

![](ex4-51_006.jpg)

![](ex4-51_007.jpg)

![](ex4-51_008.jpg)

![](ex4-51_009.jpg)

![](ex4-51_010.jpg)

![](ex4-51_011.jpg)

![](ex4-51_012.jpg)

![](ex4-51_013.jpg)

![](ex4-51_014.jpg)

![](ex4-51_015.jpg)

![](ex4-51_016.jpg)

![](ex4-51_017.jpg)

![](ex4-51_018.jpg)

![](ex4-51_019.jpg)

![](ex4-51_020.jpg)

![](ex4-51_021.jpg)

![](ex4-51_022.jpg)

![](ex4-51_023.jpg)

![](ex4-51_024.jpg)

![](ex4-51_025.jpg)

![](ex4-51_026.jpg)

![](ex4-51_027.jpg)

![](ex4-51_028.jpg)

![](ex4-51_029.jpg)

![](ex4-51_030.jpg)

![](ex4-51_031.jpg)

![](ex4-51_032.jpg)

![](ex4-51_033.jpg)

![](ex4-51_034.jpg)

![](ex4-51_035.jpg)

![](ex4-51_036.jpg)

![](ex4-51_037.jpg)

![](ex4-51_038.jpg)

![](ex4-51_039.jpg)

![](ex4-51_040.jpg)

![](ex4-51_041.jpg)

![](ex4-51_042.jpg)

![](ex4-51_043.jpg)

![](ex4-51_044.jpg)

![](ex4-51_045.jpg)

![](ex4-51_046.jpg)

![](ex4-51_047.jpg)

![](ex4-51_048.jpg)

![](ex4-51_049.jpg)

![](ex4-51_050.jpg)

![](ex4-51_051.jpg)

![](ex4-51_052.jpg)

## Exhibit 4.52

**Exhibit 4.52**

![](ex4-52_001.jpg)

![](ex4-52_002.jpg)

![](ex4-52_003.jpg)

![](ex4-52_004.jpg)

![](ex4-52_005.jpg)

![](ex4-52_006.jpg)

![](ex4-52_007.jpg)

![](ex4-52_008.jpg)

![](ex4-52_009.jpg)

![](ex4-52_010.jpg)

![](ex4-52_011.jpg)

![](ex4-52_012.jpg)

![](ex4-52_013.jpg)

![](ex4-52_014.jpg)

![](ex4-52_015.jpg)

![](ex4-52_016.jpg)

![](ex4-52_017.jpg)

![](ex4-52_018.jpg)

![](ex4-52_019.jpg)

## Exhibit 4.53

**Exhibit 4.53**

![](ex4-53_001.jpg)

![](ex4-53_002.jpg)

![](ex4-53_003.jpg)

![](ex4-53_004.jpg)

![](ex4-53_005.jpg)

![](ex4-53_006.jpg)

![](ex4-53_007.jpg)

![](ex4-53_008.jpg)

## Exhibit 4.54

**Exhibit 4.54**

![](ex4-54_001.jpg)

![](ex4-54_002.jpg)

![](ex4-54_003.jpg)

![](ex4-54_004.jpg)

![](ex4-54_005.jpg)

![](ex4-54_006.jpg)

![](ex4-54_007.jpg)

![](ex4-54_008.jpg)

![](ex4-54_009.jpg)

![](ex4-54_010.jpg)

![](ex4-54_011.jpg)

![](ex4-54_012.jpg)

![](ex4-54_013.jpg)

![](ex4-54_014.jpg)

![](ex4-54_015.jpg)

![](ex4-54_016.jpg)

![](ex4-54_017.jpg)

![](ex4-54_018.jpg)

![](ex4-54_019.jpg)

## Exhibit 8.1

**Exhibit 8.1**

![](ex8-1_001.jpg)

## Exhibit 11.2

**Exhibit 11.2**

![](ex11-2_001.jpg)

![](ex11-2_002.jpg)

![](ex11-2_003.jpg)

![](ex11-2_004.jpg)

![](ex11-2_005.jpg)

![](ex11-2_006.jpg)

![](ex11-2_007.jpg)

## Exhibit 12.1

**Exhibit 12.1**

**CERTIFICATION PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Suresh Venkatesan, certify that:

---

| | |
|:---|:---|
| 1. | I have reviewed this annual report on Form 20-F of POET Technologies Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
| 4. | The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:<br>|
|  | (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|  | (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|  | (c) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|  | (d) Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and |
| 5. | The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions): |
|  | (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and |
|  | (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting. |

---

Date: March 31, 2026

---

| | |
|:---|:---|
| By: | /s/ Suresh Venkatesan |
|  | Suresh Venkatesan |
|  | Chief Executive Officer |

---

## Exhibit 12.2

**Exhibit 12.2**

**CERTIFICATION PURSUANT TO** 

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Thomas Mika, certify that:

---

| | |
|:---|:---|
| 1. | I have reviewed this annual report on Form 20-F of POET Technologies Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
| 4. | The company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:<br>|
|  | (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|  | (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|  | (c) Evaluated the effectiveness of the company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|  | (d) Disclosed in this report any change in the company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company's internal control over financial reporting; and |
| 5. | The company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of the company's board of directors (or persons performing the equivalent functions): |
|  | (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information; and |
|  | (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting. |

---

Date: March 31, 2026

---

| | |
|:---|:---|
| By: | /s/ Thomas Mika |
|  | Thomas Mika |
|  | Chief Financial Officer |

---

## Exhibit 13.1

**Exhibit 13.1**

**Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Suresh Venkatesan, the Chief Executive Officer of POET Technologies Inc. (the "Company"), hereby certify, that, to my knowledge:

1. The Annual Report on Form 20-F for the year ended December 31, 2025 (the "Report") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is provided solely for purposes of complying with the provisions of Section 906 of the Sarbanes-Oxley Act of 2002 and is not intended to be used or relied upon for any other purpose.

Date: March 31, 2026

---

| | |
|:---|:---|
|  | /s/ Suresh Venkatesan |
| Name: | Suresh Venkatesan |
| Title: | Chief Executive Officer |

---

## Exhibit 13.2

**Exhibit 13.2**

**Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Thomas Mika, the Chief Financial Officer of POET Technologies Inc. (the "Company"), hereby certify, that, to my knowledge:

1. The Annual Report on Form 20-F for the year ended December 31, 2025 (the "Report") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is provided solely for purposes of complying with the provisions of Section 906 of the Sarbanes- Oxley Act of 2002 and is not intended to be used or relied upon for any other purpose.

Date: March 31, 2026

---

| | |
|:---|:---|
|  | /s/ Thomas Mika |
| Name: | Thomas Mika |
| Title: | Chief Financial Officer |

---

## Exhibit 23.1

**Exhibit 23.1**

![](ex23-1_001.jpg)

## Exhibit 23.2

**Exhibit 23.2**

![](ex23-2_001.jpg)